,geneid,gene_symbol,uniprotid,gene_dsi,gene_dpi,gene_pli,protein_class,protein_class_name,diseaseid,disease_name,disease_class,disease_class_name,disease_type,disease_semantic_type,score,ei
0,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0
1,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
2,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.667
3,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.667
4,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
5,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
6,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
7,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
8,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0003578,Apnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
9,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
10,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0008373,Cholesteatoma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
11,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
12,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
13,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
14,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0015230,Exanthema,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.01,1.0
15,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0016169,pathologic fistula,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,1.0
16,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
17,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0025286,Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
18,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0041207,"Truncus Arteriosus, Persistent",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
19,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0205768,Subependymal Giant Cell Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
20,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0206669,Hepatocellular Adenoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
21,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0241961,Angiomyolipoma of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
22,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0751674,Lymphangioleiomyomatosis,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
23,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,0.0
24,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
25,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.01,1.0
26,1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
0,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.51,1.0
1,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.51,1.0
2,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.769
3,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0206669,Hepatocellular Adenoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0
4,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.8
5,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.32,1.0
6,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0
7,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0276496,Familial Alzheimer Disease (FAD),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.31,1.0
8,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C3279661,alpha-2-Macroglobulin Deficiency,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.31,1.0
9,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
10,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
11,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.3,1.0
12,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
13,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
14,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0
15,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0
16,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
17,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0
18,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0
19,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0
20,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0546126,Acute Confusional Senile Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
21,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0750900,"Alzheimer's Disease, Focal Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
22,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0750901,"Alzheimer Disease, Early Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
23,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1527352,Hepatic Form of Wilson Disease,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
24,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1565662,Acute Kidney Insufficiency,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0
25,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C2609414,Acute kidney injury,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Injury or Poisoning,0.3,1.0
26,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0239981,Hypoalbuminemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.21,1.0
27,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.21,1.0
28,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0002878,"Anemia, Hemolytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.2,1.0
29,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0014072,Experimental Autoimmune Encephalomyelitis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Experimental Model of Disease,0.2,1.0
30,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0015814,Femur Head Necrosis,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.2,1.0
31,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.2,1.0
32,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0017665,Membranous glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.2,1.0
33,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.2,1.0
34,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0
35,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.2,1.0
36,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0029823,Other specified peritonitis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.2,1.0
37,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0041227,Trypanosomiasis,C01,   Infections,disease,Disease or Syndrome,0.2,1.0
38,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0206624,Hepatoblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.2,1.0
39,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.2,1.0
40,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0600327,Toxic Shock Syndrome,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.2,1.0
41,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0853897,Diabetic Cardiomyopathies,C19;C14,   Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
42,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C2676033,Hepatoblastoma Caused By Somatic Mutation,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.2,1.0
43,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0085400,Neurofibrillary degeneration (morphologic abnormality),,,phenotype,Cell or Molecular Dysfunction,0.1,
44,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,
45,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0
46,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,
47,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1837461,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3",,,disease,Finding,0.1,1.0
48,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1856170,"ALZHEIMER DISEASE, SUSCEPTIBILITY TO",,,phenotype,Finding,0.1,
49,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1865903,Long-tract signs,,,phenotype,Finding,0.1,
50,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C4703620,Decreased level of GABA in serum,,,phenotype,Finding,0.1,
51,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
52,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
53,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.04,1.0
54,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0
55,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,1.0
56,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,1.0
57,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
58,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
59,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
60,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
61,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
62,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,0.5
63,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
64,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
65,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
66,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0221757,alpha 1-Antitrypsin Deficiency,C23;C16;C06;C08,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,0.5
67,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
68,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
69,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.02,1.0
70,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
71,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
72,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
73,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
74,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
75,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
76,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
77,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
78,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
79,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
80,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
81,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
82,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
83,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0014038,Encephalitis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
84,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0014059,"Encephalomyelitis, Acute Disseminated",C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
85,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0015951,Fetal Resorption,C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",disease,Disease or Syndrome,0.01,1.0
86,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0019243,"Angioedemas, Hereditary",C16;C17;C20;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
87,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
88,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
89,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
90,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0023827,liposarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
91,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
92,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0024894,Mastitis,C13;C17,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
93,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027019,Myelomonocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
94,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
95,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027430,Nasal Polyps,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
96,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
97,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
98,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
99,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0033300,Progeria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
100,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0
101,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0033770,Prune Belly Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
102,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
103,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
104,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0040038,Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.01,1.0
105,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0042024,Urinary Incontinence,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Pathologic Function,0.01,1.0
106,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0042025,Urinary Stress Incontinence,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
107,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0085159,Seasonal Affective Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
108,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0085220,Cerebral Amyloid Angiopathy,C18;C10;C14,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
109,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0085584,Encephalopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
110,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.01,1.0
111,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
112,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0149871,Deep Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
113,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0153690,Secondary malignant neoplasm of bone,C23;C04;C05,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Musculoskeletal Diseases",disease,Neoplastic Process,0.01,1.0
114,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
115,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
116,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0238096,"Embolism, Paradoxical",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
117,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0268398,Familial lichen amyloidosis,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
118,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0278608,Adult Liposarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
119,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0279984,Childhood Liposarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
120,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
121,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0338460,Argyrophilic grain disease,,,disease,Disease or Syndrome,0.01,1.0
122,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
123,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0375381,Urethral intrinsic sphincter deficiency,,,disease,Disease or Syndrome,0.01,1.0
124,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0398623,Thrombophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
125,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
126,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
127,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0473119,Fecal peritonitis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
128,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0600260,"Lung Diseases, Obstructive",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
129,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0694549,Community acquired pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
130,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
131,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0746102,Chronic lung disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
132,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0752347,Lewy Body Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
133,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.01,1.0
134,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0867389,Chronic graft-versus-host disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
135,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
136,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0
137,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
138,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1720830,Painful Bladder Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
139,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1842937,"AURAL ATRESIA, CONGENITAL",C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,0.0
140,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C1855179,"CATARACT, ANTERIOR POLAR",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
141,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C2937421,Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
142,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
143,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
144,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
145,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
146,2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
0,3,A2MP1,,,,,,,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
0,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.75
1,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.76
2,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0
3,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0
4,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.36,0.857
5,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.32,1.0
6,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
7,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0004403,Autosome Abnormalities,C23,"   Pathological Conditions, Signs and Symptoms",group,Cell or Molecular Dysfunction,0.3,1.0
8,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0008625,Chromosome Aberrations,C23,"   Pathological Conditions, Signs and Symptoms",group,Cell or Molecular Dysfunction,0.3,1.0
9,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0013221,Drug toxicity,C25,   Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0
10,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0028796,"Dermatitis, Occupational",C17;C24,   Skin and Connective Tissue Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0
11,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0041755,Adverse reaction to drug,C25,   Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
12,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0086457,Industrial Dermatosis,C17;C24,   Skin and Connective Tissue Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0
13,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0086692,Benign Neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0
14,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.917
15,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,0.688
16,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0
17,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.917
18,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.739
19,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
20,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.09,0.778
21,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0024305,"Lymphoma, Non-Hodgkin",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,0.833
22,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.06,1.0
23,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.06,0.833
24,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.06,1.0
25,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.06,1.0
26,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.06,0.833
27,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.05,1.0
28,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1827377,Slow acetylator due to N-acetyltransferase enzyme variant,,,disease,Disease or Syndrome,0.05,1.0
29,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
30,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.04,1.0
31,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0220605,Adult Non-Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
32,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0220612,Childhood Non-Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
33,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
34,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
35,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1302401,Adenoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,0.75
36,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1827820,Fast acetylator due to N-acetyltransferase enzyme variant,,,disease,Disease or Syndrome,0.04,0.75
37,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C4721532,"Lymphoma, Non-Hodgkin, Familial",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
38,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.03,1.0
39,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.667
40,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0080178,Spina Bifida,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.03,0.667
41,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
42,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C2938924,Oestrogen receptor positive breast cancer,,,disease,Neoplastic Process,0.03,1.0
43,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
44,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
45,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
46,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.02,1.0
47,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
48,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,0.5
49,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,0.5
50,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.02,1.0
51,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
52,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
53,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0158646,Cleft palate with cleft lip,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.02,1.0
54,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
55,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0220810,Congenital defects,,,group,Congenital Abnormality,0.02,1.0
56,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0268398,Familial lichen amyloidosis,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.02,1.0
57,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0333983,Hyperplastic Polyp,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.02,1.0
58,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
59,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.02,0.5
60,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
61,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
62,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C3266076,Orofacial cleft,,,disease,Congenital Abnormality,0.02,1.0
63,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
64,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
65,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0006840,Candidiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
66,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
67,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
68,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
69,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
70,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
71,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
72,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
73,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
74,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
75,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
76,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023055,Laryngeal neoplasm,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
77,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
78,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
79,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
80,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023531,Leukoplakia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
81,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0023532,"Leukoplakia, Oral",C23;C04;C07,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Stomatognathic Diseases",disease,Neoplastic Process,0.01,1.0
82,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
83,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,0.0
84,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
85,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
86,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.01,1.0
87,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
88,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0030286,Pancreatic Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
89,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,0.0
90,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0032584,polyps,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,0.0
91,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
92,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
93,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0043346,Xeroderma Pigmentosum,C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
94,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0079772,T-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
95,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,0.0
96,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0238033,Carcinoma of Male Breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
97,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0242787,Malignant neoplasm of male breast,C04;C17;C19,   Neoplasms;    Skin and Connective Tissue Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
98,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
99,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0264423,"Asthma, Occupational",C08;C20;C24,   Respiratory Tract Diseases;    Immune System Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.01,1.0
100,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
101,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
102,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
103,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0281361,Adenocarcinoma of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
104,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0302142,Deformity,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Anatomical Abnormality,0.01,1.0
105,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0338106,Adenocarcinoma of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
106,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
107,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0595989,Carcinoma of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
108,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
109,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
110,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0740858,Substance abuse problem,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
111,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0747845,early pregnancy,,,phenotype,Disease or Syndrome,0.01,1.0
112,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
113,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0751688,Malignant Squamous Cell Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
114,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0751967,"Multiple Sclerosis, Relapsing-Remitting",C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
115,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0810364,Cleft Lip with or without Cleft Palate,,,disease,Congenital Abnormality,0.01,1.0
116,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
117,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0920506,Environment-Related Malignant Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
118,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0949059,Polyp of large intestine,C23;C06;C04,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0
119,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
120,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
121,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1302547,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
122,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,0.0
123,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1333990,Hereditary Nonpolyposis Colorectal Cancer,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Neoplastic Process,0.01,0.0
124,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1837217,"Cleft lip, isolated",,,disease,Congenital Abnormality,0.01,1.0
125,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1837218,"Cleft palate, isolated",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
126,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C1840311,Laryngeal cleft,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
127,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
128,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C2981150,Uranostaphyloschisis,C16;C05;C08;C07;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Congenital Abnormality,0.01,1.0
129,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C3160887,Node-positive breast cancer,,,disease,Neoplastic Process,0.01,1.0
130,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C3662483,Allergic sensitization,,,disease,Disease or Syndrome,0.01,1.0
131,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
132,9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C4552100,Lynch Syndrome,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,0.0
0,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.939
1,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.935
2,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.857
3,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.882
4,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.863
5,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.4,1.0
6,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.4,1.0
7,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,0.9
8,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.36,0.857
9,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,0.75
10,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.33,1.0
11,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1262760,"Hepatitis, Drug-Induced",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.33,1.0
12,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
13,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.31,1.0
14,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
15,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011999,Diastematomyelia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
16,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0013182,Drug Allergy,C20;C25,   Immune System Diseases;    Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
17,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0013221,Drug toxicity,C25,   Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0
18,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
19,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023453,L2 Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0
20,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0
21,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
22,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0027806,Neurenteric Cyst,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
23,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0028796,"Dermatitis, Occupational",C17;C24,   Skin and Connective Tissue Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0
24,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0041755,Adverse reaction to drug,C25,   Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
25,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0080218,Tethered Cord Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
26,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0086457,Industrial Dermatosis,C17;C24,   Skin and Connective Tissue Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0
27,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0152234,Iniencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
28,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0152426,Craniorachischisis,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
29,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0266453,Exencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
30,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0344479,Spinal Cord Myelodysplasia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
31,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
32,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0702169,Acrania,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
33,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1257931,"Mammary Neoplasms, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
34,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0
35,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3658290,Drug-Induced Acute Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
36,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
37,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4279912,Chemically-Induced Liver Toxicity,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
38,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4704874,"Mammary Carcinoma, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
39,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0
40,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0
41,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
42,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.969
43,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
44,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,0.957
45,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0
46,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.9
47,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,0.9
48,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.826
49,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
50,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,0.912
51,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0
52,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,0.815
53,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0
54,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.867
55,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,0.815
56,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
57,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.937
58,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,0.967
59,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,0.815
60,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
61,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1827377,Slow acetylator due to N-acetyltransferase enzyme variant,,,disease,Disease or Syndrome,0.1,0.963
62,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1827820,Fast acetylator due to N-acetyltransferase enzyme variant,,,disease,Disease or Syndrome,0.1,1.0
63,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3203670,NAT2 polymorphism,,,disease,Disease or Syndrome,0.1,0.8
64,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.1,0.946
65,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024305,"Lymphoma, Non-Hodgkin",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.09,0.889
66,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.09,0.889
67,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.08,0.625
68,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.08,1.0
69,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.07,0.714
70,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.07,0.857
71,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.06,0.833
72,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,0.833
73,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.06,0.667
74,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0220605,Adult Non-Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
75,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0220612,Childhood Non-Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
76,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0
77,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.06,0.833
78,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1302401,Adenoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.06,0.833
79,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0
80,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4721532,"Lymphoma, Non-Hodgkin, Familial",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
81,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.05,1.0
82,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
83,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.05,0.8
84,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.05,1.0
85,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.04,1.0
86,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.04,0.75
87,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.04,1.0
88,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.04,1.0
89,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.04,0.75
90,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.04,0.75
91,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.04,0.75
92,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,0.75
93,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,0.75
94,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0235833,Congenital diaphragmatic hernia,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.04,0.75
95,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
96,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.04,1.0
97,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
98,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.04,0.75
99,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667
100,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
101,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0
102,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
103,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0015230,Exanthema,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.03,0.333
104,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0019159,Hepatitis A,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.03,0.667
105,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.03,1.0
106,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
107,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.03,1.0
108,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0
109,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0333983,Hyperplastic Polyp,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.03,1.0
110,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
111,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0001824,Agranulocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
112,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
113,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
114,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,0.5
115,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.02,1.0
116,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
117,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,0.5
118,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
119,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
120,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0009081,Congenital clubfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.02,1.0
121,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
122,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
123,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
124,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.02,1.0
125,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023055,Laryngeal neoplasm,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,1.0
126,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023532,"Leukoplakia, Oral",C23;C04;C07,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Stomatognathic Diseases",disease,Neoplastic Process,0.02,1.0
127,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023891,"Liver Cirrhosis, Alcoholic",C23;C06;C25,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.02,1.0
128,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
129,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0031090,Periodontal Diseases,C07,   Stomatognathic Diseases,group,Disease or Syndrome,0.02,1.0
130,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.02,0.5
131,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0032584,polyps,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.02,0.5
132,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
133,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
134,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0085669,Acute leukemia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.02,1.0
135,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
136,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0155877,Allergic asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
137,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0158646,Cleft palate with cleft lip,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.02,1.0
138,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
139,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0279680,Transitional cell carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
140,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,1.0
141,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
142,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0497169,hiv-infection/aids,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
143,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
144,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0595989,Carcinoma of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,0.5
145,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
146,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0810364,Cleft Lip with or without Cleft Palate,,,disease,Congenital Abnormality,0.02,1.0
147,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
148,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
149,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
150,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
151,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1333990,Hereditary Nonpolyposis Colorectal Cancer,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Neoplastic Process,0.02,1.0
152,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.02,1.0
153,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1512409,Hepatocarcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.02,1.0
154,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.02,0.5
155,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1827849,IgE-mediated allergic asthma,C20,   Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
156,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3266076,Orofacial cleft,,,disease,Congenital Abnormality,0.02,1.0
157,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.02,1.0
158,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
159,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
160,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4275179,Young onset Parkinson disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
161,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4511452,Sporadic Parkinson disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
162,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0
163,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
164,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
165,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
166,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0006840,Candidiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
167,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007104,Female Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
168,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007121,Bronchogenic Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
169,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
170,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0007138,"Carcinoma, Transitional Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
171,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
172,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
173,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
174,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
175,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
176,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011268,Senile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
177,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011269,"Dementia, Vascular",C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
178,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
179,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
180,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
181,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
182,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0016034,Breast Fibrocystic Disease,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
183,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0016978,gallbladder neoplasm,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
184,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0017551,Gilbert Disease (disorder),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
185,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
186,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0017921,Glycogen storage disease type II,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
187,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0018671,Head and Neck Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
188,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
189,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
190,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0020541,Portal Hypertension,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
191,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0021841,Intestinal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
192,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
193,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023470,Myeloid Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
194,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
195,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.01,0.0
196,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
197,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024138,"Lupus Erythematosus, Discoid",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
198,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
199,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0025286,Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
200,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0026640,Mouth Neoplasms,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0
201,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
202,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
203,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
204,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0028797,Occupational Diseases,C24,   Occupational Diseases,group,Disease or Syndrome,0.01,1.0
205,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0029172,Oral Submucous Fibrosis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
206,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
207,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0030286,Pancreatic Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
208,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
209,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
210,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.01,1.0
211,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,0.0
212,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0036323,Schistosomiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
213,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
214,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
215,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0036646,Age-related cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.01,1.0
216,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
217,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0038356,Stomach Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
218,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
219,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0041295,Tuberculoma,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
220,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0041318,"Tuberculosis, Meningeal",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
221,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
222,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
223,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
224,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0080178,Spina Bifida,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
225,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0085096,Peripheral Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
226,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0085584,Encephalopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
227,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0086445,Idiopathic Membranous Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
228,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.01,1.0
229,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0087169,Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.01,1.0
230,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0151546,Oral Cavity Carcinoma,C06;C04;C07,   Digestive System Diseases;    Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
231,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0152021,Congenital heart disease,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
232,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0153382,Malignant neoplasm of oropharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
233,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0153436,Malignant neoplasm of sigmoid colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
234,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0153452,Malignant neoplasm of gallbladder,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
235,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,0.0
236,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0162670,Mitochondrial Myopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
237,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0162820,"Dermatitis, Allergic Contact",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
238,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
239,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0206677,Adenomatous Polyps,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
240,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
241,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0206704,"Carcinoma, Large Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
242,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0220624,Adult Brain Neoplasm,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
243,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,0.0
244,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0221052,Chronic berylliosis,C23;C01;C08;C24;C26,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases;    Occupational Diseases;    Wounds and Injuries",disease,Disease or Syndrome,0.01,1.0
245,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0235653,Malignant neoplasm of female breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
246,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0235782,Gallbladder Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
247,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0238462,Medullary carcinoma of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
248,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0264423,"Asthma, Occupational",C08;C20;C24,   Respiratory Tract Diseases;    Immune System Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.01,1.0
249,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0267797,Acute hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,0.0
250,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0271084,Exudative age-related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
251,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
252,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0275524,Coinfection,C01,   Infections,phenotype,Disease or Syndrome,0.01,1.0
253,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
254,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0278877,Adult Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
255,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0279628,Adenocarcinoma Of Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
256,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
257,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
258,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
259,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0280313,Squamous cell carcinoma of oropharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
260,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0341439,Chronic liver disease,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
261,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.01,1.0
262,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0392171,Influenza-like symptoms,,,phenotype,Sign or Symptom,0.01,1.0
263,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0409974,Lupus Erythematosus,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
264,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
265,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0521839,Influenza-like illness,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
266,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
267,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0553694,Oropharyngeal disorders,C06;C08;C07;C09,   Digestive System Diseases;    Respiratory Tract Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.01,1.0
268,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
269,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
270,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0741682,Premenopausal breast cancer,,,disease,Neoplastic Process,0.01,1.0
271,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0745130,Resistant hypertensive disorder,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
272,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0751688,Malignant Squamous Cell Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
273,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
274,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0947961,Atopic disorders,,,group,Disease or Syndrome,0.01,1.0
275,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0949059,Polyp of large intestine,C23;C06;C04,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0
276,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
277,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1285162,Degenerative disorder,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.01,1.0
278,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
279,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1332338,Asbestos-Related Malignant Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
280,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
281,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1337013,Differentiated Thyroid Gland Carcinoma,,,disease,Neoplastic Process,0.01,1.0
282,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1378703,Renal carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
283,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1402315,Vascular lesions,,,disease,Disease or Syndrome,0.01,1.0
284,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1565489,Renal Insufficiency,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
285,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
286,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
287,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
288,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1762616,"Meningioma, benign, no ICD-O subtype",C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
289,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1827293,"Carcinoma of urinary bladder, invasive",C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0
290,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1837217,"Cleft lip, isolated",,,disease,Congenital Abnormality,0.01,1.0
291,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1837218,"Cleft palate, isolated",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
292,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C1840311,Laryngeal cleft,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
293,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C2349952,Oropharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
294,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
295,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C2981150,Uranostaphyloschisis,C16;C05;C08;C07;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Congenital Abnormality,0.01,1.0
296,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3469186,"HEMOCHROMATOSIS, TYPE 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
297,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3541994,Drug Hypersensitivity Syndrome,C17;C20;C25,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.01,0.0
298,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3642346,Luminal B Breast Carcinoma,,,disease,Neoplastic Process,0.01,1.0
299,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3888516,CYP1A2 polymorphism,,,disease,Disease or Syndrome,0.01,1.0
300,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3888555,NAT1 polymorphism,,,disease,Disease or Syndrome,0.01,0.0
301,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C3899278,Early Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
302,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4054726,Infant Leukemia,,,disease,Neoplastic Process,0.01,1.0
303,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4505456,HIV Coinfection,C01;C20,   Infections;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
304,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4525297,Stage 0 Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
305,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4525300,Stage IIA Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
306,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4525301,Stage IIB Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
307,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4525302,Stage III Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
308,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4525305,Stage IV Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
309,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4554344,IgE-mediated food allergy,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
310,10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C4722172,Primary differentiated carcinoma of thyroid gland,,,disease,Neoplastic Process,0.01,1.0
0,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0
1,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.33,0.667
2,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0349204,Nonorganic psychosis,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.667
3,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0023794,Lipoidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0
4,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0
5,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.21,1.0
6,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0
7,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0
8,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.2,1.0
9,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
10,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1862941,"Amyotrophic Lateral Sclerosis, Sporadic",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
11,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4551993,"Amyotrophic Lateral Sclerosis, Familial",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
12,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.926
13,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
14,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
15,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0428474,Serum LDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
16,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4015793,ANTICHYMOTRYPSIN BOCHUM 1 PHENOTYPE,,,phenotype,Finding,0.1,
17,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.889
18,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.07,1.0
19,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.07,1.0
20,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.07,1.0
21,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.07,0.714
22,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.07,1.0
23,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.06,0.667
24,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,0.8
25,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.05,1.0
26,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.05,1.0
27,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.05,1.0
28,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.05,1.0
29,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.05,1.0
30,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,1.0
31,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0
32,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
33,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
34,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,0.75
35,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.04,0.75
36,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,0.75
37,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,1.0
38,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
39,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.03,0.667
40,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0007820,Cerebrovascular Disorders,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
41,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
42,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,0.667
43,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.03,1.0
44,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
45,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0
46,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
47,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
48,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
49,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,0.667
50,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0043167,Pertussis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
51,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0043168,Whooping cough due to unspecified organism,C23;C01;C08,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.03,1.0
52,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0221757,alpha 1-Antitrypsin Deficiency,C23;C16;C06;C08,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.03,0.667
53,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
54,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
55,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0600260,"Lung Diseases, Obstructive",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.03,1.0
56,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
57,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0917801,Sleeplessness,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.03,1.0
58,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
59,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
60,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
61,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.03,1.0
62,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
63,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.02,1.0
64,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
65,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,0.5
66,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,0.5
67,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
68,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
69,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
70,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
71,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0042025,Urinary Stress Incontinence,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0
72,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
73,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
74,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
75,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.02,1.0
76,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0276496,Familial Alzheimer Disease (FAD),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0
77,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.02,1.0
78,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
79,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0751713,"Inclusion Body Myopathy, Sporadic",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
80,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0752347,Lewy Body Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,0.5
81,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
82,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2936349,"Plaque, Amyloid",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.02,1.0
83,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2937358,Cerebral Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.02,1.0
84,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4290046,trachomatis,,,disease,Disease or Syndrome,0.02,1.0
85,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4721579,Secondary malignant neoplasm of colon and/or rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
86,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
87,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
88,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0002793,Anaplasia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
89,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0002875,Cooley's anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
90,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0003504,Aortic Valve Insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
91,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
92,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
93,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
94,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
95,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
96,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
97,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,0.0
98,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
99,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
100,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
101,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0008354,Cholera,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
102,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
103,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0010481,Cushing Syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
104,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
105,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011269,"Dementia, Vascular",C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
106,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
107,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
108,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
109,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
110,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
111,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
112,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
113,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0013473,Eating Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
114,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
115,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
116,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
117,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0019151,Hepatic Encephalopathy,C06;C18;C10,   Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
118,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
119,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0019159,Hepatitis A,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
120,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
121,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,0.0
122,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0019337,Heroin Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
123,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
124,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
125,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0023364,Leptospirosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
126,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
127,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
128,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0024408,Machado-Joseph Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
129,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0024535,"Malaria, Falciparum",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
130,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0024537,"Malaria, Vivax",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
131,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
132,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0027430,Nasal Polyps,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
133,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
134,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0031117,Peripheral Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
135,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0033575,Prostatic Diseases,C12,   Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
136,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0033845,Pseudotumor Cerebri,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
137,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
138,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0037090,"Signs and Symptoms, Respiratory",C23,"   Pathological Conditions, Signs and Symptoms",group,Sign or Symptom,0.01,1.0
139,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0037856,Spermatic Cord Torsion,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
140,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
141,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
142,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0042384,Vasculitis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
143,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
144,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
145,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
146,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0085220,Cerebral Amyloid Angiopathy,C18;C10;C14,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
147,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0
148,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0149871,Deep Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
149,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0151779,Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
150,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0152230,Cholinergic urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
151,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0155877,Allergic asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
152,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
153,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
154,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0206686,Adrenocortical carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
155,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
156,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0220620,Gastrointestinal Carcinoid Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
157,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
158,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
159,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0221074,"Depression, Postpartum",C13;F03,   Female Urogenital Diseases and Pregnancy Complications;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
160,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0221207,Urticaria due to cold,C17;C20;C26,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Wounds and Injuries,disease,Disease or Syndrome,0.01,1.0
161,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
162,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
163,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0242723,Parasitemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
164,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0264722,Chronic congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
165,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0268398,Familial lichen amyloidosis,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
166,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0277528,Traveler's diarrhea,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
167,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
168,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
169,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
170,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
171,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
172,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0333559,"Infarction, Lacunar",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
173,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0334463,Malignant Fibrous Histiocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
174,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
175,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0342443,Adrenal Cushing's syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
176,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
177,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
178,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0346402,Malignant neoplasm of adrenal cortex,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
179,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
180,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0375381,Urethral intrinsic sphincter deficiency,,,disease,Disease or Syndrome,0.01,1.0
181,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0409952,Idiopathic osteoarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
182,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0428791,Aortic valve calcification,C18;C14,   Nutritional and Metabolic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
183,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0431129,Adamantinous Craniopharyngioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
184,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0432215,Progressive pseudorheumatoid dysplasia,C05,   Musculoskeletal Diseases,disease,Congenital Abnormality,0.01,1.0
185,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,0.0
186,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0494165,Secondary malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
187,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0520463,Chronic active hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
188,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0521158,Recurrent tumor,,,phenotype,Neoplastic Process,0.01,1.0
189,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
190,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0578870,Chronic idiopathic urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
191,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0677898,invasive cancer,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
192,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0677949,Stage III Colorectal Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
193,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
194,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0741923,cardiac event,,,phenotype,Disease or Syndrome,0.01,1.0
195,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0750927,"Apraxia, Developmental Verbal",C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
196,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0852036,Pregnancy associated hypertension,C13;C14,   Female Urogenital Diseases and Pregnancy Complications;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
197,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
198,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0949664,Tauopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
199,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1135868,Gestational Trophoblastic Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.01,1.0
200,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
201,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1318485,Liver regeneration disorder,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.01,1.0
202,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1384584,Generalized osteoarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
203,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1402315,Vascular lesions,,,disease,Disease or Syndrome,0.01,1.0
204,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
205,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1561826,Overweight and obesity,,,disease,Disease or Syndrome,0.01,1.0
206,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1840264,IMMUNE SUPPRESSION,,,phenotype,Disease or Syndrome,0.01,1.0
207,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1842937,"AURAL ATRESIA, CONGENITAL",C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
208,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1863051,ALZHEIMER DISEASE 2,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
209,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
210,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2217035,Stage IIA Colon Cancer AJCC v7,,,disease,Neoplastic Process,0.01,0.0
211,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2717865,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,C20;C14,   Immune System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
212,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2931618,Gestational trophoblastic disease,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
213,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2945695,Limb ischemia,,,disease,Disease or Syndrome,0.01,1.0
214,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
215,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C3146250,Stage III Colorectal Cancer AJCC v7,,,disease,Neoplastic Process,0.01,1.0
216,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
217,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
218,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C3539168,"PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A",,,disease,Disease or Syndrome,0.01,1.0
219,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C3665464,Dementia due to Alzheimer's disease (disorder),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
220,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C3899403,Decreased Concentration,,,phenotype,Sign or Symptom,0.01,1.0
221,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4025285,Microspherocytosis,,,disease,Disease or Syndrome,0.01,1.0
222,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4511452,Sporadic Parkinson disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
223,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
224,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4525122,Stage IIA Colon Cancer AJCC v8,,,disease,Neoplastic Process,0.01,0.0
225,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4551689,Sleep-Disordered Breathing,C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
226,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
227,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
228,12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C4721919,malignant neoplasm of large intestine stage IIa,,,disease,Neoplastic Process,0.01,0.0
0,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
1,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.09,1.0
2,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
3,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.06,1.0
4,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
5,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.03,0.667
6,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0026985,Myelodysplasia,,,disease,Congenital Abnormality,0.03,1.0
7,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
8,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
9,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
10,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.02,1.0
11,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
12,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0
13,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0751967,"Multiple Sclerosis, Relapsing-Remitting",C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
14,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
15,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
16,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
17,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
18,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
19,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
20,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
21,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
22,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
23,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0019045,Hemoglobinopathies,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0
24,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0
25,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0023283,"Leishmaniasis, Cutaneous",C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
26,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
27,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
28,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
29,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
30,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
31,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
32,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0153594,Malignant neoplasm of testis,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
33,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
34,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0220611,Childhood Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
35,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
36,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0268238,Triglyceride storage disease with ichthyosis,C16;C18;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
37,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0279550,Adult Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
38,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
39,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
40,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0410000,Overlap syndrome,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
41,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
42,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
43,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
44,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
45,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
46,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0948441,Venoocclusive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
47,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C1261473,Sarcoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
48,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C1292778,Chronic myeloproliferative disorder,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
49,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
50,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
51,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
52,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
53,13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C4551686,Malignant neoplasm of soft tissue,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
0,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
1,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
2,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
3,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
4,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
5,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
6,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
7,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
8,14,AAMP,Q13685,0.792,0.115,0.76172,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
9,14,AAMP,Q13685,0.792,0.115,0.76172,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
10,14,AAMP,Q13685,0.792,0.115,0.76172,,,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
11,14,AAMP,Q13685,0.792,0.115,0.76172,,,C1333855,Grade 3 Colon Adenocarcinoma,,,disease,Neoplastic Process,0.01,1.0
0,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0393770,Delayed Sleep Phase Syndrome,C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Disease or Syndrome,0.31,1.0
1,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0005587,"Depression, Bipolar",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
2,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.3,1.0
3,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
4,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0494410,Nonorganic Sleep Wake Cycle Disorders,C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Mental or Behavioral Dysfunction,0.3,1.0
5,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0751758,Advanced Sleep Phase Syndrome,C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0
6,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0751759,Non-24 Hour Sleep-Wake Disorder,C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Mental or Behavioral Dysfunction,0.3,1.0
7,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0751760,Shift-Work Sleep Disorder,C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Mental or Behavioral Dysfunction,0.3,1.0
8,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0877792,"Sleep Disorders, Circadian Rhythm",C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,group,Pathologic Function,0.3,1.0
9,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
10,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0
11,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0
12,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0
13,15,AANAT,Q16613,0.67,0.692,0.002969,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0
14,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
15,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
16,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
17,15,AANAT,Q16613,0.67,0.692,0.002969,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
18,15,AANAT,Q16613,0.67,0.692,0.002969,,,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.02,1.0
19,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0001623,Adrenal gland hypofunction,C19,   Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
20,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
21,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
22,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
23,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
24,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
25,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0
26,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
27,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
28,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0206139,"Lichen Planus, Oral",C17;C07,   Skin and Connective Tissue Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
29,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
30,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0405580,Adrenal cortical hypofunction,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
31,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.01,1.0
32,15,AANAT,Q16613,0.67,0.692,0.002969,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
33,15,AANAT,Q16613,0.67,0.692,0.002969,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
34,15,AANAT,Q16613,0.67,0.692,0.002969,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
35,15,AANAT,Q16613,0.67,0.692,0.002969,,,C4285716,Melatonin deficiency,,,disease,Disease or Syndrome,0.01,1.0
0,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C2750090,"Charcot-Marie-Tooth Disease, Axonal, Type 2n",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0
1,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C4225361,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29",,,disease,Disease or Syndrome,0.7,1.0
2,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.16,1.0
3,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0543888,Epileptic encephalopathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.12,1.0
4,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.11,1.0
5,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.11,1.0
6,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0026838,Muscle Spasticity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.11,1.0
7,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0270914,Hereditary Motor and Sensory-Neuropathy Type II,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.11,1.0
8,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.11,1.0
9,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,
10,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0005745,Blepharoptosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
11,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0005747,Blepharospasm,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
12,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0008489,Chorea,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
13,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
14,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0013384,Dyskinetic syndrome,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
15,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
16,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.1,
17,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
18,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
19,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0020608,Hypodontia,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
20,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0021125,Impulsive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.1,
21,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0026837,Muscle Rigidity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
22,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0027066,Myoclonus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
23,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0028738,Nystagmus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
24,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0029124,Optic Atrophy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
25,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0033377,Ptosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
26,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0035304,Retinal Degeneration,C11,   Eye Diseases,phenotype,Pathologic Function,0.1,
27,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
28,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
29,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0039273,Talipes cavus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Anatomical Abnormality,0.1,
30,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
31,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0085584,Encephalopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,
32,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0151888,Hyporeflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
33,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0231686,"Gait, Unsteady",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
34,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0232466,Feeding difficulties,,,phenotype,Finding,0.1,
35,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0234146,Absent reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
36,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.1,
37,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0235659,Reduced fetal movement,C16;C13,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Finding,0.1,
38,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0235946,Cerebral atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
39,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0239676,High forehead,,,phenotype,Finding,0.1,
40,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0311394,Difficulty walking,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
41,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0349588,Short stature,,,phenotype,Finding,0.1,
42,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0423110,Downward slant of palpebral fissure,,,phenotype,Finding,0.1,
43,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0427065,Distal muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
44,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0454644,Delayed speech and language development,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
45,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0541794,Skeletal muscle atrophy,,,phenotype,Pathologic Function,0.1,
46,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
47,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0684276,Hypsarrhythmia,C10,   Nervous System Diseases,phenotype,Finding,0.1,
48,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1136179,Hammer Toe,C05,   Musculoskeletal Diseases,phenotype,Anatomical Abnormality,0.1,
49,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,
50,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1263857,Peripheral axonal neuropathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
51,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
52,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1836038,Poor head control,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
53,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1836830,Developmental regression,F03,   Mental Disorders,disease,Disease or Syndrome,0.1,
54,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1838391,Limb hypertonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
55,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1842581,Abnormal corpus callosum morphology,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
56,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1847584,Distal sensory impairment,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
57,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1857704,Abnormal myelination,,,phenotype,Finding,0.1,
58,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
59,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1858729,Decreased motor nerve conduction velocity,,,phenotype,Finding,0.1,
60,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1861403,Variable expressivity,,,phenotype,Finding,0.1,
61,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1866141,Foot dorsiflexor weakness,,,phenotype,Finding,0.1,
62,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1963184,"Nystagmus, CTCAE 3.0",,,phenotype,Finding,0.1,
63,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C2919142,"Short Stature, CTCAE",,,phenotype,Finding,0.1,
64,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.1,
65,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C4023687,EEG with multifocal slow activity,,,phenotype,Finding,0.1,
66,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C4025616,CNS hypomyelination,,,phenotype,Finding,0.1,
67,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C4025846,Abnormality of vision,,,disease,Finding,0.1,
68,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C4553743,"Spasticity, CTCAE",,,phenotype,Finding,0.1,
69,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C4554036,"Nystagmus, CTCAE 5.0",,,phenotype,Finding,0.1,
70,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
71,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
72,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0027121,Myositis,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
73,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
74,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0031117,Peripheral Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
75,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0037769,West Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
76,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0235025,Peripheral motor neuropathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
77,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0270612,Leukoencephalopathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
78,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
79,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
80,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0751356,Idiopathic Inflammatory Myopathies,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
81,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
82,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C1397307,Cardiac fibrosis,,,disease,Disease or Syndrome,0.01,1.0
83,16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C3711381,Hereditary Diffuse Leukoencephalopathy with Spheroids,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
0,17,AAVS1,,0.595,0.731,,,,C0008533,Hemophilia B,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.09,1.0
1,17,AAVS1,,0.595,0.731,,,,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.06,0.833
2,17,AAVS1,,0.595,0.731,,,,C0019069,Hemophilia A,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.06,1.0
3,17,AAVS1,,0.595,0.731,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
4,17,AAVS1,,0.595,0.731,,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0
5,17,AAVS1,,0.595,0.731,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
6,17,AAVS1,,0.595,0.731,,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
7,17,AAVS1,,0.595,0.731,,,,C0684275,"Hemophilia, NOS",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,1.0
8,17,AAVS1,,0.595,0.731,,,,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.02,1.0
9,17,AAVS1,,0.595,0.731,,,,C0008525,Choroideremia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.02,1.0
10,17,AAVS1,,0.595,0.731,,,,C0017921,Glycogen storage disease type II,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
11,17,AAVS1,,0.595,0.731,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
12,17,AAVS1,,0.595,0.731,,,,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
13,17,AAVS1,,0.595,0.731,,,,C0036161,Sandhoff Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
14,17,AAVS1,,0.595,0.731,,,,C0342751,Generalized glycogen storage disease of infants,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
15,17,AAVS1,,0.595,0.731,,,,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,0.5
16,17,AAVS1,,0.595,0.731,,,,C1844376,"Granulomatous Disease, Chronic, X-Linked",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
17,17,AAVS1,,0.595,0.731,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
18,17,AAVS1,,0.595,0.731,,,,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
19,17,AAVS1,,0.595,0.731,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
20,17,AAVS1,,0.595,0.731,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,0.0
21,17,AAVS1,,0.595,0.731,,,,C0007682,CNS disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
22,17,AAVS1,,0.595,0.731,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
23,17,AAVS1,,0.595,0.731,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
24,17,AAVS1,,0.595,0.731,,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
25,17,AAVS1,,0.595,0.731,,,,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
26,17,AAVS1,,0.595,0.731,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
27,17,AAVS1,,0.595,0.731,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
28,17,AAVS1,,0.595,0.731,,,,C0018203,Chronic granulomatous disease,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0
29,17,AAVS1,,0.595,0.731,,,,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
30,17,AAVS1,,0.595,0.731,,,,C0019243,"Angioedemas, Hereditary",C16;C17;C20;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
31,17,AAVS1,,0.595,0.731,,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
32,17,AAVS1,,0.595,0.731,,,,C0019880,Homocystinuria,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
33,17,AAVS1,,0.595,0.731,,,,C0020490,Hyperopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
34,17,AAVS1,,0.595,0.731,,,,C0022340,Late-Infantile Neuronal Ceroid Lipfuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
35,17,AAVS1,,0.595,0.731,,,,C0023521,Globoid cell leukodystrophy,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
36,17,AAVS1,,0.595,0.731,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
37,17,AAVS1,,0.595,0.731,,,,C0026703,Mucopolysaccharidoses,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
38,17,AAVS1,,0.595,0.731,,,,C0026706,Mucopolysaccharidosis III,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
39,17,AAVS1,,0.595,0.731,,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
40,17,AAVS1,,0.595,0.731,,,,C0027868,Neuromuscular Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
41,17,AAVS1,,0.595,0.731,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
42,17,AAVS1,,0.595,0.731,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
43,17,AAVS1,,0.595,0.731,,,,C0034951,Refractive Errors,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
44,17,AAVS1,,0.595,0.731,,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
45,17,AAVS1,,0.595,0.731,,,,C0037199,Sinusitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
46,17,AAVS1,,0.595,0.731,,,,C0039538,Teratoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
47,17,AAVS1,,0.595,0.731,,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
48,17,AAVS1,,0.595,0.731,,,,C0085109,Corneal Neovascularization,C23;C11,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
49,17,AAVS1,,0.595,0.731,,,,C0086647,Mucopolysaccharidosis Type IIIA,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
50,17,AAVS1,,0.595,0.731,,,,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
51,17,AAVS1,,0.595,0.731,,,,C0221757,alpha 1-Antitrypsin Deficiency,C23;C16;C06;C08,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
52,17,AAVS1,,0.595,0.731,,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
53,17,AAVS1,,0.595,0.731,,,,C0268164,"Primary hyperoxaluria, type I",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
54,17,AAVS1,,0.595,0.731,,,,C0268542,Ornithine carbamoyltransferase deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
55,17,AAVS1,,0.595,0.731,,,,C0271093,Stargardt's disease,,,phenotype,Disease or Syndrome,0.01,1.0
56,17,AAVS1,,0.595,0.731,,,,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
57,17,AAVS1,,0.595,0.731,,,,C0276096,Mastitis-metritis-agalactia syndrome,C13;C01;C17,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
58,17,AAVS1,,0.595,0.731,,,,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
59,17,AAVS1,,0.595,0.731,,,,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
60,17,AAVS1,,0.595,0.731,,,,C0349788,Arrhythmogenic Right Ventricular Dysplasia,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0
61,17,AAVS1,,0.595,0.731,,,,C0559470,Allergy to peanuts,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.01,1.0
62,17,AAVS1,,0.595,0.731,,,,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
63,17,AAVS1,,0.595,0.731,,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
64,17,AAVS1,,0.595,0.731,,,,C0686353,"Muscular Dystrophies, Limb-Girdle",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",group,Disease or Syndrome,0.01,1.0
65,17,AAVS1,,0.595,0.731,,,,C1279481,X-Linked Combined Immunodeficiency Diseases,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",group,Disease or Syndrome,0.01,1.0
66,17,AAVS1,,0.595,0.731,,,,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
67,17,AAVS1,,0.595,0.731,,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,0.0
68,17,AAVS1,,0.595,0.731,,,,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
69,17,AAVS1,,0.595,0.731,,,,C1840264,IMMUNE SUPPRESSION,,,phenotype,Disease or Syndrome,0.01,1.0
70,17,AAVS1,,0.595,0.731,,,,C1850386,GIANT AXONAL NEUROPATHY 1,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
71,17,AAVS1,,0.595,0.731,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
72,17,AAVS1,,0.595,0.731,,,,C2751067,"Parkinsonism-Dystonia, Infantile",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
73,17,AAVS1,,0.595,0.731,,,,C2919796,Glycogen storage disease type Ia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
74,17,AAVS1,,0.595,0.731,,,,C2936332,Alpha-Sarcoglycanopathies,C16;C05;C08;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
75,17,AAVS1,,0.595,0.731,,,,C3469521,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
76,17,AAVS1,,0.595,0.731,,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
77,17,AAVS1,,0.595,0.731,,,,C4721769,Citrullinemia Type 1,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
0,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0342708,Gamma aminobutyric acid transaminase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0
1,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0
2,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.41,1.0
3,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0023380,Lethargy,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.4,1.0
4,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0151889,Hyperreflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.4,1.0
5,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0424230,Motor retardation,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Finding,0.4,1.0
6,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.4,1.0
7,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
8,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0
9,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0022333,Jacksonian Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
10,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
11,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0026825,Flaccid Muscle Tone,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
12,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
13,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0033922,Psychomotor Disorders,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0
14,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0034933,"Reflex, Abnormal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
15,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0149958,Complex partial seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
16,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0151572,"Reflex, Corneal, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
17,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0151888,Hyporeflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
18,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0234146,Absent reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
19,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0234533,Generalized seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
20,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0234535,Clonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
21,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0234784,"Reflex, Gag, Absent",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
22,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0241772,"Reflex, Deep Tendon, Absent",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
23,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0270844,Tonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
24,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0270846,Epileptic drop attack,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
25,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0277839,Hoffman's Reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
26,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0277850,"Reflex, Pendular",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
27,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0278211,"Reflex, Corneal, Absent",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
28,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0422850,"Seizures, Somatosensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
29,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0422852,"Seizures, Auditory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
30,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0422853,Olfactory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
31,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0422854,Gustatory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
32,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0422855,Vertiginous seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
33,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0424605,Developmental delay (disorder),F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.3,1.0
34,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0427201,Floppy Muscles,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
35,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0427202,Muscle Tone Atonic,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
36,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
37,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0522345,"Reflex, Acoustic, Abnormal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
38,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0558845,"Reflex, Ankle, Absent",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
39,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0558846,"Reflex, Triceps, Absent",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
40,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0558847,"Reflex, Biceps, Absent",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
41,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0576612,"Reflex, Anal, Absent",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
42,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0743002,Abnormal Deep Tendon Reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
43,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751056,Non-epileptic convulsion,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
44,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751110,Single Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
45,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751123,Atonic Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
46,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751330,Unilateral Hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
47,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751456,Developmental Psychomotor Disorders,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0
48,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751468,"Bulbocavernosus Reflex, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
49,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751469,Bulbocavernousus Reflex Absent,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
50,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751470,Palmo-Mental Reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
51,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751471,"Reflex, Anal, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
52,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751472,"Reflex, Ankle, Abnormal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
53,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751473,"Reflex, Ankle, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
54,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751474,"Reflex, Biceps, Abnormal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
55,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751475,"Reflex, Biceps, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
56,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751476,"Reflex, Gag, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
57,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751477,"Reflex, Knee, Abnormal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
58,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751478,"Reflex, Knee, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
59,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751479,"Reflex, Moro, Asymmetric",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
60,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751480,"Reflex, Triceps, Abnormal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
61,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751481,"Reflex, Triceps, Decreased",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
62,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751494,Convulsive Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
63,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751495,"Seizures, Focal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
64,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751496,"Seizures, Sensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
65,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C2267233,Neonatal Hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
66,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C3495874,Nonepileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
67,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C4048158,Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
68,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C4316903,Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
69,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C4317109,Epileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
70,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C4317123,Myoclonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
71,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C4505436,Generalized Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
72,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0037769,West Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.21,1.0
73,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0003123,Anorexia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.2,1.0
74,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.2,1.0
75,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
76,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0013386,"Dyskinesia, Drug-Induced",C23;C10;C25,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.2,1.0
77,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0019337,Heroin Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0
78,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.2,1.0
79,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.2,1.0
80,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0
81,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0
82,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0
83,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0040264,Tinnitus,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.2,1.0
84,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0236736,Cocaine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.2,1.0
85,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.2,1.0
86,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0270857,"Epilepsy, Reflex",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
87,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.11,1.0
88,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0023520,Leukodystrophy,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
89,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
90,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0239154,High pitched cry,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
91,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0241240,Tall stature,,,phenotype,Finding,0.1,
92,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0266470,Cerebellar Hypoplasia,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Congenital Abnormality,0.1,
93,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0423110,Downward slant of palpebral fissure,,,phenotype,Finding,0.1,
94,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
95,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C1837397,Severe global developmental delay,,,phenotype,Finding,0.1,1.0
96,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C1839630,Severe muscular hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
97,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C1843392,Death in childhood,,,phenotype,Finding,0.1,
98,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C1857353,Posterior fossa cyst,,,phenotype,Finding,0.1,
99,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,1.0
100,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C2674422,"Seizures, intractable",,,phenotype,Finding,0.1,1.0
101,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C3494422,Retrognathia,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Anatomical Abnormality,0.1,
102,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
103,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
104,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C2347761,Childhood Myelodysplastic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
105,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.02,1.0
106,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C3900098,Adult Myelodysplastic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
107,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
108,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
109,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
110,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
111,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
112,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
113,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0238111,Lennox-Gastaut syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
114,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0282513,Primary Progressive Aphasia (disorder),C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,1.0
115,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0376545,Hematologic Neoplasms,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
116,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
117,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
118,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
119,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0740858,Substance abuse problem,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
120,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0751229,Hypersomnolence,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
121,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
122,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
123,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C3642347,Basal-Like Breast Carcinoma,,,disease,Neoplastic Process,0.01,1.0
124,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C3887506,Hyperkinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
125,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C3887898,Infantile Spasm,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
126,18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C4274731,Jeavons syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
0,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0039292,Tangier Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.991
1,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1704429,"Hypoalphalipoproteinemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.972
2,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.55,1.0
3,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.52,1.0
4,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.52,1.0
5,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,0.992
6,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0473527,Hypoalphalipoproteinemias,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,1.0
7,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2931838,Familial HDL deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,1.0
8,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.33,1.0
9,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
10,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
11,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0
12,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,0.923
13,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0342898,Apolipoprotein A-I deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Pathologic Function,0.3,1.0
14,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0751544,Tangier Disease Neuropathy,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
15,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1563937,Atherogenesis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
16,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1704417,Hyperlipoproteinemia Type IIb,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0
17,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3711531,"Hdl Deficiency, Type 2",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0
18,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0
19,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.24,1.0
20,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.23,1.0
21,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.22,1.0
22,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.21,1.0
23,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0206624,Hepatoblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.21,1.0
24,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.2,0.904
25,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,0.978
26,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,0.96
27,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0015696,"Fatty Liver, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.2,1.0
28,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017665,Membranous glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.2,1.0
29,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020476,Hyperlipoproteinemias,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0
30,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.2,0.938
31,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.2,1.0
32,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0
33,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,0.982
34,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2676033,Hepatoblastoma Caused By Somatic Mutation,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.2,1.0
35,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.18,1.0
36,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1867743,Premature coronary artery atherosclerosis,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.15,1.0
37,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.14,1.0
38,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.11,1.0
39,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.11,1.0
40,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0271084,Exudative age-related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,0.5
41,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0000737,Abdominal Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
42,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0
43,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,0.992
44,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0
45,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
46,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007282,Carotid Stenosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
47,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0010038,Corneal Opacity,C11,   Eye Diseases,phenotype,Finding,0.1,
48,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.1,0.909
49,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,0.926
50,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0013592,Ectropion,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
51,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0018099,Gout,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0
52,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,
53,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0019214,Hepatosplenomegaly,C23;C06;C15,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Hemic and Lymphatic Diseases",phenotype,Sign or Symptom,0.1,
54,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0038002,Splenomegaly,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
55,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0039144,Syringomyelia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
56,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0043325,Xanthomatosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
57,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
58,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0151691,Decreased HDL cholesterol concentration,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Finding,0.1,
59,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0151718,Hypocholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
60,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0151888,Hyporeflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
61,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0151908,Dry skin,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.1,
62,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0155196,Cicatricial ectropion,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
63,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
64,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0
65,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0
66,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0221260,Dystrophia unguium,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,
67,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0242231,Coronary Stenosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
68,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0344232,Blurred vision,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
69,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0375206,Hemiplegia/hemiparesis,,,disease,Disease or Syndrome,0.1,
70,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
71,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0423250,Corneal stromal opacities,C11,   Eye Diseases,phenotype,Finding,0.1,
72,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0427065,Distal muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
73,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0428472,Serum HDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
74,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0476403,Electromyogram abnormal,,,phenotype,Finding,0.1,
75,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0497156,Lymphadenopathy,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.1,
76,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
77,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0523744,Lipids measurement,,,group,Laboratory Procedure,0.1,1.0
78,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0878575,Peripheral demyelination,C10,   Nervous System Diseases,phenotype,Pathologic Function,0.1,
79,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1263857,Peripheral axonal neuropathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
80,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
81,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1536085,Geographic Atrophy,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0
82,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1557375,"Blurred Vision, CTCAE",,,phenotype,Finding,0.1,
83,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1611184,Calcification of coronary artery,C18;C14,   Nutritional and Metabolic Diseases;    Cardiovascular Diseases,phenotype,Pathologic Function,0.1,1.0
84,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1834405,Nail dysplasia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Congenital Abnormality,0.1,
85,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1836003,Facial diplegia,C01;C10;C07,   Infections;    Nervous System Diseases;    Stomatognathic Diseases,phenotype,Finding,0.1,
86,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1837522,Impaired pain sensation,,,phenotype,Finding,0.1,
87,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1848736,Distal amyotrophy,,,disease,Disease or Syndrome,0.1,
88,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1849618,Accelerated atherosclerosis,C14,   Cardiovascular Diseases,phenotype,Finding,0.1,
89,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1858970,Chronic noninfectious lymphadenopathy,C15,   Hemic and Lymphatic Diseases,phenotype,Finding,0.1,
90,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1859178,Progressive peripheral neuropathy,,,phenotype,Finding,0.1,
91,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1963094,"Dry Skin, CTCAE",,,phenotype,Finding,0.1,
92,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2237660,exudative macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0
93,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,1.0
94,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3279947,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9",,,disease,Disease or Syndrome,0.1,
95,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3665347,Visual Impairment,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
96,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4016640,"TANGIER DISEASE, VARIANT",,,phenotype,Finding,0.1,
97,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4021222,Impaired temperature sensation,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Finding,0.1,
98,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4021780,Abnormality of the liver,,,phenotype,Finding,0.1,
99,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4024968,Impaired thermal sensitivity,,,phenotype,Finding,0.1,
100,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4049938,Physical Activity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
101,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4280753,Orange discoloured tonsils,,,phenotype,Finding,0.1,
102,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.08,0.875
103,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0
104,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0
105,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.07,1.0
106,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.07,1.0
107,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0
108,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.07,1.0
109,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4703473,Atherosclerotic lesion,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.07,1.0
110,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,1.0
111,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.06,0.833
112,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,0.6
113,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0155733,Atherosclerosis of aorta,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.05,1.0
114,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.05,1.0
115,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,1.0
116,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.05,0.8
117,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,1.0
118,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0
119,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0
120,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,1.0
121,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.04,1.0
122,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0220756,"Niemann-Pick Disease, Type C",C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.04,1.0
123,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0595921,Intraocular pressure disorder,C11,   Eye Diseases,disease,Disease or Syndrome,0.04,1.0
124,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0
125,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0
126,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.03,0.667
127,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
128,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
129,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
130,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
131,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0
132,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.03,1.0
133,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1260959,Drusen,,,disease,Disease or Syndrome,0.03,1.0
134,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
135,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.03,1.0
136,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.03,1.0
137,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
138,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
139,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
140,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
141,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
142,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
143,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.02,1.0
144,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0023195,Lecithin Acyltransferase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
145,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
146,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024534,"Malaria, Cerebral",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
147,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
148,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,0.5
149,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.02,1.0
150,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0085220,Cerebral Amyloid Angiopathy,C18;C10;C14,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
151,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0154251,Lipid Metabolism Disorders,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
152,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
153,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0175694,Smith-Lemli-Opitz Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
154,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.02,1.0
155,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
156,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
157,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0302314,Xanthoma,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
158,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
159,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
160,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
161,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1504336,Polypoidal choroidal vasculopathy,,,disease,Disease or Syndrome,0.02,0.0
162,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
163,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2613439,Extramedullary Hematopoiesis (disorder),C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
164,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3165209,High density lipoprotein deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
165,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
166,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3665444,Neutrophilia (disorder),C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
167,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
168,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
169,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
170,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
171,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
172,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
173,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0007820,Cerebrovascular Disorders,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
174,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
175,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
176,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0008384,Cholesterol Ester Storage Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
177,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
178,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
179,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
180,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
181,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0013537,Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
182,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
183,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017605,Angle Closure Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
184,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017606,Primary angle-closure glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
185,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
186,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017658,Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
187,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017919,Glycogen Storage Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.01,1.0
188,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0017920,Glycogen Storage Disease Type I,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
189,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0018621,Hay fever,C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
190,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
191,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
192,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
193,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
194,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0
195,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
196,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020474,"Hyperlipidemia, Familial Combined",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
197,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0020479,Hyperlipoproteinemia Type III,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
198,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
199,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
200,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0023518,Leukocytosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.01,1.0
201,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0023794,Lipoidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
202,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
203,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
204,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024138,"Lupus Erythematosus, Discoid",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
205,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
206,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0024809,Marijuana Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
207,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
208,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
209,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
210,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
211,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0028064,Niemann-Pick Diseases,C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0
212,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
213,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
214,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
215,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
216,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
217,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
218,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0034050,Pulmonary Alveolar Proteinosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
219,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
220,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0034155,"Purpura, Thrombotic Thrombocytopenic",C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
221,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
222,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
223,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
224,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0043208,Wolman Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,0.0
225,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0085278,Antiphospholipid Syndrome,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
226,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0085648,Synovial Cyst,C04,   Neoplasms,disease,Disease or Syndrome,0.01,1.0
227,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
228,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0152136,Low Tension Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
229,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
230,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
231,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
232,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
233,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
234,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0268243,"Niemann-Pick Disease, Type B",C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
235,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0268731,Renal glomerular disease,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",group,Disease or Syndrome,0.01,1.0
236,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
237,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0275524,Coinfection,C01,   Infections,phenotype,Disease or Syndrome,0.01,0.0
238,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0276447,Rhinovirus infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
239,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
240,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0333559,"Infarction, Lacunar",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
241,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0342882,Familial hypercholesterolemia - heterozygous,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
242,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0342907,Sitosterolemia,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Congenital Abnormality,0.01,1.0
243,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
244,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0375023,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.01,1.0
245,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0409974,Lupus Erythematosus,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
246,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0409980,Primary antiphospholipid syndrome,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
247,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0520679,"Sleep Apnea, Obstructive",C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
248,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
249,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0598589,Inherited neuropathies,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
250,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0677607,Hashimoto Disease,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
251,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
252,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
253,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
254,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.01,1.0
255,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0747820,"Malaria, antepartum",,,disease,Disease or Syndrome,0.01,1.0
256,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
257,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0947751,Vascular inflammations,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
258,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0948242,"Nuchal bleb, familial",C23;C16;C04;C13;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Congenital Abnormality,0.01,1.0
259,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0948379,Impaired insulin secretion,,,disease,Disease or Syndrome,0.01,1.0
260,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1258666,Myxoid cyst,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
261,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1268935,Congenital Thrombotic Thrombocytopenic Purpura,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
262,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
263,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1292778,Chronic myeloproliferative disorder,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
264,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
265,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
266,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
267,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
268,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1531624,Cardioembolic stroke,,,disease,Disease or Syndrome,0.01,1.0
269,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
270,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1842090,Platelet Glycoprotein IV Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,0.0
271,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1843013,"Alzheimer disease, familial, type 3",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
272,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1843366,"NIEMANN-PICK DISEASE, TYPE C2",C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
273,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1858114,HUNTINGTON DISEASE-LIKE 3 (disorder),C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
274,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C1963943,Atherothrombosis,,,disease,Acquired Abnormality,0.01,1.0
275,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2747816,Complicated malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
276,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2748055,Hypoinsulinaemia (disorder),,,disease,Disease or Syndrome,0.01,1.0
277,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
278,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C2936349,"Plaque, Amyloid",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
279,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
280,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
281,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
282,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3642304,Placental Malformation,,,disease,Disease or Syndrome,0.01,1.0
283,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
284,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4048329,Immunosuppression,,,disease,Disease or Syndrome,0.01,1.0
285,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
286,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4524040,Atherogenic dyslipidaemia,,,disease,Disease or Syndrome,0.01,1.0
287,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4524373,Hamster Melanoma,,,disease,Neoplastic Process,0.01,1.0
288,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
289,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
290,19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
0,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0
1,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0869220,"Adverse effects, not elsewhere classified",,,disease,Injury or Poisoning,0.1,1.0
2,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0750901,"Alzheimer Disease, Early Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0
3,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0003857,Congenital arteriovenous malformation,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.02,1.0
4,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
5,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
6,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
7,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
8,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0027859,Acoustic Neuroma,C04;C10;C09,   Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,1.0
9,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0
10,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
11,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
12,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
13,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
14,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
15,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
16,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0011757,Developmental Coordination Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
17,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.01,1.0
18,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
19,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
20,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0025286,Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
21,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
22,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
23,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0027809,Neurilemmoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
24,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
25,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0153633,Malignant neoplasm of brain,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
26,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0278877,Adult Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
27,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
28,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
29,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
30,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
31,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0917804,"Arteriovenous Malformations, Cerebral",C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
32,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C1762616,"Meningioma, benign, no ICD-O subtype",C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
33,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
34,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C1997217,Low grade glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
35,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
36,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0
37,20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
0,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1970456,"Surfactant Metabolism Dysfunction, Pulmonary, 3",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,1.0
1,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.42,1.0
2,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0035220,"Respiratory Distress Syndrome, Newborn",C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.4,1.0
3,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0085786,Hamman-Rich syndrome,C23;C01;C08,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.4,1.0
4,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0852283,Respiratory Distress Syndrome,,,disease,Disease or Syndrome,0.4,1.0
5,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.32,1.0
6,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1861829,Cataract microcornea syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.31,1.0
7,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,
8,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
9,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
10,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0013990,Pathological accumulation of air in tissues,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
11,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0020192,Hyaline Membrane Disease,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.3,1.0
12,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.3,1.0
13,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0034050,Pulmonary Alveolar Proteinosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0
14,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C4721507,"Alveolitis, Fibrosing",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0
15,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1145670,Respiratory Failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.19,1.0
16,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0476273,Respiratory distress,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.18,0.875
17,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0238378,Desquamative interstitial pneumonia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.11,1.0
18,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0003578,Apnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
19,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0
20,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0006267,Bronchiectasis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,
21,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0009080,Clubbed Fingers,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
22,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
23,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
24,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
25,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0
26,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0034088,Pulmonary Valve Insufficiency,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,
27,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0034642,Rales,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
28,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
29,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0035229,Respiratory Insufficiency,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.1,
30,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,0.938
31,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0231807,Dyspnea on exertion,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
32,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0231835,Tachypnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
33,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0241984,Honeycomb lung,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,
34,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
35,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
36,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C4281993,Neonatal respiratory distress,C08,   Respiratory Tract Diseases,phenotype,Finding,0.1,
37,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C4476639,Ground-glass opacification on pulmonary HRCT,,,phenotype,Finding,0.1,
38,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C4476748,Reticular pattern on pulmonary HRCT,,,phenotype,Finding,0.1,
39,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0521648,Neonatal respiratory failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.05,1.0
40,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
41,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
42,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
43,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
44,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
45,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
46,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0035204,Respiration Disorders,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.02,1.0
47,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0035242,Respiratory Tract Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.02,1.0
48,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
49,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0746102,Chronic lung disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
50,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C2931829,RDS - infants,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,0.0
51,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C3161105,Neuroendocrine cell hyperplasia of infancy,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,0.5
52,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C3711368,Surfactant Dysfunction,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
53,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
54,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
55,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0004941,Behavioral Symptoms,F01,   Behavior and Behavior Mechanisms,group,Sign or Symptom,0.01,1.0
56,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
57,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
58,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0020757,Ichthyoses,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
59,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0020758,Congenital ichthyosis,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
60,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
61,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0023283,"Leishmaniasis, Cutaneous",C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
62,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
63,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
64,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0023518,Leukocytosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.01,1.0
65,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0027859,Acoustic Neuroma,C04;C10;C09,   Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
66,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0031190,Persistent Fetal Circulation Syndrome,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
67,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
68,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
69,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0206061,"Pneumonia, Interstitial",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
70,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0220621,Childhood Acute Myeloid Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
71,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
72,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0282666,Very Low Birth Weight,,,phenotype,Sign or Symptom,0.01,0.0
73,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0375023,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.01,1.0
74,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
75,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0746105,Chronic interstitial lung disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
76,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.01,1.0
77,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
78,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1832550,"Lamellar ichthyosis, type 2",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
79,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
80,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1998122,Chronic respiratory insufficiency,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
81,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C2677362,Alveolar capillary dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Congenital Abnormality,0.01,1.0
82,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C3179539,Congenital Deficiency of Pulmonary Surfactant Protein B,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
83,21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C4721509,Usual Interstitial Pneumonia,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
0,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C1845028,"ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA",C16;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.74,1.0
1,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0002896,Sideroblastic anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.43,1.0
2,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.43,1.0
3,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0240991,"Ataxia, Sensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
4,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0278161,"Ataxia, Motor",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
5,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0427190,"Ataxia, Truncal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
6,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0520966,Abnormal coordination,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
7,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0750937,"Ataxia, Appendicular",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
8,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0750940,"Tremor, Rubral",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
9,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
10,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0009024,Clonus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
11,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,
12,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.1,
13,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
14,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0028738,Nystagmus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
15,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0034935,Babinski Reflex,,,phenotype,Finding,0.1,
16,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
17,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0037822,Speech Disorders,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Disease or Syndrome,0.1,
18,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0038379,Strabismus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
19,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0151889,Hyperreflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
20,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0234162,Cerebellar Dysmetria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
21,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0234376,Action Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
22,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0234979,Dysdiadochokinesis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
23,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0271901,Microcytic hypochromic anemia (disorder),C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
24,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
25,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C1845029,Nonprogressive cerebellar ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
26,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C1845977,X- linked recessive,,,phenotype,Finding,0.1,
27,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C1963184,"Nystagmus, CTCAE 3.0",,,phenotype,Finding,0.1,
28,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C4021768,Abnormality of metabolism/homeostasis,,,phenotype,Finding,0.1,
29,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C4554036,"Nystagmus, CTCAE 5.0",,,phenotype,Finding,0.1,
30,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C4551511,X-linked sideroblastic anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.07,1.0
31,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.04,1.0
32,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0282193,Iron Overload,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.03,1.0
33,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
34,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C1264195,Refractory anemia with ringed sideroblasts,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
35,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.02,1.0
36,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
37,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
38,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
39,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
40,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
41,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0085131,Gangliosidosis GM1,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
42,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
43,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
44,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
45,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
46,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0852975,Congenital cerebellar ataxia,,,disease,Disease or Syndrome,0.01,1.0
47,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C0948192,Primary infection NOS,,,disease,Disease or Syndrome,0.01,1.0
48,22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C2981142,"Refractory anemia, without ringed sideroblasts, without excess blasts",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
0,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0020517,Hypersensitivity,C20,   Immune System Diseases,group,Pathologic Function,0.3,1.0
1,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0
2,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0032300,Lobar Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0
3,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0235874,Disease Exacerbation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0
4,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0887898,Experimental Lung Inflammation,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Experimental Model of Disease,0.3,1.0
5,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C1527304,Allergic Reaction,C20,   Immune System Diseases,phenotype,Pathologic Function,0.3,1.0
6,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0
7,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
8,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0
9,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
10,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0026896,Myasthenia Gravis,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
11,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
12,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0
13,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
14,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
15,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C2609129,Autoimmune pancreatitis,C06;C20,   Digestive System Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
16,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
17,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
18,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
19,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
20,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
21,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
22,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
23,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0162565,Acute intermittent porphyria,C16;C06;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
24,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
25,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0339143,Thyroid associated opthalmopathies,C16;C11;C20;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Immune System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
26,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0919747,Cytokine storm,,,disease,Disease or Syndrome,0.01,1.0
27,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C1279945,Acute interstitial pneumonia,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
28,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
29,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
30,23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0271093,Stargardt's disease,,,phenotype,Disease or Syndrome,1.0,0.995
1,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1855465,STARGARDT DISEASE 1 (disorder),,,disease,Disease or Syndrome,1.0,0.978
2,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1858806,CONE-ROD DYSTROPHY 3 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.9,1.0
3,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1866422,RETINITIS PIGMENTOSA 19,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.8,1.0
4,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,0.974
5,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.7,0.957
6,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3495438,"Macular Degeneration, Age-Related, 2",C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0
7,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1858080,"Retinal Dystrophy, Early Onset Severe",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.6,1.0
8,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4282180,Juvenile macular degeneration,,,disease,Disease or Syndrome,0.5,1.0
9,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.41,0.75
10,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3489532,Cone-Rod Dystrophy 2,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.4,1.0
11,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0015397,Disorder of eye,C11,   Eye Diseases,group,Disease or Syndrome,0.34,1.0
12,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0
13,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0
14,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0339539,Familial Exudative Vitreoretinopathy,,,disease,Congenital Abnormality,0.31,0.0
15,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
16,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1838644,Stargardt disease 3,C11,   Eye Diseases,disease,Disease or Syndrome,0.22,1.0
17,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0024437,Macular degeneration,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0
18,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.2,0.977
19,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0154860,Hereditary retinal dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",group,Disease or Syndrome,0.2,1.0
20,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0854723,Retinal Dystrophies,C11,   Eye Diseases,group,Disease or Syndrome,0.2,0.967
21,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1863534,Stargardt disease 4,C11,   Eye Diseases,disease,Disease or Syndrome,0.2,1.0
22,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4085590,Cone-Rod Dystrophies,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.2,1.0
23,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4551714,Rod-Cone Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.2,1.0
24,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0730292,Macular dystrophy,C11,   Eye Diseases,disease,Disease or Syndrome,0.19,1.0
25,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3665346,Unspecified visual loss,C23;C11,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases",phenotype,Sign or Symptom,0.16,1.0
26,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0456909,Blindness,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,0.15,1.0
27,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0730362,Disorder of macula of retina,C11,   Eye Diseases,group,Disease or Syndrome,0.15,1.0
28,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.13,1.0
29,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0339527,Leber Congenital Amaurosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.12,1.0
30,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.11,0.667
31,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0
32,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0009398,Color vision defect,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
33,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
34,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0018777,Conductive hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
35,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
36,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
37,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0020619,Hypogonadism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,
38,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
39,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0028077,Nyctalopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
40,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0028738,Nystagmus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
41,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0029089,Ophthalmoplegia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
42,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0029124,Optic Atrophy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
43,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0035300,Abnormal retinal morphology,C11,   Eye Diseases,phenotype,Finding,0.1,
44,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0042798,Low Vision,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
45,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0085636,Photophobia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
46,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.1,
47,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0151889,Hyperreflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
48,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0152191,"Scotoma, Central",C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
49,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0201899,Aspartate aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0
50,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
51,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0234632,Reduced visual acuity,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
52,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0235095,Visual field constriction,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
53,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0266435,Congenital hypoplasia of penis,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
54,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0271092,Progressive cone dystrophy (without rod involvement),C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0
55,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0339526,Autosomal recessive retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,0.909
56,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0339535,"Night blindness, congenital stationary",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,1.0
57,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0344290,Vitreoretinal degeneration,,,disease,Disease or Syndrome,0.1,1.0
58,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0423414,Retinal flecking,,,phenotype,Finding,0.1,
59,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0428474,Serum LDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
60,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0476397,Electroretinogram abnormal,,,phenotype,Finding,0.1,
61,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0521694,Atrophic retina,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
62,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0522214,Abnormal visual evoked potential,C10,   Nervous System Diseases,phenotype,Finding,0.1,
63,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0554970,Pallor of optic disc,,,phenotype,Finding,0.1,
64,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0730290,Cone Dystrophy,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0
65,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
66,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1828210,"Macular dystrophy, concentric annular",C11,   Eye Diseases,phenotype,Finding,0.1,1.0
67,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1836926,Bone spicule pigmentation of the retina,,,phenotype,Finding,0.1,
68,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1840077,Anteverted nostril,,,phenotype,Finding,0.1,
69,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1840457,Retinal pigment epithelial atrophy,,,phenotype,Finding,0.1,
70,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1845977,X- linked recessive,,,phenotype,Finding,0.1,
71,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1847515,Paroxysmal involuntary eye movements,,,phenotype,Finding,0.1,
72,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1849367,Nasal bridge wide,,,phenotype,Finding,0.1,
73,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1857644,Retinal pigment epithelial mottling,,,phenotype,Finding,0.1,
74,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1859486,BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,1.0
75,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1862475,Abnormality of retinal pigmentation,,,phenotype,Finding,0.1,
76,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1963184,"Nystagmus, CTCAE 3.0",,,phenotype,Finding,0.1,
77,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1970573,"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO",,,phenotype,Finding,0.1,
78,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3278975,Attenuation of retinal blood vessels,,,phenotype,Finding,0.1,
79,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3549703,Retinal thinning,,,phenotype,Finding,0.1,
80,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3665347,Visual Impairment,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
81,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3665386,Abnormal vision,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
82,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.1,
83,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4021559,Retinitis pigmentosa inversa,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
84,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4021786,Atypical scarring of skin,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
85,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4021813,Oral cleft,,,disease,Congenital Abnormality,0.1,1.0
86,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4024742,Aplasia/Hypoplasia of the macula,,,phenotype,Finding,0.1,
87,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4024756,Abnormality of macular pigmentation,,,disease,Anatomical Abnormality,0.1,
88,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4024818,Progressive night blindness,C11,   Eye Diseases,phenotype,Finding,0.1,
89,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4025836,Abnormal choroid morphology,,,disease,Anatomical Abnormality,0.1,
90,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4025849,Abnormal foveal morphology,,,disease,Anatomical Abnormality,0.1,
91,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4072987,Yellow/white lesions of the macula,,,phenotype,Finding,0.1,
92,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4477018,Sectoral retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,
93,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4554036,"Nystagmus, CTCAE 5.0",,,phenotype,Finding,0.1,
94,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4692584,MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION,,,disease,Disease or Syndrome,0.1,
95,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0339508,Hereditary macular dystrophy,,,disease,Congenital Abnormality,0.09,1.0
96,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0
97,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.07,1.0
98,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.05,1.0
99,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
100,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0
101,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
102,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.03,1.0
103,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
104,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
105,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1998028,Photoreceptor degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.03,1.0
106,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
107,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
108,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
109,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0006111,Brain Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
110,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,1.0
111,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
112,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
113,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0
114,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
115,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0035220,"Respiratory Distress Syndrome, Newborn",C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,1.0
116,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
117,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0039292,Tangier Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
118,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
119,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.02,1.0
120,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0206526,"Tuberculosis, Multidrug-Resistant",C01,   Infections,disease,Disease or Syndrome,0.02,1.0
121,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
122,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0339510,Vitelliform Macular Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.02,1.0
123,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
124,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
125,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0852283,Respiratory Distress Syndrome,,,disease,Disease or Syndrome,0.02,1.0
126,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
127,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1285162,Degenerative disorder,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.02,1.0
128,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1301509,Severe visual impairment,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
129,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
130,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1536085,Geographic Atrophy,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
131,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1720251,Retinal pigment epithelium atrophy,,,disease,Acquired Abnormality,0.02,1.0
132,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4048273,Chorioretinal atrophy,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
133,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.02,1.0
134,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
135,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
136,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
137,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
138,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
139,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
140,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
141,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
142,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
143,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
144,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
145,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
146,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0008373,Cholesteatoma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
147,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
148,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
149,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
150,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0018081,Gonorrhea,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
151,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0018552,Hamartoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
152,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0019340,Herpes NOS,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
153,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
154,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
155,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
156,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
157,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
158,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0025229,Melioidosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
159,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0026850,Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
160,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
161,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
162,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0029883,Otitis Media with Effusion,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
163,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
164,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0
165,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0040560,"Toxoplasmosis, Congenital",C16;C01;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Infections;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
166,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
167,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0041341,Tuberous Sclerosis,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
168,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
169,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0042961,Intestinal Volvulus,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
170,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0078917,"Albinism, Ocular",C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
171,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
172,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0151514,Atrophic condition of skin,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",group,Disease or Syndrome,0.01,1.0
173,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
174,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0158646,Cleft palate with cleft lip,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
175,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,0.0
176,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0162835,Hypopigmentation disorder,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
177,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
178,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0206701,"Cystadenocarcinoma, Serous",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
179,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0206726,gliosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
180,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
181,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0239849,Harlequin Fetus,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
182,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0240340,Microdontia (disorder),C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
183,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0242852,Proliferative vitreoretinopathy,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
184,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0265316,Neurocutaneous Syndromes,C16;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
185,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0271084,Exudative age-related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
186,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0271086,Toxic maculopathy,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
187,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0271215,"Blindness, Legal",C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
188,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0275544,Congenital infectious disease,C23;C16;C01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Infections",group,Disease or Syndrome,0.01,1.0
189,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
190,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0333307,Superficial ulcer,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
191,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0339546,Retinal Pigment Epithelial Detachment,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
192,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0342684,"Ocular albinism, type I",C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
193,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
194,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0391976,Pain Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
195,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,0.0
196,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0521648,Neonatal respiratory failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
197,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
198,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0566602,Primary sclerosing cholangitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
199,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
200,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0730294,North Carolina macular dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
201,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0740394,Hyperuricemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
202,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0856727,Cholesterol gallstones,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
203,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0877104,Retinal toxicity,,,disease,Anatomical Abnormality,0.01,1.0
204,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
205,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
206,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1175175,Severe Acute Respiratory Syndrome,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
207,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
208,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1288283,Atrophoderma maculatum,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
209,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
210,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0
211,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1739135,Progression of prostate cancer,,,disease,Neoplastic Process,0.01,1.0
212,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1827301,Extensively Drug-Resistant Tuberculosis,C01,   Infections,phenotype,Disease or Syndrome,0.01,1.0
213,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1837218,"Cleft palate, isolated",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,0.0
214,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1839259,"Bulbo-Spinal Atrophy, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
215,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C1861537,OROFACIAL CLEFT 1,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
216,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C2733564,Full thickness hole of macula lutea,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
217,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C2981150,Uranostaphyloschisis,C16;C05;C08;C07;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Congenital Abnormality,0.01,0.0
218,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
219,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3276706,Small Fiber Neuropathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
220,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3714514,Infection,C01,   Infections,group,Pathologic Function,0.01,1.0
221,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C3899278,Early Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
222,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4015286,"MACULAR DEGENERATION, EARLY-ONSET",,,disease,Disease or Syndrome,0.01,1.0
223,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4022725,Retinal astrocytic hamartoma,,,disease,Neoplastic Process,0.01,1.0
224,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
225,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4293702,Foveal atrophy,,,phenotype,Anatomical Abnormality,0.01,1.0
226,24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C4321245,Cleft lip or lips,,,phenotype,Anatomical Abnormality,0.01,0.0
0,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.8,0.983
1,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,0.96
2,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,0.991
3,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4539857,CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME,,,disease,Disease or Syndrome,0.6,1.0
4,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0
5,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.4,1.0
6,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,0.958
7,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0265610,Clinodactyly of fingers,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.4,1.0
8,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.9
9,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0
10,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1292769,Precursor B-cell lymphoblastic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,0.933
11,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.33,1.0
12,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.32,1.0
13,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0005941,"Bone Diseases, Developmental",C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.31,1.0
14,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.31,1.0
15,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.31,1.0
16,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0
17,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0
18,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0
19,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0
20,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0003706,Arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.3,1.0
21,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023453,L2 Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0
22,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
23,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0027659,"Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0
24,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0039075,Syndactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.3,1.0
25,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0151491,Congenital musculoskeletal anomalies,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Congenital Abnormality,0.3,1.0
26,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0205641,"Adenocarcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
27,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0205642,"Adenocarcinoma, Oxyphilic",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
28,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0205643,"Carcinoma, Cribriform",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
29,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0205644,"Carcinoma, Granular Cell",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
30,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0205645,"Adenocarcinoma, Tubular",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
31,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0282313,"Condition, Preneoplastic",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
32,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
33,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0345958,Large cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,
34,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1257931,"Mammary Neoplasms, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
35,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4551485,Clinodactyly,,,disease,Congenital Abnormality,0.3,1.0
36,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4704874,"Mammary Carcinoma, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
37,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.22,1.0
38,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0025261,Memory Disorders,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.2,1.0
39,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.2,0.988
40,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0029866,Other ureteric obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Anatomical Abnormality,0.2,1.0
41,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1709527,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,,,disease,Neoplastic Process,0.2,0.99
42,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0836924,Thrombocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.17,1.0
43,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023518,Leukocytosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.15,1.0
44,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.12,1.0
45,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0152021,Congenital heart disease,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.11,1.0
46,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0000744,Abetalipoproteinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,0.933
47,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0001815,Primary Myelofibrosis,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
48,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0003466,"Anus, Imperforate",C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,1.0
49,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.1,0.958
50,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.93
51,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,0.972
52,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0009806,Constipation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
53,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0
54,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,1.0
55,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,
56,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
57,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
58,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0016202,Flatfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Anatomical Abnormality,0.1,
59,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0016842,Congenital pectus excavatum,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,1.0
60,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.1,1.0
61,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018818,Ventricular Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.1,
62,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.1,0.985
63,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023448,Lymphoid leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
64,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.97
65,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,0.928
66,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023474,"Leukemia, Myeloid, Chronic-Phase",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
67,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
68,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0025990,Micrognathism,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0
69,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0026034,Microstomia,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0
70,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0026987,Myelofibrosis,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.1,1.0
71,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.988
72,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.1,1.0
73,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0032326,Pneumothorax,C08,   Respiratory Tract Diseases,phenotype,Disease or Syndrome,0.1,1.0
74,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0032463,Polycythemia Vera,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
75,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
76,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0038002,Splenomegaly,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
77,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0040028,"Thrombocythemia, Essential",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0
78,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.1,
79,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0040433,Tooth Crowding,C07,   Stomatognathic Diseases,phenotype,Finding,0.1,
80,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0085669,Acute leukemia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.1,0.968
81,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0152421,Macrotia,,,disease,Congenital Abnormality,0.1,1.0
82,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0221354,Frontal bossing,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,1.0
83,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0221369,Acquired Camptodactyly,,,disease,Acquired Abnormality,0.1,
84,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0231246,Failure to gain weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,1.0
85,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0232462,Decrease in appetite,C06;C10;F03,   Digestive System Diseases;    Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.1,
86,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0235833,Congenital diaphragmatic hernia,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,1.0
87,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0240635,Byzanthine arch palate,C16;C05;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
88,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0242596,"Neoplasm, Residual",C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0
89,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0263401,Cutis marmorata,C16;C04;C17;C14;C26,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases;    Wounds and Injuries",disease,Disease or Syndrome,0.1,1.0
90,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279543,Philadelphia chromosome positive chronic myelogenous leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
91,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0333068,Flexion contracture,C05,   Musculoskeletal Diseases,disease,Finding,0.1,1.0
92,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0349588,Short stature,,,phenotype,Finding,0.1,1.0
93,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0376544,Hematopoietic Neoplasms,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.1,1.0
94,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0376545,Hematologic Neoplasms,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.1,1.0
95,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0423109,Upward slant of palpebral fissure,,,phenotype,Finding,0.1,1.0
96,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0423224,Sunken eyes,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
97,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0423757,Thin skin,,,phenotype,Finding,0.1,1.0
98,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0426422,Narrow nose,,,phenotype,Finding,0.1,
99,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0
100,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0544886,Somatic mutation,,,phenotype,Cell or Molecular Dysfunction,0.1,
101,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0578038,Thin lips,,,phenotype,Finding,0.1,1.0
102,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.1,0.966
103,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0677936,Refractory cancer,C04,   Neoplasms,phenotype,Neoplastic Process,0.1,0.929
104,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0685409,Congenital Camptodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
105,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.1,0.964
106,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.1,
107,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0855997,Abnormal basophil morphology,,,phenotype,Finding,0.1,
108,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1292778,Chronic myeloproliferative disorder,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.975
109,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1304746,RDW - Red blood cell distribution width result,,,phenotype,Laboratory or Test Result,0.1,1.0
110,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,0.957
111,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.1,0.989
112,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1386048,Intrauterine retardation,,,phenotype,Pathologic Function,0.1,1.0
113,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.1,1.0
114,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1739405,CML progression,,,disease,Neoplastic Process,0.1,1.0
115,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1839798,Long nose,,,phenotype,Finding,0.1,
116,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1844505,Pointed chin,,,phenotype,Finding,0.1,
117,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1844592,Soft skin,,,phenotype,Finding,0.1,
118,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1849089,Broad forehead,,,phenotype,Finding,0.1,
119,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1850049,Clinodactyly of the 5th finger,,,disease,Congenital Abnormality,0.1,1.0
120,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1850780,Reduced leukocyte alkaline phosphatase,,,phenotype,Finding,0.1,
121,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1851835,Narrow maxilla,,,disease,Anatomical Abnormality,0.1,
122,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1854114,Short nose,,,phenotype,Finding,0.1,
123,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1855472,Acute lymphoblastic leukemia with lymphomatous features,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
124,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1856121,Broad eyebrow,,,phenotype,Finding,0.1,1.0
125,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1866806,Unilateral ptosis,C11,   Eye Diseases,phenotype,Finding,0.1,1.0
126,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2919142,"Short Stature, CTCAE",,,phenotype,Finding,0.1,
127,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.1,1.0
128,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3697248,Short lower third of face,,,phenotype,Finding,0.1,
129,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4016396,"LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB",,,phenotype,Finding,0.1,
130,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4023165,Abnormality of skeletal morphology,,,phenotype,Anatomical Abnormality,0.1,1.0
131,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4054188,Ph-Like Acute Lymphoblastic Leukemia,,,disease,Neoplastic Process,0.1,0.75
132,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4317152,Dimple chin,,,phenotype,Anatomical Abnormality,0.1,1.0
133,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4551563,Microcephaly (physical finding),,,phenotype,Finding,0.1,1.0
134,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4551570,2-3 toe syndactyly,,,disease,Congenital Abnormality,0.1,1.0
135,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.09,1.0
136,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0026499,Monosomy,C23,"   Pathological Conditions, Signs and Symptoms",group,Congenital Abnormality,0.09,0.778
137,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0349636,Pre B-cell acute lymphoblastic leukemia,,,disease,Neoplastic Process,0.09,1.0
138,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018939,Hematological Disease,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.08,1.0
139,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023470,Myeloid Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
140,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023481,Chronic Neutrophilic Leukemia,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.07,1.0
141,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.07,1.0
142,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279593,Adult B Acute Lymphoblastic Leukemia,,,disease,Neoplastic Process,0.07,1.0
143,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1292772,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.07,0.857
144,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
145,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023480,"Leukemia, Myelomonocytic, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,0.833
146,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0
147,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279549,Philadelphia chromosome negative chronic myelogenous leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,0.833
148,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0862030,Precursor B-lymphoblastic lymphoma/leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
149,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1327920,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
150,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2347761,Childhood Myelodysplastic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
151,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3900098,Adult Myelodysplastic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0
152,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.05,1.0
153,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.05,0.8
154,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0349639,Juvenile Myelomonocytic Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.05,1.0
155,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0
156,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0007789,Cerebral Palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0
157,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0
158,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.04,1.0
159,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023440,Acute Erythroblastic Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
160,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
161,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.04,1.0
162,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.04,1.0
163,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.04,0.75
164,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1301355,Myelodysplastic-Myeloproliferative Diseases,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.04,1.0
165,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,0.75
166,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,0.75
167,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1837218,"Cleft palate, isolated",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.04,1.0
168,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2004493,"Leukemia, B-Cell",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
169,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2826025,Mixed phenotype acute leukemia,,,disease,Neoplastic Process,0.04,1.0
170,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.04,1.0
171,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.03,1.0
172,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023464,Acute biphenotypic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,0.667
173,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
174,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023472,"Leukemia, Myeloid, Accelerated Phase",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
175,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.03,1.0
176,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0024314,Lymphoproliferative Disorders,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0
177,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
178,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0
179,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
180,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0206141,Idiopathic Hypereosinophilic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.03,1.0
181,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
182,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279584,Childhood B Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
183,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
184,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0432411,"Chromosome 9, trisomy",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.03,1.0
185,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0677932,Progressive Neoplastic Disease,,,phenotype,Neoplastic Process,0.03,1.0
186,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
187,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0920028,Leukaemia recurrent,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
188,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0
189,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1306759,Eosinophilic disorder,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.03,1.0
190,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1332970,Childhood Hematopoietic Neoplasm,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
191,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.667
192,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2347748,Adult Erythroleukemia,,,disease,Neoplastic Process,0.03,1.0
193,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3539781,Progressive cGVHD,,,disease,Disease or Syndrome,0.03,1.0
194,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3714514,Infection,C01,   Infections,group,Pathologic Function,0.03,1.0
195,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3888194,MIXED LINEAGE LEUKEMIA,,,disease,Neoplastic Process,0.03,1.0
196,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4520840,Erythroleukemia (Erythroid/Myeloid),C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
197,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
198,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
199,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0007133,"Carcinoma, Papillary",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
200,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
201,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,1.0
202,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
203,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
204,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5
205,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023479,Acute myelomonocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
206,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0030312,Pancytopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
207,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0032461,Polycythemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
208,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0035920,Rubella,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
209,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0085702,Monocytosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
210,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
211,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0278764,Adult Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
212,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0278787,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
213,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5
214,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0278879,Childhood Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
215,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279583,Childhood T Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
216,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0280141,Acute Undifferentiated Leukemia,,,disease,Neoplastic Process,0.02,1.0
217,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0280449,secondary acute myeloid leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5
218,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5
219,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
220,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0
221,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
222,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0346421,Chronic eosinophilic leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
223,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,0.5
224,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
225,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
226,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
227,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0856053,Leukemia secondary,,,disease,Neoplastic Process,0.02,1.0
228,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1261473,Sarcoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
229,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1282609,Granulocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
230,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1292771,"Chronic myelogenous leukemia, BCR/ABL positive",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
231,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
232,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1370868,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
233,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1378511,Undifferentiated leukemia,,,disease,Neoplastic Process,0.02,1.0
234,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0
235,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1863727,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
236,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2347507,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,,,disease,Neoplastic Process,0.02,0.5
237,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2861580,"Chronic myeloid leukemia, BCR/ABL-positive",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
238,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2939461,Myeloid neoplasm,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
239,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3469521,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
240,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
241,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3665444,Neutrophilia (disorder),C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
242,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4289946,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",,,disease,Neoplastic Process,0.02,1.0
243,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4329382,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",,,disease,Neoplastic Process,0.02,0.5
244,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
245,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4551686,Malignant neoplasm of soft tissue,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
246,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4721444,Burkitt Leukemia,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
247,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.02,1.0
248,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
249,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
250,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
251,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0002792,anaphylaxis,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.01,1.0
252,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
253,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0004626,"Pneumonia, Bacterial",C01;C08,   Infections;    Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
254,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
255,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
256,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
257,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
258,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,0.0
259,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0012546,Diphtheria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
260,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0015397,Disorder of eye,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
261,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0017152,Gastritis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
262,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018081,Gonorrhea,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
263,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018133,Graft-vs-Host Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
264,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
265,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
266,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
267,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
268,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0019214,Hepatosplenomegaly,C23;C06;C15,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Hemic and Lymphatic Diseases",phenotype,Sign or Symptom,0.01,1.0
269,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
270,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
271,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
272,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
273,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023443,Hairy Cell Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
274,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023462,Acute Megakaryocytic Leukemias,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
275,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
276,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023524,"Leukoencephalopathy, Progressive Multifocal",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
277,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,0.0
278,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
279,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0024899,Mastocytosis,C04;C17;C20,   Neoplasms;    Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
280,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
281,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.01,1.0
282,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0026985,Myelodysplasia,,,disease,Congenital Abnormality,0.01,1.0
283,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0027341,Nail-Patella Syndrome,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
284,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0029464,Osteosclerosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
285,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0029925,Ovarian Carcinoma,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
286,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0032131,Plasmacytoma,C04;C20,   Neoplasms;    Immune System Diseases,disease,Neoplastic Process,0.01,1.0
287,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0034050,Pulmonary Alveolar Proteinosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
288,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0
289,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0035436,Rheumatic Fever,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
290,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0036420,Localized scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
291,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
292,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0036920,Sezary Syndrome,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
293,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0038587,Substance Withdrawal Syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
294,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0040100,Thymoma,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
295,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0041341,Tuberous Sclerosis,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
296,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
297,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0043119,Werner Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
298,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0085077,Sweet Syndrome,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
299,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
300,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0085281,Addictive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
301,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0085692,Hemorrhagic cystitis,C23;C13;C01;C12;C15,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
302,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0086942,Rous Sarcoma,C04;C01;C22,   Neoplasms;    Infections;    Animal Diseases,disease,Neoplastic Process; Experimental Model of Disease,0.01,1.0
303,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0151650,Renal fibrosis,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
304,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
305,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0153690,Secondary malignant neoplasm of bone,C23;C04;C05,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Musculoskeletal Diseases",disease,Neoplastic Process,0.01,1.0
306,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0155773,Portal Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
307,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0205734,"Diabetes, Autoimmune",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
308,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0206630,Endometrial Stromal Sarcoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
309,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0206659,Embryonal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
310,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0206731,Angiofibroma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
311,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0220621,Childhood Acute Myeloid Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
312,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0220650,Metastatic malignant neoplasm to brain,C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
313,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0221406,Pituitary-dependent Cushing's disease,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
314,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0242006,Myelofibrosis due to another disorder,,,disease,Disease or Syndrome,0.01,1.0
315,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
316,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
317,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0262584,"Carcinoma, Small Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
318,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0264490,Acute respiratory failure,C23;C18;C08,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
319,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0265219,Miller Dieker syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
320,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0265950,Venous malformation,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
321,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
322,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0278519,Recurrent Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
323,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279582,Childhood Burkitt Leukemia,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
324,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279591,Adult Burkitt Leukemia,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
325,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279592,Adult T Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
326,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279627,Adult Acute Myelomonocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
327,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279628,Adenocarcinoma Of Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
328,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279632,Adult Acute Megakaryoblastic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
329,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279644,Childhood Acute Myelomonocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
330,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0279650,Childhood Acute Megakaryoblastic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
331,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0302486,Erythrophagocytosis,,,disease,Disease or Syndrome,0.01,1.0
332,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0349566,Squamous cell carcinoma of tongue,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
333,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0349637,Common acute lymphoblastic leukemia,,,disease,Neoplastic Process,0.01,1.0
334,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0392514,Hereditary hemochromatosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
335,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0406775,Symmetrical dyschromatosis of extremities,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
336,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0410000,Overlap syndrome,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
337,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
338,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0456889,Enteropathy-Associated T-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
339,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0476486,Generalized enlarged lymph nodes,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
340,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0598798,Lymphoid neoplasm,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
341,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0685898,Food anaphylaxis,C06;C20,   Digestive System Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
342,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0686377,CNS metastases,C04;C10,   Neoplasms;    Nervous System Diseases,phenotype,Neoplastic Process,0.01,1.0
343,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
344,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0702266,Basophilia,,,disease,Disease or Syndrome,0.01,1.0
345,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0751297,Leptomeningeal Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
346,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0751691,Perineurioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
347,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0795878,Monosomy 22,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
348,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0867389,Chronic graft-versus-host disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
349,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
350,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1279296,Chronic leukemia (category),C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
351,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1292758,Precursor T-cell lymphoblastic lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
352,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1333015,Childhood Kidney Wilms Tumor,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.01,1.0
353,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1336745,Thymic Lymphoma,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
354,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1336840,Papillary renal cell carcinoma type 2,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
355,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1370657,Soft tissue perineurioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
356,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1370658,Intraneural perineurioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
357,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1708350,Hereditary Leiomyomatosis and Renal Cell Cancer,C16;C04;C13;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.01,1.0
358,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1834582,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",C16;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.01,1.0
359,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1837249,"Malformations of Cortical Development, Group II",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
360,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1838625,Warburg Sjo Fledelius syndrome,C23;C16;C11;C05;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.01,1.0
361,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1845247,Indolence,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
362,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1850900,Familial primary gastric lymphoma,C06;C04;C20;C15,   Digestive System Diseases;    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
363,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1851710,LATERAL MENINGOCELE SYNDROME,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
364,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1854465,TUBEROUS SCLEROSIS 1 (disorder),C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
365,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
366,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1863753,LIMB-MAMMARY SYNDROME,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
367,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C1868683,"B-CELL MALIGNANCY, LOW-GRADE",,,disease,Neoplastic Process,0.01,1.0
368,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2347753,Adult Pure Erythroid Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
369,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2363142,T-Cell Prolymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
370,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.01,1.0
371,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
372,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2937220,Congenital abnormality of vein,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
373,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
374,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3152182,Anterior chamber anomalies,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",phenotype,Congenital Abnormality,0.01,1.0
375,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
376,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
377,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3890429,Liquid Tumor,,,disease,Neoplastic Process,0.01,1.0
378,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3896960,Childhood Pre-B Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
379,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C3896961,Adult Pre-B Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
380,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4022560,Splanchnic vein thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
381,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
382,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4049328,Renal medullary carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
383,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4288091,Tubulocystic renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
384,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4288892,Infant Acute Undifferentiated Leukemia,,,disease,Neoplastic Process,0.01,1.0
385,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4288893,Infant Acute Biphenotypic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
386,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4303761,Familial thrombocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
387,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4520841,Pure Erythroid Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
388,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4707057,Tetrasomy 21,,,disease,Disease or Syndrome,0.01,1.0
389,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4721413,Juvenile angiofibroma,C04;C14,   Neoplasms;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
390,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
391,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4721452,Intestinal T-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
392,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4721505,"Sarcoma, Myeloid",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
393,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
394,25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C4732730,Blood spots,,,disease,Disease or Syndrome,0.01,1.0
0,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0
1,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0
2,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1383860,Cardiac Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0
3,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
4,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
5,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0007286,Carpal Tunnel Syndrome,C10;C26,   Nervous System Diseases;    Wounds and Injuries,disease,Disease or Syndrome,0.1,1.0
6,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0
7,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0
8,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0
9,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
10,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0428472,Serum HDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
11,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.1,1.0
12,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
13,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.06,0.833
14,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.06,0.833
15,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,0.5
16,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.06,0.833
17,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0
18,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
19,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
20,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
21,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
22,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0406317,Chronic small plaque psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
23,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
24,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1512409,Hepatocarcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.02,1.0
25,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
26,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
27,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
28,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
29,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0013384,Dyskinetic syndrome,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
30,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
31,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0016470,Food Allergy,C20,   Immune System Diseases,phenotype,Pathologic Function,0.01,1.0
32,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
33,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0022735,Klinefelter Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,0.0
34,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
35,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
36,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0027947,Neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
37,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
38,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
39,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
40,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
41,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0035455,Rhinitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
42,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
43,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
44,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
45,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
46,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0206651,Clear Cell Sarcoma of Soft Tissue,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
47,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0206669,Hepatocellular Adenoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
48,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0342190,C-cell hyperplasia of thyroid,C23;C19,"   Pathological Conditions, Signs and Symptoms;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
49,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0432474,Klinefelter's syndrome - male with more than two X chromosomes,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,0.0
50,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0578870,Chronic idiopathic urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
51,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1306759,Eosinophilic disorder,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
52,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1833921,Familial medullary thyroid carcinoma,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0
53,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1847540,"Azoospermia, Nonobstructive",C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
54,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1861821,"CATARACT, MARNER TYPE",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
55,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C1960398,HER2-positive carcinoma of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
56,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C2363929,Histamine intolerance,,,disease,Disease or Syndrome,0.01,1.0
57,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
58,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C2919945,Cavernous Hemangioma of Brain,C16;C04;C10;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.01,1.0
59,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C4023106,Obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
60,26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C4554344,IgE-mediated food allergy,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
0,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.2,1.0
1,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
2,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
3,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
4,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
5,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
6,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
7,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
8,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
9,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0000744,Abetalipoproteinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,0.0
10,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
11,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
12,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
13,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
14,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
15,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
16,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
17,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0023470,Myeloid Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
18,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
19,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
20,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
21,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0024899,Mastocytosis,C04;C17;C20,   Neoplasms;    Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
22,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
23,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
24,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
25,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0152020,Gastroparesis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
26,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0162666,Mitochondrial Encephalomyopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
27,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
28,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0205710,Alpers Syndrome (disorder),C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
29,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0220650,Metastatic malignant neoplasm to brain,C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
30,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0238339,Hereditary pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,0.0
31,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0278764,Adult Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
32,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0278879,Childhood Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
33,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
34,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
35,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0333983,Hyperplastic Polyp,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.01,0.0
36,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0
37,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
38,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,0.0
39,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0
40,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
41,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
42,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.01,1.0
43,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
44,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1261473,Sarcoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
45,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1328504,Hormone refractory prostate cancer,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
46,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1332201,Adult Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
47,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,0.0
48,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1720505,Adult growth hormone deficiency,,,disease,Disease or Syndrome,0.01,1.0
49,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
50,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1847540,"Azoospermia, Nonobstructive",C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
51,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
52,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
53,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
54,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.01,1.0
55,27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C4551686,Malignant neoplasm of soft tissue,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
0,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.5,0.96
1,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.5,0.9
2,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0013295,Duodenal Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.43,1.0
3,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.43,1.0
4,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,0.933
5,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.4,1.0
6,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.35,1.0
7,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.34,1.0
8,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,0.5
9,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
10,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
11,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0010474,Curling Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
12,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0
13,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0
14,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0751956,Acute Cerebrovascular Accidents,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
15,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4505353,Diverticular Bleeding,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
16,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,0.938
17,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.2,0.923
18,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
19,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.2,0.962
20,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.2,1.0
21,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.2,0.958
22,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.15,1.0
23,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.15,0.857
24,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.14,1.0
25,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.13,1.0
26,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.13,0.5
27,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0149871,Deep Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.12,1.0
28,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0
29,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.11,1.0
30,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.11,0.5
31,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0005806,Blood Group Incompatibility,,,disease,Disease or Syndrome,0.1,0.9
32,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0
33,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
34,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.885
35,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,0.929
36,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.1,0.818
37,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
38,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0
39,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018935,Hematocrit procedure,,,phenotype,Laboratory Procedure,0.1,1.0
40,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
41,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
42,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.857
43,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0030605,Activated Partial Thromboplastin Time measurement,,,phenotype,Laboratory Procedure,0.1,1.0
44,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
45,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0034065,Pulmonary Embolism,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Pathologic Function,0.1,1.0
46,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0
47,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0042487,Venous Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,1.0
48,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0
49,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0
50,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
51,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
52,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0
53,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
54,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0201850,Alkaline phosphatase measurement,,,phenotype,Laboratory Procedure,0.1,1.0
55,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0201973,Creatine kinase measurement,,,phenotype,Laboratory Procedure,0.1,1.0
56,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
57,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0
58,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0202230,Thyroid stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0
59,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0
60,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0337438,Glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0
61,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.1,0.909
62,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0
63,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0428321,Measurement of liver enzyme,,,phenotype,Laboratory Procedure,0.1,1.0
64,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0428474,Serum LDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
65,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0
66,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0441683,Hormone measurement,,,group,Laboratory Procedure,0.1,1.0
67,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0495706,elevated blood glucose level,,,phenotype,Finding,0.1,1.0
68,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0518015,Hemoglobin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
69,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
70,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0523677,Glycine measurement,,,phenotype,Laboratory Procedure,0.1,1.0
71,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0
72,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
73,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0750880,Monocyte count result,,,phenotype,Laboratory or Test Result,0.1,1.0
74,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1167912,Coagulation factor measurement,,,phenotype,Laboratory Procedure,0.1,1.0
75,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1168443,Pseudocholinesterase Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
76,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0
77,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1272321,Autoantibody measurement,,,phenotype,Laboratory Procedure,0.1,1.0
78,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1287351,Finding of liver enzyme levels,,,phenotype,Laboratory or Test Result,0.1,1.0
79,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1304746,RDW - Red blood cell distribution width result,,,phenotype,Laboratory or Test Result,0.1,1.0
80,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,0.882
81,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
82,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1527304,Allergic Reaction,C20,   Immune System Diseases,phenotype,Pathologic Function,0.1,1.0
83,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1837461,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3",,,disease,Finding,0.1,1.0
84,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,0.8
85,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2239219,von Willebrand's factor (lab test),,,phenotype,Laboratory Procedure,0.1,1.0
86,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2242817,Homocysteine measurement,,,phenotype,Laboratory Procedure,0.1,1.0
87,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2825856,Factor VII measurement,,,phenotype,Laboratory Procedure,0.1,1.0
88,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2825857,Factor VIII measurement,,,phenotype,Laboratory Procedure,0.1,1.0
89,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
90,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3272931,Fibroblast Growth Factor 23 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
91,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3828530,Platelet Component Distribution Width Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
92,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3897558,Soluble Interleukin 6 Receptor Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
93,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0
94,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4722217,E-selectin Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
95,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.08,1.0
96,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0034902,Pure Red-Cell Aplasia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.08,1.0
97,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0860218,ABO incompatibility,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.08,1.0
98,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.06,0.667
99,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.06,0.833
100,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024535,"Malaria, Falciparum",C01,   Infections,disease,Disease or Syndrome,0.06,1.0
101,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2747816,Complicated malaria,C01,   Infections,disease,Disease or Syndrome,0.06,1.0
102,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3665905,Passenger lymphocyte syndrome,,,disease,Disease or Syndrome,0.06,1.0
103,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.05,1.0
104,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,0.8
105,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,0.8
106,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,0.8
107,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018133,Graft-vs-Host Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.05,0.6
108,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.05,1.0
109,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
110,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0030360,Papillon-Lefevre Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.05,1.0
111,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0948201,Alloimmunisation,,,disease,Disease or Syndrome,0.05,1.0
112,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
113,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2939465,Deficiency of glucose-6-phosphate dehydrogenase,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.05,1.0
114,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,0.75
115,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0020433,Hyperbilirubinemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.04,1.0
116,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0030920,Peptic Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.04,1.0
117,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0037054,Sickle Cell Trait,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.04,0.75
118,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0085669,Acute leukemia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.04,1.0
119,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
120,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0
121,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,0.75
122,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0850666,Infection caused by Helicobacter pylori,C01,   Infections,disease,Disease or Syndrome,0.04,1.0
123,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,1.0
124,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
125,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
126,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0014761,"Erythroblastosis, Fetal",C16;C13;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,1.0
127,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019069,Hemophilia A,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,1.0
128,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.03,1.0
129,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
130,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
131,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0042974,von Willebrand Disease,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,1.0
132,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0262655,Recurrent urinary tract infection,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,0.667
133,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0270202,Hemolytic disease of fetus OR newborn due to ABO immunization,C16;C13;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,1.0
134,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0376545,Hematologic Neoplasms,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0
135,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0398623,Thrombophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.03,1.0
136,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,0.333
137,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
138,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
139,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
140,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
141,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4324411,Blood type incompatibility,,,disease,Disease or Syndrome,0.03,1.0
142,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.02,1.0
143,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,0.5
144,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
145,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
146,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
147,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007138,"Carcinoma, Transitional Cell",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
148,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0008354,Cholera,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
149,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.02,1.0
150,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
151,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.02,1.0
152,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0017154,"Gastritis, Atrophic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
153,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
154,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
155,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
156,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
157,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
158,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
159,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
160,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
161,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.02,1.0
162,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0025303,Meningococcal Infections,C01,   Infections,group,Disease or Syndrome,0.02,0.5
163,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.02,1.0
164,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
165,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0028768,Obsessive-Compulsive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,0.5
166,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
167,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0034155,"Purpura, Thrombotic Thrombocytopenic",C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
168,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0036323,Schistosomiasis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
169,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
170,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.02,1.0
171,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0040128,Thyroid Diseases,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.02,1.0
172,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0041341,Tuberous Sclerosis,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.02,1.0
173,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,0.0
174,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0085096,Peripheral Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
175,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
176,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
177,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
178,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0235575,Hemolytic reaction,,,phenotype,Disease or Syndrome,0.02,1.0
179,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0241961,Angiomyolipoma of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
180,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
181,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0242723,Parasitemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.02,0.5
182,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0265333,Tricho-dento-osseous syndrome (disorder),C16;C17;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.02,1.0
183,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
184,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0392788,Nasal Type Extranodal NK/T-Cell Lymphoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5
185,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
186,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
187,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0595921,Intraocular pressure disorder,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
188,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
189,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0742343,Acute Chest Syndrome,C16;C08;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
190,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.02,1.0
191,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0856825,Acute GVH disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
192,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1264039,"von Willebrand Disease, Type 1",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
193,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
194,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
195,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
196,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
197,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1531624,Cardioembolic stroke,,,disease,Disease or Syndrome,0.02,1.0
198,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,1.0
199,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1847835,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,0.0
200,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.02,1.0
201,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3534585,Infection caused by Norovirus,C01,   Infections,group,Disease or Syndrome,0.02,0.5
202,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4048329,Immunosuppression,,,disease,Disease or Syndrome,0.02,1.0
203,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4699512,Large-artery atherosclerosis (embolus/thrombosis),,,disease,Disease or Syndrome,0.02,1.0
204,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
205,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0001824,Agranulocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
206,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0001883,Airway Obstruction,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
207,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
208,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
209,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002792,anaphylaxis,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.01,1.0
210,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002878,"Anemia, Hemolytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
211,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0002902,Anencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
212,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0003509,Aortitis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
213,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0003862,Arthralgia,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.01,1.0
214,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,0.0
215,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
216,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
217,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
218,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
219,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
220,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
221,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
222,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
223,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
224,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
225,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
226,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0008497,Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
227,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
228,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0009186,Coccidioidomycosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
229,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
230,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0009946,Conversion disorder,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
231,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
232,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0010823,Cytomegalovirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
233,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
234,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,0.0
235,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
236,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0013537,Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
237,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,0.0
238,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
239,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0016085,Filariasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
240,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0017551,Gilbert Disease (disorder),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
241,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
242,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
243,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018021,Goiter,C19,   Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
244,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018081,Gonorrhea,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
245,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018621,Hay fever,C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
246,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
247,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
248,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
249,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0018889,Helminthiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
250,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019045,Hemoglobinopathies,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0
251,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019061,Hemolytic-Uremic Syndrome,C13;C12;C15,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
252,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019243,"Angioedemas, Hereditary",C16;C17;C20;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
253,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
254,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0
255,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0020217,Hydatidiform Mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
256,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0020305,Hydrops Fetalis,C23;C16;C13;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
257,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
258,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
259,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0020701,Hysteria,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
260,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0021053,Immune System Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
261,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0022346,Icterus,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
262,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0022353,Neonatal Jaundice,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",phenotype,Disease or Syndrome,0.01,1.0
263,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
264,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
265,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
266,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
267,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
268,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,0.0
269,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
270,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024248,Lymphocele,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
271,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024537,"Malaria, Vivax",C01,   Infections,disease,Disease or Syndrome,0.01,0.0
272,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0024894,Mastitis,C13;C17,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
273,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0025267,Multiple Endocrine Neoplasia Type 1,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0
274,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0025268,Multiple Endocrine Neoplasia Type 2a,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0
275,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0026267,Mitral Valve Prolapse Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
276,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
277,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
278,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
279,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0027932,Neurotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
280,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0027947,Neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
281,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
282,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0029172,Oral Submucous Fibrosis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,0.0
283,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
284,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,0.0
285,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0029882,Otitis Media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
286,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
287,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0030286,Pancreatic Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
288,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0031069,Familial Mediterranean Fever,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
289,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0035204,Respiration Disorders,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
290,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
291,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,0.0
292,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0035436,Rheumatic Fever,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
293,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0035439,Rheumatic Heart Disease,C01;C14,   Infections;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
294,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0035920,Rubella,C01,   Infections,disease,Disease or Syndrome,0.01,0.0
295,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
296,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0036347,"Schizophrenia, Disorganized",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
297,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0036349,Paranoid Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
298,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
299,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
300,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0037354,Smallpox,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
301,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0038443,"Stress, Psychological",F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
302,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
303,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0039614,Tetanus,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
304,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0039730,Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0
305,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
306,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0041234,Chagas Disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
307,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0041466,Typhoid Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
308,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
309,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0042998,Vulvovaginitis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
310,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0043144,Wheezing,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
311,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
312,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0079772,T-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
313,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0080024,Piebaldism,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
314,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0080178,Spina Bifida,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
315,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
316,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
317,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0086438,Hypogammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
318,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0149678,Epstein-Barr Virus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
319,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0151723,Hypomagnesemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
320,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
321,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0151936,Disorder of tendon,C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0
322,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0152021,Congenital heart disease,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
323,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0152136,Low Tension Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
324,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0
325,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,0.0
326,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0158371,Acute osteomyelitis,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,0.0
327,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
328,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0205882,"Infections, Parvovirus",C01,   Infections,group,Disease or Syndrome,0.01,1.0
329,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0206633,Angiomyolipoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
330,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0206663,"Neuroectodermal Tumor, Primitive",C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
331,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
332,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0221074,"Depression, Postpartum",C13;F03,   Female Urogenital Diseases and Pregnancy Complications;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
333,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0221239,Rapidly progressive glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
334,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
335,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0234935,Acute urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,0.0
336,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0238339,Hereditary pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,0.0
337,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0240066,Iron deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
338,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0240912,Vertical Talus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
339,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0242172,Pelvic Inflammatory Disease,C13;C01,   Female Urogenital Diseases and Pregnancy Complications;    Infections,group,Disease or Syndrome,0.01,0.0
340,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0242363,Islet Cell Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,0.0
341,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
342,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
343,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0264490,Acute respiratory failure,C23;C18;C08,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
344,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0264716,Chronic heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
345,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0265110,Cerebral Vasospasm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
346,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0267446,Acute gastroenteritis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
347,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0268186,Congenital glucose-galactose malabsorption,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0
348,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0268307,Conjugated hyperbilirubinemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
349,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0272322,Severe hereditary factor VIII deficiency disease,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
350,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0277919,Postthrombotic Syndrome,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
351,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0278134,Absence of sensation,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
352,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0278480,Stage III Colon Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
353,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0278678,Metastatic Renal Cell Cancer,,,disease,Neoplastic Process,0.01,0.0
354,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
355,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0279606,Childhood Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
356,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0279607,Adult Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
357,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
358,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0281267,bilateral breast cancer,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
359,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0282666,Very Low Birth Weight,,,phenotype,Sign or Symptom,0.01,1.0
360,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0333307,Superficial ulcer,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
361,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0333983,Hyperplastic Polyp,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.01,0.0
362,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0334294,Multiple adenomatous polyps,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
363,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
364,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0340194,Respiratory failure without hypercapnia,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
365,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0340978,May-Hegglin anomaly,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.01,1.0
366,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0343363,Viral gastroenteritis due to Rotavirus,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
367,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
368,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0346648,Malignant tumor of exocrine pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,0.0
369,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0349231,Phobic anxiety disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
370,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0362046,Prediabetes syndrome,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
371,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0375071,Malignant neoplasm of vulva,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
372,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
373,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0403529,Anti-Glomerular Basement Membrane Disease,C13;C12;C08;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
374,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0432487,Post-transplant lymphoproliferative disorder,C01;C20;C15,   Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
375,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0522274,Humoral immune defect,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
376,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
377,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
378,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0578575,Dissection of proximal aorta,,,disease,Disease or Syndrome,0.01,1.0
379,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0584960,Factor V Leiden mutation,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
380,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0600502,Vascular Hemostatic Disorders,C15;C14,   Hemic and Lymphatic Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
381,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0677055,CARCINOMA OF VULVA,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
382,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0684337,Ewings sarcoma-primitive neuroectodermal tumor (PNET),C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
383,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0685938,Malignant neoplasm of gastrointestinal tract,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
384,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
385,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
386,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0740985,Acute anaemia,,,disease,Disease or Syndrome,0.01,1.0
387,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
388,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0852949,Arteriopathic disease,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",group,Disease or Syndrome,0.01,1.0
389,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
390,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0867389,Chronic graft-versus-host disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
391,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0876973,Infectious Lung Disorder,C01;C08,   Infections;    Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
392,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0940937,precancerous lesions,,,phenotype,Neoplastic Process,0.01,1.0
393,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
394,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1096184,West Nile viral infection,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
395,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1112459,Unresectable Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
396,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1134719,Invasive Ductal Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
397,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1260403,prothrombin gene mutation,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.01,1.0
398,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1263988,Hemolytic disorder,C16;C13;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
399,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
400,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1271398,Pigment dispersion syndrome (disorder),C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
401,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1332201,Adult Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
402,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1336076,Sporadic Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
403,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1337011,Well Differentiated Pancreatic Endocrine Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,0.0
404,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1378703,Renal carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
405,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1399819,Humoral immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
406,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
407,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1536220,ST segment elevation myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
408,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
409,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1561826,Overweight and obesity,,,disease,Disease or Syndrome,0.01,1.0
410,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1568272,Tendinopathy,C05;C26,   Musculoskeletal Diseases;    Wounds and Injuries,disease,Disease or Syndrome,0.01,1.0
411,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
412,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
413,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1719672,Severe Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
414,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1839839,MAJOR AFFECTIVE DISORDER 2,C16;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,1.0
415,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1842981,NEUROTICISM,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
416,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1847800,Waardenburg Syndrome Type 1,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
417,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1861305,TARSAL-CARPAL COALITION SYNDROME,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
418,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1861502,COLCHICINE RESISTANCE,,,phenotype,Disease or Syndrome,0.01,1.0
419,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1959584,Cardiac Carcinoma,C04;C14,   Neoplasms;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
420,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C1959635,Parvovirus B19 (disease),,,disease,Disease or Syndrome,0.01,1.0
421,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2242816,Chronic secretory otitis media,,,disease,Disease or Syndrome,0.01,1.0
422,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C2827407,Infectious Otitis Media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
423,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3146254,Stage III Colon Cancer AJCC v7,,,disease,Neoplastic Process,0.01,1.0
424,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3150911,"GASTRIC CANCER, INTESTINAL",,,disease,Neoplastic Process,0.01,1.0
425,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3249881,Infection - suppurative,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",group,Disease or Syndrome,0.01,1.0
426,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3266898,Waardenburg Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
427,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
428,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3463897,"HYDATIDIFORM MOLE, RECURRENT, 1",,,disease,Disease or Syndrome,0.01,1.0
429,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3839507,Diminished ovarian reserve,C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
430,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3853779,Neonatal Alloimmune Thrombocytopenia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
431,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C3875265,Febrile urinary tract infection,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
432,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4039867,Acute hypoxemic respiratory failure,,,disease,Disease or Syndrome,0.01,1.0
433,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4048306,Multiple endocrine neoplasia Type 2,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0
434,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4082937,Necrotizing enterocolitis in fetus OR newborn,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
435,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4288754,Metastatic urothelial carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
436,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4290140,recurrent myocardial infarction,,,disease,Disease or Syndrome,0.01,1.0
437,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4321477,Sickle Cell-SS Disease,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
438,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4525124,Stage III Colon Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
439,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4551898,"Cholestasis, progressive familial intrahepatic 1",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
440,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4703482,Severe Epstein Barr virus infection,,,disease,Disease or Syndrome,0.01,1.0
441,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4721698,Metastatic Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0
442,28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C4721773,Postoperative cognitive dysfunction,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
0,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,1.0
1,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0
2,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
3,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0019069,Hemophilia A,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
4,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
5,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0027859,Acoustic Neuroma,C04;C10;C09,   Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,1.0
6,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0684275,"Hemophilia, NOS",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
7,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C1328504,Hormone refractory prostate cancer,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
8,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
9,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
10,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0004310,Auditory Perceptual Disorders,C23;C10;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0
11,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
12,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
13,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
14,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
15,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0018777,Conductive hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,0.0
16,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,0.0
17,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
18,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
19,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
20,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
21,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
22,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0035372,Rett Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
23,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0040264,Tinnitus,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0
24,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
25,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
26,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0206663,"Neuroectodermal Tumor, Primitive",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
27,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
28,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0265219,Miller Dieker syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
29,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0266589,Congenital ear anomaly NOS (disorder),C16;C13;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Otorhinolaryngologic Diseases",group,Congenital Abnormality,0.01,1.0
30,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0278510,Childhood Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
31,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0278876,Adult Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
32,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0280783,Juvenile Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
33,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0333307,Superficial ulcer,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
34,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0334579,Anaplastic astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
35,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0343386,Clostridium difficile infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
36,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
37,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
38,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
39,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
40,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
41,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C1519670,Tumor Angiogenesis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
42,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C1847835,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
43,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C3887524,Skin Erosion,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
44,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C4021533,Severe sensorineural hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
45,29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C4551989,Tibial aplasia and ectrodactyly syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
0,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
1,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C1536500,Deficiency of acetyl-CoA acetyltransferase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.04,1.0
2,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
3,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
4,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
5,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0022638,Ketosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
6,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0024305,"Lymphoma, Non-Hodgkin",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
7,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0155877,Allergic asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
8,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
9,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
10,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
11,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C1827849,IgE-mediated allergic asthma,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
12,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
13,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C3658299,Zellweger Spectrum,C16;C06;C18;C13;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
14,30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,31,ACACA,Q13085,0.48,0.846,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0
1,31,ACACA,Q13085,0.48,0.846,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0
2,31,ACACA,Q13085,0.48,0.846,1.0,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
3,31,ACACA,Q13085,0.48,0.846,1.0,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
4,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023212,Left-Sided Heart Failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
5,31,ACACA,Q13085,0.48,0.846,1.0,,,C0235527,"Heart Failure, Right-Sided",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
6,31,ACACA,Q13085,0.48,0.846,1.0,,,C0268603,Acetyl-CoA: carboxylase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,
7,31,ACACA,Q13085,0.48,0.846,1.0,,,C1959583,Myocardial Failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
8,31,ACACA,Q13085,0.48,0.846,1.0,,,C1961112,Heart Decompensation,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
9,31,ACACA,Q13085,0.48,0.846,1.0,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.21,1.0
10,31,ACACA,Q13085,0.48,0.846,1.0,,,C0015696,"Fatty Liver, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.2,1.0
11,31,ACACA,Q13085,0.48,0.846,1.0,,,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.2,1.0
12,31,ACACA,Q13085,0.48,0.846,1.0,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.933
13,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,1.0
14,31,ACACA,Q13085,0.48,0.846,1.0,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
15,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
16,31,ACACA,Q13085,0.48,0.846,1.0,,,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.1,
17,31,ACACA,Q13085,0.48,0.846,1.0,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
18,31,ACACA,Q13085,0.48,0.846,1.0,,,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,1.0
19,31,ACACA,Q13085,0.48,0.846,1.0,,,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.1,1.0
20,31,ACACA,Q13085,0.48,0.846,1.0,,,C0456070,Growth delay,,,phenotype,Pathologic Function,0.1,
21,31,ACACA,Q13085,0.48,0.846,1.0,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
22,31,ACACA,Q13085,0.48,0.846,1.0,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,0.923
23,31,ACACA,Q13085,0.48,0.846,1.0,,,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
24,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.08,1.0
25,31,ACACA,Q13085,0.48,0.846,1.0,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.07,0.857
26,31,ACACA,Q13085,0.48,0.846,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0
27,31,ACACA,Q13085,0.48,0.846,1.0,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.07,1.0
28,31,ACACA,Q13085,0.48,0.846,1.0,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0
29,31,ACACA,Q13085,0.48,0.846,1.0,,,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.06,1.0
30,31,ACACA,Q13085,0.48,0.846,1.0,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,0.833
31,31,ACACA,Q13085,0.48,0.846,1.0,,,C3665365,"Arteriosclerotic cardiovascular disease, NOS",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.06,1.0
32,31,ACACA,Q13085,0.48,0.846,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.05,0.8
33,31,ACACA,Q13085,0.48,0.846,1.0,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.05,1.0
34,31,ACACA,Q13085,0.48,0.846,1.0,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.04,1.0
35,31,ACACA,Q13085,0.48,0.846,1.0,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,0.75
36,31,ACACA,Q13085,0.48,0.846,1.0,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0
37,31,ACACA,Q13085,0.48,0.846,1.0,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.04,1.0
38,31,ACACA,Q13085,0.48,0.846,1.0,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.04,1.0
39,31,ACACA,Q13085,0.48,0.846,1.0,,,C0206686,Adrenocortical carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
40,31,ACACA,Q13085,0.48,0.846,1.0,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,1.0
41,31,ACACA,Q13085,0.48,0.846,1.0,,,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.04,1.0
42,31,ACACA,Q13085,0.48,0.846,1.0,,,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.04,1.0
43,31,ACACA,Q13085,0.48,0.846,1.0,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0
44,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
45,31,ACACA,Q13085,0.48,0.846,1.0,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.03,1.0
46,31,ACACA,Q13085,0.48,0.846,1.0,,,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.03,1.0
47,31,ACACA,Q13085,0.48,0.846,1.0,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
48,31,ACACA,Q13085,0.48,0.846,1.0,,,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0
49,31,ACACA,Q13085,0.48,0.846,1.0,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
50,31,ACACA,Q13085,0.48,0.846,1.0,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0
51,31,ACACA,Q13085,0.48,0.846,1.0,,,C0003125,Anorexia Nervosa,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
52,31,ACACA,Q13085,0.48,0.846,1.0,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
53,31,ACACA,Q13085,0.48,0.846,1.0,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
54,31,ACACA,Q13085,0.48,0.846,1.0,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
55,31,ACACA,Q13085,0.48,0.846,1.0,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
56,31,ACACA,Q13085,0.48,0.846,1.0,,,C0021125,Impulsive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
57,31,ACACA,Q13085,0.48,0.846,1.0,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.02,1.0
58,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
59,31,ACACA,Q13085,0.48,0.846,1.0,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
60,31,ACACA,Q13085,0.48,0.846,1.0,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
61,31,ACACA,Q13085,0.48,0.846,1.0,,,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
62,31,ACACA,Q13085,0.48,0.846,1.0,,,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
63,31,ACACA,Q13085,0.48,0.846,1.0,,,C0028768,Obsessive-Compulsive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
64,31,ACACA,Q13085,0.48,0.846,1.0,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
65,31,ACACA,Q13085,0.48,0.846,1.0,,,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.02,1.0
66,31,ACACA,Q13085,0.48,0.846,1.0,,,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,0.5
67,31,ACACA,Q13085,0.48,0.846,1.0,,,C0206667,Adrenal Cortical Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
68,31,ACACA,Q13085,0.48,0.846,1.0,,,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
69,31,ACACA,Q13085,0.48,0.846,1.0,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
70,31,ACACA,Q13085,0.48,0.846,1.0,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
71,31,ACACA,Q13085,0.48,0.846,1.0,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
72,31,ACACA,Q13085,0.48,0.846,1.0,,,C0795950,Corpus callosum agenesis neuronopathy,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
73,31,ACACA,Q13085,0.48,0.846,1.0,,,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
74,31,ACACA,Q13085,0.48,0.846,1.0,,,C0867389,Chronic graft-versus-host disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
75,31,ACACA,Q13085,0.48,0.846,1.0,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
76,31,ACACA,Q13085,0.48,0.846,1.0,,,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
77,31,ACACA,Q13085,0.48,0.846,1.0,,,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0
78,31,ACACA,Q13085,0.48,0.846,1.0,,,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
79,31,ACACA,Q13085,0.48,0.846,1.0,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
80,31,ACACA,Q13085,0.48,0.846,1.0,,,C3539168,"PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A",,,disease,Disease or Syndrome,0.02,1.0
81,31,ACACA,Q13085,0.48,0.846,1.0,,,C0000846,Agenesis,,,disease,Congenital Abnormality,0.01,1.0
82,31,ACACA,Q13085,0.48,0.846,1.0,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
83,31,ACACA,Q13085,0.48,0.846,1.0,,,C0001624,Adrenal Gland Neoplasms,C04;C19,   Neoplasms;    Endocrine System Diseases,group,Neoplastic Process,0.01,1.0
84,31,ACACA,Q13085,0.48,0.846,1.0,,,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
85,31,ACACA,Q13085,0.48,0.846,1.0,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
86,31,ACACA,Q13085,0.48,0.846,1.0,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
87,31,ACACA,Q13085,0.48,0.846,1.0,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
88,31,ACACA,Q13085,0.48,0.846,1.0,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
89,31,ACACA,Q13085,0.48,0.846,1.0,,,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
90,31,ACACA,Q13085,0.48,0.846,1.0,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
91,31,ACACA,Q13085,0.48,0.846,1.0,,,C0006370,Bulimia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Mental or Behavioral Dysfunction,0.01,1.0
92,31,ACACA,Q13085,0.48,0.846,1.0,,,C0006625,Cachexia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
93,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
94,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
95,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
96,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007112,Adenocarcinoma of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
97,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
98,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
99,31,ACACA,Q13085,0.48,0.846,1.0,,,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
100,31,ACACA,Q13085,0.48,0.846,1.0,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
101,31,ACACA,Q13085,0.48,0.846,1.0,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
102,31,ACACA,Q13085,0.48,0.846,1.0,,,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
103,31,ACACA,Q13085,0.48,0.846,1.0,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
104,31,ACACA,Q13085,0.48,0.846,1.0,,,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.01,1.0
105,31,ACACA,Q13085,0.48,0.846,1.0,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
106,31,ACACA,Q13085,0.48,0.846,1.0,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
107,31,ACACA,Q13085,0.48,0.846,1.0,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
108,31,ACACA,Q13085,0.48,0.846,1.0,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
109,31,ACACA,Q13085,0.48,0.846,1.0,,,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
110,31,ACACA,Q13085,0.48,0.846,1.0,,,C0017154,"Gastritis, Atrophic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
111,31,ACACA,Q13085,0.48,0.846,1.0,,,C0017574,Gingivitis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
112,31,ACACA,Q13085,0.48,0.846,1.0,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
113,31,ACACA,Q13085,0.48,0.846,1.0,,,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
114,31,ACACA,Q13085,0.48,0.846,1.0,,,C0018133,Graft-vs-Host Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
115,31,ACACA,Q13085,0.48,0.846,1.0,,,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
116,31,ACACA,Q13085,0.48,0.846,1.0,,,C0018824,Heart valve disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
117,31,ACACA,Q13085,0.48,0.846,1.0,,,C0019079,Hemoptysis,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
118,31,ACACA,Q13085,0.48,0.846,1.0,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
119,31,ACACA,Q13085,0.48,0.846,1.0,,,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
120,31,ACACA,Q13085,0.48,0.846,1.0,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
121,31,ACACA,Q13085,0.48,0.846,1.0,,,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
122,31,ACACA,Q13085,0.48,0.846,1.0,,,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
123,31,ACACA,Q13085,0.48,0.846,1.0,,,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
124,31,ACACA,Q13085,0.48,0.846,1.0,,,C0020555,Hypertrichosis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
125,31,ACACA,Q13085,0.48,0.846,1.0,,,C0022283,Incontinentia Pigmenti Achromians,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
126,31,ACACA,Q13085,0.48,0.846,1.0,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
127,31,ACACA,Q13085,0.48,0.846,1.0,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
128,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
129,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
130,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
131,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
132,31,ACACA,Q13085,0.48,0.846,1.0,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
133,31,ACACA,Q13085,0.48,0.846,1.0,,,C0024305,"Lymphoma, Non-Hodgkin",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,0.0
134,31,ACACA,Q13085,0.48,0.846,1.0,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
135,31,ACACA,Q13085,0.48,0.846,1.0,,,C0026265,Diseases of mitral valve,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
136,31,ACACA,Q13085,0.48,0.846,1.0,,,C0026918,Mycobacterium Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
137,31,ACACA,Q13085,0.48,0.846,1.0,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
138,31,ACACA,Q13085,0.48,0.846,1.0,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
139,31,ACACA,Q13085,0.48,0.846,1.0,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,0.0
140,31,ACACA,Q13085,0.48,0.846,1.0,,,C0030421,Paraganglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
141,31,ACACA,Q13085,0.48,0.846,1.0,,,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
142,31,ACACA,Q13085,0.48,0.846,1.0,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
143,31,ACACA,Q13085,0.48,0.846,1.0,,,C0034013,Precocious Puberty,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
144,31,ACACA,Q13085,0.48,0.846,1.0,,,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
145,31,ACACA,Q13085,0.48,0.846,1.0,,,C0035439,Rheumatic Heart Disease,C01;C14,   Infections;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
146,31,ACACA,Q13085,0.48,0.846,1.0,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
147,31,ACACA,Q13085,0.48,0.846,1.0,,,C0037286,Skin Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
148,31,ACACA,Q13085,0.48,0.846,1.0,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
149,31,ACACA,Q13085,0.48,0.846,1.0,,,C0040954,Infection by Trichuris trichiura,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
150,31,ACACA,Q13085,0.48,0.846,1.0,,,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
151,31,ACACA,Q13085,0.48,0.846,1.0,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
152,31,ACACA,Q13085,0.48,0.846,1.0,,,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
153,31,ACACA,Q13085,0.48,0.846,1.0,,,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
154,31,ACACA,Q13085,0.48,0.846,1.0,,,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
155,31,ACACA,Q13085,0.48,0.846,1.0,,,C0151449,Primary Sjgren's syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
156,31,ACACA,Q13085,0.48,0.846,1.0,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
157,31,ACACA,Q13085,0.48,0.846,1.0,,,C0153594,Malignant neoplasm of testis,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,0.0
158,31,ACACA,Q13085,0.48,0.846,1.0,,,C0153690,Secondary malignant neoplasm of bone,C23;C04;C05,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Musculoskeletal Diseases",disease,Neoplastic Process,0.01,1.0
159,31,ACACA,Q13085,0.48,0.846,1.0,,,C0154251,Lipid Metabolism Disorders,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
160,31,ACACA,Q13085,0.48,0.846,1.0,,,C0162359,Christ-Siemens-Touraine syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
161,31,ACACA,Q13085,0.48,0.846,1.0,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
162,31,ACACA,Q13085,0.48,0.846,1.0,,,C0206682,Follicular thyroid carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
163,31,ACACA,Q13085,0.48,0.846,1.0,,,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
164,31,ACACA,Q13085,0.48,0.846,1.0,,,C0233477,Dysphoric mood,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
165,31,ACACA,Q13085,0.48,0.846,1.0,,,C0234251,Inflammatory pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
166,31,ACACA,Q13085,0.48,0.846,1.0,,,C0236663,Alcohol withdrawal syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
167,31,ACACA,Q13085,0.48,0.846,1.0,,,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.01,1.0
168,31,ACACA,Q13085,0.48,0.846,1.0,,,C0237123,Alcohol or Other Drugs use,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
169,31,ACACA,Q13085,0.48,0.846,1.0,,,C0238461,Anaplastic thyroid carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
170,31,ACACA,Q13085,0.48,0.846,1.0,,,C0266574,Ablepharon,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0
171,31,ACACA,Q13085,0.48,0.846,1.0,,,C0266929,Chronic Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
172,31,ACACA,Q13085,0.48,0.846,1.0,,,C0270549,Generalized Anxiety Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
173,31,ACACA,Q13085,0.48,0.846,1.0,,,C0278139,Moderate pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
174,31,ACACA,Q13085,0.48,0.846,1.0,,,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
175,31,ACACA,Q13085,0.48,0.846,1.0,,,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
176,31,ACACA,Q13085,0.48,0.846,1.0,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
177,31,ACACA,Q13085,0.48,0.846,1.0,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
178,31,ACACA,Q13085,0.48,0.846,1.0,,,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
179,31,ACACA,Q13085,0.48,0.846,1.0,,,C0333693,Triploidy syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
180,31,ACACA,Q13085,0.48,0.846,1.0,,,C0334342,Skin appendage adenoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
181,31,ACACA,Q13085,0.48,0.846,1.0,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
182,31,ACACA,Q13085,0.48,0.846,1.0,,,C0344482,Hypoplasia of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
183,31,ACACA,Q13085,0.48,0.846,1.0,,,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
184,31,ACACA,Q13085,0.48,0.846,1.0,,,C0349458,Cervical intraepithelial neoplasia grade 1,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
185,31,ACACA,Q13085,0.48,0.846,1.0,,,C0438696,Suicidal,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,0.0
186,31,ACACA,Q13085,0.48,0.846,1.0,,,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
187,31,ACACA,Q13085,0.48,0.846,1.0,,,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
188,31,ACACA,Q13085,0.48,0.846,1.0,,,C0520463,Chronic active hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
189,31,ACACA,Q13085,0.48,0.846,1.0,,,C0521158,Recurrent tumor,,,phenotype,Neoplastic Process,0.01,1.0
190,31,ACACA,Q13085,0.48,0.846,1.0,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
191,31,ACACA,Q13085,0.48,0.846,1.0,,,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
192,31,ACACA,Q13085,0.48,0.846,1.0,,,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
193,31,ACACA,Q13085,0.48,0.846,1.0,,,C0600104,Obsessive compulsive behavior,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
194,31,ACACA,Q13085,0.48,0.846,1.0,,,C0679427,myeloblastosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
195,31,ACACA,Q13085,0.48,0.846,1.0,,,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
196,31,ACACA,Q13085,0.48,0.846,1.0,,,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.01,1.0
197,31,ACACA,Q13085,0.48,0.846,1.0,,,C0740447,Diabetic peripheral neuropathy,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
198,31,ACACA,Q13085,0.48,0.846,1.0,,,C0740858,Substance abuse problem,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
199,31,ACACA,Q13085,0.48,0.846,1.0,,,C0742343,Acute Chest Syndrome,C16;C08;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
200,31,ACACA,Q13085,0.48,0.846,1.0,,,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
201,31,ACACA,Q13085,0.48,0.846,1.0,,,C0751951,Central Core Myopathy (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
202,31,ACACA,Q13085,0.48,0.846,1.0,,,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
203,31,ACACA,Q13085,0.48,0.846,1.0,,,C0856825,Acute GVH disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
204,31,ACACA,Q13085,0.48,0.846,1.0,,,C0878521,Beta thalassemia trait,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
205,31,ACACA,Q13085,0.48,0.846,1.0,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
206,31,ACACA,Q13085,0.48,0.846,1.0,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
207,31,ACACA,Q13085,0.48,0.846,1.0,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
208,31,ACACA,Q13085,0.48,0.846,1.0,,,C0949083,Hospital acquired pneumonia,C23;C01;C08,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
209,31,ACACA,Q13085,0.48,0.846,1.0,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
210,31,ACACA,Q13085,0.48,0.846,1.0,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
211,31,ACACA,Q13085,0.48,0.846,1.0,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
212,31,ACACA,Q13085,0.48,0.846,1.0,,,C1266086,Polymorphous low grade adenocarcinoma,,,disease,Neoplastic Process,0.01,1.0
213,31,ACACA,Q13085,0.48,0.846,1.0,,,C1266184,Atypical Teratoid Rhabdoid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
214,31,ACACA,Q13085,0.48,0.846,1.0,,,C1331548,Infection by Ascaris lumbricoides,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
215,31,ACACA,Q13085,0.48,0.846,1.0,,,C1332167,Adenoid cystic breast carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
216,31,ACACA,Q13085,0.48,0.846,1.0,,,C1443237,Healthcare associated pneumonia,C23;C01;C08,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases",phenotype,Disease or Syndrome,0.01,1.0
217,31,ACACA,Q13085,0.48,0.846,1.0,,,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
218,31,ACACA,Q13085,0.48,0.846,1.0,,,C1456332,Stimulant abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
219,31,ACACA,Q13085,0.48,0.846,1.0,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
220,31,ACACA,Q13085,0.48,0.846,1.0,,,C1519346,Skin Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
221,31,ACACA,Q13085,0.48,0.846,1.0,,,C1536220,ST segment elevation myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
222,31,ACACA,Q13085,0.48,0.846,1.0,,,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.01,1.0
223,31,ACACA,Q13085,0.48,0.846,1.0,,,C1696708,Prehypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
224,31,ACACA,Q13085,0.48,0.846,1.0,,,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
225,31,ACACA,Q13085,0.48,0.846,1.0,,,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
226,31,ACACA,Q13085,0.48,0.846,1.0,,,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
227,31,ACACA,Q13085,0.48,0.846,1.0,,,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
228,31,ACACA,Q13085,0.48,0.846,1.0,,,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
229,31,ACACA,Q13085,0.48,0.846,1.0,,,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
230,31,ACACA,Q13085,0.48,0.846,1.0,,,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
231,31,ACACA,Q13085,0.48,0.846,1.0,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
232,31,ACACA,Q13085,0.48,0.846,1.0,,,C3539920,"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.01,1.0
233,31,ACACA,Q13085,0.48,0.846,1.0,,,C3544321,Treatment-resistant schizophrenia,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
234,31,ACACA,Q13085,0.48,0.846,1.0,,,C3642345,Luminal A Breast Carcinoma,,,disease,Neoplastic Process,0.01,1.0
235,31,ACACA,Q13085,0.48,0.846,1.0,,,C3887494,"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
236,31,ACACA,Q13085,0.48,0.846,1.0,,,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
237,31,ACACA,Q13085,0.48,0.846,1.0,,,C4551472,Hypertrophic obstructive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
238,31,ACACA,Q13085,0.48,0.846,1.0,,,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
239,31,ACACA,Q13085,0.48,0.846,1.0,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
240,31,ACACA,Q13085,0.48,0.846,1.0,,,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
0,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.5,1.0
1,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.34,1.0
2,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0920563,Insulin Sensitivity,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.3,1.0
3,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,
4,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0
5,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0015696,"Fatty Liver, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.2,1.0
6,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0
7,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,1.0
8,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.05,1.0
9,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0
10,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.04,1.0
11,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.04,1.0
12,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.04,1.0
13,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
14,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
15,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
16,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
17,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
18,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
19,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
20,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
21,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
22,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
23,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
24,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
25,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
26,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0011389,Dental Plaque,C07,   Stomatognathic Diseases,phenotype,Disease or Syndrome,0.01,1.0
27,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
28,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
29,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
30,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
31,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0028756,"Obesity, Morbid",C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
32,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
33,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
34,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0153398,Hypopharyngeal Cancer,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
35,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0220636,Malignant neoplasm of salivary gland,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
36,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
37,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0279746,Adenocarcinoma of salivary gland,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
38,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
39,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0742343,Acute Chest Syndrome,C16;C08;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
40,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0948750,Salivary gland carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
41,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
42,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C1368404,Hypopharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
43,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
44,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
45,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C2362324,Pediatric Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
46,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C4082937,Necrotizing enterocolitis in fetus OR newborn,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
47,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
48,32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0220711,Long chain acyl-CoA dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.5,1.0
1,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C3887523,Very long chain acyl-CoA dehydrogenase deficiency,C16;C18;C05;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.2,1.0
2,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0004239,Atrial Flutter,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,
3,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
4,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
5,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,
6,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0020672,"Hypothermia, natural",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
7,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0
8,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0023380,Lethargy,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.1,
9,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0042963,Vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
10,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0085298,Sudden Cardiac Death,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,
11,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0151878,Prolonged QT interval,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.1,
12,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0220994,Hyperammonemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.1,
13,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0221170,Muscular stiffness,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.1,
14,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0231528,Myalgia,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
15,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0231835,Tachypnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
16,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0232466,Feeding difficulties,,,phenotype,Finding,0.1,
17,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0523446,Acylcarnitines measurement,,,phenotype,Laboratory Procedure,0.1,1.0
18,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
19,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0746674,Generalized muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
20,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0856975,Autistic behavior,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,
21,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0947912,Myasthenias,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
22,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1142132,Carnitine deficiency,,,phenotype,Finding,0.1,
23,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
24,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.1,1.0
25,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1845155,Exercise-induced myoglobinuria,C05,   Musculoskeletal Diseases,phenotype,Finding,0.1,
26,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1855038,Hepatocellular necrosis,,,phenotype,Disease or Syndrome,0.1,
27,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1856432,Dicarboxylic aciduria,,,phenotype,Finding,0.1,
28,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
29,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1859236,Prolonged neonatal jaundice,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",phenotype,Finding,0.1,
30,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1865292,Nonketotic hypoglycemia,C18,   Nutritional and Metabolic Diseases,phenotype,Finding,0.1,
31,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
32,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C3532934,Mild expressive language delay,,,disease,Mental or Behavioral Dysfunction,0.1,
33,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C4021526,Exercise-induced rhabdomyolysis,C05,   Musculoskeletal Diseases,phenotype,Finding,0.1,
34,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C4021726,EMG: myopathic abnormalities,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,phenotype,Pathologic Function,0.1,
35,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C4024700,Elevated creatine kinase after exercise,,,phenotype,Finding,0.1,
36,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C4477062,Decreased activity of 3-hydroxyacyl-CoA dehydrogenase,,,phenotype,Finding,0.1,
37,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C4552811,"Generalized Muscle Weakness, CTCAE",,,phenotype,Finding,0.1,
38,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
39,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
40,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0020615,Hypoglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
41,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
42,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
43,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
44,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
45,33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
0,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0220710,Medium-chain acyl-coenzyme A dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.991
1,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0038644,Sudden infant death syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.4,1.0
2,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0
3,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0
4,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0035410,Rhabdomyolysis,C05,   Musculoskeletal Diseases,phenotype,Pathologic Function,0.3,
5,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0
6,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0085605,Liver Failure,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
7,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0520459,Necrotizing Enterocolitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
8,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C2750440,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1",,,disease,Finding,0.2,1.0
9,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C2750441,"LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1",,,phenotype,Finding,0.2,1.0
10,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C3150651,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2",,,phenotype,Finding,0.2,1.0
11,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0020615,Hypoglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.16,1.0
12,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0042963,Vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.11,1.0
13,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.1,
14,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
15,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0006114,Cerebral Edema,C10,   Nervous System Diseases,phenotype,Pathologic Function,0.1,
16,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0006625,Cachexia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
17,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0009421,Comatose,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
18,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
19,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
20,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
21,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
22,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.1,
23,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,
24,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0022638,Ketosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
25,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0023380,Lethargy,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.1,
26,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
27,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.1,
28,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
29,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0037763,Spasm,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
30,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0041657,Unconscious State,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
31,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
32,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0220981,Metabolic acidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.1,
33,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0220994,Hyperammonemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.1,
34,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0221355,Macrocephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
35,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0221629,Proximal muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
36,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0231807,Dyspnea on exertion,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
37,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0232744,Decreased liver function,,,phenotype,Finding,0.1,
38,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0241005,Creatine phosphokinase serum increased,,,phenotype,Finding,0.1,
39,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0265213,Distal arthrogryposis syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,
40,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0428474,Serum LDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
41,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0454644,Delayed speech and language development,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
42,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
43,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0523677,Glycine measurement,,,phenotype,Laboratory Procedure,0.1,1.0
44,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0541794,Skeletal muscle atrophy,,,phenotype,Pathologic Function,0.1,
45,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0543541,HYPERGLYCINURIA (disorder),C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,
46,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
47,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1142132,Carnitine deficiency,,,phenotype,Finding,0.1,
48,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1848701,Elevated hepatic transaminase,,,phenotype,Finding,0.1,
49,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1850830,Exercise-induced myalgia,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
50,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1856432,Dicarboxylic aciduria,,,phenotype,Finding,0.1,
51,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
52,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1860081,Medium chain dicarboxylic aciduria,,,phenotype,Finding,0.1,
53,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1866934,Reduced tendon reflexes,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
54,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
55,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C3554691,"HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES",,,disease,Disease or Syndrome,0.1,
56,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C4022414,Elevated urinary 3-hydroxybutyric acid,,,phenotype,Finding,0.1,
57,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C4022584,Fatigable weakness of neck muscles,,,phenotype,Finding,0.1,
58,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C4023117,Decreased plasma total carnitine,,,phenotype,Finding,0.1,
59,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C4073168,Abnormal lactate dehydrogenase activity,,,phenotype,Finding,0.1,
60,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.04,1.0
61,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
62,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0025521,Inborn Errors of Metabolism,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome; Congenital Abnormality,0.03,1.0
63,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0268634,Disorder of fatty acid metabolism,C23;C16;C18,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.03,1.0
64,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1456270,Fatty acid oxidation disorder,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0
65,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
66,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5
67,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C4732730,Blood spots,,,disease,Disease or Syndrome,0.02,1.0
68,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0002792,anaphylaxis,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.01,1.0
69,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
70,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
71,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0017919,Glycogen Storage Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.01,1.0
72,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0020617,Hypoglycemic coma,C23;C18;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
73,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
74,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0023976,Long QT Syndrome,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
75,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
76,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0030552,Paresis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
77,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0031485,Phenylketonurias,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",group,Disease or Syndrome,0.01,1.0
78,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0035400,Reye Syndrome,C06;C18;C10,   Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
79,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
80,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0151786,Muscle Weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
81,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0162557,"Liver Failure, Acute",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
82,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
83,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
84,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0342788,Renal carnitine transport defect,C23;C05;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
85,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0347959,Lactic acidemia,,,phenotype,Disease or Syndrome,0.01,1.0
86,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
87,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
88,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
89,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
90,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0751486,Reye-Like Syndrome,C06;C18;C10,   Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
91,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C1829742,Fatty acid oxidation defects,,,group,Disease or Syndrome,0.01,1.0
92,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C2718001,Protein Misfolding Disorders,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
93,34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0342783,Deficiency of butyryl-CoA dehydrogenase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0
1,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
2,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
3,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
4,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0023212,Left-Sided Heart Failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
5,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0235527,"Heart Failure, Right-Sided",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
6,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1959583,Myocardial Failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
7,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1961112,Heart Decompensation,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
8,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.11,1.0
9,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.11,1.0
10,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0015469,Facial paralysis,C23;C10;C07,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.1,
11,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0
12,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0023380,Lethargy,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.1,
13,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
14,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,
15,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
16,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
17,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0
18,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0333068,Flexion contracture,C05,   Musculoskeletal Diseases,disease,Finding,0.1,
19,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
20,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0428472,Serum HDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
21,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0454644,Delayed speech and language development,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
22,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
23,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0
24,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
25,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,
26,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0948163,Leukoaraiosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
27,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
28,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.1,1.0
29,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1855106,Neonatal onset,,,phenotype,Finding,0.1,
30,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
31,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1859516,Episodic metabolic acidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Finding,0.1,
32,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1865353,Ethylmalonic aciduria,,,phenotype,Finding,0.1,
33,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C2674608,Feeding difficulties in infancy,,,phenotype,Finding,0.1,
34,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0
35,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
36,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
37,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
38,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
39,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
40,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0014742,Erythema Multiforme,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
41,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
42,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
43,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
44,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0220710,Medium-chain acyl-coenzyme A dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
45,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
46,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
47,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0741933,cardiac symptom,,,phenotype,Sign or Symptom,0.01,1.0
48,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
49,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
50,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1852540,"Coronary Artery Dissection, Spontaneous",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
51,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
52,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
53,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C2315100,Pediatric failure to thrive,C23;C18;F03,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
54,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C3887638,Failure to thrive in infant,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
55,35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C4732730,Blood spots,,,disease,Disease or Syndrome,0.01,0.0
0,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C1864912,2-Methylbutyryl-CoA Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0
1,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
2,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0015310,Exotropia,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
3,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0020615,Hypoglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
4,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0020672,"Hypothermia, natural",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
5,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0023380,Lethargy,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.1,
6,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
7,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
8,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
9,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0520947,Clumsiness - motor delay,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.1,
10,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
11,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C1389113,Generalized amyotrophy,,,disease,Disease or Syndrome,0.1,
12,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C1854301,Motor delay,F03,   Mental Disorders,phenotype,Finding,0.1,
13,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
14,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C3807980,Apneic episodes in infancy,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
15,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
16,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
17,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
18,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
19,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
20,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0175694,Smith-Lemli-Opitz Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
21,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0282313,"Condition, Preneoplastic",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
22,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0342783,Deficiency of butyryl-CoA dehydrogenase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
23,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0406740,Kohlschutter Tonz syndrome,C16;C10;F03;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
24,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
25,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C1969809,Isobutyryl-CoA dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
26,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C2198591,2-methylbutyrylglycinuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
27,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
28,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C2751532,3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
29,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C3266731,2-methyl-3-hydroxybutyric aciduria,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
30,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C3281160,"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2",,,disease,Disease or Syndrome,0.01,1.0
31,36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C3696376,3-Methylglutaconic Aciduria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
0,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C3887523,Very long chain acyl-CoA dehydrogenase deficiency,C16;C18;C05;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.989
1,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
2,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
3,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0242184,Hypoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
4,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0270984,Metabolic myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.3,1.0
5,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0369183,Erythrocyte Mean Corpuscular Hemoglobin Test,,,phenotype,Laboratory Procedure,0.3,1.0
6,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0700292,Hypoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0
7,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.3,1.0
8,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0282507,Heat Stress Disorders,C26,   Wounds and Injuries,phenotype,Injury or Poisoning,0.2,1.0
9,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0
10,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C2750440,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1",,,disease,Finding,0.2,1.0
11,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C2750441,"LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1",,,phenotype,Finding,0.2,1.0
12,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C3150651,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2",,,phenotype,Finding,0.2,1.0
13,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0
14,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,1.0
15,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.11,1.0
16,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0031039,Pericardial effusion,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0
17,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,1.0
18,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0004245,Atrioventricular Block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
19,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,
20,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0016522,"Foramen Ovale, Patent",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.1,
21,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0018818,Ventricular Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.1,
22,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,
23,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0020598,Hypocalcemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.1,
24,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0020639,Hypoproteinemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
25,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0020672,"Hypothermia, natural",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
26,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0022346,Icterus,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
27,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0023380,Lethargy,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.1,
28,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
29,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,
30,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
31,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,
32,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0035410,Rhabdomyolysis,C05,   Musculoskeletal Diseases,phenotype,Pathologic Function,0.1,
33,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0037763,Spasm,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
34,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0042510,Ventricular Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
35,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0042514,"Tachycardia, Ventricular",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
36,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0042963,Vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
37,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0085298,Sudden Cardiac Death,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,
38,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0151786,Muscle Weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
39,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0151878,Prolonged QT interval,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.1,
40,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0220981,Metabolic acidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.1,
41,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0220994,Hyperammonemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.1,
42,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0221170,Muscular stiffness,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.1,
43,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0221355,Macrocephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
44,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0231835,Tachypnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
45,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0232466,Feeding difficulties,,,phenotype,Finding,0.1,
46,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0235991,Small for gestational age (disorder),C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Finding,0.1,
47,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0241005,Creatine phosphokinase serum increased,,,phenotype,Finding,0.1,
48,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0302511,Small for gestational age fetus,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
49,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0342784,Pearson's marrow-pancreas syndrome,C23;C16;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0
50,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0476273,Respiratory distress,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
51,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0497406,Overweight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
52,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
53,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1142132,Carnitine deficiency,,,phenotype,Finding,0.1,
54,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1838705,Anteriorly placed anus,,,phenotype,Finding,0.1,
55,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1845155,Exercise-induced myoglobinuria,C05,   Musculoskeletal Diseases,phenotype,Finding,0.1,
56,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1848701,Elevated hepatic transaminase,,,phenotype,Finding,0.1,
57,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1850830,Exercise-induced myalgia,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
58,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1853377,Enlarged cisterna magna,,,phenotype,Finding,0.1,
59,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1855038,Hepatocellular necrosis,,,phenotype,Disease or Syndrome,0.1,
60,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1856432,Dicarboxylic aciduria,,,phenotype,Finding,0.1,
61,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1856438,Hypoketotic hypoglycemia,C18,   Nutritional and Metabolic Diseases,phenotype,Finding,0.1,
62,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
63,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1860834,Infantile muscular hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
64,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1865292,Nonketotic hypoglycemia,C18,   Nutritional and Metabolic Diseases,phenotype,Finding,0.1,
65,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C3806218,Episodic tachypnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
66,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C3875321,Inflammatory dermatosis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
67,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C4021526,Exercise-induced rhabdomyolysis,C05,   Musculoskeletal Diseases,phenotype,Finding,0.1,
68,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C4023591,Abnormality of circulating enzyme level,,,phenotype,Finding,0.1,
69,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C4280773,Increased circulating free fatty acid level,,,phenotype,Finding,0.1,
70,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
71,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0001627,Congenital adrenal hyperplasia,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
72,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
73,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
74,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0020615,Hypoglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
75,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
76,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0033626,Protein Deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
77,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
78,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0206667,Adrenal Cortical Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
79,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0221757,alpha 1-Antitrypsin Deficiency,C23;C16;C06;C08,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
80,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
81,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C0302280,Adrenogenital Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
82,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1145670,Respiratory Failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
83,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1282975,"von Willebrand Disease, Type 2N",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
84,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C1969443,Trifunctional Protein Deficiency With Myopathy And Neuropathy,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
85,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C3150275,COMPLEMENT COMPONENT 2 DEFICIENCY,,,disease,Disease or Syndrome,0.01,1.0
86,37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C4551472,Hypertrophic obstructive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
0,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1536500,Deficiency of acetyl-CoA acetyltransferase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0
1,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.5,1.0
2,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0
3,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0022333,Jacksonian Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
4,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
5,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0149958,Complex partial seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
6,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0234533,Generalized seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
7,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0234535,Clonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
8,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
9,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0270844,Tonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
10,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0270846,Epileptic drop attack,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
11,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0422850,"Seizures, Somatosensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
12,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0422852,"Seizures, Auditory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
13,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0422853,Olfactory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
14,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0422854,Gustatory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
15,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0422855,Vertiginous seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
16,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
17,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0751056,Non-epileptic convulsion,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
18,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0751110,Single Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
19,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0751123,Atonic Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
20,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0751494,Convulsive Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
21,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0751495,"Seizures, Focal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
22,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0751496,"Seizures, Sensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
23,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C3495874,Nonepileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
24,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4048158,Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
25,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4316903,Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
26,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4317109,Epileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
27,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4317123,Myoclonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
28,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4505436,Generalized Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
29,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.2,1.0
30,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0
31,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0022638,Ketosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.13,1.0
32,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.11,1.0
33,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.11,1.0
34,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0003123,Anorexia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
35,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
36,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0009421,Comatose,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
37,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
38,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.1,
39,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
40,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0013604,Edema,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
41,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
42,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,
43,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0020615,Hypoglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
44,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0020649,Hypotension,C14,   Cardiovascular Diseases,phenotype,Finding,0.1,
45,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0023364,Leptospirosis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0
46,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0023518,Leukocytosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.1,
47,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0026106,Mild Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,
48,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
49,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0026838,Muscle Spasticity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
50,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0030232,Pallor,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
51,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0036857,Severe intellectual disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,
52,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0042963,Vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
53,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0085595,Body odor,,,phenotype,Finding,0.1,
54,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0085631,Agitation,C10;F03;F01,   Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.1,
55,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0085632,Apathy,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.1,
56,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0151888,Hyporeflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
57,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0162275,Ketonuria,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
58,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0220981,Metabolic acidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.1,
59,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0220982,Ketoacidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.1,1.0
60,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0220994,Hyperammonemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.1,
61,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0231835,Tachypnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
62,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0278061,Abnormal mental state,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",phenotype,Mental or Behavioral Dysfunction,0.1,1.0
63,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0520947,Clumsiness - motor delay,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.1,
64,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0521654,Neurologic Deficits,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Finding,0.1,1.0
65,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0694563,Excessive daytime somnolence,,,phenotype,Disease or Syndrome,0.1,
66,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0740394,Hyperuricemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
67,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0836924,Thrombocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
68,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1262477,Weight decreased,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
69,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1836440,Increased serum lactate,C18,   Nutritional and Metabolic Diseases,phenotype,Finding,0.1,
70,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1848528,Extrapyramidal dyskinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
71,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1854301,Motor delay,F03,   Mental Disorders,phenotype,Finding,0.1,
72,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1859860,Episodic ketoacidosis,,,phenotype,Finding,0.1,
73,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1963060,"Agitation, CTCAE 3.0",,,phenotype,Finding,0.1,
74,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C3665983,Oral aversion,,,disease,Mental or Behavioral Dysfunction,0.1,
75,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.1,
76,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4022764,Abnormal metabolic brain imaging by MRS,,,phenotype,Finding,0.1,
77,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4552855,"Agitation, CTCAE 5.0",,,phenotype,Finding,0.1,
78,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4553743,"Spasticity, CTCAE",,,phenotype,Finding,0.1,
79,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4554061,"Body Odor, CTCAE",,,phenotype,Finding,0.1,
80,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.08,1.0
81,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.08,1.0
82,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.08,1.0
83,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
84,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
85,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
86,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0
87,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0
88,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
89,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
90,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
91,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
92,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
93,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
94,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0025521,Inborn Errors of Metabolism,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome; Congenital Abnormality,0.02,1.0
95,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
96,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0043325,Xanthomatosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
97,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
98,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0268621,Hepatic methionine adenosyltransferase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
99,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0342869,Deficiency of acetyl-CoA acyltransferase (disorder),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
100,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
101,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0
102,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
103,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C2931852,Clear-cell metastatic renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
104,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
105,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4048705,Hypermethioninemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.02,1.0
106,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
107,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4703473,Atherosclerotic lesion,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
108,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
109,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
110,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
111,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
112,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
113,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
114,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
115,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
116,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
117,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
118,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
119,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0010481,Cushing Syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
120,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0013238,Dry Eye Syndromes,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
121,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
122,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0018553,"Hamartoma Syndrome, Multiple",C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Neoplastic Process,0.01,1.0
123,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0018965,Hematuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Disease or Syndrome,0.01,1.0
124,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
125,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
126,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0021125,Impulsive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
127,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
128,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
129,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
130,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0
131,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
132,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0039538,Teratoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
133,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
134,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0153567,Uterine Cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
135,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
136,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0154251,Lipid Metabolism Disorders,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
137,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
138,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0206686,Adrenocortical carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
139,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0221032,Familial generalized lipodystrophy,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
140,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0237123,Alcohol or Other Drugs use,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
141,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
142,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
143,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
144,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0243038,"Carcinoma, Lewis Lung",C04,   Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.01,1.0
145,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0268490,"Tyrosinemia, Type I",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
146,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
147,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
148,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0279606,Childhood Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
149,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0279607,Adult Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
150,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
151,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
152,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0314719,Dryness of eye,C11,   Eye Diseases,phenotype,Sign or Symptom,0.01,1.0
153,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
154,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0342443,Adrenal Cushing's syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
155,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0343804,Chronic Chagas' disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
156,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
157,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
158,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
159,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
160,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
161,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1266042,Chromophobe Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
162,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1285498,Vegetation,,,disease,Anatomical Abnormality,0.01,0.0
163,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1304249,Cutaneous xanthoma,,,disease,Disease or Syndrome,0.01,1.0
164,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
165,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1512409,Hepatocarcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
166,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1512981,Mammary Tumorigenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
167,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1535939,Pneumocystis jiroveci pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
168,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0
169,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
170,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
171,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C2938940,Post stroke depression,F03,   Mental Disorders,disease,Disease or Syndrome,0.01,1.0
172,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.01,1.0
173,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4324621,Opioid use disorder,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
174,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
175,38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0342735,Cytosolic acetoacetyl-CoA thiolase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,
1,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.2,1.0
2,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0008489,Chorea,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
3,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
4,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1096202,Lipoprotein (a) measurement,,,phenotype,Laboratory Procedure,0.1,1.0
5,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1836440,Increased serum lactate,C18,   Nutritional and Metabolic Diseases,phenotype,Finding,0.1,
6,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1849488,Increased serum pyruvate,,,phenotype,Finding,0.1,
7,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1853237,Isolated cases,,,phenotype,Finding,0.1,
8,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
9,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
10,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
11,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
12,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0
13,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
14,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
15,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
16,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
17,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
18,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
19,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
20,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
21,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
22,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
23,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
24,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
25,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0
26,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
27,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
28,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
29,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0342869,Deficiency of acetyl-CoA acyltransferase (disorder),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
30,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
31,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0856727,Cholesterol gallstones,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
32,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0947622,Cholecystolithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
33,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
34,39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C1536500,Deficiency of acetyl-CoA acetyltransferase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
0,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
1,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
2,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
3,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0017565,Gingival Hemorrhage,C23;C07,"   Pathological Conditions, Signs and Symptoms;    Stomatognathic Diseases",phenotype,Pathologic Function,0.1,1.0
4,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
5,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0
6,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0
7,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
8,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0
9,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0
10,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,1.0
11,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0
12,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
13,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
14,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C1519383,Smoking Behaviors,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0
15,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C1837461,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3",,,disease,Finding,0.1,1.0
16,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C3893645,response to ACE inhibitor,,,phenotype,Organism Function,0.1,1.0
17,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
18,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
19,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0
20,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
21,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0
22,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
23,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
24,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.02,1.0
25,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
26,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
27,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
28,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
29,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
30,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
31,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
32,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
33,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
34,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
35,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
36,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
37,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
38,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0030319,Panic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
39,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
40,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0034152,Henoch-Schoenlein Purpura,C23;C20;C15;C14,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
41,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
42,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
43,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
44,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
45,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
46,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0494165,Secondary malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
47,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
48,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
49,40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
0,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
1,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
2,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0917798,Cerebral Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Pathologic Function,0.3,1.0
3,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0030319,Panic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0
4,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,0.333
5,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
6,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
7,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,0.0
8,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
9,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
10,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5
11,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
12,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0007682,CNS disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
13,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
14,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
15,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
16,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0013170,Drug habituation,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
17,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
18,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
19,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0018834,Heartburn,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
20,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
21,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
22,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
23,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0024408,Machado-Joseph Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
24,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
25,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
26,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
27,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0029124,Optic Atrophy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
28,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
29,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
30,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
31,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
32,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0154723,Migraine with Aura,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
33,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0158026,Monoarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
34,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0178782,Orofacial Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
35,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0184567,Acute onset pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
36,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0221505,Lesion of brain,,,group,Disease or Syndrome,0.01,1.0
37,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0267071,Oropharyngeal Dysphagia,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
38,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
39,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
40,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0282488,Interstitial Cystitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
41,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0596240,Cancer Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
42,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0600040,Chronic interstitial cystitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
43,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
44,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0751964,"Multiple Sclerosis, Primary Progressive",C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
45,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C1095979,Progressive multiple sclerosis,,,disease,Disease or Syndrome,0.01,1.0
46,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
47,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C1274924,Cutaneous allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
48,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C2936719,Mechanical Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
49,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
50,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
51,41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.4,0.985
1,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.4,1.0
2,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.931
3,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.4,1.0
4,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.35,1.0
5,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0
6,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0
7,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.33,1.0
8,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.32,1.0
9,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
10,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0
11,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0
12,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0
13,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0025261,Memory Disorders,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.31,1.0
14,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
15,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0149958,Complex partial seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0
16,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751295,Memory Loss,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.31,1.0
17,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4048158,Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.31,1.0
18,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0
19,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0013221,Drug toxicity,C25,   Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0
20,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0018273,Growth Disorders,C23,"   Pathological Conditions, Signs and Symptoms",group,Pathologic Function,0.3,1.0
21,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0022333,Jacksonian Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
22,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023186,Learning Disorders,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",group,Mental or Behavioral Dysfunction,0.3,1.0
23,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
24,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0
25,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0026850,Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
26,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0
27,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
28,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0040827,Saturnine Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
29,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0041755,Adverse reaction to drug,C25,   Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
30,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0149840,Senile Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
31,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234370,Persistent Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
32,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234371,Continuous Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
33,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234372,Intermittent Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
34,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234373,Fine Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
35,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234374,Coarse Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
36,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234375,Massive Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
37,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234376,Action Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
38,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234377,Passive Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
39,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234378,Static Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
40,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234379,Resting Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
41,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234381,Darkness Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
42,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234533,Generalized seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
43,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234535,Clonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
44,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0235078,"Tremor, Perioral",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
45,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0235081,"Tremor, Limb",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
46,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0235082,"Tremor, Muscle",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
47,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0235083,Nerve Tremors,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
48,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0235843,"Tremor, Neonatal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
49,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
50,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0236804,Amphetamine Addiction,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
51,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0236807,Amphetamine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
52,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0266487,Etat Marbre,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0
53,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
54,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0270844,Tonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
55,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0270846,Epileptic drop attack,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
56,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0276496,Familial Alzheimer Disease (FAD),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
57,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
58,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0353676,Organophosphorus Poisoning,C25,   Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
59,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
60,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0422850,"Seizures, Somatosensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
61,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0422852,"Seizures, Auditory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
62,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0422853,Olfactory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
63,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0422854,Gustatory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
64,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0422855,Vertiginous seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
65,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
66,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0546126,Acute Confusional Senile Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
67,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0700359,Organophosphate poisoning,C25,   Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
68,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0750900,"Alzheimer's Disease, Focal Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
69,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0750901,"Alzheimer Disease, Early Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
70,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751056,Non-epileptic convulsion,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
71,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751110,Single Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
72,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751123,Atonic Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
73,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751262,Adult Learning Disorders,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",group,Mental or Behavioral Dysfunction,0.3,1.0
74,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751263,Learning Disturbance,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.3,1.0
75,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751265,Learning Disabilities,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.3,1.0
76,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751292,Age-Related Memory Disorders,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0
77,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751293,"Memory Disorder, Semantic",C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.3,1.0
78,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751294,"Memory Disorder, Spatial",C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.3,1.0
79,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751494,Convulsive Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
80,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751495,"Seizures, Focal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
81,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751496,"Seizures, Sensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
82,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751564,Pill Rolling Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
83,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751565,"Tremor, Semirhythmic",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
84,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1257931,"Mammary Neoplasms, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
85,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1266042,Chromophobe Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
86,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1266043,Sarcomatoid Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
87,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1266044,Collecting Duct Carcinoma of the Kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
88,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1306837,Papillary Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
89,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1330966,Developmental Academic Disorder,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",phenotype,Finding,0.3,1.0
90,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.3,1.0
91,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1527384,Involuntary Quiver,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
92,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3494247,Organothiophosphonate Poisoning,C25,   Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
93,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3494248,Organothiophosphate Poisoning,C25,   Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
94,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3495874,Nonepileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
95,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4316903,Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
96,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4317109,Epileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
97,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4317123,Myoclonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
98,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4505436,Generalized Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
99,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4704874,"Mammary Carcinoma, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
100,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
101,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023364,Leptospirosis,C01,   Infections,disease,Disease or Syndrome,0.2,1.0
102,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0029488,Other acute reactions to stress,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0
103,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0043102,Weil Disease,C01,   Infections,disease,Disease or Syndrome,0.2,1.0
104,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0
105,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0026896,Myasthenia Gravis,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
106,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
107,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
108,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.1,1.0
109,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,0.951
110,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
111,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0428472,Serum HDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
112,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,0.929
113,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0
114,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0542476,Forgetful,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.1,1.0
115,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751882,"Myasthenic Syndromes, Congenital",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.905
116,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0877008,Enzyme inhibition disorder,,,phenotype,Disease or Syndrome,0.1,0.938
117,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
118,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1821417,RESTING HEART RATE,,,phenotype,Finding,0.1,1.0
119,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.08,1.0
120,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.08,1.0
121,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.07,1.0
122,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
123,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.07,1.0
124,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
125,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.06,1.0
126,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0393947,Cholinergic crisis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.06,1.0
127,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.05,1.0
128,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.05,1.0
129,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.05,1.0
130,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0231230,Fatigability,,,phenotype,Sign or Symptom,0.05,1.0
131,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.05,1.0
132,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
133,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0
134,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
135,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,1.0
136,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0232197,Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,0.75
137,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.04,1.0
138,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,1.0
139,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.04,1.0
140,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0
141,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.03,1.0
142,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.03,1.0
143,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
144,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.03,1.0
145,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
146,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.03,1.0
147,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.03,1.0
148,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0030552,Paresis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.03,1.0
149,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0
150,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0085632,Apathy,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.03,1.0
151,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0151786,Muscle Weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.03,1.0
152,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.03,1.0
153,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
154,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0752347,Lewy Body Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0
155,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
156,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
157,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
158,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3494652,Severe dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
159,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4721772,Postoperative delirium,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.03,1.0
160,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,1.0
161,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
162,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0003578,Apnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.02,1.0
163,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
164,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.02,1.0
165,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
166,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0
167,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009806,Constipation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
168,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011206,Delirium,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.02,1.0
169,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011268,Senile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
170,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011269,"Dementia, Vascular",C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
171,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
172,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
173,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
174,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
175,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0022972,Lambert-Eaton Myasthenic Syndrome,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
176,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.02,1.0
177,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
178,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
179,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
180,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.02,1.0
181,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0041234,Chagas Disease,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
182,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
183,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0085281,Addictive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
184,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.02,0.5
185,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
186,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0234119,Neuromuscular inhibition,,,disease,Disease or Syndrome,0.02,1.0
187,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0235031,Neurologic Symptoms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Sign or Symptom,0.02,1.0
188,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
189,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0262405,Cerebral dysfunction,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
190,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
191,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0282513,Primary Progressive Aphasia (disorder),C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.02,0.5
192,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.02,1.0
193,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0
194,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0393756,Hangover from alcohol,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.02,1.0
195,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0393934,Slow channel syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
196,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0521170,Osteoporotic Fractures,C26,   Wounds and Injuries,group,Disease or Syndrome,0.02,1.0
197,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
198,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0549225,Myasthenic Syndrome,,,disease,Disease or Syndrome,0.02,1.0
199,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751950,Neuromuscular Junction Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
200,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0854193,Cognitive deterioration,,,disease,Mental or Behavioral Dysfunction,0.02,1.0
201,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
202,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
203,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1145670,Respiratory Failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
204,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
205,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
206,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1336076,Sporadic Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
207,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0
208,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1843013,"Alzheimer disease, familial, type 3",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0
209,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3494871,Moderate dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
210,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3887551,Memory dysfunction,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
211,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
212,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
213,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002894,Refractory anaemia with excess blasts,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
214,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
215,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
216,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
217,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
218,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
219,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0004941,Behavioral Symptoms,F01,   Behavior and Behavior Mechanisms,group,Sign or Symptom,0.01,1.0
220,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0005818,Blood Platelet Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
221,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
222,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
223,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0007682,CNS disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,0.0
224,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0007789,Cerebral Palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
225,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
226,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
227,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
228,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009946,Conversion disorder,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
229,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
230,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
231,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
232,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
233,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0010308,Congenital Hypothyroidism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
234,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,0.0
235,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0010692,Cystitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
236,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
237,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0012833,Dizziness,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
238,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0013363,Dysautonomia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
239,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0013384,Dyskinetic syndrome,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
240,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0014057,Japanese Encephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
241,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0014179,Endometritis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
242,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0014378,Enterovirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
243,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0015732,Fecal Incontinence,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
244,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
245,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0017495,Gerstmann-Straussler-Scheinker Disease,C16;C01;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Infections;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
246,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
247,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0018553,"Hamartoma Syndrome, Multiple",C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Neoplastic Process,0.01,1.0
248,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
249,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
250,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0018794,Heart Block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
251,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
252,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
253,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
254,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0021125,Impulsive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
255,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
256,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0021832,"Intestinal Diseases, Parasitic",C06;C01,   Digestive System Diseases;    Infections,group,Disease or Syndrome,0.01,1.0
257,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0022104,Irritable Bowel Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
258,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
259,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
260,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
261,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
262,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
263,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023479,Acute myelomonocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
264,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023480,"Leukemia, Myelomonocytic, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
265,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
266,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,0.0
267,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
268,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
269,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
270,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
271,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
272,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
273,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0025312,Meningomyelocele,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
274,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
275,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
276,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
277,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
278,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0027868,Neuromuscular Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
279,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0028756,"Obesity, Morbid",C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
280,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0029182,orbit (eye disorders),C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
281,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0029227,"Delirium, Dementia, Amnestic, Cognitive Disorders",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
282,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
283,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0030469,Paranasal Sinus Disorder,C08;C09,   Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.01,1.0
284,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
285,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0036323,Schistosomiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
286,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0036391,Schwartz-Jampel Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
287,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0036939,Shared Paranoid Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
288,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0037317,Sleep disturbances,C10;F03;F01,   Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0
289,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0038443,"Stress, Psychological",F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
290,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0038505,Sturge-Weber Syndrome,C04;C10;C14,   Neoplasms;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
291,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0038580,Substance Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
292,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0039483,Giant Cell Arteritis,C17;C20;C10;C14,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
293,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0039743,Thanatophoric Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
294,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0040115,Thymus Hyperplasia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
295,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0041227,Trypanosomiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
296,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
297,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0042420,Vasovagal syncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
298,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0042571,Vertigo,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Sign or Symptom,0.01,1.0
299,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0079035,Bradyarrhythmia (disorder),C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
300,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
301,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0085084,Motor Neuron Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
302,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0085577,Normocytic anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
303,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0085584,Encephalopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
304,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
305,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
306,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
307,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
308,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
309,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0175709,Centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
310,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
311,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0206664,Teratocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
312,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0206727,Nerve Sheath Tumors,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
313,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0221100,Hangover from any Alcohol or Other Drugs substance,,,phenotype,Sign or Symptom,0.01,1.0
314,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0221170,Muscular stiffness,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.01,1.0
315,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0221271,Elastosis perforans serpiginosa,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
316,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0231528,Myalgia,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
317,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0233763,"Hallucinations, Visual",C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
318,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0242287,Isaacs syndrome,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
319,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0242350,Erectile dysfunction,C12;F03,   Male Urogenital Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
320,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0262385,Autonomic nervous system imbalance,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
321,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0265261,Multiple pterygium syndrome,C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
322,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0266159,Pyloric Atresia,C06,   Digestive System Diseases,disease,Congenital Abnormality,0.01,1.0
323,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0268380,Systemic amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
324,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0270942,Myasthenic crisis,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
325,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0278134,Absence of sensation,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
326,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0278510,Childhood Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
327,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0278876,Adult Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
328,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
329,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
330,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0281479,Primary Systemic Amyloidosis,C04;C18;C20,   Neoplasms;    Nutritional and Metabolic Diseases;    Immune System Diseases,disease,Neoplastic Process,0.01,1.0
331,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0282550,Persian Gulf Syndrome,C24,   Occupational Diseases,disease,Disease or Syndrome,0.01,1.0
332,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0302142,Deformity,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Anatomical Abnormality,0.01,1.0
333,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0302332,Poisoning syndrome,,,disease,Disease or Syndrome,0.01,1.0
334,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0332853,Anastomosis,,,disease,Acquired Abnormality,0.01,1.0
335,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0333693,Triploidy syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
336,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0338831,Manic,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
337,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0339143,Thyroid associated opthalmopathies,C16;C11;C20;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Immune System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
338,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0343401,MRSA - Methicillin resistant Staphylococcus aureus infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
339,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0343560,Congenital Varicella Syndrome,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
340,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0345237,Short segment Hirschsprung's disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.01,1.0
341,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0345244,Neuronal intestinal dysplasia,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
342,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0349204,Nonorganic psychosis,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
343,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0349476,Congenital goiter,C16;C13;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
344,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0393561,Subcortical Vascular Dementia,C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
345,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
346,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0403824,Teratozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
347,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0410203,X-linked centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Congenital Abnormality,0.01,1.0
348,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
349,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0457334,Acute monoblastic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
350,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0520716,Pallidopontonigral degeneration,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
351,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0525041,Neurobehavioral Manifestations,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
352,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0557875,Tired,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
353,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0577573,Mass of body region,,,phenotype,Sign or Symptom,0.01,1.0
354,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
355,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0595995,Idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.01,1.0
356,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
357,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0600041,Infective cystitis,C23;C13;C01;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
358,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0677898,invasive cancer,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
359,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
360,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
361,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0700201,Dyssomnias,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
362,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0728821,Parasympathomimetic Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
363,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.01,1.0
364,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0741585,BODY ACHE,,,phenotype,Sign or Symptom,0.01,1.0
365,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751122,Infantile Severe Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
366,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751340,"Myasthenia Gravis, Ocular",C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
367,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751362,Narcolepsy-Cataplexy Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
368,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751398,Familial Olivopontocerebellar Atrophy,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
369,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0751783,Lafora Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
370,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0851578,Sleep Disorders,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",group,Mental or Behavioral Dysfunction,0.01,1.0
371,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0860603,Anxiety symptoms,,,phenotype,Sign or Symptom,0.01,1.0
372,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0871189,Psychotic symptom,,,phenotype,Sign or Symptom,0.01,1.0
373,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0877854,Cerebral Arteriosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
374,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0917801,Sleeplessness,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.01,1.0
375,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
376,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0920233,Pisa syndrome,,,disease,Disease or Syndrome,0.01,1.0
377,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0947912,Myasthenias,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
378,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0949664,Tauopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
379,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1142436,Sundowning,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
380,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1145628,Autonomic nervous system disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
381,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
382,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1257763,Overnutrition,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
383,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1260880,Rhinorrhea,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,phenotype,Sign or Symptom,0.01,1.0
384,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1263892,Neoplasm of cauda equina,C10,   Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
385,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1290884,Inflammatory disorder,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.01,1.0
386,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
387,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1510472,Drug Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
388,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1519670,Tumor Angiogenesis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
389,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1527395,Ogilvie Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
390,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
391,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1839333,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
392,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1839736,WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME,C23;C16;C18;C17;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
393,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1845050,"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS",C23;C16;C18;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
394,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1845248,Outbursts,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
395,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1847835,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
396,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1852467,"Creutzfeldt-Jakob Disease, Sporadic",C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
397,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1863051,ALZHEIMER DISEASE 2,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
398,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1864233,ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
399,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1868112,"Crossed Polydactyly, Type I",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
400,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1868678,"THANATOPHORIC DYSPLASIA, TYPE I (disorder)",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
401,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1868684,"EAR, PATELLA, SHORT STATURE SYNDROME",C23;C16;C05;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
402,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C1868717,Behavioural and psychiatric symptoms of dementia,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
403,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
404,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C2936349,"Plaque, Amyloid",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
405,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C2981142,"Refractory anemia, without ringed sideroblasts, without excess blasts",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
406,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3164407,Oligoasthenozoospermia,,,disease,Disease or Syndrome,0.01,1.0
407,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
408,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3203501,Hypoactive delirium,,,disease,Mental or Behavioral Dysfunction,0.01,0.0
409,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3203671,CYP2D6 polymorphism,,,disease,Disease or Syndrome,0.01,1.0
410,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
411,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
412,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3665464,Dementia due to Alzheimer's disease (disorder),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
413,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3854173,Pre-renal acute kidney injury,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
414,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3875321,Inflammatory dermatosis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
415,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
416,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4041080,Neurocognitive Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
417,43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C4302061,Ischemic vascular dementia,C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
0,46,ACLS,,0.931,0.154,,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
1,46,ACLS,,0.931,0.154,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
2,46,ACLS,,0.931,0.154,,,,C0268059,Neonatal hemochromatosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
3,46,ACLS,,0.931,0.154,,,,C0344432,"Ventricular tachycardia, polymorphic",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
0,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0
1,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
2,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
3,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0023212,Left-Sided Heart Failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
4,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0
5,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0235527,"Heart Failure, Right-Sided",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
6,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1959583,Myocardial Failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
7,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1961112,Heart Decompensation,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
8,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
9,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,0.938
10,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
11,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0
12,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0
13,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
14,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
15,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.06,1.0
16,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.05,1.0
17,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.05,1.0
18,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0
19,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
20,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
21,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.04,1.0
22,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.04,1.0
23,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0
24,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0
25,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
26,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
27,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1142253,Arthrofibrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
28,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
29,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C2894027,Post traumatic osteoarthritis,,,disease,Disease or Syndrome,0.03,1.0
30,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0003869,"Arthritis, Infectious",C01;C05,   Infections;    Musculoskeletal Diseases,group,Disease or Syndrome,0.02,1.0
31,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
32,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
33,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
34,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
35,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0015302,External exotoses,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
36,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
37,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
38,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0151650,Renal fibrosis,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0
39,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
40,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0231749,Knee pain,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.02,1.0
41,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
42,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0546964,Genu recurvatum,,,disease,Anatomical Abnormality,0.02,1.0
43,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
44,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0745581,knee symptoms,,,phenotype,Sign or Symptom,0.02,1.0
45,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1692886,"Arthritis, Bacterial",C01;C05,   Infections;    Musculoskeletal Diseases,group,Disease or Syndrome,0.02,1.0
46,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1956089,Osteophyte,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
47,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
48,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C2931852,Clear-cell metastatic renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
49,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
50,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
51,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
52,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
53,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
54,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
55,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0009918,Contracture of joint,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.01,1.0
56,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
57,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
58,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
59,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
60,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0023461,"Leukemia, Mast-Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
61,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
62,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
63,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
64,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
65,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
66,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0028945,oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
67,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
68,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0035127,Cumulative Trauma Disorders,C26,   Wounds and Injuries,group,Disease or Syndrome,0.01,1.0
69,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0039103,Synovitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,0.0
70,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0040997,Trigeminal Neuralgia,C10;C07,   Nervous System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
71,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
72,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
73,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0178664,Glomerulosclerosis (disorder),C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
74,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
75,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0231451,Hyperextension,,,phenotype,Sign or Symptom,0.01,1.0
76,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0238013,Invasive aspergillosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
77,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0272285,Heparin-induced thrombocytopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
78,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0278678,Metastatic Renal Cell Cancer,,,disease,Neoplastic Process,0.01,1.0
79,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0279070,Adult Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
80,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
81,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
82,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0280475,Childhood Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
83,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0559359,Subchondral hematoma,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Acquired Abnormality,0.01,0.0
84,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0574996,Knee joint laxity,C05,   Musculoskeletal Diseases,phenotype,Sign or Symptom,0.01,1.0
85,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
86,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
87,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
88,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
89,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
90,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0751396,Well Differentiated Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
91,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0751713,"Inclusion Body Myopathy, Sporadic",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
92,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C0872084,Sarcopenia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
93,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
94,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1285498,Vegetation,,,disease,Anatomical Abnormality,0.01,1.0
95,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
96,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
97,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
98,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C1708350,Hereditary Leiomyomatosis and Renal Cell Cancer,C16;C04;C13;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.01,1.0
99,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C2347126,Microscopic Polyarteritis,C20;C10;C14,   Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
100,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
101,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C3665365,"Arteriosclerotic cardiovascular disease, NOS",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
102,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C3887964,POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,,,disease,Disease or Syndrome,0.01,1.0
103,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C4285782,Kinesiophobia,,,disease,Disease or Syndrome,0.01,1.0
104,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
105,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
106,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
107,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C4721698,Metastatic Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
108,47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0
1,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
2,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0086743,Osteoarthrosis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
3,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0010474,Curling Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0
4,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0013295,Duodenal Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0
5,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0403592,Chronic rejection of renal transplant,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0
6,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C2750440,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1",,,disease,Finding,0.2,1.0
7,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C2750441,"LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1",,,phenotype,Finding,0.2,1.0
8,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C3150651,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2",,,phenotype,Finding,0.2,1.0
9,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
10,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0
11,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
12,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0
13,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
14,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
15,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.02,1.0
16,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0018995,Hemochromatosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
17,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
18,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0032461,Polycythemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
19,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0240066,Iron deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
20,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0392514,Hereditary hemochromatosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
21,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0
22,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
23,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
24,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
25,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
26,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
27,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
28,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
29,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
30,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
31,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0032463,Polycythemia Vera,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
32,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0032969,Pregnancy in Diabetics,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Disease or Syndrome,0.01,1.0
33,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0040558,Toxoplasmosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
34,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0085576,Iron-Refractory Iron Deficiency Anemia,C18;C15,   Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
35,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0151779,Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
36,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0162316,Iron deficiency anemia,C18;C15,   Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
37,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0233565,Bradykinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
38,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
39,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0238644,"Anemia, severe",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
40,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
41,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0282193,Iron Overload,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
42,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
43,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
44,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C1318533,Secondary polycythemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
45,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C1395512,Placental dysfunction,,,disease,Disease or Syndrome,0.01,1.0
46,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C1833213,"Hyperferritinemia, hereditary, with congenital cataracts",C18;C11,   Nutritional and Metabolic Diseases;    Eye Diseases,disease,Disease or Syndrome,0.01,1.0
47,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
48,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
49,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
50,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
51,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
52,48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C4749274,Chuvash erythrocytosis,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
0,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
1,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0016053,Fibromyalgia,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,0.909
2,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
3,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0
4,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0040137,Thyroid Nodule,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.09,1.0
5,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
6,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
7,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.07,0.857
8,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0151449,Primary Sjgren's syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.07,1.0
9,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.06,1.0
10,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.06,1.0
11,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.06,1.0
12,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.06,1.0
13,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.05,1.0
14,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.05,1.0
15,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0039263,Takayasu Arteritis,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0
16,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0751356,Idiopathic Inflammatory Myopathies,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.05,0.8
17,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.04,1.0
18,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.04,0.75
19,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0032533,Polymyalgia Rheumatica,C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.04,1.0
20,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.04,1.0
21,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0042384,Vasculitis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
22,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0003615,Appendicitis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.03,1.0
23,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
24,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
25,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.03,0.333
26,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0028259,Nodule,,,phenotype,Acquired Abnormality,0.03,1.0
27,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0039483,Giant Cell Arteritis,C17;C20;C10;C14,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
28,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.03,1.0
29,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
30,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
31,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.03,1.0
32,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.03,1.0
33,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
34,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3495801,Granulomatosis with polyangiitis,C08;C20;C14,   Respiratory Tract Diseases;    Immune System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
35,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
36,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0003862,Arthralgia,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.02,1.0
37,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
38,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
39,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
40,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
41,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
42,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
43,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
44,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0018939,Hematological Disease,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.02,1.0
45,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0035435,Rheumatism,C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
46,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
47,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
48,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0085278,Antiphospholipid Syndrome,C20,   Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
49,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
50,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0221056,Adult type dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,0.5
51,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
52,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
53,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1096155,Macrophage Activation Syndrome,C20,   Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
54,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1412000,Mesenteric vascular insufficiency,C06;C14,   Digestive System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
55,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
56,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C2717865,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,C20;C14,   Immune System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
57,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4048329,Immunosuppression,,,disease,Disease or Syndrome,0.02,1.0
58,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0000737,Abdominal Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
59,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
60,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
61,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0002878,"Anemia, Hemolytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
62,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
63,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0003509,Aortitis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
64,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
65,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0004604,Back Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
66,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
67,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
68,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
69,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
70,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0007859,Neck Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
71,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0008728,Eosinophilic granulomatosis with polyangiitis,C20;C15;C14,   Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
72,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0008733,Chylothorax,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
73,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0009326,Collagen Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
74,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
75,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0009812,Constitutional Symptom,,,phenotype,Sign or Symptom,0.01,1.0
76,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0010266,Cranial nerve diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
77,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0010823,Cytomegalovirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
78,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.01,1.0
79,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
80,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
81,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011633,Dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,0.0
82,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011644,Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
83,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
84,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
85,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0012813,Diverticulitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
86,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0013404,Dyspnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
87,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0014060,"Encephalitis, St. Louis",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
88,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
89,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
90,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0017086,Gangrene,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
91,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0017658,Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
92,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0018965,Hematuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Disease or Syndrome,0.01,1.0
93,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
94,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0019559,Hip joint pain,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.01,1.0
95,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0020545,"Hypertension, Renovascular",C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
96,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0021053,Immune System Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
97,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0021775,Intermittent Claudication,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
98,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0022354,"Jaundice, Obstructive",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
99,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0022408,Arthropathy,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0
100,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
101,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0024031,Low Back Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
102,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
103,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0024138,"Lupus Erythematosus, Discoid",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
104,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
105,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0024312,Lymphopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
106,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0024902,Mastodynia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
107,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0027543,Avascular necrosis of bone,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Disease or Syndrome,0.01,1.0
108,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
109,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
110,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0027697,Nephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
111,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
112,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
113,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0029410,Osteoarthritis of hip,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
114,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
115,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
116,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0030283,Pancreatic Cyst,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0
117,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0031036,Polyarteritis Nodosa,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
118,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
119,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
120,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0037011,Shoulder Pain,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.01,1.0
121,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0037199,Sinusitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
122,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
123,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
124,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0040128,Thyroid Diseases,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
125,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0040264,Tinnitus,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0
126,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
127,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0042571,Vertigo,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Sign or Symptom,0.01,1.0
128,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
129,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0085096,Peripheral Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
130,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0085253,Adult-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
131,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0085655,Polymyositis,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
132,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0086981,Sicca Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
133,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0149614,Adnexal mass,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Anatomical Abnormality,0.01,1.0
134,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0149741,nipple discharge,,,phenotype,Sign or Symptom,0.01,1.0
135,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0149871,Deep Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
136,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0151450,Secondary Sjgren's syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
137,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0152021,Congenital heart disease,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
138,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0158026,Monoarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
139,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0162872,"Aortic Aneurysm, Thoracic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
140,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0206138,CREST Syndrome,C06;C18;C17;C14,   Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
141,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
142,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0221785,Pain in wrist,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.01,1.0
143,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0235299,Right upper quadrant pain,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Sign or Symptom,0.01,1.0
144,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0238551,Left lower quadrant pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
145,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0239161,Dactylitis,,,disease,Disease or Syndrome,0.01,1.0
146,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
147,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0262988,Vasculitis of the skin,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
148,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0263666,"Dermatomyositis, Childhood Type",C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
149,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0267917,Acute cholangitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
150,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
151,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0279646,Childhood Acute Monocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
152,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
153,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0280634,Adult Acute Monocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
154,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0333307,Superficial ulcer,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
155,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0334294,Multiple adenomatous polyps,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
156,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0342500,Adrenal mass,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
157,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
158,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
159,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0400979,Obstruction of biliary tree,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
160,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0404484,Chronic pelvic pain of female,C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Sign or Symptom,0.01,1.0
161,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0406645,Amyopathic dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
162,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0409652,Seronegative rheumatoid arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
163,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0409974,Lupus Erythematosus,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
164,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
165,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0476227,pricking of skin,,,phenotype,Sign or Symptom,0.01,1.0
166,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0497156,Lymphadenopathy,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.01,1.0
167,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0520575,Acute pyelonephritis,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
168,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0521158,Recurrent tumor,,,phenotype,Neoplastic Process,0.01,1.0
169,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
170,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0553713,BREAST PAIN FEMALE,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",phenotype,Sign or Symptom,0.01,1.0
171,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0574785,Lower Urinary Tract Symptoms,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
172,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0574960,Sacroiliitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
173,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
174,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0687720,Central Diabetes Insipidus,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
175,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0694551,Right lower quadrant pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
176,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
177,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
178,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
179,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0742186,"Radiculopathy, Cervical",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
180,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0744939,hip pain chronic,,,disease,Disease or Syndrome,0.01,1.0
181,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0745571,knee pain chronic,,,disease,Disease or Syndrome,0.01,1.0
182,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0746306,lupus cutaneous,,,disease,Disease or Syndrome,0.01,1.0
183,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0752335,Neuropsychiatric Systemic Lupus Erythematosus,C01;C17;C20;C10;C14,   Infections;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
184,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0849640,skin damage,,,phenotype,Sign or Symptom,0.01,1.0
185,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0854778,Pancreatic carcinoma resectable,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
186,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0856054,Mental status changes,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
187,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0856742,Post MI,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
188,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
189,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0949690,Spondylarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
190,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0949691,Spondylarthropathies,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0
191,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1135868,Gestational Trophoblastic Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.01,1.0
192,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
193,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
194,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1282952,Enthesitis,C17;C05;C10;C26,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Wounds and Injuries,disease,Disease or Syndrome,0.01,1.0
195,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1318544,M5b Acute differentiated monocytic leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
196,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1333001,Childhood Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
197,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
198,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1335437,Plexopathy,,,disease,Disease or Syndrome,0.01,1.0
199,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1456418,Absence of muscle,,,disease,Congenital Abnormality,0.01,1.0
200,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1701938,Associated Pulmonary Arterial Hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
201,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
202,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
203,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
204,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
205,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C2317127,Suspected inflammatory arthritis,,,disease,Disease or Syndrome,0.01,1.0
206,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C2347126,Microscopic Polyarteritis,C20;C10;C14,   Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
207,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C2931618,Gestational trophoblastic disease,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
208,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
209,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3178789,Widespread Chronic Pain,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
210,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3203509,Neuropsychiatric syndrome,,,disease,Disease or Syndrome,0.01,1.0
211,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3203547,Axial spondyloarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
212,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
213,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3495919,Enthesitis-Related Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
214,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3665346,Unspecified visual loss,C23;C11,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases",phenotype,Sign or Symptom,0.01,1.0
215,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3839854,Chronic ankle pain,,,phenotype,Sign or Symptom,0.01,1.0
216,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
217,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3887524,Skin Erosion,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
218,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3889038,Non-radiographic axial spondyloarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
219,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3892044,Oligoarticular Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
220,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C3899278,Early Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
221,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4021107,Non-obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
222,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4049342,Foot osteomyelitis,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
223,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4050407,Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
224,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4087124,Immunoglobulin G4-Related Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
225,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4477048,Heliotrope rash,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.01,1.0
226,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4551516,Hip pain,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.01,1.0
227,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4551649,Congenital Dysplasia Of The Hip,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
228,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
229,49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C3281192,INFANTILE CEREBELLAR-RETINAL DEGENERATION,,,disease,Disease or Syndrome,0.74,1.0
1,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C4225384,OPTIC ATROPHY 9,,,disease,Disease or Syndrome,0.7,1.0
2,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0
3,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,
4,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0
5,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0029124,Optic Atrophy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.12,1.0
6,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0740279,Cerebellar atrophy,,,disease,Disease or Syndrome,0.12,1.0
7,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
8,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0004158,Athetosis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
9,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0
10,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
11,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0
12,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0028738,Nystagmus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
13,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0030232,Pallor,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
14,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0035242,Respiratory Tract Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0
15,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
16,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0036857,Severe intellectual disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,
17,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0038379,Strabismus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
18,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0078981,Arachnoid Cysts,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
19,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0151888,Hyporeflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
20,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0155016,"Color Blindness, Red-Green",C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
21,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0221354,Frontal bossing,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
22,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0234146,Absent reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
23,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0234632,Reduced visual acuity,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
24,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0270922,Peripheral demyelinating neuropathy,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
25,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0271197,"Scotoma, Paracentral",C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
26,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0344482,Hypoplasia of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
27,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0423110,Downward slant of palpebral fissure,,,phenotype,Finding,0.1,
28,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0427190,"Ataxia, Truncal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
29,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0452138,"Sensorineural hearing loss, bilateral",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
30,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
31,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
32,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0854723,Retinal Dystrophies,C11,   Eye Diseases,group,Disease or Syndrome,0.1,
33,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C1837397,Severe global developmental delay,,,phenotype,Finding,0.1,
34,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C1850456,Progressive microcephaly,,,phenotype,Finding,0.1,
35,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
36,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C1963184,"Nystagmus, CTCAE 3.0",,,phenotype,Finding,0.1,
37,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C3806442,Myoclonic spasms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
38,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C4022919,Appendicular hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
39,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C4551583,Cerebral cortical atrophy,,,disease,Disease or Syndrome,0.1,
40,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C4554036,"Nystagmus, CTCAE 5.0",,,phenotype,Finding,0.1,
41,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
42,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
43,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.03,1.0
44,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0029132,Disorder of the optic nerve,C11;C10,   Eye Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
45,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
46,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C3887709,Optic Neuropathy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
47,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
48,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
49,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
50,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
51,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
52,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
53,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0021670,insulinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
54,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
55,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
56,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
57,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
58,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
59,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
60,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
61,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
62,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0338508,Optic Atrophy 1,C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
63,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0342770,Fumarase deficiency,C23;C16;C18;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.01,1.0
64,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0342782,Depletion of mitochondrial DNA,,,disease,Disease or Syndrome,0.01,1.0
65,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
66,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
67,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
68,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
69,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C1378703,Renal carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
70,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C1856689,FRIEDREICH ATAXIA 1,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
71,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C3276549,"OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY",,,disease,Disease or Syndrome,0.01,1.0
72,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C3714948,PACHYONYCHIA CONGENITA 3,,,disease,Disease or Syndrome,0.01,1.0
73,50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1849678,Peroxisomal ACYL-COA oxidase deficiency,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.92,1.0
1,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0
2,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0002152,Alloxan Diabetes,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.3,1.0
3,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.3,1.0
4,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0038433,Streptozotocin Diabetes,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.3,1.0
5,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0023520,Leukodystrophy,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.11,1.0
6,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,
7,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
8,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
9,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
10,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,
11,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0020534,Orbital separation excessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
12,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0020608,Hypodontia,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
13,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0022107,Irritable Mood,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
14,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0026826,Muscle Hypertonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
15,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
16,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
17,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0028738,Nystagmus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
18,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0029124,Optic Atrophy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
19,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0034935,Babinski Reflex,,,phenotype,Finding,0.1,
20,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0035229,Respiratory Insufficiency,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.1,
21,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,
22,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
23,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0036857,Severe intellectual disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,
24,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0037822,Speech Disorders,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Disease or Syndrome,0.1,
25,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0038379,Strabismus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
26,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0151611,Electroencephalogram abnormal,C10,   Nervous System Diseases,phenotype,Finding,0.1,
27,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0151889,Hyperreflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
28,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0158733,Hand polydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
29,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0221354,Frontal bossing,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
30,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0221356,Brachycephaly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
31,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0239234,Low set ears,,,disease,Congenital Abnormality,0.1,
32,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0269269,Inversion of nipple (disorder),C17,   Skin and Connective Tissue Diseases,disease,Anatomical Abnormality,0.1,
33,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0338474,Central nervous system demyelination,,,disease,Disease or Syndrome,0.1,
34,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0
35,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0452138,"Sensorineural hearing loss, bilateral",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
36,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0476397,Electroretinogram abnormal,,,phenotype,Finding,0.1,
37,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0522214,Abnormal visual evoked potential,C10,   Nervous System Diseases,phenotype,Finding,0.1,
38,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
39,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0575081,Gait abnormality,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Finding,0.1,
40,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0678230,Congenital Epicanthus,,,disease,Congenital Abnormality,0.1,
41,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
42,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1836542,Depressed nasal bridge,,,phenotype,Finding,0.1,
43,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1836830,Developmental regression,F03,   Mental Disorders,disease,Disease or Syndrome,0.1,
44,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1837397,Severe global developmental delay,,,phenotype,Finding,0.1,
45,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1839025,Decreased light- and dark-adapted electroretinogram amplitude,,,phenotype,Finding,0.1,
46,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1846149,"Intellectual disability, progressive",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Finding,0.1,
47,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1848701,Elevated hepatic transaminase,,,phenotype,Finding,0.1,
48,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1849367,Nasal bridge wide,,,phenotype,Finding,0.1,
49,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1849683,No social interaction,F03,   Mental Disorders,phenotype,Finding,0.1,
50,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1849686,Diffuse hepatic steatosis,C06,   Digestive System Diseases,phenotype,Finding,0.1,
51,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1858430,Death in infancy,,,phenotype,Finding,0.1,
52,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1963184,"Nystagmus, CTCAE 3.0",,,phenotype,Finding,0.1,
53,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C2267233,Neonatal Hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
54,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C2700617,Irritation - emotion,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,
55,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C4021768,Abnormality of metabolism/homeostasis,,,phenotype,Finding,0.1,
56,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C4022810,Abnormality of nervous system morphology,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Anatomical Abnormality,0.1,
57,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C4551714,Rod-Cone Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,
58,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C4551915,"Gait Disturbance, CTCAE",,,phenotype,Finding,0.1,
59,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C4552810,"Irritability, CTCAE",,,phenotype,Finding,0.1,
60,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C4554036,"Nystagmus, CTCAE 5.0",,,phenotype,Finding,0.1,
61,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.06,1.0
62,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
63,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
64,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0282528,Peroxisomal Disorders,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.02,1.0
65,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
66,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1512409,Hepatocarcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.02,1.0
67,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
68,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
69,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
70,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,0.0
71,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
72,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
73,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
74,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
75,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
76,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0154251,Lipid Metabolism Disorders,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
77,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0158731,Congenital pectus carinatum,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
78,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
79,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0220650,Metastatic malignant neoplasm to brain,C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
80,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0240765,Acquired pectus carinatum,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.01,1.0
81,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
82,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
83,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
84,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
85,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0410158,Muscle damage,,,phenotype,Acquired Abnormality,0.01,1.0
86,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0494165,Secondary malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
87,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
88,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
89,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
90,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
91,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
92,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
93,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
94,51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1863844,Adult-onset citrullinemia type 2,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
0,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
1,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
2,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
3,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,0.923
4,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
5,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
6,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
7,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.05,1.0
8,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.05,1.0
9,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.05,0.8
10,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0
11,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.04,1.0
12,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.04,1.0
13,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0003076,Aniridia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.03,0.667
14,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
15,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,0.667
16,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,0.667
17,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
18,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0021053,Immune System Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.03,1.0
19,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
20,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.02,1.0
21,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
22,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0
23,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.02,1.0
24,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0015702,Favism,C16;C25;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Chemically-Induced Disorders;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
25,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.02,0.5
26,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.02,1.0
27,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.02,1.0
28,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.02,1.0
29,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
30,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
31,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
32,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
33,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
34,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
35,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
36,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
37,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
38,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0005806,Blood Group Incompatibility,,,disease,Disease or Syndrome,0.01,1.0
39,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
40,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
41,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
42,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
43,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0009691,Congenital cataract,C23;C16;C13;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
44,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
45,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
46,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0010276,Craniopharyngioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
47,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
48,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
49,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
50,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
51,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0017154,"Gastritis, Atrophic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
52,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
53,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0022346,Icterus,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
54,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0022353,Neonatal Jaundice,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",phenotype,Disease or Syndrome,0.01,1.0
55,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0022638,Ketosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
56,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
57,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
58,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
59,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
60,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0024408,Machado-Joseph Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
61,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,0.0
62,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
63,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
64,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
65,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
66,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0030499,Parasitic Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
67,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
68,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
69,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0042341,Varicocele,C12;C14,   Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
70,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0175704,LEOPARD Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
71,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
72,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0234533,Generalized seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
73,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0234972,Convulsive disorder,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
74,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0235575,Hemolytic reaction,,,phenotype,Disease or Syndrome,0.01,1.0
75,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
76,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
77,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0270850,Idiopathic generalized epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
78,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0278652,Childhood Craniopharyngioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
79,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0278875,Adult Craniopharyngioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
80,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
81,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
82,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0344542,Aniridia type 1,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0
83,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0349543,Brain Glioblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
84,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
85,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
86,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
87,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
88,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
89,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0545044,Acrokeratoelastoidosis of Costa,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
90,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
91,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0677607,Hashimoto Disease,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
92,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
93,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
94,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0751783,Lafora Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
95,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0852733,Completed Suicide,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
96,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
97,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1328504,Hormone refractory prostate cancer,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
98,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1332187,Adult Brain Glioblastoma,,,disease,Neoplastic Process,0.01,1.0
99,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
100,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
101,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C1840264,IMMUNE SUPPRESSION,,,phenotype,Disease or Syndrome,0.01,1.0
102,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
103,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C2939465,Deficiency of glucose-6-phosphate dehydrogenase,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
104,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C3469521,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
105,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C4554065,Childhood Brain Glioblastoma,,,disease,Neoplastic Process,0.01,1.0
106,52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C4721579,Secondary malignant neoplasm of colon and/or rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
0,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0268410,Acid Phosphatase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,
1,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
2,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0042963,Vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
3,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0151818,Opisthotonus,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
4,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
5,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C1458140,Bleeding tendency,C15,   Hemic and Lymphatic Diseases,phenotype,Pathologic Function,0.1,
6,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
7,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,0.0
8,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
9,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0026709,Mucopolysaccharidosis VI,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
10,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0282687,"Hemorrhagic Fever, Ebola",C01,   Infections,disease,Disease or Syndrome,0.01,0.0
11,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0339682,Regular astigmatism - corneal,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
12,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
13,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
14,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
15,53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C2062441,Influenza A,,,disease,Disease or Syndrome,0.01,1.0
0,54,ACP5,P13686,0.561,0.731,0.078651,,,C1842763,SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION,C16;C05;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.72,1.0
1,54,ACP5,P13686,0.561,0.731,0.078651,,,C0432222,Spondyloenchondrodysplasia,C16;C05;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.57,1.0
2,54,ACP5,P13686,0.561,0.731,0.078651,,,C0020503,"Hyperparathyroidism, Secondary",C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0
3,54,ACP5,P13686,0.561,0.731,0.078651,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
4,54,ACP5,P13686,0.561,0.731,0.078651,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0
5,54,ACP5,P13686,0.561,0.731,0.078651,,,C0878659,Disproportionate short stature,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",phenotype,Finding,0.3,
6,54,ACP5,P13686,0.561,0.731,0.078651,,,C3860213,Autoinflammatory disorder,,,disease,Disease or Syndrome,0.3,1.0
7,54,ACP5,P13686,0.561,0.731,0.078651,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
8,54,ACP5,P13686,0.561,0.731,0.078651,,,C0029458,"Osteoporosis, Postmenopausal",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.2,1.0
9,54,ACP5,P13686,0.561,0.731,0.078651,,,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.11,1.0
10,54,ACP5,P13686,0.561,0.731,0.078651,,,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0
11,54,ACP5,P13686,0.561,0.731,0.078651,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,
12,54,ACP5,P13686,0.561,0.731,0.078651,,,C0022821,Kyphosis deformity of spine,C05,   Musculoskeletal Diseases,phenotype,Anatomical Abnormality,0.1,
13,54,ACP5,P13686,0.561,0.731,0.078651,,,C0023882,Little's Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
14,54,ACP5,P13686,0.561,0.731,0.078651,,,C0024003,Lordosis,C05,   Musculoskeletal Diseases,phenotype,Disease or Syndrome,0.1,
15,54,ACP5,P13686,0.561,0.731,0.078651,,,C0025995,Micromelia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
16,54,ACP5,P13686,0.561,0.731,0.078651,,,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,
17,54,ACP5,P13686,0.561,0.731,0.078651,,,C0034150,Purpura,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,
18,54,ACP5,P13686,0.561,0.731,0.078651,,,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
19,54,ACP5,P13686,0.561,0.731,0.078651,,,C0239174,Late tooth eruption,,,phenotype,Finding,0.1,
20,54,ACP5,P13686,0.561,0.731,0.078651,,,C0239234,Low set ears,,,disease,Congenital Abnormality,0.1,
21,54,ACP5,P13686,0.561,0.731,0.078651,,,C0345392,Congenital kyphoscoliosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
22,54,ACP5,P13686,0.561,0.731,0.078651,,,C0349588,Short stature,,,phenotype,Finding,0.1,
23,54,ACP5,P13686,0.561,0.731,0.078651,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,
24,54,ACP5,P13686,0.561,0.731,0.078651,,,C0426422,Narrow nose,,,phenotype,Finding,0.1,
25,54,ACP5,P13686,0.561,0.731,0.078651,,,C0494261,Combined immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.1,
26,54,ACP5,P13686,0.561,0.731,0.078651,,,C0497156,Lymphadenopathy,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.1,
27,54,ACP5,P13686,0.561,0.731,0.078651,,,C0575158,Kyphoscoliosis deformity of spine,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
28,54,ACP5,P13686,0.561,0.731,0.078651,,,C0581354,Recurrent sinusitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,
29,54,ACP5,P13686,0.561,0.731,0.078651,,,C0600033,Acquired Kyphoscoliosis,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.1,
30,54,ACP5,P13686,0.561,0.731,0.078651,,,C0700635,Strudwick syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,
31,54,ACP5,P13686,0.561,0.731,0.078651,,,C0747085,Recurrent otitis media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,
32,54,ACP5,P13686,0.561,0.731,0.078651,,,C1184923,Lumbar hyperlordosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
33,54,ACP5,P13686,0.561,0.731,0.078651,,,C1838662,Metaphyseal irregularity,,,phenotype,Finding,0.1,
34,54,ACP5,P13686,0.561,0.731,0.078651,,,C1839326,Abnormal form of the vertebral bodies,,,phenotype,Finding,0.1,
35,54,ACP5,P13686,0.561,0.731,0.078651,,,C1842153,Irregular vertebral endplates,,,phenotype,Finding,0.1,
36,54,ACP5,P13686,0.561,0.731,0.078651,,,C1842774,Hypermelanotic macule,,,phenotype,Finding,0.1,
37,54,ACP5,P13686,0.561,0.731,0.078651,,,C1844666,Immune dysregulation,,,phenotype,Finding,0.1,
38,54,ACP5,P13686,0.561,0.731,0.078651,,,C1844704,Platyspondyly,,,phenotype,Finding,0.1,
39,54,ACP5,P13686,0.561,0.731,0.078651,,,C1855204,Cellular immunodeficiency,C20,   Immune System Diseases,phenotype,Finding,0.1,
40,54,ACP5,P13686,0.561,0.731,0.078651,,,C1859736,Progressive spastic quadriplegia,,,phenotype,Finding,0.1,
41,54,ACP5,P13686,0.561,0.731,0.078651,,,C1866730,Rhizomelia,,,disease,Congenital Abnormality,0.1,
42,54,ACP5,P13686,0.561,0.731,0.078651,,,C1969372,Tubulointerstitial fibrosis,,,phenotype,Disease or Syndrome,0.1,
43,54,ACP5,P13686,0.561,0.731,0.078651,,,C2919142,"Short Stature, CTCAE",,,phenotype,Finding,0.1,
44,54,ACP5,P13686,0.561,0.731,0.078651,,,C2931322,T-Lymphocytopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Finding,0.1,
45,54,ACP5,P13686,0.561,0.731,0.078651,,,C3277226,Restrictive ventilatory defect,,,phenotype,Finding,0.1,
46,54,ACP5,P13686,0.561,0.731,0.078651,,,C3552526,Metaphyseal sclerosis,,,phenotype,Finding,0.1,
47,54,ACP5,P13686,0.561,0.731,0.078651,,,C3806482,Recurrent respiratory infections,C01;C08,   Infections;    Respiratory Tract Diseases,phenotype,Finding,0.1,
48,54,ACP5,P13686,0.561,0.731,0.078651,,,C4021611,Abnormality of epiphysis morphology,,,phenotype,Anatomical Abnormality,0.1,
49,54,ACP5,P13686,0.561,0.731,0.078651,,,C4024618,Large iliac wings,,,phenotype,Finding,0.1,
50,54,ACP5,P13686,0.561,0.731,0.078651,,,C4024852,Hypopigmented skin patches on arms,,,phenotype,Finding,0.1,
51,54,ACP5,P13686,0.561,0.731,0.078651,,,C4025814,Abnormality of the metaphysis,,,disease,Anatomical Abnormality,0.1,
52,54,ACP5,P13686,0.561,0.731,0.078651,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0
53,54,ACP5,P13686,0.561,0.731,0.078651,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0
54,54,ACP5,P13686,0.561,0.731,0.078651,,,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.04,1.0
55,54,ACP5,P13686,0.561,0.731,0.078651,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
56,54,ACP5,P13686,0.561,0.731,0.078651,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
57,54,ACP5,P13686,0.561,0.731,0.078651,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
58,54,ACP5,P13686,0.561,0.731,0.078651,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.03,1.0
59,54,ACP5,P13686,0.561,0.731,0.078651,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
60,54,ACP5,P13686,0.561,0.731,0.078651,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
61,54,ACP5,P13686,0.561,0.731,0.078651,,,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
62,54,ACP5,P13686,0.561,0.731,0.078651,,,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.03,1.0
63,54,ACP5,P13686,0.561,0.731,0.078651,,,C0005940,Bone Diseases,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.02,1.0
64,54,ACP5,P13686,0.561,0.731,0.078651,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
65,54,ACP5,P13686,0.561,0.731,0.078651,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
66,54,ACP5,P13686,0.561,0.731,0.078651,,,C0029454,Osteopetrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
67,54,ACP5,P13686,0.561,0.731,0.078651,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
68,54,ACP5,P13686,0.561,0.731,0.078651,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
69,54,ACP5,P13686,0.561,0.731,0.078651,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
70,54,ACP5,P13686,0.561,0.731,0.078651,,,C0001622,Adrenal Gland Hyperfunction,C19,   Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
71,54,ACP5,P13686,0.561,0.731,0.078651,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
72,54,ACP5,P13686,0.561,0.731,0.078651,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
73,54,ACP5,P13686,0.561,0.731,0.078651,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
74,54,ACP5,P13686,0.561,0.731,0.078651,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
75,54,ACP5,P13686,0.561,0.731,0.078651,,,C0005967,Bone neoplasms,C04;C05,   Neoplasms;    Musculoskeletal Diseases,group,Neoplastic Process,0.01,1.0
76,54,ACP5,P13686,0.561,0.731,0.078651,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
77,54,ACP5,P13686,0.561,0.731,0.078651,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
78,54,ACP5,P13686,0.561,0.731,0.078651,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
79,54,ACP5,P13686,0.561,0.731,0.078651,,,C0010481,Cushing Syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
80,54,ACP5,P13686,0.561,0.731,0.078651,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
81,54,ACP5,P13686,0.561,0.731,0.078651,,,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
82,54,ACP5,P13686,0.561,0.731,0.078651,,,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
83,54,ACP5,P13686,0.561,0.731,0.078651,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
84,54,ACP5,P13686,0.561,0.731,0.078651,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
85,54,ACP5,P13686,0.561,0.731,0.078651,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
86,54,ACP5,P13686,0.561,0.731,0.078651,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
87,54,ACP5,P13686,0.561,0.731,0.078651,,,C0024031,Low Back Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
88,54,ACP5,P13686,0.561,0.731,0.078651,,,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
89,54,ACP5,P13686,0.561,0.731,0.078651,,,C0024138,"Lupus Erythematosus, Discoid",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
90,54,ACP5,P13686,0.561,0.731,0.078651,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
91,54,ACP5,P13686,0.561,0.731,0.078651,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
92,54,ACP5,P13686,0.561,0.731,0.078651,,,C0026709,Mucopolysaccharidosis VI,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
93,54,ACP5,P13686,0.561,0.731,0.078651,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
94,54,ACP5,P13686,0.561,0.731,0.078651,,,C0026838,Muscle Spasticity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
95,54,ACP5,P13686,0.561,0.731,0.078651,,,C0029401,Osteitis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
96,54,ACP5,P13686,0.561,0.731,0.078651,,,C0029422,Osteochondrodysplasias,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Disease or Syndrome,0.01,1.0
97,54,ACP5,P13686,0.561,0.731,0.078651,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
98,54,ACP5,P13686,0.561,0.731,0.078651,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
99,54,ACP5,P13686,0.561,0.731,0.078651,,,C0035086,Renal Osteodystrophy,C18;C13;C05;C12;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
100,54,ACP5,P13686,0.561,0.731,0.078651,,,C0037317,Sleep disturbances,C10;F03;F01,   Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0
101,54,ACP5,P13686,0.561,0.731,0.078651,,,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
102,54,ACP5,P13686,0.561,0.731,0.078651,,,C0085078,Lysosomal Storage Diseases,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.01,0.0
103,54,ACP5,P13686,0.561,0.731,0.078651,,,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
104,54,ACP5,P13686,0.561,0.731,0.078651,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
105,54,ACP5,P13686,0.561,0.731,0.078651,,,C0153690,Secondary malignant neoplasm of bone,C23;C04;C05,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Musculoskeletal Diseases",disease,Neoplastic Process,0.01,1.0
106,54,ACP5,P13686,0.561,0.731,0.078651,,,C0234253,Rest pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
107,54,ACP5,P13686,0.561,0.731,0.078651,,,C0235031,Neurologic Symptoms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Sign or Symptom,0.01,1.0
108,54,ACP5,P13686,0.561,0.731,0.078651,,,C0240066,Iron deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
109,54,ACP5,P13686,0.561,0.731,0.078651,,,C0242510,Drug usage,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
110,54,ACP5,P13686,0.561,0.731,0.078651,,,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
111,54,ACP5,P13686,0.561,0.731,0.078651,,,C0409974,Lupus Erythematosus,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
112,54,ACP5,P13686,0.561,0.731,0.078651,,,C0410438,Primary osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
113,54,ACP5,P13686,0.561,0.731,0.078651,,,C0410528,Skeletal dysplasia,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
114,54,ACP5,P13686,0.561,0.731,0.078651,,,C0520679,"Sleep Apnea, Obstructive",C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
115,54,ACP5,P13686,0.561,0.731,0.078651,,,C0524909,"Hepatitis B, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
116,54,ACP5,P13686,0.561,0.731,0.078651,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
117,54,ACP5,P13686,0.561,0.731,0.078651,,,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
118,54,ACP5,P13686,0.561,0.731,0.078651,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
119,54,ACP5,P13686,0.561,0.731,0.078651,,,C0700201,Dyssomnias,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
120,54,ACP5,P13686,0.561,0.731,0.078651,,,C0851578,Sleep Disorders,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",group,Mental or Behavioral Dysfunction,0.01,1.0
121,54,ACP5,P13686,0.561,0.731,0.078651,,,C0878787,Growth failure,,,phenotype,Disease or Syndrome,0.01,1.0
122,54,ACP5,P13686,0.561,0.731,0.078651,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
123,54,ACP5,P13686,0.561,0.731,0.078651,,,C1512409,Hepatocarcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
124,54,ACP5,P13686,0.561,0.731,0.078651,,,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
125,54,ACP5,P13686,0.561,0.731,0.078651,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
126,54,ACP5,P13686,0.561,0.731,0.078651,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
127,54,ACP5,P13686,0.561,0.731,0.078651,,,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
128,54,ACP5,P13686,0.561,0.731,0.078651,,,C4272579,Autosomal Dominant Osteopetrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
129,54,ACP5,P13686,0.561,0.731,0.078651,,,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
1,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
2,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
3,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C3714758,Juvenile psoriatic arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
4,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4552091,"Polyarthritis, Juvenile, Rheumatoid Factor Negative",C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
5,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4704862,"Polyarthritis, Juvenile, Rheumatoid Factor Positive",C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
6,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.24,1.0
7,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917
8,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.929
9,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.957
10,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
11,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0
12,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0520679,"Sleep Apnea, Obstructive",C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0
13,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0343641,Human papilloma virus infection,C01,   Infections,disease,Disease or Syndrome,0.04,1.0
14,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
15,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0
16,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0033581,prostatitis,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
17,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0206708,Cervical Intraepithelial Neoplasia,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
18,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
19,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0
20,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
21,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
22,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0
23,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
24,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
25,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.02,1.0
26,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
27,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
28,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
29,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.02,1.0
30,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
31,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
32,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
33,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
34,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
35,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0037315,Sleep Apnea Syndromes,C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
36,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
37,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
38,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
39,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0221026,X-linked agammaglobulinemia,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
40,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
41,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
42,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
43,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0936223,Metastatic Prostate Carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
44,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1282496,Metastasis from malignant tumor of prostate,,,disease,Neoplastic Process,0.02,1.0
45,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
46,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1868683,"B-CELL MALIGNANCY, LOW-GRADE",,,disease,Neoplastic Process,0.02,1.0
47,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C2936719,Mechanical Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.02,1.0
48,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
49,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4721208,Metastatic castration-resistant prostate cancer,,,disease,Neoplastic Process,0.02,1.0
50,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
51,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
52,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
53,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,0.0
54,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0003578,Apnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
55,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
56,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
57,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
58,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0004610,Bacteremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
59,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
60,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
61,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0006111,Brain Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
62,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0006144,Breast Cyst,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Acquired Abnormality,0.01,1.0
63,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0006145,Breast Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
64,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0006666,Calciphylaxis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
65,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0007868,Cervical dysplasia,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
66,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
67,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
68,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0011644,Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
69,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
70,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0017551,Gilbert Disease (disorder),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
71,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
72,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
73,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
74,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0
75,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
76,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
77,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0020550,Hyperthyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
78,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0
79,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
80,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
81,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
82,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
83,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0026936,Mycoplasma Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
84,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
85,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
86,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
87,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
88,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
89,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
90,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0034186,Pyelonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
91,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
92,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
93,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
94,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0037384,Snoring,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
95,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
96,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0040961,Tricuspid Valve Insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
97,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0042341,Varicocele,C12;C14,   Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
98,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
99,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
100,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
101,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0151718,Hypocholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
102,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0153690,Secondary malignant neoplasm of bone,C23;C04;C05,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Musculoskeletal Diseases",disease,Neoplastic Process,0.01,1.0
103,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0162557,"Liver Failure, Acute",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
104,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
105,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
106,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
107,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
108,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0242670,Persistent Vegetative State,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
109,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
110,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0262380,Asymptomatic bacteriuria,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
111,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0268353,"Cutis laxa, x-linked",C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
112,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0268398,Familial lichen amyloidosis,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
113,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0278510,Childhood Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
114,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0278838,Prostate cancer recurrent,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
115,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0278876,Adult Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
116,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
117,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
118,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0334276,Adenocarcinoma in Situ,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
119,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0334660,Angioendotheliomatosis,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
120,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0338508,Optic Atrophy 1,C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
121,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0343401,MRSA - Methicillin resistant Staphylococcus aureus infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
122,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
123,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0349459,Cervical intraepithelial neoplasia grade 2,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
124,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.01,0.0
125,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0403720,X-linked recessive nephrolithiasis with renal failure,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
126,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0520575,Acute pyelonephritis,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
127,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
128,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0598935,Tumor Initiation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
129,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
130,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0745242,Immunoglobulin deficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
131,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0851140,Carcinoma in situ of uterine cervix,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
132,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
133,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
134,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
135,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
136,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1654637,androgen independent prostate cancer,,,disease,Neoplastic Process,0.01,1.0
137,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
138,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1739135,Progression of prostate cancer,,,disease,Neoplastic Process,0.01,1.0
139,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C1861455,STOMATOCYTOSIS I,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
140,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
141,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C3501843,Nonmedullary Thyroid Carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
142,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C3887487,Postaxial polydactyly type A,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
143,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4025735,Nonspherocytic hemolytic anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
144,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4076240,Chronic kidney disease mineral and bone disorder,C18;C13;C05;C12;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
145,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4285911,C5 palsy,,,disease,Disease or Syndrome,0.01,1.0
146,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4505432,XMRV Infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
147,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4524264,Uncomplicated pyelonephritis,,,disease,Disease or Syndrome,0.01,1.0
148,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4551689,Sleep-Disordered Breathing,C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
149,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
150,55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C4759295,Non-metastatic prostate cancer,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
0,56,ACRV1,P26436,1.0,0.077,1.2111e-06,,,C1175175,Severe Acute Respiratory Syndrome,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
0,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3711389,Actin-Accumulation Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.93,1.0
1,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0546264,Congenital Fiber Type Disproportion,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Congenital Abnormality,0.74,1.0
2,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4225181,"MYOPATHY, SCAPULOHUMEROPERONEAL",,,disease,Disease or Syndrome,0.7,1.0
3,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1834339,"Myopathy, Actin, Congenital, with Excess of Thin Myofilaments",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.6,1.0
4,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2750537,"Myopathy, Actin, Congenital, With Cores",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.6,1.0
5,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.53,1.0
6,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.4,1.0
7,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.4,0.976
8,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0270969,Zebra body myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0
9,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0
10,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0175709,Centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
11,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0410180,Eichsfeld type congenital muscular dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
12,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0410203,X-linked centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Congenital Abnormality,0.3,
13,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0410207,Tubular Aggregate Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
14,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0546125,"Nemaline Myopathy, Childhood Onset",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
15,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0752282,Congenital Structural Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
16,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1834558,"Myopathy, Centronuclear, Autosomal Dominant",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
17,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3645536,Autosomal Recessive Centronuclear Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
18,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3661489,Autosomal Dominant Myotubular Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
19,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4551952,"Myopathy, Centronuclear, 1",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,
20,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.2,1.0
21,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0042510,Ventricular Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
22,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2750536,"Nemaline Myopathy 3, With Intranuclear Rods",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
23,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2678065,Myofibrillar Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.12,1.0
24,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0027868,Neuromuscular Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.11,1.0
25,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0029089,Ophthalmoplegia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.11,1.0
26,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1145670,Respiratory Failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0
27,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0003886,Arthrogryposis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,
28,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0005745,Blepharoptosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
29,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0006157,Breech Presentation,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,
30,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0009081,Congenital clubfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
31,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
32,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,
33,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
34,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0015469,Facial paralysis,C23;C10;C07,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.1,
35,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
36,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0016842,Congenital pectus excavatum,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
37,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0019553,Hip Contracture,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.1,
38,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0020224,Polyhydramnios,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,
39,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0020534,Orbital separation excessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
40,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0022821,Kyphosis deformity of spine,C05,   Musculoskeletal Diseases,phenotype,Anatomical Abnormality,0.1,
41,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0024003,Lordosis,C05,   Musculoskeletal Diseases,phenotype,Disease or Syndrome,0.1,
42,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0025990,Micrognathism,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
43,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,1.0
44,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,
45,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0033377,Ptosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
46,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0035229,Respiratory Insufficiency,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.1,
47,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
48,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0039273,Talipes cavus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Anatomical Abnormality,0.1,
49,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0040485,Torticollis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
50,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0086437,Joint laxity,C05,   Musculoskeletal Diseases,phenotype,Pathologic Function,0.1,
51,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0086439,Hypokinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
52,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0151526,Premature Birth,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,
53,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0151888,Hyporeflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
54,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0221170,Muscular stiffness,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.1,
55,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0221629,Proximal muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
56,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0231666,Wrist-Drop,C10,   Nervous System Diseases,phenotype,Finding,0.1,
57,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0231712,Waddling gait,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
58,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0232466,Feeding difficulties,,,phenotype,Finding,0.1,
59,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0233565,Bradykinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
60,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0233844,Clumsiness,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",phenotype,Sign or Symptom,0.1,
61,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0234146,Absent reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
62,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0234182,Gowers sign,,,phenotype,Finding,0.1,
63,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0234860,Weak cry,,,phenotype,Finding,0.1,
64,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0235659,Reduced fetal movement,C16;C13,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Finding,0.1,
65,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0239067,Difficulty walking up stairs,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
66,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0239234,Low set ears,,,disease,Congenital Abnormality,0.1,
67,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0239830,Hand muscle atrophy,,,phenotype,Finding,0.1,
68,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0240421,Progressive muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
69,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0240479,Neck muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
70,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0240635,Byzanthine arch palate,C16;C05;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
71,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0240953,Winged scapula,,,phenotype,Finding,0.1,
72,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0241005,Creatine phosphokinase serum increased,,,phenotype,Finding,0.1,
73,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0265783,Congenital hypoplasia of lung,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Congenital Abnormality,0.1,
74,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0270960,Congenital myopathy (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Congenital Abnormality,0.1,1.0
75,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0311394,Difficulty walking,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
76,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0332615,Myopathic facies,,,phenotype,Finding,0.1,
77,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0345392,Congenital kyphoscoliosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
78,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0349588,Short stature,,,phenotype,Finding,0.1,
79,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0409338,Flexion contracture - elbow,,,disease,Acquired Abnormality,0.1,
80,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0410264,Contracture of tendo achilles,,,disease,Anatomical Abnormality,0.1,
81,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0410266,Contracture of hamstring(s),C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.1,
82,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0424448,Mask-like facies,C10,   Nervous System Diseases,phenotype,Finding,0.1,
83,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0424551,Impaired exercise tolerance,,,phenotype,Finding,0.1,
84,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0426790,Narrow thorax,,,phenotype,Finding,0.1,
85,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0426818,Thin rib,,,phenotype,Finding,0.1,
86,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0427065,Distal muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
87,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0432072,Dysmorphic features,,,disease,Congenital Abnormality,0.1,1.0
88,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0456132,Large fontanelle,,,phenotype,Finding,0.1,
89,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0476405,Lung function testing abnormal,,,phenotype,Finding,0.1,
90,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0476408,Reduced vital capacity,,,phenotype,Finding,0.1,
91,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0520947,Clumsiness - motor delay,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.1,
92,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0521525,Short neck,,,phenotype,Finding,0.1,
93,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0541794,Skeletal muscle atrophy,,,phenotype,Pathologic Function,0.1,
94,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0544755,Genu varum,C05,   Musculoskeletal Diseases,phenotype,Finding,0.1,
95,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0544966,Autophagic vaculoes (finding),,,phenotype,Finding,0.1,
96,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
97,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0575158,Kyphoscoliosis deformity of spine,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
98,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0576093,Knee joint valgus deformity,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
99,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0587246,Muscle weakness of limb,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
100,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0600033,Acquired Kyphoscoliosis,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.1,
101,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0686353,"Muscular Dystrophies, Limb-Girdle",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",group,Disease or Syndrome,0.1,
102,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0746674,Generalized muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
103,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.1,
104,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0850703,Frequent falls,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
105,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,
106,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1184923,Lumbar hyperlordosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
107,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1276035,Pena-Shokeir syndrome type I,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,
108,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1387005,Penis agenesis,C12,   Male Urogenital Diseases,disease,Congenital Abnormality,0.1,
109,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1836003,Facial diplegia,C01;C10;C07,   Infections;    Nervous System Diseases;    Stomatognathic Diseases,phenotype,Finding,0.1,
110,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1836038,Poor head control,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
111,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1836047,Long face,,,phenotype,Finding,0.1,
112,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1836057,Muscle fiber splitting,,,phenotype,Finding,0.1,
113,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1837142,Poor suck,,,phenotype,Finding,0.1,
114,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1837262,Increased muscle lipid content,,,phenotype,Finding,0.1,
115,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1837404,"High, narrow palate",,,phenotype,Finding,0.1,
116,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1837463,Narrow face,,,phenotype,Finding,0.1,
117,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1838114,Generalized limb muscle atrophy,,,disease,Disease or Syndrome,0.1,
118,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1839630,Severe muscular hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
119,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1839767,Tented upper lip vermilion,,,phenotype,Finding,0.1,
120,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1842170,Centrally nucleated skeletal muscle fibers,,,phenotype,Finding,0.1,
121,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1842820,Cardiac conduction abnormality,,,phenotype,Finding,0.1,
122,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1843057,Calf muscle hypertrophy,,,phenotype,Finding,0.1,
123,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1843637,Neck flexor weakness,,,phenotype,Finding,0.1,
124,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1843643,Nocturnal hypoventilation,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
125,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1843697,Axial muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
126,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1843700,Increased variability in muscle fiber diameter,,,phenotype,Finding,0.1,
127,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1848873,Abnormality of the diaphragm,,,phenotype,Anatomical Abnormality,0.1,
128,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1850573,Slender build,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
129,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1850848,Muscle fiber necrosis,,,phenotype,Pathologic Function,0.1,
130,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1853171,Multiple prenatal fractures,,,phenotype,Finding,0.1,
131,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1853932,Rimmed vacuoles on biopsy,,,phenotype,Finding,0.1,
132,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1854301,Motor delay,F03,   Mental Disorders,phenotype,Finding,0.1,
133,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1854387,Type 1 muscle fiber predominance,,,phenotype,Finding,0.1,
134,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1854494,Slow progression,,,phenotype,Finding,0.1,
135,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1856507,Bulbar signs,,,phenotype,Finding,0.1,
136,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1857304,Flexion contracture of finger,,,phenotype,Finding,0.1,
137,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1858025,Spinal rigidity,,,phenotype,Finding,0.1,
138,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
139,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1858127,Limb-girdle muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
140,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1861403,Variable expressivity,,,phenotype,Finding,0.1,
141,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1865014,Long philtrum,,,phenotype,Finding,0.1,
142,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1866021,Increased connective tissue,,,phenotype,Finding,0.1,
143,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1866141,Foot dorsiflexor weakness,,,phenotype,Finding,0.1,
144,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1866934,Reduced tendon reflexes,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
145,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1868623,Handgrip myotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
146,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2267233,Neonatal Hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
147,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2674608,Feeding difficulties in infancy,,,phenotype,Finding,0.1,
148,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2732374,Edema of dorsum of hand,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
149,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2919142,"Short Stature, CTCAE",,,phenotype,Finding,0.1,
150,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3494422,Retrognathia,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Anatomical Abnormality,0.1,
151,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3554617,Adducted thumb,C05,   Musculoskeletal Diseases,phenotype,Finding,0.1,
152,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.1,
153,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3806467,Respiratory insufficiency due to muscle weakness,C08,   Respiratory Tract Diseases,phenotype,Finding,0.1,
154,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3806482,Recurrent respiratory infections,C01;C08,   Infections;    Respiratory Tract Diseases,phenotype,Finding,0.1,
155,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3808039,Nemaline bodies,,,phenotype,Finding,0.1,
156,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3808250,Reduced forced vital capacity,,,phenotype,Finding,0.1,
157,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4021726,EMG: myopathic abnormalities,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,phenotype,Pathologic Function,0.1,
158,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4021727,EMG: neuropathic changes,,,phenotype,Finding,0.1,
159,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4021797,Abnormality of the thorax,,,disease,Anatomical Abnormality,0.1,
160,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4022583,Fatiguable weakness of proximal limb muscles,,,phenotype,Finding,0.1,
161,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4022585,Fatigable weakness of distal limb muscles,,,phenotype,Finding,0.1,
162,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4022587,Fatigable weakness of respiratory muscles,,,phenotype,Finding,0.1,
163,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4022591,Fatigable weakness of bulbar muscles,,,phenotype,Finding,0.1,
164,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4023180,Type 1 muscle fiber atrophy,,,disease,Disease or Syndrome,0.1,
165,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4025565,Late-onset distal muscle weakness,,,phenotype,Finding,0.1,
166,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4025571,Type 1 fibers relatively smaller than type 2 fibers,,,phenotype,Finding,0.1,
167,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4025729,Neuromuscular dysphagia,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,
168,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4082299,Bulbar palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
169,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4551649,Congenital Dysplasia Of The Hip,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
170,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4552811,"Generalized Muscle Weakness, CTCAE",,,phenotype,Finding,0.1,
171,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0030552,Paresis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.08,1.0
172,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0151786,Muscle Weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.08,1.0
173,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3711377,Intranuclear Rod Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0
174,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0751336,Distal Muscular Dystrophies,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",group,Disease or Syndrome,0.02,1.0
175,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3710589,Cap Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome; Congenital Abnormality,0.02,1.0
176,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
177,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
178,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,0.0
179,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
180,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
181,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
182,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
183,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0023860,Listeriosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
184,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
185,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
186,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0029401,Osteitis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
187,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
188,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
189,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0043116,HMN (Hereditary Motor Neuropathy) Proximal Type I,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
190,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
191,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0085436,"Meningitis, Cryptococcal",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
192,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0234958,Muscle degeneration,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
193,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
194,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0241910,Autoimmune Chronic Hepatitis,C06;C20,   Digestive System Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
195,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
196,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0270971,Floppy infant syndrome,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
197,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0270992,Secondary myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
198,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0341858,Endometriosis of uterus,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
199,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0520459,Necrotizing Enterocolitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
200,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
201,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0699743,Congenital muscular dystrophy (disorder),C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
202,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0751656,"Nemaline Myopathy, Autosomal Dominant",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
203,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C0751657,"Nemaline Myopathy, Autosomal Recessive",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
204,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1142253,Arthrofibrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
205,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
206,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
207,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0
208,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1833662,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA,C16;C18;C05;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
209,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1839615,X-linked myopathy with excessive autophagy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
210,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C1853926,NONAKA MYOPATHY,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
211,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2931230,Vacuolar myopathy,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
212,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C2931268,Scapuloperoneal myopathy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
213,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4024911,Acute infantile spinal muscular atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
214,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4082937,Necrotizing enterocolitis in fetus OR newborn,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
215,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4551472,Hypertrophic obstructive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
216,58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C4721555,Autoimmune hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
0,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3151201,MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME,,,disease,Disease or Syndrome,0.78,1.0
1,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2673186,"Aortic Aneurysm, Familial Thoracic 6",C23;C17;C14,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0
2,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3279690,MOYAMOYA DISEASE 5,,,disease,Disease or Syndrome,0.7,1.0
3,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.6,1.0
4,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4707243,Familial thoracic aortic aneurysm and aortic dissection,,,disease,Disease or Syndrome,0.6,1.0
5,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0162872,"Aortic Aneurysm, Thoracic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.43,1.0
6,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2931384,Moyamoya disease 1,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.39,1.0
7,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.32,1.0
8,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0
9,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.31,1.0
10,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.31,1.0
11,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0005398,"Cholestasis, Extrahepatic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
12,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
13,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
14,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
15,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.3,1.0
16,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0
17,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0019189,"Hepatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
18,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
19,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.3,1.0
20,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0
21,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
22,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0
23,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0027719,Nephrosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0
24,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0
25,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0041956,Ureteral obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0
26,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0086432,"Hyalinosis, Segmental Glomerular",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0
27,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0086565,Liver Dysfunction,C06,   Digestive System Diseases,phenotype,Finding,0.3,1.0
28,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0149519,Chronic Persistent Hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
29,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0269102,Endometrioma,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.3,1.0
30,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0340630,"Aortic Aneurysm, Thoracoabdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
31,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0520463,Chronic active hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
32,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0524611,Cryptogenic Chronic Hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
33,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
34,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1257931,"Mammary Neoplasms, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
35,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.3,1.0
36,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1619692,Nephrogenic Fibrosing Dermopathy,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.3,1.0
37,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1876165,Copper-Overload Cirrhosis,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
38,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4704874,"Mammary Carcinoma, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
39,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4721507,"Alveolitis, Fibrosing",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0
40,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
41,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0160390,Injury of liver,C06;C26,   Digestive System Diseases;    Wounds and Injuries,disease,Injury or Poisoning,0.2,1.0
42,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0013274,Patent ductus arteriosus,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.14,1.0
43,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.13,1.0
44,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.13,1.0
45,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0026961,Mydriasis,C11,   Eye Diseases,phenotype,Sign or Symptom,0.12,1.0
46,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0149630,Bicuspid aortic valve,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.12,1.0
47,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0
48,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0
49,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0003504,Aortic Valve Insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
50,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0003706,Arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
51,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
52,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0008031,Chest Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
53,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0
54,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0
55,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0009782,Connective Tissue Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.1,
56,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0
57,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
58,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0013405,"Dyspnea, Paroxysmal",C23;C08;C14,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
59,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0016202,Flatfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Anatomical Abnormality,0.1,
60,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.1,
61,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0019079,Hemoptysis,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
62,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0019294,"Hernia, Inguinal",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.1,
63,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0020534,Orbital separation excessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
64,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,
65,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
66,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0032326,Pneumothorax,C08,   Respiratory Tract Diseases,phenotype,Disease or Syndrome,0.1,
67,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0
68,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
69,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
70,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0
71,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
72,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0039446,Telangiectasis,C14,   Cardiovascular Diseases,disease,Finding,0.1,
73,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0221210,Congenital malrotation of intestine,C23;C16;C06,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,
74,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0231807,Dyspnea on exertion,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
75,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0231835,Tachypnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Finding,0.1,
76,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0232474,Increased peristalsis,,,phenotype,Finding,0.1,
77,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0241240,Tall stature,,,phenotype,Finding,0.1,
78,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0
79,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0242698,"Ventricular Dysfunction, Left",C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,
80,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0263401,Cutis marmorata,C16;C04;C17;C14;C26,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases;    Wounds and Injuries",disease,Disease or Syndrome,0.1,
81,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0281967,Retinal infarction,,,disease,Disease or Syndrome,0.1,
82,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0423798,Increased tendency to bruise,C26,   Wounds and Injuries,phenotype,Finding,0.1,
83,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0546884,Hypovolemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
84,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0
85,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0855095,Small Lymphocytic Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0
86,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0856747,Aneurysm of ascending aorta,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,
87,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1298820,Aneurysm of aortic root,C14,   Cardiovascular Diseases,disease,Anatomical Abnormality,0.1,
88,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1388233,Aneurysm of descending thoracic aorta,C14,   Cardiovascular Diseases,phenotype,Anatomical Abnormality,0.1,
89,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1531647,Cerebral ventriculomegaly,C10,   Nervous System Diseases,phenotype,Finding,0.1,
90,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1836653,Ascending aortic dissection,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,
91,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1837404,"High, narrow palate",,,phenotype,Finding,0.1,
92,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1846837,"Aortic Aneurysm, Familial Thoracic 2",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
93,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1851712,Dural ectasia,,,phenotype,Finding,0.1,
94,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1860493,Abnormality of the sternum,,,phenotype,Anatomical Abnormality,0.1,
95,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2674950,"LUNG CANCER, SUSCEPTIBILITY TO",,,phenotype,Finding,0.1,
96,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0
97,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
98,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3278923,Dilated ventricles (finding),,,phenotype,Finding,0.1,
99,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3494422,Retrognathia,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Anatomical Abnormality,0.1,
100,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.1,
101,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4022001,Abnormality of the cerebral vasculature,,,disease,Anatomical Abnormality,0.1,
102,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4022878,Descending aortic dissection,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
103,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4023169,Moyamoya phenomenon,,,disease,Disease or Syndrome,0.1,
104,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4025272,Peripheral arterial stenosis,,,disease,Disease or Syndrome,0.1,
105,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4025690,Prenatal maternal abnormality,,,disease,Anatomical Abnormality,0.1,
106,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4025845,Abnormality iris morphology,,,disease,Anatomical Abnormality,0.1,
107,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4293686,Periventricular white matter hyperdensities,,,phenotype,Pathologic Function,0.1,
108,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4476540,Dilatation of the cerebral artery,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,phenotype,Anatomical Abnormality,0.1,
109,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4476554,Carotid artery dilatation,,,phenotype,Anatomical Abnormality,0.1,
110,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.07,1.0
111,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0852949,Arteriopathic disease,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",group,Disease or Syndrome,0.07,1.0
112,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.05,1.0
113,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0340643,Dissection of aorta,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0
114,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
115,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0007820,Cerebrovascular Disorders,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.04,1.0
116,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
117,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.04,1.0
118,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0003493,Aortic Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
119,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
120,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
121,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.03,1.0
122,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0241868,acute aortic dissection,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
123,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0345050,Congenital aneurysm of ascending aorta,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.03,1.0
124,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1303010,"Mydriasis, Congenital",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.03,0.667
125,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
126,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3495549,Patent ductus arteriosus - persisting type,C16;C08;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.03,1.0
127,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.02,1.0
128,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0024796,Marfan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
129,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
130,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0033770,Prune Belly Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.02,1.0
131,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0158638,Congenital anomaly of cerebrovascular system,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",group,Congenital Abnormality,0.02,1.0
132,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0235833,Congenital diaphragmatic hernia,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.02,1.0
133,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
134,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0949658,"Cardiomyopathy, Hypertrophic, Familial",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
135,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
136,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
137,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4477072,Iris flocculi,,,phenotype,Anatomical Abnormality,0.02,1.0
138,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
139,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
140,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0002949,"Aneurysm, Dissecting",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
141,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
142,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
143,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
144,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
145,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
146,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
147,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
148,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
149,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
150,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
151,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
152,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0012736,Dissecting aortic aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
153,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0013720,Ehlers-Danlos Syndrome,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
154,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
155,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0016052,Fibromuscular Dysplasia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
156,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,0.0
157,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
158,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
159,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0018816,Heart Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
160,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0021831,Intestinal Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
161,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
162,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0037285,Skin Manifestations,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
163,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0040021,Thromboangiitis Obliterans,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
164,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0085436,"Meningitis, Cryptococcal",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
165,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
166,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
167,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0152171,Idiopathic pulmonary hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
168,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
169,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
170,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0235031,Neurologic Symptoms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Sign or Symptom,0.01,0.0
171,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
172,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0270612,Leukoencephalopathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
173,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
174,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0340629,Aortic aneurysm without mention of rupture NOS,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
175,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
176,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
177,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0392775,Cystic medial necrosis of aorta,C23;C04;C14,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
178,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0403647,Hypotonic bladder disorder,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Disease or Syndrome,0.01,1.0
179,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0431401,Gillespie syndrome,C23;C16;C11;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.01,1.0
180,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
181,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
182,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
183,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0740394,Hyperuricemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
184,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0741621,Brachial artery occlusion,,,disease,Disease or Syndrome,0.01,1.0
185,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C0750145,Occlusive vascular disease,,,disease,Disease or Syndrome,0.01,1.0
186,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1299567,Neonatal stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
187,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C1332965,Congenital Mesoblastic Nephroma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
188,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2004461,Bowel dysfunction,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
189,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
190,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2931117,Fetal megacystis,C16;C13,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",disease,Disease or Syndrome,0.01,1.0
191,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C2945695,Limb ischemia,,,disease,Disease or Syndrome,0.01,1.0
192,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3888391,Nonnuclear polymorphic congenital cataract,,,disease,Congenital Abnormality,0.01,1.0
193,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3888570,Degenerative mitral valve disease,,,disease,Disease or Syndrome,0.01,1.0
194,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4082974,Dupuytren's Disease,C04;C17;C05,   Neoplasms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,0.0
195,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4289994,Adenosine Deaminase 2 Deficiency,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
196,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4551472,Hypertrophic obstructive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
197,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
198,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4732796,Apical hypertrophic cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
199,59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C4744444,Metastatic Lung Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1855722,"Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation",C23;C16;C11;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.72,1.0
1,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1846331,Juvenile-onset dystonia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0
2,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.5,1.0
3,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.4,1.0
4,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,1.0
5,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.972
6,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.39,0.9
7,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,1.0
8,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1853623,Fryns-Aftimos Syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.36,1.0
9,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.32,1.0
10,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.32,1.0
11,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0205697,"Carcinoma, Spindle-Cell",C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0
12,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0
13,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
14,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005818,Blood Platelet Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.31,1.0
15,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009363,Congenital ocular coloboma (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.31,1.0
16,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.31,1.0
17,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.31,1.0
18,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0263579,Pigmented hairy epidermal nevus,C16;C04;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Neoplastic Process,0.31,1.0
19,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0272183,Qualitative abnormality of granulocyte,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.31,1.0
20,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1858042,Becker Nevus Syndrome,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.31,1.0
21,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
22,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
23,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013393,Dysostoses,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
24,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
25,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024667,Animal Mammary Neoplasms,C04;C22,   Neoplasms;    Animal Diseases,phenotype,Neoplastic Process,0.3,1.0
26,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0
27,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0
28,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0086743,Osteoarthrosis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
29,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
30,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0205696,Anaplastic carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
31,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0205698,Undifferentiated carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
32,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0205699,Carcinomatosis,C04,   Neoplasms,phenotype,Neoplastic Process,0.3,1.0
33,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0242184,Hypoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
34,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265541,Cranioschisis,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
35,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0376634,Craniofacial Abnormalities,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Congenital Abnormality,0.3,1.0
36,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0393588,"Dystonia, Paroxysmal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
37,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0393610,"Dystonia, Diurnal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
38,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0497552,Congenital neurologic anomalies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.3,1.0
39,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0700292,Hypoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0
40,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751093,"Dystonia, Limb",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
41,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.3,1.0
42,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1257925,"Mammary Carcinoma, Animal",C04;C22,   Neoplasms;    Animal Diseases,disease,Neoplastic Process,0.3,1.0
43,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1262760,"Hepatitis, Drug-Induced",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
44,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1691779,Sensory hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.3,1.0
45,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3658290,Drug-Induced Acute Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
46,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4279912,Chemically-Induced Liver Toxicity,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
47,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4554007,Uveoretinal Coloboma,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.3,1.0
48,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0
49,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
50,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2750440,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1",,,disease,Finding,0.2,1.0
51,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2750441,"LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1",,,phenotype,Finding,0.2,1.0
52,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3150651,"FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2",,,phenotype,Finding,0.2,1.0
53,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.2,1.0
54,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0149630,Bicuspid aortic valve,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.14,1.0
55,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013274,Patent ductus arteriosus,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.13,1.0
56,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.13,1.0
57,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.13,1.0
58,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0033377,Ptosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.12,1.0
59,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.12,1.0
60,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.12,1.0
61,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005745,Blepharoptosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0
62,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.11,1.0
63,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.11,1.0
64,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266483,Pachygyria,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.11,1.0
65,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0
66,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0
67,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
68,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003507,Aortic Valve Stenosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
69,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003537,Aphasia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,
70,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
71,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.9
72,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
73,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
74,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0
75,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
76,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0
77,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
78,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
79,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
80,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
81,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,
82,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0
83,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0
84,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
85,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013528,Echolalia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.1,
86,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014848,Esophageal Achalasia,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
87,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
88,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0016842,Congenital pectus excavatum,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
89,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
90,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.1,0.923
91,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0
92,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018552,Hamartoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,
93,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0
94,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0
95,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020295,Hydronephrosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,
96,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020534,Orbital separation excessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
97,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
98,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022821,Kyphosis deformity of spine,C05,   Musculoskeletal Diseases,phenotype,Anatomical Abnormality,0.1,
99,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023221,Leg Length Inequality,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Finding,0.1,
100,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023787,Lipodystrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
101,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024421,Macroglossia,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,
102,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024433,Macrostomia,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
103,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
104,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025990,Micrognathism,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
105,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025995,Micromelia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
106,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026106,Mild Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,
107,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
108,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026837,Muscle Rigidity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,1.0
109,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.1,1.0
110,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026884,Mutism,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",phenotype,Disease or Syndrome,0.1,
111,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0
112,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.952
113,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
114,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029422,Osteochondrodysplasias,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Disease or Syndrome,0.1,
115,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029429,Osteochondrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
116,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
117,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0030552,Paresis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,1.0
118,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
119,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
120,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
121,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0041956,Ureteral obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Disease or Syndrome,0.1,1.0
122,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.1,1.0
123,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0043194,Wiskott-Aldrich Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,0.963
124,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0080174,Spina Bifida Occulta,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
125,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151650,Renal fibrosis,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,1.0
126,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151786,Muscle Weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,1.0
127,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0152439,Retinoschisis,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
128,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0155299,Coloboma of optic disc,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,
129,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0158731,Congenital pectus carinatum,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
130,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162285,Edema of eyelid,C13;C11;C17;C12;C20;C14,   Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases;    Cardiovascular Diseases,phenotype,Pathologic Function,0.1,
131,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162298,Joint stiffness,C05,   Musculoskeletal Diseases,phenotype,Sign or Symptom,0.1,
132,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
133,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.1,1.0
134,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,0.967
135,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0221217,Neck webbing,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.1,
136,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0232466,Feeding difficulties,,,phenotype,Finding,0.1,
137,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,0.923
138,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235991,Small for gestational age (disorder),C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Finding,0.1,
139,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0239234,Low set ears,,,disease,Congenital Abnormality,0.1,
140,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0239676,High forehead,,,phenotype,Finding,0.1,
141,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0
142,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0240063,Coloboma of iris,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Anatomical Abnormality,0.1,
143,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0240896,Fundus coloboma,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,
144,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265535,Trigonocephaly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
145,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265695,Congenital fusion of ribs,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
146,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266011,Accessory nipple,C17,   Skin and Connective Tissue Diseases,disease,Congenital Abnormality,0.1,
147,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266464,Polymicrogyria,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
148,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266544,Microcornea,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,
149,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266551,Congenital coloboma of iris,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,
150,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0270960,Congenital myopathy (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Congenital Abnormality,0.1,1.0
151,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0277828,Late fontanel closure,,,phenotype,Finding,0.1,
152,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
153,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
154,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
155,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0302511,Small for gestational age fetus,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
156,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0345392,Congenital kyphoscoliosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
157,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0345397,Accessory rib,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
158,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,0.929
159,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0349588,Short stature,,,phenotype,Finding,0.1,
160,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.964
161,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0410528,Skeletal dysplasia,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
162,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0423110,Downward slant of palpebral fissure,,,phenotype,Finding,0.1,
163,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0423113,Telecanthus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
164,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0423318,Heterochromia iridis,C23;C11;C17,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Skin and Connective Tissue Diseases",phenotype,Finding,0.1,
165,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0426415,Large nose,,,phenotype,Finding,0.1,
166,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0426421,Wide nose,,,phenotype,Finding,0.1,
167,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0432072,Dysmorphic features,,,disease,Congenital Abnormality,0.1,1.0
168,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0456070,Growth delay,,,phenotype,Pathologic Function,0.1,
169,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0456132,Large fontanelle,,,phenotype,Finding,0.1,
170,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0456909,Blindness,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
171,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0521525,Short neck,,,phenotype,Finding,0.1,
172,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0521620,Dilatation of ureter,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Anatomical Abnormality,0.1,
173,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0
174,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0575158,Kyphoscoliosis deformity of spine,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
175,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0578038,Thin lips,,,phenotype,Finding,0.1,
176,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
177,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0
178,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0
179,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0600033,Acquired Kyphoscoliosis,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.1,
180,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.963
181,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
182,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0678230,Congenital Epicanthus,,,disease,Congenital Abnormality,0.1,
183,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0
184,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
185,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.1,1.0
186,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,0.923
187,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0973461,Dysphasia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
188,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0
189,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,0.987
190,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1280433,Lipoatrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
191,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1303001,Congenital euryblepharon,,,disease,Congenital Abnormality,0.1,
192,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
193,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0
194,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
195,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1387005,Penis agenesis,C12,   Male Urogenital Diseases,disease,Congenital Abnormality,0.1,
196,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,0.882
197,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.1,1.0
198,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
199,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
200,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1623258,Electrocardiography,,,phenotype,Diagnostic Procedure,0.1,1.0
201,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
202,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1837731,Overfolded helix,,,phenotype,Finding,0.1,
203,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1839798,Long nose,,,phenotype,Finding,0.1,
204,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1840077,Anteverted nostril,,,phenotype,Finding,0.1,
205,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1842774,Hypermelanotic macule,,,phenotype,Finding,0.1,
206,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1843367,Poor school performance,,,phenotype,Finding,0.1,
207,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1844505,Pointed chin,,,phenotype,Finding,0.1,
208,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1845847,Coarse facial features,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
209,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1846339,Externally rotated hips,,,phenotype,Finding,0.1,
210,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1846434,Hypoplastic scapulae,,,phenotype,Finding,0.1,
211,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1847766,Shoulder girdle muscle atrophy,,,phenotype,Finding,0.1,
212,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1848954,Generalized dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
213,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1849295,Hypoplastic labia minora,,,phenotype,Finding,0.1,
214,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1849340,Long palpebral fissure,,,phenotype,Finding,0.1,
215,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1849367,Nasal bridge wide,,,phenotype,Finding,0.1,
216,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1853242,Midface retrusion,,,phenotype,Finding,0.1,
217,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1854114,Short nose,,,phenotype,Finding,0.1,
218,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1855728,Low posterior hairline,,,phenotype,Finding,0.1,
219,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1857479,Short columella,,,phenotype,Finding,0.1,
220,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1857949,Prominent metopic ridge,,,phenotype,Finding,0.1,
221,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
222,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1859717,Depressed nasal tip,,,phenotype,Finding,0.1,
223,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1859778,Postnatal growth retardation,,,phenotype,Finding,0.1,
224,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1865014,Long philtrum,,,phenotype,Finding,0.1,
225,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1865017,Thin upper lip vermilion,,,phenotype,Finding,0.1,
226,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1866231,Full cheeks,,,phenotype,Finding,0.1,
227,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1868571,Highly arched eyebrow,,,phenotype,Finding,0.1,
228,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2919142,"Short Stature, CTCAE",,,phenotype,Finding,0.1,
229,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.1,1.0
230,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3494422,Retrognathia,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Anatomical Abnormality,0.1,
231,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3540764,Coloboma of the Retina,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,
232,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4012968,Mild global developmental delay,,,phenotype,Finding,0.1,
233,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4021370,Duplication of thumb phalanx,,,disease,Anatomical Abnormality,0.1,
234,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4021768,Abnormality of metabolism/homeostasis,,,phenotype,Finding,0.1,
235,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4021813,Oral cleft,,,disease,Congenital Abnormality,0.1,
236,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4022012,Death in early adulthood,,,phenotype,Finding,0.1,
237,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4022024,Upper limb asymmetry,,,disease,Anatomical Abnormality,0.1,
238,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4022153,Cerebral cortical hemiatrophy,,,disease,Disease or Syndrome,0.1,
239,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4023018,Subcortical cerebral atrophy,,,disease,Disease or Syndrome,0.1,
240,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4023911,Aplasia/Hypoplasia of the breasts,,,phenotype,Finding,0.1,
241,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4025663,Abnormality of tibia morphology,,,disease,Anatomical Abnormality,0.1,
242,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4025790,Specific learning disability,,,disease,Mental or Behavioral Dysfunction,0.1,
243,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4025895,Abnormality of the scrotum,,,disease,Anatomical Abnormality,0.1,
244,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
245,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0
246,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4551472,Hypertrophic obstructive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0
247,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0
248,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002793,Anaplasia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.09,1.0
249,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.09,1.0
250,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.09,0.889
251,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.09,1.0
252,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.09,0.889
253,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.09,0.889
254,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.09,0.889
255,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.09,1.0
256,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.09,0.889
257,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1969372,Tubulointerstitial fibrosis,,,phenotype,Disease or Syndrome,0.09,1.0
258,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.08,1.0
259,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.08,1.0
260,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.08,1.0
261,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.08,1.0
262,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.08,1.0
263,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.08,1.0
264,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.08,1.0
265,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.08,1.0
266,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.08,1.0
267,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.08,1.0
268,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.07,0.857
269,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
270,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.07,0.857
271,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.07,1.0
272,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.07,1.0
273,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023462,Acute Megakaryocytic Leukemias,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
274,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.07,1.0
275,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027832,Neurofibromatosis 2,C16;C04;C10;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Neoplastic Process,0.07,1.0
276,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.07,1.0
277,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.07,1.0
278,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0
279,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.07,1.0
280,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.07,1.0
281,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0
282,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.06,1.0
283,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.06,1.0
284,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011119,Decompression Sickness,C26,   Wounds and Injuries,disease,Disease or Syndrome,0.06,1.0
285,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.06,1.0
286,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.06,1.0
287,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.06,1.0
288,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.06,1.0
289,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.06,1.0
290,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.06,0.667
291,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0
292,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.06,1.0
293,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0424790,Rigor - Temperature-associated observation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.06,1.0
294,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.06,1.0
295,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.06,1.0
296,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.06,1.0
297,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.06,1.0
298,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2678065,Myofibrillar Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.06,1.0
299,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.06,0.833
300,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.05,1.0
301,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013371,Shigella Infections,C06;C01,   Digestive System Diseases;    Infections,group,Disease or Syndrome,0.05,1.0
302,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.05,1.0
303,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.05,1.0
304,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.05,1.0
305,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.05,0.6
306,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.05,1.0
307,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.05,1.0
308,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.05,1.0
309,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037889,Hereditary spherocytosis,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.05,1.0
310,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.05,1.0
311,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.05,1.0
312,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.05,1.0
313,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0178664,Glomerulosclerosis (disorder),C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0
314,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.05,1.0
315,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0375023,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.05,1.0
316,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0546264,Congenital Fiber Type Disproportion,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Congenital Abnormality,0.05,1.0
317,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1397307,Cardiac fibrosis,,,disease,Disease or Syndrome,0.05,1.0
318,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1608393,Megacystis microcolon intestinal hypoperistalsis syndrome,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.05,1.0
319,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0
320,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.05,1.0
321,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3711389,Actin-Accumulation Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0
322,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.05,1.0
323,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
324,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
325,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.04,1.0
326,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0
327,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0
328,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.04,1.0
329,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0
330,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018916,Hemangioma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
331,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.04,1.0
332,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
333,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
334,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.04,1.0
335,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.04,1.0
336,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
337,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0028259,Nodule,,,phenotype,Acquired Abnormality,0.04,1.0
338,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0028860,Oculocerebrorenal Syndrome,C16;C18;C13;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0
339,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.04,1.0
340,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
341,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.04,1.0
342,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.04,0.75
343,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0
344,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162810,"Cicatrix, Hypertrophic",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.04,1.0
345,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
346,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206624,Hepatoblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
347,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0234119,Neuromuscular inhibition,,,disease,Disease or Syndrome,0.04,1.0
348,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0241910,Autoimmune Chronic Hepatitis,C06;C20,   Digestive System Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,1.0
349,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0302142,Deformity,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Anatomical Abnormality,0.04,1.0
350,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0406557,Poikiloderma of Kindler,C23;C16;C17;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.04,1.0
351,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0410158,Muscle damage,,,phenotype,Acquired Abnormality,0.04,1.0
352,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.04,1.0
353,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751674,Lymphangioleiomyomatosis,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
354,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1628319,Lattice corneal dystrophy Type II,C16;C18;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases",disease,Disease or Syndrome,0.04,1.0
355,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.04,1.0
356,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1837249,"Malformations of Cortical Development, Group II",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.04,1.0
357,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2062441,Influenza A,,,disease,Disease or Syndrome,0.04,1.0
358,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.04,1.0
359,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3811653,Experimental Organism Basal Cell Carcinoma,C04,   Neoplasms,phenotype,Neoplastic Process,0.04,1.0
360,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4290046,trachomatis,,,disease,Disease or Syndrome,0.04,1.0
361,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4721555,Autoimmune hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.04,1.0
362,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
363,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0
364,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
365,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.03,1.0
366,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.03,1.0
367,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
368,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008073,Developmental Disabilities,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0
369,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,0.667
370,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009917,Contracture,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.03,1.0
371,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
372,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010823,Cytomegalovirus Infections,C01,   Infections,group,Disease or Syndrome,0.03,1.0
373,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0
374,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
375,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.03,1.0
376,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.03,1.0
377,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.03,1.0
378,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
379,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.03,1.0
380,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.03,1.0
381,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023440,Acute Erythroblastic Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
382,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
383,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
384,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025286,Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.03,1.0
385,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.03,1.0
386,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026936,Mycoplasma Infections,C01,   Infections,group,Disease or Syndrome,0.03,1.0
387,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027126,Myotonic Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0
388,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027809,Neurilemmoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.333
389,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.03,1.0
390,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0086942,Rous Sarcoma,C04;C01;C22,   Neoplasms;    Infections;    Animal Diseases,disease,Neoplastic Process; Experimental Model of Disease,0.03,1.0
391,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.03,1.0
392,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235833,Congenital diaphragmatic hernia,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.03,1.0
393,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0338106,Adenocarcinoma of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
394,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0340427,Familial dilated cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
395,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0340629,Aortic aneurysm without mention of rupture NOS,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
396,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.03,1.0
397,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.03,1.0
398,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.03,0.667
399,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0494165,Secondary malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
400,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0595921,Intraocular pressure disorder,C11,   Eye Diseases,disease,Disease or Syndrome,0.03,1.0
401,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0
402,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0853879,Invasive carcinoma of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
403,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0858252,Breast adenocarcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
404,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
405,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0949658,"Cardiomyopathy, Hypertrophic, Familial",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0
406,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
407,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
408,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
409,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
410,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1336052,Spindle Cell Neoplasm,,,disease,Neoplastic Process,0.03,0.333
411,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.03,1.0
412,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.03,0.667
413,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
414,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1839163,THROMBOCYTOPENIA 1 (disorder),C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,1.0
415,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1842937,"AURAL ATRESIA, CONGENITAL",C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.03,1.0
416,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1851710,LATERAL MENINGOCELE SYNDROME,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0
417,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1853926,NONAKA MYOPATHY,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0
418,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1863753,LIMB-MAMMARY SYNDROME,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.03,1.0
419,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1962942,TRICHOMONAS VAGINALIS (finding),,,disease,Disease or Syndrome,0.03,1.0
420,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2347748,Adult Erythroleukemia,,,disease,Neoplastic Process,0.03,1.0
421,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2751260,Macrothrombocytopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.03,1.0
422,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2931384,Moyamoya disease 1,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
423,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.03,1.0
424,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0
425,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.03,1.0
426,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3711377,Intranuclear Rod Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0
427,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
428,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4520840,Erythroleukemia (Erythroid/Myeloid),C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
429,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
430,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
431,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0
432,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002991,Cutaneous Fibrous Histiocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
433,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003493,Aortic Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
434,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
435,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
436,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.02,1.0
437,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.02,1.0
438,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.02,0.5
439,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006309,Brucellosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
440,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007121,Bronchogenic Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
441,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
442,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
443,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
444,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008525,Choroideremia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.02,1.0
445,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0
446,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
447,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
448,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014057,Japanese Encephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
449,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
450,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014527,Epidermolysis Bullosa,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.02,1.0
451,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0015826,Fenestration (morphologic abnormality),,,disease,Acquired Abnormality,0.02,1.0
452,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0015923,Fetal Alcohol Syndrome,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.02,1.0
453,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.02,1.0
454,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017150,Gastrinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
455,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017665,Membranous glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
456,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
457,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.02,1.0
458,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019187,"Hepatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.02,1.0
459,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
460,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
461,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
462,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0
463,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
464,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023269,leiomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
465,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
466,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
467,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023461,"Leukemia, Mast-Cell",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
468,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.02,1.0
469,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.02,1.0
470,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
471,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024138,"Lupus Erythematosus, Discoid",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
472,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024312,Lymphopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,0.5
473,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
474,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026010,Microphthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.02,0.5
475,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026850,Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
476,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029172,Oral Submucous Fibrosis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0
477,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
478,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
479,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0030389,Parainfluenza,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
480,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0031036,Polyarteritis Nodosa,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
481,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0033036,Atrial Premature Complexes,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
482,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
483,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.02,1.0
484,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036117,Salmonella infections,C01,   Infections,group,Disease or Syndrome,0.02,1.0
485,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037354,Smallpox,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
486,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037579,Soft Tissue Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
487,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
488,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
489,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042974,von Willebrand Disease,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
490,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
491,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0
492,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151718,Hypocholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
493,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0152171,Idiopathic pulmonary hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
494,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162872,"Aortic Aneurysm, Thoracic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
495,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0175697,Van der Woude syndrome,C23;C16;C04;C05;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.02,1.0
496,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0175709,Centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
497,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0205204,Scab,,,disease,Acquired Abnormality,0.02,1.0
498,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206139,"Lichen Planus, Oral",C17;C07,   Skin and Connective Tissue Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0
499,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206645,Desmoplastic fibroma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
500,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206648,Myofibromatosis,C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5
501,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206656,Embryonal Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
502,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206657,Alveolar Soft Part Sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
503,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220611,Childhood Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
504,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.02,1.0
505,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235259,Subcapsular cataract,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Acquired Abnormality,0.02,1.0
506,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235989,Renal interstitial fibrosis,C13;C17;C12,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
507,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
508,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266463,Lissencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.02,1.0
509,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266833,"Visceral Myopathy, Familial",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
510,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0268731,Renal glomerular disease,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",group,Disease or Syndrome,0.02,1.0
511,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0270969,Zebra body myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
512,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.02,1.0
513,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278877,Adult Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0
514,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279550,Adult Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
515,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279628,Adenocarcinoma Of Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
516,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
517,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0311370,Lupus anticoagulant disorder,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
518,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0334121,Inflammatory Myofibroblastic Tumor,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.02,0.5
519,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0334294,Multiple adenomatous polyps,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
520,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0342649,Vascular calcification,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.02,1.0
521,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0346957,Disseminated Malignant Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.02,1.0
522,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0393576,Chorea Acanthocytosis Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
523,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0393593,Dystonia Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
524,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0409974,Lupus Erythematosus,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.02,1.0
525,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0424605,Developmental delay (disorder),F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
526,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0432284,Infantile myofibromatosis,C04,   Neoplasms,disease,Disease or Syndrome,0.02,0.5
527,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
528,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
529,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0521607,Peritoneal Fibrosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.02,1.0
530,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0524528,Pervasive Development Disorder,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
531,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0542476,Forgetful,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.02,1.0
532,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
533,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.02,1.0
534,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
535,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0677944,Sentinel node (disorder),,,disease,Disease or Syndrome,0.02,1.0
536,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
537,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
538,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.02,1.0
539,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
540,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0752123,Spinocerebellar Ataxia Type 5,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
541,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0796074,MOHR-TRANEBJAERG SYNDROME,C23;C16;C11;C10;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.02,1.0
542,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0949664,Tauopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
543,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1096184,West Nile viral infection,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
544,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1176475,Ductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
545,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1290884,Inflammatory disorder,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.02,1.0
546,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1300127,Perivascular Epithelioid Cell Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5
547,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
548,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1411966,Clostridium; difficile (disorder),,,disease,Disease or Syndrome,0.02,1.0
549,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1519670,Tumor Angiogenesis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
550,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1708350,Hereditary Leiomyomatosis and Renal Cell Cancer,C16;C04;C13;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.02,1.0
551,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1762616,"Meningioma, benign, no ICD-O subtype",C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0
552,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1848934,SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0
553,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1858695,Chudley-Mccullough syndrome,C23;C16;C04;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.02,1.0
554,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.02,1.0
555,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2938924,Oestrogen receptor positive breast cancer,,,disease,Neoplastic Process,0.02,1.0
556,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3151201,MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME,,,disease,Disease or Syndrome,0.02,1.0
557,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3544347,Intestinal fibrosis,,,phenotype,Anatomical Abnormality,0.02,1.0
558,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3642347,Basal-Like Breast Carcinoma,,,disease,Neoplastic Process,0.02,1.0
559,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3710589,Cap Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome; Congenital Abnormality,0.02,1.0
560,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3840252,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,,,disease,Neoplastic Process,0.02,1.0
561,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3887654,"POLYARTERITIS NODOSA, CHILDHOOD-ONSET",C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
562,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3888088,SMITH-MCCORT DYSPLASIA 1,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0
563,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
564,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4049446,Neointimal hyperplasia,,,disease,Disease or Syndrome,0.02,1.0
565,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4049702,"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
566,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.02,1.0
567,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4551993,"Amyotrophic Lateral Sclerosis, Familial",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
568,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4732796,Apical hypertrophic cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
569,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0000744,Abetalipoproteinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
570,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0001486,Adenovirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
571,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0001618,Tumors of Adrenal Cortex,C04;C19,   Neoplasms;    Endocrine System Diseases,group,Neoplastic Process,0.01,1.0
572,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0001815,Primary Myelofibrosis,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
573,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
574,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002312,alpha-Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
575,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002382,Alveolar Bone Loss,C05;C07,   Musculoskeletal Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
576,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002448,Ameloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
577,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,0.0
578,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
579,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0002986,Fabry Disease,C16;C18;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
580,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003175,Anthrax disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
581,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003516,Aortopulmonary Septal Defect,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
582,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003851,Arteriosclerosis Obliterans,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
583,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003857,Congenital arteriovenous malformation,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
584,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
585,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
586,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0
587,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
588,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
589,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.01,1.0
590,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005859,Bloom Syndrome,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
591,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0005967,Bone neoplasms,C04;C05,   Neoplasms;    Musculoskeletal Diseases,group,Neoplastic Process,0.01,0.0
592,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006023,Borna Disease,C01;C22,   Infections;    Animal Diseases,disease,Disease or Syndrome,0.01,1.0
593,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006625,Cachexia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
594,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0006846,Cutaneous Candidiasis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
595,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007095,Carcinoid Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
596,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
597,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007133,"Carcinoma, Papillary",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
598,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007140,Carcinosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
599,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007282,Carotid Stenosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
600,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007682,CNS disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
601,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
602,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
603,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
604,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007820,Cerebrovascular Disorders,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
605,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
606,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0007965,Chediak-Higashi Syndrome,C16;C11;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
607,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008149,Chlamydia Infections,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
608,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
609,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008479,Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
610,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
611,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
612,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
613,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
614,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009676,Confusion,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
615,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009777,Conn Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
616,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0009918,Contracture of joint,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.01,1.0
617,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010034,Corneal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
618,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010276,Craniopharyngioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
619,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
620,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010414,Infection by Cryptococcus neoformans,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
621,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0010701,Phyllodes Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
622,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.01,1.0
623,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011269,"Dementia, Vascular",C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
624,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011633,Dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
625,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
626,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0011992,Infantile Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,0.0
627,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013312,Dupuytren Contracture,C04;C17;C05,   Neoplasms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
628,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013537,Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
629,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013720,Ehlers-Danlos Syndrome,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
630,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0013902,"Elliptocytosis, Hereditary",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
631,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014040,Encephalitis Lethargica,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
632,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
633,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
634,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0015230,Exanthema,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.01,1.0
635,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0015674,Chronic Fatigue Syndrome,C01;C05;C10,   Infections;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
636,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0016038,Fibroelastosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
637,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0016045,fibroma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
638,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0016057,Fibrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
639,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0016781,Fuchs Endothelial Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
640,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017536,Giardiasis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
641,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
642,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0017921,Glycogen storage disease type II,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
643,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018572,"Hand, Foot and Mouth Disease",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
644,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
645,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018834,Heartburn,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
646,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0018922,hemangiopericytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
647,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
648,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019159,Hepatitis A,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
649,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019372,Herpesviridae Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
650,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
651,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
652,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0020550,Hyperthyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
653,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0021053,Immune System Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
654,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0
655,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0021832,"Intestinal Diseases, Parasitic",C06;C01,   Digestive System Diseases;    Infections,group,Disease or Syndrome,0.01,1.0
656,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022354,"Jaundice, Obstructive",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
657,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.01,1.0
658,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022573,Keratoconjunctivitis,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
659,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
660,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023240,Legionellosis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
661,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023290,"Leishmaniasis, Visceral",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
662,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
663,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023492,"Leukemia, T-Cell",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
664,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
665,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023521,Globoid cell leukodystrophy,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
666,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023522,"Leukodystrophy, Metachromatic",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
667,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
668,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023643,Lichen disease,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
669,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023860,Listeriosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
670,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023891,"Liver Cirrhosis, Alcoholic",C23;C06;C25,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.01,1.0
671,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
672,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024232,Lymphatic Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
673,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024291,"Lymphohistiocytosis, Hemophagocytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
674,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024449,Mycetoma,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
675,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024534,"Malaria, Cerebral",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
676,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024790,Paroxysmal nocturnal hemoglobinuria,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
677,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0024796,Marfan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
678,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
679,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025267,Multiple Endocrine Neoplasia Type 1,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0
680,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
681,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
682,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026470,Monoclonal Gammopathy of Undetermined Significance,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
683,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
684,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026946,Mycoses,C01,   Infections,group,Disease or Syndrome,0.01,1.0
685,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026961,Mydriasis,C11,   Eye Diseases,phenotype,Sign or Symptom,0.01,1.0
686,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0026985,Myelodysplasia,,,disease,Congenital Abnormality,0.01,1.0
687,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027121,Myositis,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
688,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027441,Nasopharyngitis,C01;C08;C07;C09,   Infections;    Respiratory Tract Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
689,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027720,Nephrosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
690,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.01,1.0
691,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027868,Neuromuscular Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
692,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027889,Hereditary Sensory and Autonomic Neuropathies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Disease or Syndrome,0.01,1.0
693,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0027947,Neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
694,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
695,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
696,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0028768,Obsessive-Compulsive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
697,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0028945,oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
698,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0
699,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
700,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0030354,Papilloma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
701,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0030848,Peyronie Disease,C17;C12,   Skin and Connective Tissue Diseases;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
702,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0031117,Peripheral Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
703,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
704,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0032227,Pleural effusion disorder,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
705,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0032300,Lobar Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
706,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0033300,Progeria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
707,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0
708,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
709,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0033999,Pterygium,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
710,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0034362,Q Fever,C01,   Infections,disease,Disease or Syndrome,0.01,0.0
711,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035078,Kidney Failure,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
712,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035235,Respiratory Syncytial Virus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
713,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035344,Retinopathy of Prematurity,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
714,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035369,Retroviridae Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
715,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035372,Rett Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
716,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035411,Rhabdomyoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
717,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035436,Rheumatic Fever,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
718,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035613,Rift Valley Fever,C06;C01;C22,   Digestive System Diseases;    Infections;    Animal Diseases,disease,Disease or Syndrome,0.01,1.0
719,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0035869,Rotavirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
720,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
721,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036220,Kaposi Sarcoma,C04;C01,   Neoplasms;    Infections,disease,Neoplastic Process,0.01,1.0
722,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036420,Localized scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
723,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0036631,Seminoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
724,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037054,Sickle Cell Trait,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
725,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037221,Situs Inversus,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
726,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
727,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037769,West Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
728,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0037933,Spinal Diseases,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0
729,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
730,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0038358,Gastric ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
731,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0038826,Superinfection,C01,   Infections,group,Disease or Syndrome,0.01,1.0
732,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0039240,Supraventricular tachycardia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
733,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0039483,Giant Cell Arteritis,C17;C20;C10;C14,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
734,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0039584,Testicular Diseases,C12;C19,   Male Urogenital Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
735,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
736,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0040015,Thrombasthenia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
737,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0040580,Tracheal Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
738,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0041234,Chagas Disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
739,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0041341,Tuberous Sclerosis,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
740,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0041466,Typhoid Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
741,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0041471,TYPHUS,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
742,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0041834,Erythema,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",phenotype,Disease or Syndrome,0.01,1.0
743,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042140,Uterine Prolapse,C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Anatomical Abnormality,0.01,1.0
744,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042341,Varicocele,C12;C14,   Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
745,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042781,Visceral Myopathy,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
746,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0042798,Low Vision,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
747,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0043119,Werner Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
748,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0079298,Epidermolysis Bullosa Simplex,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
749,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0079474,Hallopeau-Siemens Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
750,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
751,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085078,Lysosomal Storage Diseases,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.01,1.0
752,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085084,Motor Neuron Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
753,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085106,Familial benign pemphigus,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
754,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085167,Granular cell tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
755,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
756,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
757,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085220,Cerebral Amyloid Angiopathy,C18;C10;C14,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
758,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085281,Addictive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
759,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085399,Ehrlichiosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
760,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085436,"Meningitis, Cryptococcal",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
761,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
762,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085612,Ventricular arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
763,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085624,Burning sensation,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
764,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085669,Acute leukemia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
765,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0085681,Hyperphosphatemia (disorder),C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
766,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
767,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0149678,Epstein-Barr Virus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
768,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151449,Primary Sjgren's syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
769,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151468,Thyroid Gland Follicular Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
770,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151514,Atrophic condition of skin,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",group,Disease or Syndrome,0.01,1.0
771,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151546,Oral Cavity Carcinoma,C06;C04;C07,   Digestive System Diseases;    Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
772,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151785,Disease of mucous membrane,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.01,1.0
773,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0151846,Periosteal Disorder,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
774,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
775,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0152069,Echinococcus multilocularis infection,C01,   Infections,disease,Disease or Syndrome,0.01,0.0
776,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0
777,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0153452,Malignant neoplasm of gallbladder,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
778,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0153594,Malignant neoplasm of testis,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
779,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0154254,Polyclonal hypergammaglobulinemia,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.01,1.0
780,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0155862,Streptococcal pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
781,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0156181,Peritoneal adhesion,C06;C17,   Digestive System Diseases;    Skin and Connective Tissue Diseases,disease,Acquired Abnormality,0.01,1.0
782,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0158252,Intervertebral disc disorder,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",group,Disease or Syndrome,0.01,1.0
783,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0158266,Intervertebral Disc Degeneration,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
784,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0158570,Vascular anomaly,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",phenotype,Anatomical Abnormality,0.01,1.0
785,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
786,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162635,Angelman Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
787,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
788,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162672,MERRF Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
789,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0162739,HELLP Syndrome,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
790,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0175701,Aarskog syndrome,C16;C05;C19;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
791,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
792,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0175778,Larsen syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
793,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0205647,Follicular adenoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
794,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0205766,Myxofibroma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
795,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206061,"Pneumonia, Interstitial",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
796,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
797,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206138,CREST Syndrome,C06;C18;C17;C14,   Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
798,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
799,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206628,Mesoblastic Nephroma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
800,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206630,Endometrial Stromal Sarcoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
801,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206633,Angiomyolipoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
802,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206647,Dermatofibrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
803,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206653,Angiomyoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
804,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206658,Smooth Muscle Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
805,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206659,Embryonal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
806,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206669,Hepatocellular Adenoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
807,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
808,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206718,Ganglioneuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
809,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0206743,Rhabdoid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
810,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220597,Adult Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
811,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
812,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220633,Uveal melanoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0
813,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
814,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220644,Childhood Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
815,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220650,Metastatic malignant neoplasm to brain,C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
816,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
817,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0220810,Congenital defects,,,group,Congenital Abnormality,0.01,1.0
818,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0221056,Adult type dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
819,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0221170,Muscular stiffness,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.01,1.0
820,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0221271,Elastosis perforans serpiginosa,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
821,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0221292,Basophilic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
822,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0233407,Disorientation,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
823,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
824,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0234233,Sore to touch,C23;F03,"   Pathological Conditions, Signs and Symptoms;    Mental Disorders",phenotype,Sign or Symptom,0.01,1.0
825,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235031,Neurologic Symptoms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Sign or Symptom,0.01,1.0
826,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235782,Gallbladder Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
827,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0235950,Zinc deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
828,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0236642,Pick Disease of the Brain,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
829,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.01,1.0
830,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0238031,Breast Phyllodes Tumor,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
831,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0238062,Chronic intestinal pseudo-obstruction,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
832,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0238190,Inclusion Body Myositis (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
833,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0241961,Angiomyolipoma of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
834,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0242350,Erectile dysfunction,C12;F03,   Male Urogenital Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
835,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
836,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0242510,Drug usage,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
837,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0243010,Viral Encephalitis,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
838,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0243038,"Carcinoma, Lewis Lung",C04,   Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.01,1.0
839,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0262587,Parathyroid Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
840,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0263912,Rotator cuff syndrome,C26,   Wounds and Injuries,disease,Disease or Syndrome,0.01,1.0
841,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0264490,Acute respiratory failure,C23;C18;C08,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
842,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0264545,Thickening of pleura,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
843,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265101,Carotid artery occlusion,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
844,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265224,Freeman-Sheldon syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
845,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265259,Popliteal pterygium syndrome,C16;C13;C11;C05;C12;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
846,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265268,Adams Oliver syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
847,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265283,"Atelosteogenesis, type 1",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
848,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0265970,"Porokeratosis, Disseminated Superficial Actinic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
849,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266200,Microcolon,C06,   Digestive System Diseases,disease,Congenital Abnormality,0.01,1.0
850,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0266568,Persistent Hyperplastic Primary Vitreous,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0
851,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0267187,Intestinal metaplasia of gastric mucosa,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
852,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0267809,"Cirrhosis, Cryptogenic",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
853,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0268079,Hyperphosphaturia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
854,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0268393,Familial Cerebral Amyloid Angiopathy,C16;C18;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
855,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0268450,Gitelman Syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
856,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
857,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0270992,Secondary myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
858,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0271097,Usher Syndrome,C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
859,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0271979,Thalassemia Intermedia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
860,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0272170,Shwachman syndrome,,,disease,Disease or Syndrome,0.01,1.0
861,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0275524,Coinfection,C01,   Infections,phenotype,Disease or Syndrome,0.01,1.0
862,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0276447,Rhinovirus infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
863,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0276496,Familial Alzheimer Disease (FAD),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
864,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278510,Childhood Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
865,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278595,Adult Fibrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
866,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278607,Adult Leiomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
867,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
868,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278876,Adult Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
869,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
870,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
871,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
872,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279070,Adult Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
873,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279565,Invasive Lobular Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
874,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279612,Childhood Embryonal Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
875,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
876,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0279986,Childhood Leiomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
877,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
878,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0280313,Squamous cell carcinoma of oropharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
879,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
880,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0280475,Childhood Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
881,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0280631,Leiomyosarcoma of uterus,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
882,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0281361,Adenocarcinoma of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
883,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0282201,Phosphate Diabetes,C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
884,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0282687,"Hemorrhagic Fever, Ebola",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
885,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0302486,Erythrophagocytosis,,,disease,Disease or Syndrome,0.01,1.0
886,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0332853,Anastomosis,,,disease,Acquired Abnormality,0.01,1.0
887,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0333293,Healing ulcer,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
888,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0333440,Hyaline body,,,disease,Anatomical Abnormality,0.01,1.0
889,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
890,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0334037,Intestinal metaplasia,,,phenotype,Disease or Syndrome,0.01,1.0
891,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0334299,Carcinoid tumor no ICD-O subtype,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
892,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0334463,Malignant Fibrous Histiocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
893,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0334474,Spindle cell lipoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
894,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0339143,Thyroid associated opthalmopathies,C16;C11;C20;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Immune System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
895,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0339510,Vitelliform Macular Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
896,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
897,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0339578,Corticosteroid-induced glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
898,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0340100,High altitude pulmonary edema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
899,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0340194,Respiratory failure without hypercapnia,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
900,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0340643,Dissection of aorta,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
901,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0341306,Microvillus inclusion disease,C16;C06;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
902,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0343758,Typhus group rickettsial disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
903,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0345050,Congenital aneurysm of ascending aorta,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.01,1.0
904,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
905,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0345905,Intrahepatic Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
906,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0362046,Prediabetes syndrome,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
907,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0376154,Skin callus,C17,   Skin and Connective Tissue Diseases,disease,Acquired Abnormality,0.01,1.0
908,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0376618,Endotoxemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Disease or Syndrome,0.01,1.0
909,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0392777,Poikiloderma,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
910,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0392784,Dermatofibrosarcoma Protuberans,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
911,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0399440,Hereditary gingival fibromatosis,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
912,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0399526,Class III malocclusion,C07,   Stomatognathic Diseases,disease,Congenital Abnormality,0.01,1.0
913,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
914,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
915,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0403824,Teratozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
916,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0410438,Primary osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
917,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0521158,Recurrent tumor,,,phenotype,Neoplastic Process,0.01,1.0
918,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0521175,Neuropil Threads,,,disease,Acquired Abnormality,0.01,1.0
919,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0521707,Bilateral cataracts (disorder),C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
920,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
921,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
922,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0549493,Alveolitis,C17;C08,   Skin and Connective Tissue Diseases;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
923,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0553580,Ewings sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
924,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0555198,Malignant Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
925,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0595936,Aqueous Humor Disorders,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
926,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0595995,Idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.01,1.0
927,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0598608,Hyperhomocysteinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
928,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0677950,Stage IV Colorectal Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
929,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0699949,airway disease,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
930,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0733682,"Hypophosphatemic Rickets, X-Linked Dominant",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
931,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0740340,"Amyloidosis, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
932,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.01,1.0
933,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
934,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751295,Memory Loss,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,0.0
935,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751336,Distal Muscular Dystrophies,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",group,Disease or Syndrome,0.01,1.0
936,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751396,Well Differentiated Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
937,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751560,Malignant neoplasm tonsil,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
938,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751587,CADASIL Syndrome,C23;C16;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
939,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751656,"Nemaline Myopathy, Autosomal Dominant",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,0.0
940,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751657,"Nemaline Myopathy, Autosomal Recessive",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
941,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751688,Malignant Squamous Cell Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
942,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751713,"Inclusion Body Myopathy, Sporadic",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
943,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751951,Central Core Myopathy (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
944,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0751967,"Multiple Sclerosis, Relapsing-Remitting",C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
945,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0752121,Spinocerebellar Ataxia Type 2,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
946,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0796154,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",C23;C16;C05;C10;C19;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
947,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0850666,Infection caused by Helicobacter pylori,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
948,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0854211,Bacterial keratitis,C23;C01;C11,"   Pathological Conditions, Signs and Symptoms;    Infections;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
949,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0860580,Medullary carcinoma of breast,,,disease,Neoplastic Process,0.01,1.0
950,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0860659,Aloof,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
951,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0877009,Muscle fibrosis,,,phenotype,Sign or Symptom,0.01,1.0
952,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
953,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0877430,Asthma chronic,,,disease,Disease or Syndrome,0.01,1.0
954,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0877445,Candidemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
955,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0877854,Cerebral Arteriosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
956,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0878486,Arteriolosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
957,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0879615,Stromal Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
958,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0917713,Becker Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
959,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
960,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0917996,Cerebral Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
961,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
962,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0948444,Mitochondrial DNA mutation,,,disease,Congenital Abnormality,0.01,1.0
963,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C0950121,Denys-Drash Syndrome,C16;C04;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
964,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1112433,Thromboembolic stroke,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
965,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1112486,Aggressive Systemic Mastocytosis,C04;C20,   Neoplasms;    Immune System Diseases,disease,Neoplastic Process,0.01,1.0
966,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1112768,Anterior subcapsular cataract,,,disease,Disease or Syndrome,0.01,1.0
967,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1134719,Invasive Ductal Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0
968,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1142253,Arthrofibrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
969,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1153706,Endometrial adenocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
970,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1168327,High-Grade Prostatic Intraepithelial Neoplasia,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
971,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1261473,Sarcoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
972,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1262313,Invasive Fungal Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
973,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1263858,"Muscular dystrophy congenital, merosin negative",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
974,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1266025,Traditional Serrated Adenoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
975,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1266119,Solitary fibrous tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
976,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1266121,Myofibroma (morphologic abnormality),C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
977,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1266184,Atypical Teratoid Rhabdoid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
978,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1273070,Left ventricular diastolic dysfunction,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
979,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1276035,Pena-Shokeir syndrome type I,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
980,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1290162,Disorder of smooth muscle,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
981,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1300346,Desmoplastic fibroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
982,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1302401,Adenoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
983,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1302808,Myopericytoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0
984,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1306242,Aggressive angiomyxoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
985,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1314694,"Astrocytoma, low grade",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
986,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1318485,Liver regeneration disorder,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.01,1.0
987,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1332078,"Anaplastic large cell lymphoma, ALK negative",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
988,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1332201,Adult Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
989,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1332965,Congenital Mesoblastic Nephroma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
990,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1333001,Childhood Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
991,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1333500,Extragastrointestinal Gastrointestinal Stromal Tumor,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
992,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1334177,Infiltrating Cervical Carcinoma,,,disease,Neoplastic Process,0.01,1.0
993,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1334455,Pulmonary Sclerosing Hemangioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,0.0
994,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1334699,Mesenchymal Cell Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
995,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
996,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1336076,Sporadic Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
997,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1368237,Solitary Myofibromatosis,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
998,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1368683,Epithelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
999,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1370889,"Liposarcoma, well differentiated",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
1000,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1384494,Metastatic Carcinoma,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
1001,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0
1002,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1402315,Vascular lesions,,,disease,Disease or Syndrome,0.01,1.0
1003,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1444680,Posterior capsule opacification,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
1004,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1456418,Absence of muscle,,,disease,Congenital Abnormality,0.01,1.0
1005,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1456873,alpha^+^ Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
1006,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1510472,Drug Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
1007,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1510489,"Cerebral Amyloid Angiopathy, Hereditary",C16;C18;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
1008,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1511789,Desmoplastic,,,disease,Disease or Syndrome,0.01,1.0
1009,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1519666,Tumor-Associated Vasculature,,,disease,Acquired Abnormality,0.01,1.0
1010,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1527298,"Dysentery, Bacillary",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
1011,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1527383,Morphea,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
1012,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
1013,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1535939,Pneumocystis jiroveci pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
1014,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1739135,Progression of prostate cancer,,,disease,Neoplastic Process,0.01,1.0
1015,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1812607,Aortic aneurysm and dissection,,,disease,Disease or Syndrome,0.01,1.0
1016,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1837454,SPINOCEREBELLAR ATAXIA 8,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1017,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1837819,Cerebrofrontofacial Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
1018,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1842090,Platelet Glycoprotein IV Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
1019,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1842160,"MYOPATHY, MYOSIN STORAGE (disorder)",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
1020,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1844696,"OTOPALATODIGITAL SYNDROME, TYPE II",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
1021,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1845052,"AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
1022,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1848638,"USHER SYNDROME, TYPE IB (disorder)",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
1023,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1849157,Resistance to Insulin-Like Growth Factor I,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
1024,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1850900,Familial primary gastric lymphoma,C06;C04;C20;C15,   Digestive System Diseases;    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
1025,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1854520,SEBASTIAN SYNDROME,C23;C10;C09;C15,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
1026,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1856689,FRIEDREICH ATAXIA 1,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1027,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1857276,Trichohepatoenteric Syndrome,C23;C16;C13;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
1028,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1858517,SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1,C16;C08;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1029,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1861861,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
1030,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1862382,SVEINSSON CHORIORETINAL ATROPHY,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
1031,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1867441,Pterygium Of Conjunctiva And Cornea,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
1032,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1868684,"EAR, PATELLA, SHORT STATURE SYNDROME",C23;C16;C05;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
1033,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1868938,End stage cardiac failure,,,disease,Disease or Syndrome,0.01,1.0
1034,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1869123,Limb-girdle muscular dystrophy type 2A,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1035,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1959588,Angioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
1036,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1960469,Left ventricular noncompaction,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
1037,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
1038,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1961121,Congenital vascular anomaly,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
1039,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2004489,Regurgitation,,,phenotype,Sign or Symptom,0.01,1.0
1040,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2211694,medullary carcinoma with lymphoid stroma of breast,,,disease,Neoplastic Process,0.01,1.0
1041,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
1042,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
1043,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2712360,Severe hypoxic ischemic encephalopathy,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
1044,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2745900,Promyelocytic leukemia,,,disease,Neoplastic Process,0.01,1.0
1045,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2919166,Autosomal dominant focal segmental glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
1046,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2931689,Dystrophia myotonica 2,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1047,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2936349,"Plaque, Amyloid",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
1048,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2936664,Acquired Hypogammaglobulinemia,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
1049,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2939094,Skin sensitisation,,,disease,Disease or Syndrome,0.01,1.0
1050,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
1051,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3146251,Stage IV Colorectal Cancer AJCC v7,,,disease,Neoplastic Process,0.01,1.0
1052,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3250443,MYOTONIC DYSTROPHY 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1053,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3267073,Autoinflammatory disease,,,disease,Disease or Syndrome,0.01,1.0
1054,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3274592,Lipofibromatosis,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
1055,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3274639,Neonatal Opiate Withdrawal Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Mental or Behavioral Dysfunction,0.01,1.0
1056,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3281200,"LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS",C16;C04;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1057,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3472623,Serrated adenocarcinoma,,,disease,Neoplastic Process,0.01,1.0
1058,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3489532,Cone-Rod Dystrophy 2,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
1059,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3495549,Patent ductus arteriosus - persisting type,C16;C08;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
1060,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3532222,Inflammatory cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
1061,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3532942,Mixed dementia,C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Mental or Behavioral Dysfunction,0.01,1.0
1062,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3536983,Familial Hypophosphatemic Rickets,C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
1063,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3536984,"Vitamin D-Resistant Rickets, X-Linked",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
1064,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3544205,Ovarian clear cell carcinoma,,,disease,Neoplastic Process,0.01,1.0
1065,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3693482,Giant Cell Fibroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
1066,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3714581,Multicystic Dysplastic Kidney,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
1067,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3714976,ACTIVATED PI3K-DELTA SYNDROME,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
1068,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3810365,Central visual impairment,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1069,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3839205,Signet-ring stromal tumor,,,disease,Neoplastic Process,0.01,1.0
1070,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
1071,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3888896,Wet age-related macular degeneration,,,disease,Disease or Syndrome,0.01,1.0
1072,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3899278,Early Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
1073,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C3899403,Decreased Concentration,,,phenotype,Sign or Symptom,0.01,1.0
1074,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4024896,Motor neuron atrophy,,,disease,Disease or Syndrome,0.01,1.0
1075,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4048329,Immunosuppression,,,disease,Disease or Syndrome,0.01,1.0
1076,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4054188,Ph-Like Acute Lymphoblastic Leukemia,,,disease,Neoplastic Process,0.01,1.0
1077,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4076349,Chronic alcoholic liver disease,,,disease,Disease or Syndrome,0.01,1.0
1078,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4082937,Necrotizing enterocolitis in fetus OR newborn,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
1079,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4085370,"Fibromatosis, Palmar",C04;C17;C05,   Neoplasms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
1080,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4085590,Cone-Rod Dystrophies,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
1081,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4086158,Childhood Ganglioneuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
1082,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4087124,Immunoglobulin G4-Related Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
1083,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4277690,Ciliopathies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
1084,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4284013,Primary cholangiocarcinoma of intrahepatic biliary tract,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
1085,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4290000,acute flaccid myelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
1086,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4303164,Autoimmune hepatitis type 1,,,disease,Disease or Syndrome,0.01,1.0
1087,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4324548,Non-compaction cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
1088,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4477072,Iris flocculi,,,phenotype,Anatomical Abnormality,0.01,1.0
1089,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4520843,Pterygium of eye,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
1090,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4525297,Stage 0 Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
1091,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4525300,Stage IIA Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
1092,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4525301,Stage IIB Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
1093,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4525302,Stage III Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
1094,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4525305,Stage IV Gallbladder Cancer AJCC v8,,,disease,Neoplastic Process,0.01,1.0
1095,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4551482,Adams-Oliver syndrome 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
1096,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4551649,Congenital Dysplasia Of The Hip,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
1097,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
1098,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4551686,Malignant neoplasm of soft tissue,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
1099,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4551714,Rod-Cone Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
1100,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4552000,Episodic Kinesigenic Dyskinesia 1,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1101,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4552072,X-linked infantile spasms,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
1102,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4552766,Miscarriage,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
1103,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4554215,Duchenne or Becker muscular dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
1104,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4699184,Fuchs,,,disease,Disease or Syndrome,0.01,1.0
1105,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
1106,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4721773,Postoperative cognitive dysfunction,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
1107,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4723838,Metastatic Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
1108,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4732730,Blood spots,,,disease,Disease or Syndrome,0.01,1.0
1109,60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C4733092,estrogen receptor-negative breast cancer,,,disease,Neoplastic Process,0.01,1.0
0,62,ACTBP2,,0.861,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
1,62,ACTBP2,,0.861,0.077,,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
2,62,ACTBP2,,0.861,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
3,62,ACTBP2,,0.861,0.077,,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
4,62,ACTBP2,,0.861,0.077,,,,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
0,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C3150681,"CARDIOMYOPATHY, DILATED, 1R",,,disease,Disease or Syndrome,0.8,1.0
1,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.7,0.962
2,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C2677506,"Cardiomyopathy, Familial Hypertrophic, 11",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0
3,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C2748552,Atrial Septal Defect 5,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0
4,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.65,1.0
5,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C3150682,LEFT VENTRICULAR NONCOMPACTION 4,,,disease,Disease or Syndrome,0.6,
6,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.46,1.0
7,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1960469,Left ventricular noncompaction,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.41,1.0
8,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.37,1.0
9,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C4021133,Left ventricular noncompaction cardiomyopathy,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.32,1.0
10,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0340427,Familial dilated cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
11,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0344724,Ostium secundum atrial septal defect,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.31,1.0
12,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
13,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0
14,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0034951,Refractive Errors,C11,   Eye Diseases,group,Disease or Syndrome,0.3,1.0
15,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0038356,Stomach Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
16,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0282313,"Condition, Preneoplastic",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
17,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1527310,Ametropia,C11,   Eye Diseases,disease,Disease or Syndrome,0.3,1.0
18,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1708349,Hereditary Diffuse Gastric Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
19,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0
20,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0376618,Endotoxemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Disease or Syndrome,0.2,1.0
21,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.19,1.0
22,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0949658,"Cardiomyopathy, Hypertrophic, Familial",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.13,1.0
23,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.12,1.0
24,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.11,1.0
25,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0
26,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
27,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0023787,Lipodystrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
28,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0043202,Wolff-Parkinson-White Syndrome,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
29,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0241005,Creatine phosphokinase serum increased,,,phenotype,Finding,0.1,
30,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0427515,Neutrophil abnormality,,,phenotype,Finding,0.1,
31,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0476403,Electromyogram abnormal,,,phenotype,Finding,0.1,
32,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1280433,Lipoatrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
33,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C4551675,"Keratoderma, Palmoplantar",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,
34,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C4551472,Hypertrophic obstructive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,0.8
35,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
36,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C4732796,Apical hypertrophic cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
37,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
38,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.02,1.0
39,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
40,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
41,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
42,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
43,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.02,1.0
44,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
45,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
46,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0007930,Chagas Cardiomyopathy,C01;C14,   Infections;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
47,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0013274,Patent ductus arteriosus,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
48,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
49,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0018816,Heart Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
50,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0018818,Ventricular Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
51,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0033036,Atrial Premature Complexes,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
52,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
53,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0039070,Syncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
54,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
55,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0152021,Congenital heart disease,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
56,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0154778,"Myopia, Degenerative",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
57,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
58,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
59,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
60,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
61,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
62,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
63,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
64,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1856689,FRIEDREICH ATAXIA 1,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
65,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1861861,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
66,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C1862389,ATRIAL SEPTAL DEFECT 1,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
67,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C2678065,Myofibrillar Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
68,70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C4317339,Juvenile Absence Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
0,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1858172,"Deafness, Autosomal Dominant 20",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0
1,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3281235,BARAITSER-WINTER SYNDROME 2,,,disease,Disease or Syndrome,0.7,1.0
2,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.43,1.0
3,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0005745,Blepharoptosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.41,1.0
4,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0009363,Congenital ocular coloboma (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.41,1.0
5,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0033377,Ptosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.41,1.0
6,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0024433,Macrostomia,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.4,1.0
7,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0266551,Congenital coloboma of iris,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.4,1.0
8,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0857379,Abnormality of the pinna,,,phenotype,Finding,0.4,1.0
9,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1843156,Progressive sensorineural hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.4,1.0
10,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1844505,Pointed chin,,,phenotype,Finding,0.4,1.0
11,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1849340,Long palpebral fissure,,,phenotype,Finding,0.4,1.0
12,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1865014,Long philtrum,,,phenotype,Finding,0.4,1.0
13,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1865017,Thin upper lip vermilion,,,phenotype,Finding,0.4,1.0
14,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1868571,Highly arched eyebrow,,,phenotype,Finding,0.4,1.0
15,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1853623,Fryns-Aftimos Syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.38,1.0
16,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.33,1.0
17,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
18,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0
19,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0
20,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0
21,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0024667,Animal Mammary Neoplasms,C04;C22,   Neoplasms;    Animal Diseases,phenotype,Neoplastic Process,0.3,1.0
22,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0
23,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
24,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0029459,"Osteoporosis, Senile",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
25,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0205696,Anaplastic carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
26,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0205697,"Carcinoma, Spindle-Cell",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
27,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0205698,Undifferentiated carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
28,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0205699,Carcinomatosis,C04,   Neoplasms,phenotype,Neoplastic Process,0.3,1.0
29,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0240583,Short upturned nose,,,phenotype,Finding,0.3,1.0
30,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0265541,Cranioschisis,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0
31,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0376634,Craniofacial Abnormalities,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Congenital Abnormality,0.3,1.0
32,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0497552,Congenital neurologic anomalies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.3,1.0
33,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0751406,Post-Traumatic Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
34,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
35,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1257925,"Mammary Carcinoma, Animal",C04;C22,   Neoplasms;    Animal Diseases,disease,Neoplastic Process,0.3,1.0
36,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1855722,"Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation",C23;C16;C11;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.3,1.0
37,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1970280,Hearing loss begins with loss of high frequencies,,,phenotype,Finding,0.3,1.0
38,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1970281,Audiogram shows sloping configuration,,,phenotype,Finding,0.3,1.0
39,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1970282,"Deafness, profound, by 6th decade",,,phenotype,Finding,0.3,1.0
40,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3279369,Microphthalmia (in some patients),,,phenotype,Finding,0.3,1.0
41,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3549665,Deafness (in some patients),,,phenotype,Finding,0.3,1.0
42,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3808883,Short neck (in some patients),,,phenotype,Finding,0.3,1.0
43,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4012410,Enlarged ventricles (in some patients),,,phenotype,Finding,0.3,1.0
44,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4229649,Heart defect (in some patients),,,phenotype,Finding,0.3,1.0
45,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4229650,Pterygium colli (in some patients),,,phenotype,Finding,0.3,1.0
46,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4229651,Hypertelorism/telecanthus,,,phenotype,Finding,0.3,1.0
47,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4229652,Eye coloboma (in some patients),,,phenotype,Finding,0.3,1.0
48,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4229653,Trigonocephaly/metopic ridge,,,phenotype,Finding,0.3,1.0
49,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4231117,Pectus (in some patients),,,phenotype,Finding,0.3,1.0
50,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4231118,Kyphosis/scoliosis (in some patients),,,phenotype,Finding,0.3,1.0
51,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4231120,Prominent nasal root on profile,,,phenotype,Finding,0.3,1.0
52,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4231121,"Large, squared nose tip",,,phenotype,Finding,0.3,1.0
53,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4231123,Retrognathia (in some patients),,,phenotype,Finding,0.3,1.0
54,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4231124,Prominent/full/wide cheeks,,,phenotype,Finding,0.3,1.0
55,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4554007,Uveoretinal Coloboma,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.3,1.0
56,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4708599,Coloboma of choroid and retina,,,disease,Congenital Abnormality,0.3,1.0
57,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0266483,Pachygyria,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.11,1.0
58,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.11,1.0
59,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0
60,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0
61,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0003537,Aphasia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,
62,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
63,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
64,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0013528,Echolalia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.1,
65,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
66,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0020295,Hydronephrosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,
67,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0020534,Orbital separation excessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
68,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
69,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0025990,Micrognathism,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
70,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0026884,Mutism,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",phenotype,Disease or Syndrome,0.1,
71,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0029422,Osteochondrodysplasias,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Disease or Syndrome,0.1,
72,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0029429,Osteochondrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
73,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
74,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
75,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0
76,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0152439,Retinoschisis,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
77,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0155299,Coloboma of optic disc,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,
78,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0162285,Edema of eyelid,C13;C11;C17;C12;C20;C14,   Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases;    Cardiovascular Diseases,phenotype,Pathologic Function,0.1,
79,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0162298,Joint stiffness,C05,   Musculoskeletal Diseases,phenotype,Sign or Symptom,0.1,
80,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0221217,Neck webbing,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.1,
81,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0232466,Feeding difficulties,,,phenotype,Finding,0.1,
82,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0240063,Coloboma of iris,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Anatomical Abnormality,0.1,
83,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0265535,Trigonocephaly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
84,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0266463,Lissencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
85,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0266464,Polymicrogyria,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
86,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0266544,Microcornea,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,
87,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0277828,Late fontanel closure,,,phenotype,Finding,0.1,
88,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0410528,Skeletal dysplasia,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
89,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0423110,Downward slant of palpebral fissure,,,phenotype,Finding,0.1,
90,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0423113,Telecanthus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
91,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0423318,Heterochromia iridis,C23;C11;C17,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Skin and Connective Tissue Diseases",phenotype,Finding,0.1,
92,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0426415,Large nose,,,phenotype,Finding,0.1,
93,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0426421,Wide nose,,,phenotype,Finding,0.1,
94,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0432072,Dysmorphic features,,,disease,Congenital Abnormality,0.1,1.0
95,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0452138,"Sensorineural hearing loss, bilateral",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
96,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0456070,Growth delay,,,phenotype,Pathologic Function,0.1,
97,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0456132,Large fontanelle,,,phenotype,Finding,0.1,
98,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0521525,Short neck,,,phenotype,Finding,0.1,
99,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0521620,Dilatation of ureter,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Anatomical Abnormality,0.1,
100,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
101,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0578038,Thin lips,,,phenotype,Finding,0.1,
102,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0678230,Congenital Epicanthus,,,disease,Congenital Abnormality,0.1,
103,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0973461,Dysphasia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
104,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1303001,Congenital euryblepharon,,,disease,Congenital Abnormality,0.1,
105,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1839798,Long nose,,,phenotype,Finding,0.1,
106,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1845847,Coarse facial features,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
107,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1847514,Postnatal microcephaly,,,phenotype,Finding,0.1,
108,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1849367,Nasal bridge wide,,,phenotype,Finding,0.1,
109,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1855728,Low posterior hairline,,,phenotype,Finding,0.1,
110,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1857479,Short columella,,,phenotype,Finding,0.1,
111,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1857949,Prominent metopic ridge,,,phenotype,Finding,0.1,
112,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1859717,Depressed nasal tip,,,phenotype,Finding,0.1,
113,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1866231,Full cheeks,,,phenotype,Finding,0.1,
114,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3494422,Retrognathia,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Anatomical Abnormality,0.1,
115,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3554568,Young adult onset,,,phenotype,Finding,0.1,
116,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4021370,Duplication of thumb phalanx,,,disease,Anatomical Abnormality,0.1,
117,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4022153,Cerebral cortical hemiatrophy,,,disease,Disease or Syndrome,0.1,
118,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4023018,Subcortical cerebral atrophy,,,disease,Disease or Syndrome,0.1,
119,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4025790,Specific learning disability,,,disease,Mental or Behavioral Dysfunction,0.1,
120,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
121,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0
122,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.06,1.0
123,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
124,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0
125,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.05,1.0
126,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.04,0.75
127,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0
128,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.03,1.0
129,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
130,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
131,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.03,1.0
132,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0
133,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0043167,Pertussis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
134,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0043168,Whooping cough due to unspecified organism,C23;C01;C08,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.03,1.0
135,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0349204,Nonorganic psychosis,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
136,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
137,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0917801,Sleeplessness,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.03,1.0
138,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1837819,Cerebrofrontofacial Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.03,1.0
139,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
140,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4721579,Secondary malignant neoplasm of colon and/or rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
141,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
142,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007820,Cerebrovascular Disorders,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
143,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,0.5
144,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
145,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,0.5
146,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
147,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
148,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0031117,Peripheral Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
149,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0042025,Urinary Stress Incontinence,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0
150,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
151,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.02,1.0
152,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
153,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
154,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.02,1.0
155,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0302142,Deformity,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Anatomical Abnormality,0.02,1.0
156,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
157,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
158,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
159,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
160,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
161,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
162,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
163,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4290046,trachomatis,,,disease,Disease or Syndrome,0.02,1.0
164,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
165,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
166,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0002875,Cooley's anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
167,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
168,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
169,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
170,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
171,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
172,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
173,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
174,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
175,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
176,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
177,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
178,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
179,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
180,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
181,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
182,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
183,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
184,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0013473,Eating Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
185,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
186,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
187,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
188,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
189,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0019100,Severe Dengue,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
190,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
191,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0019159,Hepatitis A,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
192,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0
193,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
194,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
195,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
196,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
197,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
198,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0024535,"Malaria, Falciparum",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
199,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0024537,"Malaria, Vivax",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
200,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
201,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
202,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0027430,Nasal Polyps,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
203,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
204,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
205,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0037090,"Signs and Symptoms, Respiratory",C23,"   Pathological Conditions, Signs and Symptoms",group,Sign or Symptom,0.01,1.0
206,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0037856,Spermatic Cord Torsion,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
207,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0040264,Tinnitus,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0
208,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
209,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
210,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
211,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0042749,Viremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
212,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
213,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
214,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
215,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0
216,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0149871,Deep Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
217,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0151313,Sensory neuropathy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
218,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
219,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0206686,Adrenocortical carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
220,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
221,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0220620,Gastrointestinal Carcinoid Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
222,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
223,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
224,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0221074,"Depression, Postpartum",C13;F03,   Female Urogenital Diseases and Pregnancy Complications;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
225,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0221271,Elastosis perforans serpiginosa,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
226,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
227,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
228,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0242723,Parasitemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
229,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0264722,Chronic congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
230,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0266449,Congenital anomaly of brain,C16;C13;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Nervous System Diseases",group,Congenital Abnormality,0.01,1.0
231,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0268079,Hyperphosphaturia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
232,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0277528,Traveler's diarrhea,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
233,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
234,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
235,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
236,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
237,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0282201,Phosphate Diabetes,C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
238,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
239,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0338106,Adenocarcinoma of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
240,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
241,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
242,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0343641,Human papilloma virus infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
243,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
244,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
245,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0346402,Malignant neoplasm of adrenal cortex,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
246,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0375381,Urethral intrinsic sphincter deficiency,,,disease,Disease or Syndrome,0.01,1.0
247,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0395971,Dominant sensorineural hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
248,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0432215,Progressive pseudorheumatoid dysplasia,C05,   Musculoskeletal Diseases,disease,Congenital Abnormality,0.01,1.0
249,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
250,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
251,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0578870,Chronic idiopathic urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
252,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0600260,"Lung Diseases, Obstructive",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
253,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0677949,Stage III Colorectal Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
254,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
255,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
256,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
257,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0751713,"Inclusion Body Myopathy, Sporadic",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
258,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0852036,Pregnancy associated hypertension,C13;C14,   Female Urogenital Diseases and Pregnancy Complications;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
259,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
260,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0877635,Cytomegalovirus viremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
261,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
262,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
263,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1135868,Gestational Trophoblastic Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.01,1.0
264,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1141957,HIV disease progression,,,disease,Disease or Syndrome,0.01,1.0
265,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
266,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
267,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1561826,Overweight and obesity,,,disease,Disease or Syndrome,0.01,1.0
268,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0
269,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1619738,Immune Reconstitution Inflammatory Syndrome,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
270,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1840264,IMMUNE SUPPRESSION,,,phenotype,Disease or Syndrome,0.01,1.0
271,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1868684,"EAR, PATELLA, SHORT STATURE SYNDROME",C23;C16;C05;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
272,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1956147,Microlissencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
273,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
274,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C2217035,Stage IIA Colon Cancer AJCC v7,,,disease,Neoplastic Process,0.01,0.0
275,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.01,1.0
276,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C2931618,Gestational trophoblastic disease,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
277,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C2945695,Limb ischemia,,,disease,Disease or Syndrome,0.01,1.0
278,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
279,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3146250,Stage III Colorectal Cancer AJCC v7,,,disease,Neoplastic Process,0.01,1.0
280,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
281,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
282,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3539168,"PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A",,,disease,Disease or Syndrome,0.01,1.0
283,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C3665464,Dementia due to Alzheimer's disease (disorder),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
284,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4025285,Microspherocytosis,,,disease,Disease or Syndrome,0.01,1.0
285,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
286,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4505456,HIV Coinfection,C01;C20,   Infections;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
287,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4525122,Stage IIA Colon Cancer AJCC v8,,,disease,Neoplastic Process,0.01,0.0
288,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4551689,Sleep-Disordered Breathing,C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
289,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
290,71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C4721919,malignant neoplasm of large intestine stage IIa,,,disease,Neoplastic Process,0.01,0.0
0,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0042781,Visceral Myopathy,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.75,0.917
1,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1608393,Megacystis microcolon intestinal hypoperistalsis syndrome,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.66,1.0
2,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0266833,"Visceral Myopathy, Familial",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.52,1.0
3,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
4,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
5,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1835084,Megaduodenum and-or Megacystis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
6,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0238062,Chronic intestinal pseudo-obstruction,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.13,1.0
7,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0021847,Intestinal Pseudo-Obstruction,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,1.0
8,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0162429,Malnutrition,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.11,1.0
9,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0000731,Abdomen distended,C06,   Digestive System Diseases,phenotype,Finding,0.1,
10,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0000737,Abdominal Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
11,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0
12,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0
13,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0003706,Arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
14,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
15,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
16,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0009806,Constipation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
17,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
18,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,
19,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
20,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0018809,Heart Neoplasm,C04;C14,   Neoplasms;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,
21,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,
22,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0020224,Polyhydramnios,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,
23,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0020295,Hydronephrosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,
24,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0020502,Hyperparathyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,
25,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
26,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0025990,Micrognathism,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,
27,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0027498,Nausea and vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
28,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0037221,Situs Inversus,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
29,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0042580,Vesico-Ureteral Reflux,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,
30,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0042963,Vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
31,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0080274,Urinary Retention,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Finding,0.1,
32,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0162298,Joint stiffness,C05,   Musculoskeletal Diseases,phenotype,Sign or Symptom,0.1,
33,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0221210,Congenital malrotation of intestine,C23;C16;C06,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,
34,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0232475,Decreased peristalsis,,,phenotype,Finding,0.1,1.0
35,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0239479,Round face,,,phenotype,Finding,0.1,
36,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.1,
37,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0265998,ANONYCHIA,C23,"   Pathological Conditions, Signs and Symptoms",disease,Congenital Abnormality,0.1,
38,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0266200,Microcolon,C06,   Digestive System Diseases,disease,Congenital Abnormality,0.1,
39,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0409348,Flexion contracture of proximal interphalangeal joint,,,phenotype,Finding,0.1,
40,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0426790,Narrow thorax,,,phenotype,Finding,0.1,
41,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0521620,Dilatation of ureter,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Anatomical Abnormality,0.1,
42,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0549253,Dilatation of the bladder,C13;C12;C10,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases,phenotype,Finding,0.1,1.0
43,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0795690,Congenital omphalocele,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
44,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1306503,Congenital exomphalos,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
45,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1840077,Anteverted nostril,,,phenotype,Finding,0.1,
46,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1849089,Broad forehead,,,phenotype,Finding,0.1,
47,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1854113,Prominent nasal bridge,,,phenotype,Finding,0.1,
48,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1855311,Megacystis,C16;C13,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Finding,0.1,1.0
49,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1857486,"Low-set, posteriorly rotated ears",,,phenotype,Finding,0.1,
50,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1858430,Death in infancy,,,phenotype,Finding,0.1,
51,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1864996,"Visceral Neuropathy, Familial, Autosomal Dominant",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
52,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C3714581,Multicystic Dysplastic Kidney,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,
53,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4023909,Aplasia/Hypoplasia of the abdominal wall musculature,,,phenotype,Finding,0.1,
54,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4049796,Abnormality of cardiovascular system morphology,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.1,
55,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.06,1.0
56,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0
57,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
58,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
59,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.04,0.75
60,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
61,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
62,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
63,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0
64,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
65,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0043167,Pertussis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
66,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0043168,Whooping cough due to unspecified organism,C23;C01;C08,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.03,1.0
67,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0349204,Nonorganic psychosis,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0
68,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
69,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0917801,Sleeplessness,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.03,1.0
70,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
71,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0007820,Cerebrovascular Disorders,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
72,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,0.5
73,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
74,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,0.5
75,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
76,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0042025,Urinary Stress Incontinence,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0
77,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
78,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.02,1.0
79,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
80,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
81,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.02,1.0
82,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
83,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
84,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
85,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
86,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
87,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
88,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
89,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1851710,LATERAL MENINGOCELE SYNDROME,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
90,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1857276,Trichohepatoenteric Syndrome,C23;C16;C13;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.02,1.0
91,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1863753,LIMB-MAMMARY SYNDROME,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0
92,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
93,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.02,1.0
94,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4290046,trachomatis,,,disease,Disease or Syndrome,0.02,1.0
95,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4721579,Secondary malignant neoplasm of colon and/or rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
96,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
97,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0002793,Anaplasia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
98,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0002875,Cooley's anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
99,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
100,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
101,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
102,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
103,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
104,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
105,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
106,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
107,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
108,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
109,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
110,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
111,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
112,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
113,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0013473,Eating Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
114,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
115,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0016059,Fibrosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
116,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
117,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
118,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
119,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0019159,Hepatitis A,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
120,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
121,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
122,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0024535,"Malaria, Falciparum",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
123,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0024537,"Malaria, Vivax",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
124,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
125,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
126,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0027430,Nasal Polyps,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
127,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0029454,Osteopetrosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
128,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
129,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0031117,Peripheral Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
130,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.01,1.0
131,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
132,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0037090,"Signs and Symptoms, Respiratory",C23,"   Pathological Conditions, Signs and Symptoms",group,Sign or Symptom,0.01,1.0
133,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0037856,Spermatic Cord Torsion,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
134,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
135,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
136,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
137,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
138,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
139,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0
140,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0149871,Deep Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
141,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0206686,Adrenocortical carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
142,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
143,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0220620,Gastrointestinal Carcinoid Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
144,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
145,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
146,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0221074,"Depression, Postpartum",C13;F03,   Female Urogenital Diseases and Pregnancy Complications;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
147,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
148,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
149,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0242723,Parasitemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
150,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0264722,Chronic congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
151,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0268318,Cholestasis of pregnancy,C06;C13,   Digestive System Diseases;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,0.0
152,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0277528,Traveler's diarrhea,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
153,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
154,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
155,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
156,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
157,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
158,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
159,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
160,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
161,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
162,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0346402,Malignant neoplasm of adrenal cortex,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
163,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0375381,Urethral intrinsic sphincter deficiency,,,disease,Disease or Syndrome,0.01,1.0
164,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0432215,Progressive pseudorheumatoid dysplasia,C05,   Musculoskeletal Diseases,disease,Congenital Abnormality,0.01,1.0
165,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
166,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
167,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
168,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0578870,Chronic idiopathic urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
169,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
170,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
171,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0600260,"Lung Diseases, Obstructive",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
172,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0677949,Stage III Colorectal Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
173,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0685828,Congenital dilatation of bladder,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
174,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
175,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0751587,CADASIL Syndrome,C23;C16;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
176,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0751713,"Inclusion Body Myopathy, Sporadic",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
177,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
178,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0852036,Pregnancy associated hypertension,C13;C14,   Female Urogenital Diseases and Pregnancy Complications;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
179,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
180,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
181,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
182,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1135868,Gestational Trophoblastic Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.01,1.0
183,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
184,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1290162,Disorder of smooth muscle,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
185,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
186,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1561826,Overweight and obesity,,,disease,Disease or Syndrome,0.01,1.0
187,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0
188,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C1840264,IMMUNE SUPPRESSION,,,phenotype,Disease or Syndrome,0.01,1.0
189,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C2217035,Stage IIA Colon Cancer AJCC v7,,,disease,Neoplastic Process,0.01,0.0
190,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C2931117,Fetal megacystis,C16;C13,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",disease,Disease or Syndrome,0.01,1.0
191,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C2931618,Gestational trophoblastic disease,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
192,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C2945695,Limb ischemia,,,disease,Disease or Syndrome,0.01,1.0
193,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
194,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C3146250,Stage III Colorectal Cancer AJCC v7,,,disease,Neoplastic Process,0.01,1.0
195,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
196,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
197,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C3539168,"PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A",,,disease,Disease or Syndrome,0.01,1.0
198,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C3665464,Dementia due to Alzheimer's disease (disorder),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
199,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4025285,Microspherocytosis,,,disease,Disease or Syndrome,0.01,1.0
200,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4525122,Stage IIA Colon Cancer AJCC v8,,,disease,Neoplastic Process,0.01,0.0
201,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4551689,Sleep-Disordered Breathing,C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
202,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
203,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
204,72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C4721919,malignant neoplasm of large intestine stage IIa,,,disease,Neoplastic Process,0.01,0.0
0,81,ACTN4,O43707,0.508,0.808,1.0,,,C4551527,Focal segmental glomerulosclerosis 1,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.8,1.0
1,81,ACTN4,O43707,0.508,0.808,1.0,,,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.5,1.0
2,81,ACTN4,O43707,0.508,0.808,1.0,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.32,1.0
3,81,ACTN4,O43707,0.508,0.808,1.0,,,C1868672,"NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0
4,81,ACTN4,O43707,0.508,0.808,1.0,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
5,81,ACTN4,O43707,0.508,0.808,1.0,,,C0024667,Animal Mammary Neoplasms,C04;C22,   Neoplasms;    Animal Diseases,phenotype,Neoplastic Process,0.3,1.0
6,81,ACTN4,O43707,0.508,0.808,1.0,,,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0
7,81,ACTN4,O43707,0.508,0.808,1.0,,,C0086432,"Hyalinosis, Segmental Glomerular",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,
8,81,ACTN4,O43707,0.508,0.808,1.0,,,C0205696,Anaplastic carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
9,81,ACTN4,O43707,0.508,0.808,1.0,,,C0205697,"Carcinoma, Spindle-Cell",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
10,81,ACTN4,O43707,0.508,0.808,1.0,,,C0205698,Undifferentiated carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
11,81,ACTN4,O43707,0.508,0.808,1.0,,,C0205699,Carcinomatosis,C04,   Neoplasms,phenotype,Neoplastic Process,0.3,1.0
12,81,ACTN4,O43707,0.508,0.808,1.0,,,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.3,1.0
13,81,ACTN4,O43707,0.508,0.808,1.0,,,C1257925,"Mammary Carcinoma, Animal",C04;C22,   Neoplasms;    Animal Diseases,disease,Neoplastic Process,0.3,1.0
14,81,ACTN4,O43707,0.508,0.808,1.0,,,C1262760,"Hepatitis, Drug-Induced",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
15,81,ACTN4,O43707,0.508,0.808,1.0,,,C3658290,Drug-Induced Acute Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
16,81,ACTN4,O43707,0.508,0.808,1.0,,,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
17,81,ACTN4,O43707,0.508,0.808,1.0,,,C4279912,Chemically-Induced Liver Toxicity,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
18,81,ACTN4,O43707,0.508,0.808,1.0,,,C0451720,"Nephrotic syndrome, focal and segmental glomerular lesions",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0
19,81,ACTN4,O43707,0.508,0.808,1.0,,,C2902887,Nephrotic syndrome with focal and segmental hyalinosis,,,disease,Disease or Syndrome,0.2,1.0
20,81,ACTN4,O43707,0.508,0.808,1.0,,,C2902888,Nephrotic syndrome with focal and segmental sclerosis,,,disease,Disease or Syndrome,0.2,1.0
21,81,ACTN4,O43707,0.508,0.808,1.0,,,C2902889,Nephrotic syndrome with focal glomerulonephritis,,,disease,Disease or Syndrome,0.2,1.0
22,81,ACTN4,O43707,0.508,0.808,1.0,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.11,1.0
23,81,ACTN4,O43707,0.508,0.808,1.0,,,C0033687,Proteinuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.11,1.0
24,81,ACTN4,O43707,0.508,0.808,1.0,,,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
25,81,ACTN4,O43707,0.508,0.808,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
26,81,ACTN4,O43707,0.508,0.808,1.0,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.944
27,81,ACTN4,O43707,0.508,0.808,1.0,,,C0013604,Edema,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
28,81,ACTN4,O43707,0.508,0.808,1.0,,,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
29,81,ACTN4,O43707,0.508,0.808,1.0,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.1,1.0
30,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0
31,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.923
32,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.1,1.0
33,81,ACTN4,O43707,0.508,0.808,1.0,,,C0239981,Hypoalbuminemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
34,81,ACTN4,O43707,0.508,0.808,1.0,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,0.952
35,81,ACTN4,O43707,0.508,0.808,1.0,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,0.944
36,81,ACTN4,O43707,0.508,0.808,1.0,,,C1854494,Slow progression,,,phenotype,Finding,0.1,
37,81,ACTN4,O43707,0.508,0.808,1.0,,,C1861403,Variable expressivity,,,phenotype,Finding,0.1,
38,81,ACTN4,O43707,0.508,0.808,1.0,,,C4049702,"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.08,1.0
39,81,ACTN4,O43707,0.508,0.808,1.0,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,0.833
40,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027721,Lipoid nephrosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.06,1.0
41,81,ACTN4,O43707,0.508,0.808,1.0,,,C0035078,Kidney Failure,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.06,1.0
42,81,ACTN4,O43707,0.508,0.808,1.0,,,C0268731,Renal glomerular disease,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",group,Disease or Syndrome,0.06,1.0
43,81,ACTN4,O43707,0.508,0.808,1.0,,,C0403397,Steroid-resistant nephrotic syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.06,0.667
44,81,ACTN4,O43707,0.508,0.808,1.0,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.06,1.0
45,81,ACTN4,O43707,0.508,0.808,1.0,,,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.06,1.0
46,81,ACTN4,O43707,0.508,0.808,1.0,,,C3266102,Steroid resistant nephrotic syndrome of childhood,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.06,0.667
47,81,ACTN4,O43707,0.508,0.808,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0
48,81,ACTN4,O43707,0.508,0.808,1.0,,,C0017665,Membranous glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.05,1.0
49,81,ACTN4,O43707,0.508,0.808,1.0,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.05,1.0
50,81,ACTN4,O43707,0.508,0.808,1.0,,,C0078911,AIDS-Associated Nephropathy,C13;C01;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.05,1.0
51,81,ACTN4,O43707,0.508,0.808,1.0,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.05,1.0
52,81,ACTN4,O43707,0.508,0.808,1.0,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0
53,81,ACTN4,O43707,0.508,0.808,1.0,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0
54,81,ACTN4,O43707,0.508,0.808,1.0,,,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.05,1.0
55,81,ACTN4,O43707,0.508,0.808,1.0,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
56,81,ACTN4,O43707,0.508,0.808,1.0,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0
57,81,ACTN4,O43707,0.508,0.808,1.0,,,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.04,1.0
58,81,ACTN4,O43707,0.508,0.808,1.0,,,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0
59,81,ACTN4,O43707,0.508,0.808,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
60,81,ACTN4,O43707,0.508,0.808,1.0,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
61,81,ACTN4,O43707,0.508,0.808,1.0,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.03,1.0
62,81,ACTN4,O43707,0.508,0.808,1.0,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
63,81,ACTN4,O43707,0.508,0.808,1.0,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
64,81,ACTN4,O43707,0.508,0.808,1.0,,,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.03,1.0
65,81,ACTN4,O43707,0.508,0.808,1.0,,,C1636149,"Macular dystrophy, corneal type 1",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.03,1.0
66,81,ACTN4,O43707,0.508,0.808,1.0,,,C1704321,"Nephrotic Syndrome, Minimal Change",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
67,81,ACTN4,O43707,0.508,0.808,1.0,,,C1709661,Primary Focal Segmental Glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
68,81,ACTN4,O43707,0.508,0.808,1.0,,,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.03,1.0
69,81,ACTN4,O43707,0.508,0.808,1.0,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
70,81,ACTN4,O43707,0.508,0.808,1.0,,,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
71,81,ACTN4,O43707,0.508,0.808,1.0,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
72,81,ACTN4,O43707,0.508,0.808,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
73,81,ACTN4,O43707,0.508,0.808,1.0,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,0.5
74,81,ACTN4,O43707,0.508,0.808,1.0,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
75,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.02,1.0
76,81,ACTN4,O43707,0.508,0.808,1.0,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
77,81,ACTN4,O43707,0.508,0.808,1.0,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
78,81,ACTN4,O43707,0.508,0.808,1.0,,,C0178664,Glomerulosclerosis (disorder),C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
79,81,ACTN4,O43707,0.508,0.808,1.0,,,C0268747,Diffuse mesangial sclerosis (disorder),C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0
80,81,ACTN4,O43707,0.508,0.808,1.0,,,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
81,81,ACTN4,O43707,0.508,0.808,1.0,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
82,81,ACTN4,O43707,0.508,0.808,1.0,,,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
83,81,ACTN4,O43707,0.508,0.808,1.0,,,C0687120,Nephronophthisis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
84,81,ACTN4,O43707,0.508,0.808,1.0,,,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
85,81,ACTN4,O43707,0.508,0.808,1.0,,,C0854985,"Adenocarcinoma of lung, stage I",,,disease,Neoplastic Process,0.02,1.0
86,81,ACTN4,O43707,0.508,0.808,1.0,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
87,81,ACTN4,O43707,0.508,0.808,1.0,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
88,81,ACTN4,O43707,0.508,0.808,1.0,,,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
89,81,ACTN4,O43707,0.508,0.808,1.0,,,C1710040,Secondary Focal Segmental Glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
90,81,ACTN4,O43707,0.508,0.808,1.0,,,C2919166,Autosomal dominant focal segmental glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
91,81,ACTN4,O43707,0.508,0.808,1.0,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
92,81,ACTN4,O43707,0.508,0.808,1.0,,,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.02,1.0
93,81,ACTN4,O43707,0.508,0.808,1.0,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
94,81,ACTN4,O43707,0.508,0.808,1.0,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
95,81,ACTN4,O43707,0.508,0.808,1.0,,,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
96,81,ACTN4,O43707,0.508,0.808,1.0,,,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
97,81,ACTN4,O43707,0.508,0.808,1.0,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
98,81,ACTN4,O43707,0.508,0.808,1.0,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
99,81,ACTN4,O43707,0.508,0.808,1.0,,,C0017658,Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
100,81,ACTN4,O43707,0.508,0.808,1.0,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
101,81,ACTN4,O43707,0.508,0.808,1.0,,,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
102,81,ACTN4,O43707,0.508,0.808,1.0,,,C0020951,Immune Complex Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
103,81,ACTN4,O43707,0.508,0.808,1.0,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
104,81,ACTN4,O43707,0.508,0.808,1.0,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
105,81,ACTN4,O43707,0.508,0.808,1.0,,,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
106,81,ACTN4,O43707,0.508,0.808,1.0,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
107,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027697,Nephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
108,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027719,Nephrosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
109,81,ACTN4,O43707,0.508,0.808,1.0,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
110,81,ACTN4,O43707,0.508,0.808,1.0,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
111,81,ACTN4,O43707,0.508,0.808,1.0,,,C0029925,Ovarian Carcinoma,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
112,81,ACTN4,O43707,0.508,0.808,1.0,,,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
113,81,ACTN4,O43707,0.508,0.808,1.0,,,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
114,81,ACTN4,O43707,0.508,0.808,1.0,,,C0085273,Erythema Infectiosum,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
115,81,ACTN4,O43707,0.508,0.808,1.0,,,C0151650,Renal fibrosis,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
116,81,ACTN4,O43707,0.508,0.808,1.0,,,C0153349,Malignant neoplasm of tongue,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
117,81,ACTN4,O43707,0.508,0.808,1.0,,,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
118,81,ACTN4,O43707,0.508,0.808,1.0,,,C0156259,Hypertrophy of kidney,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
119,81,ACTN4,O43707,0.508,0.808,1.0,,,C0158687,Congenital malformation of genital organs,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",group,Congenital Abnormality,0.01,1.0
120,81,ACTN4,O43707,0.508,0.808,1.0,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
121,81,ACTN4,O43707,0.508,0.808,1.0,,,C0206681,"Adenocarcinoma, Clear Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
122,81,ACTN4,O43707,0.508,0.808,1.0,,,C0206682,Follicular thyroid carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
123,81,ACTN4,O43707,0.508,0.808,1.0,,,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
124,81,ACTN4,O43707,0.508,0.808,1.0,,,C0220650,Metastatic malignant neoplasm to brain,C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
125,81,ACTN4,O43707,0.508,0.808,1.0,,,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
126,81,ACTN4,O43707,0.508,0.808,1.0,,,C0233532,Maladaptive behavior associated with physical illness,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
127,81,ACTN4,O43707,0.508,0.808,1.0,,,C0264657,Renal sclerosis with hypertension,C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
128,81,ACTN4,O43707,0.508,0.808,1.0,,,C0278688,Stage IV Ovarian Carcinoma,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
129,81,ACTN4,O43707,0.508,0.808,1.0,,,C0333497,Segmental glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
130,81,ACTN4,O43707,0.508,0.808,1.0,,,C0341698,Atrophy of kidney,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,0.0
131,81,ACTN4,O43707,0.508,0.808,1.0,,,C0346989,Secondary malignant neoplasm of peritoneum,,,disease,Neoplastic Process,0.01,1.0
132,81,ACTN4,O43707,0.508,0.808,1.0,,,C0403548,Salcedo syndrome,C16;C13;C17;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
133,81,ACTN4,O43707,0.508,0.808,1.0,,,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
134,81,ACTN4,O43707,0.508,0.808,1.0,,,C0558353,Tongue Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
135,81,ACTN4,O43707,0.508,0.808,1.0,,,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
136,81,ACTN4,O43707,0.508,0.808,1.0,,,C0677932,Progressive Neoplastic Disease,,,phenotype,Neoplastic Process,0.01,1.0
137,81,ACTN4,O43707,0.508,0.808,1.0,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
138,81,ACTN4,O43707,0.508,0.808,1.0,,,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
139,81,ACTN4,O43707,0.508,0.808,1.0,,,C0795949,Galloway Mowat syndrome,C23;C16;C13;C05;C12;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,0.0
140,81,ACTN4,O43707,0.508,0.808,1.0,,,C0848548,hypertensive nephropathy,C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
141,81,ACTN4,O43707,0.508,0.808,1.0,,,C0854078,Diabetic end stage renal disease,,,disease,Disease or Syndrome,0.01,1.0
142,81,ACTN4,O43707,0.508,0.808,1.0,,,C0887833,"Carcinoma, Pancreatic Ductal",C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
143,81,ACTN4,O43707,0.508,0.808,1.0,,,C0948750,Salivary gland carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
144,81,ACTN4,O43707,0.508,0.808,1.0,,,C1134719,Invasive Ductal Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
145,81,ACTN4,O43707,0.508,0.808,1.0,,,C1305904,Familial hematuria,,,disease,Disease or Syndrome,0.01,1.0
146,81,ACTN4,O43707,0.508,0.808,1.0,,,C1332900,Cerebellar hemangioblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
147,81,ACTN4,O43707,0.508,0.808,1.0,,,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
148,81,ACTN4,O43707,0.508,0.808,1.0,,,C1333015,Childhood Kidney Wilms Tumor,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.01,1.0
149,81,ACTN4,O43707,0.508,0.808,1.0,,,C1333964,Liver Dysplastic Nodule,,,disease,Disease or Syndrome,0.01,1.0
150,81,ACTN4,O43707,0.508,0.808,1.0,,,C1336527,"Carcinoma of urinary bladder, superficial",C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
151,81,ACTN4,O43707,0.508,0.808,1.0,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
152,81,ACTN4,O43707,0.508,0.808,1.0,,,C1533172,Infantile nystagmus syndrome,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
153,81,ACTN4,O43707,0.508,0.808,1.0,,,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
154,81,ACTN4,O43707,0.508,0.808,1.0,,,C1708565,Invasive Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
155,81,ACTN4,O43707,0.508,0.808,1.0,,,C1827293,"Carcinoma of urinary bladder, invasive",C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
156,81,ACTN4,O43707,0.508,0.808,1.0,,,C1862389,ATRIAL SEPTAL DEFECT 1,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
157,81,ACTN4,O43707,0.508,0.808,1.0,,,C1865974,"Hypomagnesemia 1, Intestinal",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
158,81,ACTN4,O43707,0.508,0.808,1.0,,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
159,81,ACTN4,O43707,0.508,0.808,1.0,,,C2749515,Collapsing glomerulopathy,,,disease,Disease or Syndrome,0.01,1.0
160,81,ACTN4,O43707,0.508,0.808,1.0,,,C2931852,Clear-cell metastatic renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
161,81,ACTN4,O43707,0.508,0.808,1.0,,,C3496337,Idiopathic Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
162,81,ACTN4,O43707,0.508,0.808,1.0,,,C3539781,Progressive cGVHD,,,disease,Disease or Syndrome,0.01,1.0
163,81,ACTN4,O43707,0.508,0.808,1.0,,,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
164,81,ACTN4,O43707,0.508,0.808,1.0,,,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
165,81,ACTN4,O43707,0.508,0.808,1.0,,,C4511620,Autosomal dominant tubulointerstitial kidney disease,,,disease,Disease or Syndrome,0.01,1.0
0,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0
1,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0424605,Developmental delay (disorder),F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.3,1.0
2,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.3,1.0
3,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0037917,Spina Bifida Cystica,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.2,1.0
4,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.1,
5,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0019294,"Hernia, Inguinal",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.1,
6,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0019322,Umbilical hernia,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.1,
7,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0039070,Syncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
8,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0040485,Torticollis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
9,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0426429,Broad nasal tip,,,phenotype,Finding,0.1,
10,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0426891,Broad thumbs,,,phenotype,Finding,0.1,
11,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0454644,Delayed speech and language development,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
12,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0747085,Recurrent otitis media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,
13,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C1845847,Coarse facial features,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
14,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C1859077,Aplasia/Hypoplasia of the nails,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
15,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C4023295,Cleft anterior mitral valve leaflet,,,phenotype,Anatomical Abnormality,0.1,
16,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C4317146,Acid reflux,,,phenotype,Finding,0.1,
17,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
18,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0
19,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
20,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
21,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
22,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
23,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
24,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
25,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
26,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
27,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
28,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
29,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
30,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
31,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0220611,Childhood Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
32,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0271907,Acquired aplastic anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
33,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0279550,Adult Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
34,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
35,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
36,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
37,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
38,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
39,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
40,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
41,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
42,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
43,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
44,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C4551463,Colon adenoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
45,86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
0,87,ACTN1,P12814,0.695,0.577,0.99997,,,C3554663,"BLEEDING DISORDER, PLATELET-TYPE, 15",,,disease,Disease or Syndrome,0.7,1.0
1,87,ACTN1,P12814,0.695,0.577,0.99997,,,C2751260,Macrothrombocytopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.48,0.889
2,87,ACTN1,P12814,0.695,0.577,0.99997,,,C4304021,Autosomal dominant macrothrombocytopenia,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.32,1.0
3,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
4,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.17,1.0
5,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
6,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0
7,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0221278,Anisocytosis,,,phenotype,Finding,0.1,
8,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
9,87,ACTN1,P12814,0.695,0.577,0.99997,,,C1096367,Increased mean platelet volume,,,phenotype,Finding,0.1,
10,87,ACTN1,P12814,0.695,0.577,0.99997,,,C1739105,Platelet anisocytosis,,,phenotype,Pathologic Function,0.1,
11,87,ACTN1,P12814,0.695,0.577,0.99997,,,C2698117,Anisocyte Measurement,,,phenotype,Laboratory Procedure,0.1,
12,87,ACTN1,P12814,0.695,0.577,0.99997,,,C3828530,Platelet Component Distribution Width Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
13,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
14,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
15,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
16,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
17,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
18,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
19,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
20,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
21,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
22,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
23,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
24,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
25,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0085662,Macrocytosis,,,disease,Disease or Syndrome,0.01,1.0
26,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
27,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0206687,"Carcinoma, Endometrioid",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
28,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
29,87,ACTN1,P12814,0.695,0.577,0.99997,,,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
30,87,ACTN1,P12814,0.695,0.577,0.99997,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,0.0
31,87,ACTN1,P12814,0.695,0.577,0.99997,,,C1701940,"Pneumonia, Ventilator-Associated",C23;C01;C08,"   Pathological Conditions, Signs and Symptoms;    Infections;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
32,87,ACTN1,P12814,0.695,0.577,0.99997,,,C3642347,Basal-Like Breast Carcinoma,,,disease,Neoplastic Process,0.01,1.0
33,87,ACTN1,P12814,0.695,0.577,0.99997,,,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,88,ACTN2,P35609,0.686,0.462,0.99968,,,C2677338,"Cardiomyopathy, Dilated, 1AA",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.7,1.0
1,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0
2,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0340427,Familial dilated cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
3,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.14,1.0
4,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.12,1.0
5,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0014117,Endocardial Fibroelastosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0
6,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.11,1.0
7,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
8,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0023787,Lipodystrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
9,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0241005,Creatine phosphokinase serum increased,,,phenotype,Finding,0.1,
10,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0349788,Arrhythmogenic Right Ventricular Dysplasia,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.1,
11,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0427515,Neutrophil abnormality,,,phenotype,Finding,0.1,
12,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0476403,Electromyogram abnormal,,,phenotype,Finding,0.1,
13,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0553980,Endomyocardial Fibrosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,
14,88,ACTN2,P35609,0.686,0.462,0.99968,,,C1280433,Lipoatrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
15,88,ACTN2,P35609,0.686,0.462,0.99968,,,C4227331,Cardiomyocyte hypertrophy,,,phenotype,Finding,0.1,
16,88,ACTN2,P35609,0.686,0.462,0.99968,,,C4551675,"Keratoderma, Palmoplantar",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,
17,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0
18,88,ACTN2,P35609,0.686,0.462,0.99968,,,C4551472,Hypertrophic obstructive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
19,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
20,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
21,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
22,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
23,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0032463,Polycythemia Vera,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
24,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0035439,Rheumatic Heart Disease,C01;C14,   Infections;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
25,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0040921,Trichomonas Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
26,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0042514,"Tachycardia, Ventricular",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
27,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0333519,Caries (morphologic abnormality),C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
28,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0340493,Paroxysmal familial ventricular fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
29,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0686353,"Muscular Dystrophies, Limb-Girdle",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",group,Disease or Syndrome,0.01,1.0
30,88,ACTN2,P35609,0.686,0.462,0.99968,,,C0949658,"Cardiomyopathy, Hypertrophic, Familial",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
31,88,ACTN2,P35609,0.686,0.462,0.99968,,,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
32,88,ACTN2,P35609,0.686,0.462,0.99968,,,C1853926,NONAKA MYOPATHY,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
33,88,ACTN2,P35609,0.686,0.462,0.99968,,,C1962942,TRICHOMONAS VAGINALIS (finding),,,disease,Disease or Syndrome,0.01,1.0
34,88,ACTN2,P35609,0.686,0.462,0.99968,,,C3888204,ACTN3 DEFICIENCY,,,disease,Disease or Syndrome,0.01,0.0
0,89,ACTN3,Q08043,0.663,0.5,,,,C3888204,ACTN3 DEFICIENCY,,,disease,Disease or Syndrome,0.2,0.909
1,89,ACTN3,Q08043,0.663,0.5,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
2,89,ACTN3,Q08043,0.663,0.5,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
3,89,ACTN3,Q08043,0.663,0.5,,,,C0410158,Muscle damage,,,phenotype,Acquired Abnormality,0.1,1.0
4,89,ACTN3,Q08043,0.663,0.5,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
5,89,ACTN3,Q08043,0.663,0.5,,,,C3888203,SPRINTING PERFORMANCE,,,phenotype,Organism Attribute,0.1,
6,89,ACTN3,Q08043,0.663,0.5,,,,C0017924,Glycogen Storage Disease Type V,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0
7,89,ACTN3,Q08043,0.663,0.5,,,,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
8,89,ACTN3,Q08043,0.663,0.5,,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
9,89,ACTN3,Q08043,0.663,0.5,,,,C0011633,Dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
10,89,ACTN3,Q08043,0.663,0.5,,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
11,89,ACTN3,Q08043,0.663,0.5,,,,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
12,89,ACTN3,Q08043,0.663,0.5,,,,C0017921,Glycogen storage disease type II,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
13,89,ACTN3,Q08043,0.663,0.5,,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
14,89,ACTN3,Q08043,0.663,0.5,,,,C0024636,Malocclusion,C07,   Stomatognathic Diseases,disease,Anatomical Abnormality,0.01,1.0
15,89,ACTN3,Q08043,0.663,0.5,,,,C0026850,Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
16,89,ACTN3,Q08043,0.663,0.5,,,,C0027121,Myositis,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
17,89,ACTN3,Q08043,0.663,0.5,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,0.0
18,89,ACTN3,Q08043,0.663,0.5,,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
19,89,ACTN3,Q08043,0.663,0.5,,,,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
20,89,ACTN3,Q08043,0.663,0.5,,,,C0037054,Sickle Cell Trait,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
21,89,ACTN3,Q08043,0.663,0.5,,,,C0085655,Polymyositis,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
22,89,ACTN3,Q08043,0.663,0.5,,,,C0221056,Adult type dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
23,89,ACTN3,Q08043,0.663,0.5,,,,C0221170,Muscular stiffness,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.01,1.0
24,89,ACTN3,Q08043,0.663,0.5,,,,C0231230,Fatigability,,,phenotype,Sign or Symptom,0.01,0.0
25,89,ACTN3,Q08043,0.663,0.5,,,,C0234233,Sore to touch,C23;F03,"   Pathological Conditions, Signs and Symptoms;    Mental Disorders",phenotype,Sign or Symptom,0.01,1.0
26,89,ACTN3,Q08043,0.663,0.5,,,,C0264716,Chronic heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
27,89,ACTN3,Q08043,0.663,0.5,,,,C0342751,Generalized glycogen storage disease of infants,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
28,89,ACTN3,Q08043,0.663,0.5,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.01,0.0
29,89,ACTN3,Q08043,0.663,0.5,,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
30,89,ACTN3,Q08043,0.663,0.5,,,,C0595995,Idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.01,1.0
31,89,ACTN3,Q08043,0.663,0.5,,,,C0751356,Idiopathic Inflammatory Myopathies,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
32,89,ACTN3,Q08043,0.663,0.5,,,,C0872084,Sarcopenia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
33,89,ACTN3,Q08043,0.663,0.5,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
34,89,ACTN3,Q08043,0.663,0.5,,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
35,89,ACTN3,Q08043,0.663,0.5,,,,C1852502,"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",C05;C07,   Musculoskeletal Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
36,89,ACTN3,Q08043,0.663,0.5,,,,C1861922,CAMPOMELIC DYSPLASIA,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
37,89,ACTN3,Q08043,0.663,0.5,,,,C2827469,Coronary Microvascular Disease,,,disease,Disease or Syndrome,0.01,1.0
38,89,ACTN3,Q08043,0.663,0.5,,,,C3489532,Cone-Rod Dystrophy 2,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
39,89,ACTN3,Q08043,0.663,0.5,,,,C3714535,"Malocclusion, Angle class II",C07,   Stomatognathic Diseases,disease,Anatomical Abnormality,0.01,1.0
40,89,ACTN3,Q08043,0.663,0.5,,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
0,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0016037,Fibrodysplasia Ossificans Progressiva,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,1.0,1.0
1,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0
2,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,0.75
3,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,0.75
4,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0
5,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0
6,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0027122,Myositis Ossificans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.31,1.0
7,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0555198,Malignant Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0
8,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0009782,Connective Tissue Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,
9,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0085576,Iron-Refractory Iron Deficiency Anemia,C18;C15,   Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0
10,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0205768,Subependymal Giant Cell Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
11,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0242488,Acute Lung Injury,C08,   Respiratory Tract Diseases,disease,Injury or Poisoning,0.3,1.0
12,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0259783,mixed gliomas,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
13,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0280783,Juvenile Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
14,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0280785,Diffuse Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
15,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0334579,Anaplastic astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
16,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0334580,Protoplasmic astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
17,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0334581,Gemistocytic astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
18,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0334582,Fibrillary Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
19,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0334583,Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
20,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0338070,Childhood Cerebral Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
21,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0547065,Mixed oligoastrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
22,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0750935,Cerebral Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
23,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0750936,Intracranial Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
24,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1257931,"Mammary Neoplasms, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
25,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.3,1.0
26,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1704230,Grade I Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
27,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4704874,"Mammary Carcinoma, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
28,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0
29,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0018536,Hallux Valgus,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.11,1.0
30,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0
31,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,
32,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
33,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
34,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
35,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0018552,Hamartoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,
36,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0018777,Conductive hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
37,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
38,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0035229,Respiratory Insufficiency,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.1,
39,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
40,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
41,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0151811,Subcutaneous nodule,C04;C17;C05,   Neoplasms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,phenotype,Pathologic Function,0.1,
42,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
43,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0332790,Osseous ankylosis,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.1,
44,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0677865,Brain Stem Glioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.1,1.0
45,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1145670,Respiratory Failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,
46,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.1,
47,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1834129,Abnormal vertebral morphology,,,phenotype,Finding,0.1,
48,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1844813,Widely spaced teeth,,,phenotype,Finding,0.1,
49,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1849016,Broad femoral neck,,,phenotype,Finding,0.1,
50,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1849039,Metaphyseal widening,,,phenotype,Finding,0.1,
51,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1849311,Short 1st metacarpal,,,phenotype,Finding,0.1,
52,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1850049,Clinodactyly of the 5th finger,,,disease,Congenital Abnormality,0.1,
53,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1851129,Progressive cervical vertebral spine fusion,,,phenotype,Finding,0.1,
54,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1851130,Small cervical vertebral bodies,,,phenotype,Finding,0.1,
55,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1857108,Limitation of joint mobility,,,phenotype,Finding,0.1,
56,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1858025,Spinal rigidity,,,phenotype,Finding,0.1,
57,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1865992,Short hallux,,,phenotype,Finding,0.1,
58,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C2986658,Diffuse Intrinsic Pontine Glioma,,,disease,Neoplastic Process,0.1,1.0
59,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.1,
60,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4023094,Ectopic ossification in ligament tissue,C23,"   Pathological Conditions, Signs and Symptoms",disease,Anatomical Abnormality,0.1,
61,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4023095,Ectopic ossification in tendon tissue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
62,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4023096,Ectopic ossification in muscle tissue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
63,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4024079,Aplasia/Hypoplasia of the phalanges of the hallux,,,phenotype,Finding,0.1,
64,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4024082,Abnormality of the first metatarsal bone,,,disease,Anatomical Abnormality,0.1,
65,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0
66,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.08,1.0
67,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
68,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0
69,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.04,1.0
70,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
71,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.03,1.0
72,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0302142,Deformity,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Anatomical Abnormality,0.03,1.0
73,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1292778,Chronic myeloproliferative disorder,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
74,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
75,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.02,1.0
76,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
77,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C2827362,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,,,disease,Neoplastic Process,0.02,1.0
78,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
79,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
80,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
81,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
82,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
83,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0008073,Developmental Disabilities,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
84,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
85,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0011430,Dentin Dysplasia,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
86,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
87,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0014116,Endocardial Cushion Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
88,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0022408,Arthropathy,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0
89,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0025988,Microglossia,C07,   Stomatognathic Diseases,disease,Congenital Abnormality,0.01,1.0
90,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
91,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
92,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0028756,"Obesity, Morbid",C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
93,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
94,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0029422,Osteochondrodysplasias,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Disease or Syndrome,0.01,1.0
95,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
96,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
97,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
98,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
99,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0036631,Seminoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
100,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
101,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0158458,Acquired hallux valgus,C05,   Musculoskeletal Diseases,disease,Acquired Abnormality,0.01,1.0
102,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
103,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0206648,Myofibromatosis,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
104,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0206681,"Adenocarcinoma, Clear Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
105,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0220603,Childhood Brain Neoplasm,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
106,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0220620,Gastrointestinal Carcinoid Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
107,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0233705,Cancerophobia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
108,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
109,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0265656,Congenital hallux valgus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
110,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0282193,Iron Overload,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
111,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
112,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0334041,Osteoma cutis,C23;C16;C18;C17;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0
113,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0344735,Partial atrioventricular canal,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
114,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
115,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0410528,Skeletal dysplasia,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
116,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0432284,Infantile myofibromatosis,C04,   Neoplasms,disease,Disease or Syndrome,0.01,1.0
117,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
118,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
119,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0598935,Tumor Initiation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
120,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0858617,Posterior subcapsular cataract,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
121,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0879615,Stromal Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
122,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
123,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0949690,Spondylarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
124,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1266129,Atypical Lipoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
125,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1302790,Congenital malformation syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
126,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1332079,"Anaplastic Large Cell Lymphoma, ALK-Positive",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
127,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1332951,Childhood Brain Stem Neoplasm,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
128,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1337014,Grade I Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
129,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1389016,ATRIOVENTRICULAR CANAL DEFECT,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.01,1.0
130,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1389018,Atrioventricular Septal Defect,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
131,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C1705254,Neonatal Deformity,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
132,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C2930619,Sex Differentiation Disorders,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",group,Disease or Syndrome,0.01,0.0
133,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0
134,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4021626,Lethal skeletal dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Anatomical Abnormality,0.01,1.0
135,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
136,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4049796,Abnormality of cardiovascular system morphology,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,0.0
137,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
138,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4277690,Ciliopathies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0
139,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
140,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
141,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4552766,Miscarriage,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
142,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4722099,High grade glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
143,90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0
0,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
1,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.13,1.0
2,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0
3,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0200633,Neutrophil count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0
4,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
5,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0
6,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0
7,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0857490,Granulocyte count,,,phenotype,Laboratory Procedure,0.1,1.0
8,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0
9,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,0.833
10,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
11,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
12,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0
13,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
14,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
15,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
16,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
17,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
18,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
19,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
20,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
21,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
22,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
23,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0018021,Goiter,C19,   Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
24,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
25,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
26,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
27,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
28,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0036631,Seminoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
29,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0278803,Adenocarcinoma of small intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
30,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
31,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
32,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
33,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
34,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0741276,ATRIAL ENLARGEMENT,,,disease,Disease or Syndrome,0.01,1.0
35,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C1397307,Cardiac fibrosis,,,disease,Disease or Syndrome,0.01,1.0
36,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C1519670,Tumor Angiogenesis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
37,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
38,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C4511687,Pancreatic Intraductal Papillary Mucinous Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
39,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
40,91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
0,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,
1,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0920269,Microsatellite Instability,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0
2,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1721098,Replication Error Phenotype,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0
3,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0031900,Pierre Robin Syndrome,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.2,1.0
4,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0
5,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0
6,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0018099,Gout,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0
7,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0201976,"Creatinine measurement, serum (procedure)",,,phenotype,Laboratory Procedure,0.1,1.0
8,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
9,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.667
10,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.07,1.0
11,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.06,1.0
12,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0008476,"Chondromatosis, Synovial",C05,   Musculoskeletal Diseases,disease,Neoplastic Process,0.03,1.0
13,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.03,1.0
14,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0013537,Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.03,1.0
15,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
16,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0029427,Synovial osteochondromatosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
17,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
18,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
19,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0
20,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.03,1.0
21,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.03,1.0
22,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0008479,Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
23,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0
24,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1391732,Cancer cachexia,,,disease,Neoplastic Process,0.02,1.0
25,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
26,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0005940,Bone Diseases,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0
27,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
28,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
29,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0014084,Enchondromatosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
30,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0015306,Hereditary Multiple Exostoses,C16;C04;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0
31,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0017185,Gastrointestinal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
32,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0018021,Goiter,C19,   Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
33,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
34,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0024814,Marinesco-Sjogren syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,0.0
35,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
36,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
37,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.01,1.0
38,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0
39,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0154084,Stage 0 Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
40,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
41,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0206641,Osteochondromatosis,C04;C05,   Neoplasms;    Musculoskeletal Diseases,disease,Neoplastic Process,0.01,1.0
42,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0206708,Cervical Intraepithelial Neoplasia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
43,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0264009,Osteodystrophy,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0
44,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0278803,Adenocarcinoma of small intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
45,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0342649,Vascular calcification,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
46,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
47,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
48,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
49,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
50,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0685938,Malignant neoplasm of gastrointestinal tract,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
51,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0852519,Benign chondrogenic neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
52,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0936248,Chondroma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
53,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
54,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1332922,Cervical Squamous Intraepithelial Neoplasia,C23;C04;C13,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications",disease,Neoplastic Process,0.01,1.0
55,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1333990,Hereditary Nonpolyposis Colorectal Cancer,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Neoplastic Process,0.01,1.0
56,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C1567741,Alport Syndrome,C16;C13;C17;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
57,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
58,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
59,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C4520821,Stage 0 Breast Cancer AJCC v6 and v7,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
60,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C4543877,Osteopenia due to disuse,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
61,92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C4544822,Microsatellite instability-high colorectal cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
0,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3151057,"HETEROTAXY, VISCERAL, 4, AUTOSOMAL",,,disease,Disease or Syndrome,0.9,1.0
1,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3178805,Heterotaxy Syndrome,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0
2,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0266642,Situs ambiguus,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.61,1.0
3,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0175707,Asplenia Syndrome,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,1.0
4,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0265357,Polysplenia Syndrome,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.5,1.0
5,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3178806,Right Atrial Isomerism,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.5,1.0
6,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0037221,Situs Inversus,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.3,1.0
7,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1167664,Situs ambiguous,,,disease,Congenital Abnormality,0.3,
8,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3178807,Left Atrial Isomerism,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.3,1.0
9,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C4277690,Ciliopathies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.3,
10,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0344692,Isomerism of atrial appendages,,,disease,Congenital Abnormality,0.2,1.0
11,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1415817,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",,,disease,Disease or Syndrome,0.2,1.0
12,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1844020,"HETEROTAXY, VISCERAL, 1, X-LINKED",C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
13,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1853444,"Heterotaxy, Visceral, 3, Autosomal",C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
14,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1876171,Polyasplenia,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
15,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1876172,"VAH, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.2,1.0
16,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1876173,"Heterotaxy, Visceroatrial, Autosomal Recessive",C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
17,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C2910124,Isomerism of atrial appendages with asplenia or polysplenia,,,disease,Congenital Abnormality,0.2,1.0
18,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3151867,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED",,,disease,Disease or Syndrome,0.2,1.0
19,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3553676,"HETEROTAXY, VISCERAL, 6, AUTOSOMAL",,,disease,Disease or Syndrome,0.2,1.0
20,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0011813,Dextrocardia,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.1,
21,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0
22,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0018818,Ventricular Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.1,
23,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0035615,Right aortic arch (disorder),C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
24,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0266632,Ectopic spleen,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.1,
25,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
26,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1389016,ATRIOVENTRICULAR CANAL DEFECT,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.1,
27,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0
28,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0006625,Cachexia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.05,1.0
29,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.04,1.0
30,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
31,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1391732,Cancer cachexia,,,disease,Neoplastic Process,0.02,1.0
32,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
33,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
34,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
35,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
36,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
37,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
38,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,0.0
39,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
40,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
41,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
42,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
43,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
44,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0022521,Kartagener Syndrome,C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
45,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
46,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0026850,Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
47,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.01,1.0
48,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
49,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0032584,polyps,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,1.0
50,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0036631,Seminoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
51,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0039730,Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0
52,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0040761,Transposition of Great Vessels,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
53,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
54,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0151517,Complete atrioventricular block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
55,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
56,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
57,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0302142,Deformity,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Anatomical Abnormality,0.01,1.0
58,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
59,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C0752304,Hypoxic-Ischemic Encephalopathy,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
60,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1153706,Endometrial adenocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
61,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
62,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
63,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1318485,Liver regeneration disorder,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.01,1.0
64,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1320468,Nephrogenic rest,,,disease,Anatomical Abnormality,0.01,1.0
65,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1378703,Renal carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
66,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C1866091,Left-Right Axis Malformations,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
67,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
68,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3898147,Neonatal Hypoxic Ischemic Encephalopathy,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
69,93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C4551720,Primary Ciliary Dyskinesia,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
0,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1838163,OSLER-RENDU-WEBER SYNDROME 2,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.76,1.0
1,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0039445,Hereditary hemorrhagic telangiectasia,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0
2,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0340543,Familial primary pulmonary hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.56,1.0
3,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.51,1.0
4,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C2973725,Pulmonary arterial hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.5,0.909
5,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.5,0.971
6,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4551861,"Telangiectasia, Hereditary Hemorrhagic, Type 1",C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.42,1.0
7,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0014591,Epistaxis,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",phenotype,Pathologic Function,0.4,1.0
8,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0155675,Pulmonary Arteriovenous Fistulas,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0
9,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0241790,Congenital pulmonary arteriovenous malformation,C08,   Respiratory Tract Diseases,disease,Congenital Abnormality,0.4,1.0
10,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0520557,Arteriovenous malformation of liver,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.4,1.0
11,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1832529,HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED PULMONARY ARTERIAL HYPERTENSION,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0
12,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1857690,Pulmonary arteriovenous malformation,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.4,1.0
13,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0039446,Telangiectasis,C14,   Cardiovascular Diseases,disease,Finding,0.34,1.0
14,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0005779,Blood Coagulation Disorders,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.31,1.0
15,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
16,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1150929,"2-oxo-hept-3-ene-1,7-dioate hydratase activity",,,phenotype,Molecular Function,0.3,1.0
17,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1458140,Bleeding tendency,C15,   Hemic and Lymphatic Diseases,phenotype,Pathologic Function,0.3,1.0
18,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1701939,Familial pulmonary arterial hypertension,,,disease,Disease or Syndrome,0.3,1.0
19,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C3850148,Vascular Remodeling,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organ or Tissue Function,0.3,1.0
20,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C3852953,Pulmonary Arterial Remodeling,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organ or Tissue Function,0.3,1.0
21,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4707243,Familial thoracic aortic aneurysm and aortic dissection,,,disease,Disease or Syndrome,0.3,
22,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0007772,Intracranial Arteriovenous Malformation,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.2,
23,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.17,1.0
24,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.13,1.0
25,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0917804,"Arteriovenous Malformations, Cerebral",C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",group,Congenital Abnormality,0.13,1.0
26,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.11,1.0
27,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0006105,Brain Abscess,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0
28,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C3809715,"Spontaneous, recurrent epistaxis",C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",phenotype,Sign or Symptom,0.11,1.0
29,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0002418,Amblyopia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,
30,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0003857,Congenital arteriovenous malformation,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.1,0.977
31,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0008325,Cholecystitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
32,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
33,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0009080,Clubbed Fingers,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,
34,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0010520,Cyanosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
35,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0013404,Dyspnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
36,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0
37,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0014867,Esophageal Varices,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
38,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0017181,Gastrointestinal Hemorrhage,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Pathologic Function,0.1,
39,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0018920,"Hemangioma, Cavernous",C04;C15;C14,   Neoplasms;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,
40,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0018926,Hematemesis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Sign or Symptom,0.1,
41,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0018932,Hematochezia,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Disease or Syndrome,0.1,
42,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0018965,Hematuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Disease or Syndrome,0.1,
43,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0019079,Hemoptysis,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
44,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0020541,Portal Hypertension,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
45,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
46,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0025222,Melena,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Pathologic Function,0.1,
47,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
48,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0032461,Polycythemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
49,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0034065,Pulmonary Embolism,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Pathologic Function,0.1,
50,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
51,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,
52,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0042487,Venous Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,
53,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0085576,Iron-Refractory Iron Deficiency Anemia,C18;C15,   Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
54,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0085605,Liver Failure,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
55,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0149651,Clubbing,,,phenotype,Sign or Symptom,0.1,
56,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,
57,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0154835,Retinal telangiectasia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
58,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
59,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0206180,Ki-1+ Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.8
60,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0239105,Conjunctival telangiectasis,,,disease,Disease or Syndrome,0.1,
61,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0334533,Arteriovenous hemangioma,C16;C04;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Cardiovascular Diseases",disease,Neoplastic Process,0.1,1.0
62,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0348023,Spinal arteriovenous malformation,C16;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.1,
63,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0392525,Nephrolithiasis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,
64,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0428871,Right to left cardiovascular shunt (finding),,,phenotype,Finding,0.1,
65,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0744321,Gastrointestinal arteriovenous malformation,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.1,
66,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0750880,Monocyte count result,,,phenotype,Laboratory or Test Result,0.1,1.0
67,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0854242,Gastrointestinal angiodysplasia,,,disease,Disease or Syndrome,0.1,
68,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
69,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1257915,Intestinal Polyposis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
70,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1619711,Gastrointestinal telangiectasia,,,disease,Disease or Syndrome,0.1,
71,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
72,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1697453,Spontaneous hematomas,,,disease,Disease or Syndrome,0.1,
73,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1838167,Nail bed telangiectasia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.1,
74,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1857697,Lip telangiectasia,,,phenotype,Finding,0.1,
75,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1857699,Palate telangiectasia,,,phenotype,Finding,0.1,
76,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1861248,Fingerpad telangiectases,,,phenotype,Finding,0.1,
77,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C2937358,Cerebral Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,
78,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C3275758,Choriocapillaris atrophy,,,phenotype,Finding,0.1,
79,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4021971,Peripheral arteriovenous fistula,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.1,
80,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4021977,Visceral angiomatosis,,,disease,Disease or Syndrome,0.1,
81,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4022018,Telangiectasia of the skin,C14,   Cardiovascular Diseases,phenotype,Finding,0.1,
82,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4025853,Nasal mucosa telangiectasia,,,disease,Anatomical Abnormality,0.1,
83,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4025878,Tongue telangiectasia,,,disease,Anatomical Abnormality,0.1,
84,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4552070,"Pulmonary Hypertension, Primary, 1",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
85,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0334121,Inflammatory Myofibroblastic Tumor,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.09,1.0
86,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0152171,Idiopathic pulmonary hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.07,1.0
87,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1332182,Adult Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,0.833
88,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1332942,Childhood Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,0.833
89,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0
90,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.04,1.0
91,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0158570,Vascular anomaly,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",phenotype,Anatomical Abnormality,0.04,1.0
92,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.04,1.0
93,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
94,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
95,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0
96,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0
97,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
98,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0345893,Juvenile polyposis syndrome,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.03,1.0
99,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
100,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
101,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
102,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
103,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
104,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
105,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0221045,High output heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
106,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
107,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
108,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
109,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
110,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,0.5
111,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1332079,"Anaplastic Large Cell Lymphoma, ALK-Positive",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,0.5
112,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
113,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
114,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1519670,Tumor Angiogenesis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
115,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1701938,Associated Pulmonary Arterial Hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
116,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1842180,CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION (disorder),C16;C17;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
117,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
118,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4721579,Secondary malignant neoplasm of colon and/or rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
119,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
120,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
121,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0002793,Anaplasia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
122,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0002991,Cutaneous Fibrous Histiocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
123,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
124,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0
125,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
126,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
127,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
128,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
129,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0009782,Connective Tissue Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
130,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,0.0
131,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
132,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
133,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
134,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,0.0
135,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0020981,Angioimmunoblastic Lymphadenopathy,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
136,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0023269,leiomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
137,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
138,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
139,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
140,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
141,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
142,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
143,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0026936,Mycoplasma Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
144,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0026948,Mycosis Fungoides,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,0.0
145,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
146,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0029182,orbit (eye disorders),C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
147,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0032584,polyps,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,1.0
148,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0034091,Pulmonary Veno-Occlusive Disease (disorder),C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
149,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
150,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
151,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
152,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
153,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0037579,Soft Tissue Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
154,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
155,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
156,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0043208,Wolman Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
157,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0079772,T-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
158,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0079774,Peripheral T-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
159,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0085411,Angiodysplasia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
160,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
161,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0206138,CREST Syndrome,C06;C18;C17;C14,   Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
162,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0206139,"Lichen Planus, Oral",C17;C07,   Skin and Connective Tissue Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
163,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0206644,"Histiocytoma, Benign Fibrous",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
164,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0206645,Desmoplastic fibroma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
165,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0
166,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0220611,Childhood Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
167,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
168,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0220650,Metastatic malignant neoplasm to brain,C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
169,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
170,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
171,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0265333,Tricho-dento-osseous syndrome (disorder),C16;C17;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
172,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0267370,Angiodysplasia of colon,C06;C14,   Digestive System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
173,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
174,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0278607,Adult Leiomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
175,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0278622,Adult Malignant Peripheral Nerve Sheath Tumor,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
176,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0278678,Metastatic Renal Cell Cancer,,,disease,Neoplastic Process,0.01,1.0
177,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
178,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0279550,Adult Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
179,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0279986,Childhood Leiomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
180,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0279987,Childhood Malignant Peripheral Nerve Sheath Tumor,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
181,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
182,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0334463,Malignant Fibrous Histiocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
183,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0339510,Vitelliform Macular Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
184,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0340100,High altitude pulmonary edema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
185,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0340542,Sporadic primary pulmonary hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,0.0
186,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
187,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0346053,Atypical fibroxanthoma of skin,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
188,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0398635,Thromboxane synthetase deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
189,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
190,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
191,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0751690,Malignant Peripheral Nerve Sheath Tumor,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
192,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0752156,Dural Arteriovenous Fistula,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.01,1.0
193,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
194,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
195,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1266121,Myofibroma (morphologic abnormality),C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
196,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1266127,"Histiocytoma, Angiomatoid Fibrous",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
197,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
198,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
199,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1276146,Cutaneous lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
200,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1301362,Primary Cutaneous Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
201,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1302772,Primary cutaneous lymphoma,C04;C17;C20;C15,   Neoplasms;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
202,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1332214,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
203,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
204,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
205,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1336548,Systemic Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
206,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1368237,Solitary Myofibromatosis,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
207,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1397307,Cardiac fibrosis,,,disease,Disease or Syndrome,0.01,1.0
208,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1562503,Vein of Galen Malformations,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0
209,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1658953,tumor vasculature,,,phenotype,Neoplastic Process,0.01,1.0
210,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1855496,Contiguous gene syndrome,,,disease,Disease or Syndrome,0.01,1.0
211,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1961121,Congenital vascular anomaly,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
212,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
213,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C2826323,Refractory Cytopenia of Childhood,,,disease,Neoplastic Process,0.01,1.0
214,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C2919945,Cavernous Hemangioma of Brain,C16;C04;C10;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.01,1.0
215,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
216,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C3887658,"PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT",C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
217,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
218,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4527152,Tricuspid Valve Regurgitation Velocity,,,phenotype,Sign or Symptom,0.01,1.0
219,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4551903,Total anomalous pulmonary venous return,C16;C08;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
220,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4721698,Metastatic Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
221,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
222,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4727069,Advanced Renal Cell Carcinoma,,,disease,Neoplastic Process,0.01,1.0
223,94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C4748670,CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2,,,disease,Disease or Syndrome,0.01,1.0
0,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1835922,Aminoacylase 1 deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0
1,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0
2,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,
3,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0
4,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
5,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0282313,"Condition, Preneoplastic",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
6,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1266042,Chromophobe Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
7,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1266043,Sarcomatoid Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
8,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1266044,Collecting Duct Carcinoma of the Kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
9,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1306837,Papillary Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0
10,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0
11,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0039144,Syringomyelia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0
12,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.11,1.0
13,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0003578,Apnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
14,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
15,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,
16,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0020534,Orbital separation excessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
17,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
18,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
19,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0042963,Vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
20,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0085584,Encephalopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,
21,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0151786,Muscle Weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
22,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0235946,Cerebral atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
23,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0424230,Motor retardation,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Finding,0.1,
24,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.1,
25,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0426421,Wide nose,,,phenotype,Finding,0.1,
26,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0740279,Cerebellar atrophy,,,disease,Disease or Syndrome,0.1,
27,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0746674,Generalized muscle weakness,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
28,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1306587,Acute encephalopathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
29,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1849367,Nasal bridge wide,,,phenotype,Finding,0.1,
30,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1855676,Aplasia/Hypoplasia of the cerebellar vermis,,,phenotype,Finding,0.1,
31,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
32,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1861866,Aplasia/Hypoplasia of the corpus callosum,,,phenotype,Finding,0.1,
33,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C4021758,Delayed CNS myelination,,,disease,Anatomical Abnormality,0.1,
34,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C4552811,"Generalized Muscle Weakness, CTCAE",,,phenotype,Finding,0.1,
35,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,0.75
36,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0025521,Inborn Errors of Metabolism,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome; Congenital Abnormality,0.03,1.0
37,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
38,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
39,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
40,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0007112,Adenocarcinoma of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
41,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
42,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
43,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
44,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
45,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
46,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0014077,"Leukoencephalitis, Acute Hemorrhagic",C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
47,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
48,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
49,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
50,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0
51,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0036857,Severe intellectual disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
52,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
53,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0220754,Biotinidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
54,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0235031,Neurologic Symptoms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Sign or Symptom,0.01,1.0
55,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0393593,Dystonia Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
56,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
57,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
58,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
59,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
60,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
61,95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C2750088,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO",,,disease,Finding,0.3,1.0
1,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
2,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0008707,Chronic osteomyelitis,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
3,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0
4,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0085298,Sudden Cardiac Death,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,1.0
5,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
6,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C1720824,Sudden Cardiac Arrest,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,1.0
7,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
8,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.02,1.0
9,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
10,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
11,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,0.5
12,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0340100,High altitude pulmonary edema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,0.5
13,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
14,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
15,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.02,0.5
16,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
17,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
18,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
19,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
20,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
21,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
22,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
23,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
24,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
25,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
26,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
27,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
28,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
29,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
30,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
31,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
32,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
33,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0685938,Malignant neoplasm of gastrointestinal tract,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
34,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
35,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
36,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
37,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
38,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
39,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C1333001,Childhood Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
40,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
41,98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
0,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0392607,Severe combined immunodeficiency due to adenosine deaminase deficiency,C16;C18;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.977
1,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0268124,Adenosine deaminase deficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.6,1.0
2,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1863236,"SCID Due to ADA Deficiency, Early-Onset",,,disease,Disease or Syndrome,0.6,1.0
3,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2700553,Omenn Syndrome,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.51,1.0
4,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.5,0.991
5,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1863239,Partial adenosine deaminase deficiency,C16;C18;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.42,1.0
6,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0
7,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.33,1.0
8,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020452,Hyperemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0
9,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
10,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0
11,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0037928,Spinal Cord Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0
12,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0042484,Venous Engorgement,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
13,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0178824,Reactive Hyperemia,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
14,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0220744,Multiple gastrointestinal atresias (disorder),C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.3,
15,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0333233,Active Hyperemia,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
16,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0700216,Structural Clinical Interview for DSM-III,,,phenotype,Diagnostic Procedure,0.3,1.0
17,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,
18,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.23,1.0
19,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.21,1.0
20,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
21,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0
22,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023364,Leptospirosis,C01,   Infections,disease,Disease or Syndrome,0.2,1.0
23,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.2,1.0
24,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0029823,Other specified peritonitis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.2,1.0
25,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0034063,Pulmonary Edema,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.2,1.0
26,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0041227,Trypanosomiasis,C01,   Infections,disease,Disease or Syndrome,0.2,1.0
27,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0043102,Weil Disease,C01,   Infections,disease,Disease or Syndrome,0.2,1.0
28,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.2,1.0
29,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.15,1.0
30,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.13,1.0
31,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.12,1.0
32,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002880,Autoimmune hemolytic anemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.11,1.0
33,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.11,1.0
34,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0
35,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,
36,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
37,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0004368,Autoimmune state,,,phenotype,Pathologic Function,0.1,
38,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
39,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011606,Exfoliative dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
40,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,0.833
41,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.1,0.833
42,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,0.938
43,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
44,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0013604,Edema,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
45,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,
46,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
47,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
48,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,
49,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020517,Hypersensitivity,C20,   Immune System Diseases,group,Pathologic Function,0.1,
50,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0
51,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024312,Lymphopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0
52,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0033774,Pruritus,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",phenotype,Finding,0.1,
53,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0034088,Pulmonary Valve Insufficiency,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,
54,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0037199,Sinusitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,
55,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0038002,Splenomegaly,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
56,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0040147,Thyroiditis,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,
57,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0
58,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0041326,Pleural Tuberculosis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
59,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.1,
60,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0151908,Dry skin,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.1,
61,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0221277,Atypical lymphocyte,,,phenotype,Finding,0.1,
62,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0241165,Thick skin,,,phenotype,Finding,0.1,
63,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.1,
64,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0268747,Diffuse mesangial sclerosis (disorder),C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,
65,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0362046,Prediabetes syndrome,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0
66,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,
67,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0401151,Chronic diarrhea,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,
68,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0406775,Symmetrical dyschromatosis of extremities,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.1,1.0
69,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0497156,Lymphadenopathy,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.1,
70,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0576999,Tonsil absent,,,phenotype,Finding,0.1,
71,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0581381,Recurrent upper respiratory tract infection,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,
72,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0685894,Congenital absence of thymus,C20,   Immune System Diseases,disease,Congenital Abnormality,0.1,
73,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0694550,Recurrent pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Finding,0.1,
74,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0747085,Recurrent otitis media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,
75,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
76,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1399128,Growth arrest lines,,,phenotype,Finding,0.1,
77,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1832324,Recurrent opportunistic infections,C01,   Infections,phenotype,Finding,0.1,
78,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1836195,Short toe,,,phenotype,Finding,0.1,
79,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1837066,Recurrent viral infection,C01,   Infections,phenotype,Finding,0.1,
80,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1842714,Desquamation of skin soon after birth,,,phenotype,Finding,0.1,
81,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1844383,Recurrent bacterial infection,C01,   Infections,phenotype,Finding,0.1,
82,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1844384,Recurrent fungal infections,,,phenotype,Finding,0.1,
83,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1844704,Platyspondyly,,,phenotype,Finding,0.1,
84,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1846154,Anterior rib cupping,,,phenotype,Finding,0.1,
85,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1847383,Absence of lymph node germinal center,,,phenotype,Finding,0.1,
86,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1849426,Lack of T cell function,,,phenotype,Finding,0.1,
87,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1855067,B lymphocytopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,phenotype,Finding,0.1,
88,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1863246,Absent specific antibody response,,,phenotype,Finding,0.1,
89,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1863715,Severe B lymphocytopenia,,,phenotype,Finding,0.1,
90,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1963094,"Dry Skin, CTCAE",,,phenotype,Finding,0.1,
91,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2931322,T-Lymphocytopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Finding,0.1,
92,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2959467,Tuberculous pleural effusion,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
93,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3875321,Inflammatory dermatosis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
94,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4020847,Abnormality of pelvic girdle bone morphology,,,disease,Anatomical Abnormality,0.1,
95,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4021956,Aplasia/Hypoplasia of the eyebrow,,,phenotype,Finding,0.1,
96,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4022544,Reduced red cell adenosine deaminase activity,,,phenotype,Finding,0.1,
97,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4025814,Abnormality of the metaphysis,,,disease,Anatomical Abnormality,0.1,
98,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4476743,Anti-thyroid peroxidase antibody positivity,,,phenotype,Laboratory or Test Result,0.1,
99,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.09,1.0
100,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.08,0.875
101,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
102,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0041318,"Tuberculosis, Meningeal",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.08,1.0
103,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002881,"Anemia, Hemolytic, Congenital",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.06,1.0
104,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.06,1.0
105,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0032227,Pleural effusion disorder,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.06,1.0
106,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0342276,Maturity onset diabetes mellitus in young,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,1.0
107,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.06,1.0
108,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.05,1.0
109,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0018203,Chronic granulomatous disease,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.05,1.0
110,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0021053,Immune System Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.05,1.0
111,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.05,1.0
112,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0041325,"Peritonitis, Tuberculous",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.05,1.0
113,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0080032,"Pleural Effusion, Malignant",C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.05,1.0
114,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.05,1.0
115,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1279481,X-Linked Combined Immunodeficiency Diseases,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",group,Disease or Syndrome,0.05,1.0
116,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
117,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024314,Lymphoproliferative Disorders,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.04,1.0
118,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0043194,Wiskott-Aldrich Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.04,1.0
119,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0398686,Primary immune deficiency disorder,C20,   Immune System Diseases,group,Disease or Syndrome,0.04,1.0
120,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0494261,Combined immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.04,1.0
121,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0
122,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002878,"Anemia, Hemolytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.03,1.0
123,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.03,1.0
124,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
125,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
126,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
127,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
128,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
129,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
130,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
131,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0042384,Vasculitis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
132,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0264550,Pleural effusion associated with pulmonary infection,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
133,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
134,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
135,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
136,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
137,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
138,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
139,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1851585,"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.03,1.0
140,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.02,1.0
141,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
142,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
143,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
144,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
145,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0018553,"Hamartoma Syndrome, Multiple",C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Neoplastic Process,0.02,1.0
146,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
147,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.02,1.0
148,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
149,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.02,1.0
150,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
151,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023443,Hairy Cell Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
152,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024302,Reticulosarcoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
153,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
154,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
155,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
156,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0031039,Pericardial effusion,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
157,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0032231,Pleurisy,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
158,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0037277,"Skin Diseases, Genetic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",group,Disease or Syndrome,0.02,1.0
159,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
160,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.02,1.0
161,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
162,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
163,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.02,1.0
164,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
165,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0268125,Purine-nucleoside phosphorylase deficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.02,0.5
166,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.02,1.0
167,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0334663,Histiocytic sarcoma,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
168,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.02,1.0
169,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
170,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0
171,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.02,1.0
172,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0
173,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2711630,Combined immunodeficiency disease,,,disease,Disease or Syndrome,0.02,1.0
174,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.02,1.0
175,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4025272,Peripheral arterial stenosis,,,disease,Disease or Syndrome,0.02,1.0
176,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4543811,Adult-onset immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
177,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
178,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
179,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
180,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
181,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
182,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
183,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
184,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
185,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0005806,Blood Group Incompatibility,,,disease,Disease or Syndrome,0.01,1.0
186,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
187,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
188,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
189,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
190,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0008060,child abuse behavior,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
191,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0008487,Chordoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
192,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0008497,Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
193,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0009207,Cockayne Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
194,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
195,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
196,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
197,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
198,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
199,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
200,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,0.0
201,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0011644,Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
202,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0012118,Dictyocaulus Infections,C01;C22,   Infections;    Animal Diseases,disease,Disease or Syndrome,0.01,1.0
203,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,0.0
204,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0014009,Empyema,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
205,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
206,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
207,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0015652,Fascioliasis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
208,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
209,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
210,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019068,Reactive Hemophagocytic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
211,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019080,Hemorrhage,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
212,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
213,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019159,Hepatitis A,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
214,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
215,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
216,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,0.0
217,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020217,Hydatidiform Mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
218,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020433,Hyperbilirubinemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
219,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
220,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020550,Hyperthyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
221,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0020619,Hypogonadism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
222,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
223,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0022104,Irritable Bowel Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
224,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0022353,Neonatal Jaundice,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",phenotype,Disease or Syndrome,0.01,1.0
225,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
226,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023281,Leishmaniasis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
227,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023290,"Leishmaniasis, Visceral",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
228,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
229,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
230,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
231,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023522,"Leukodystrophy, Metachromatic",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
232,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0023817,Hyperlipoproteinemia Type I,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
233,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
234,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024282,Lymphocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
235,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024291,"Lymphohistiocytosis, Hemophagocytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
236,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
237,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
238,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0026106,Mild Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
239,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
240,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0026918,Mycobacterium Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
241,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
242,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
243,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.01,1.0
244,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
245,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
246,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0030312,Pancytopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
247,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
248,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0030848,Peyronie Disease,C17;C12,   Skin and Connective Tissue Diseases;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
249,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0030920,Peptic Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
250,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0031036,Polyarteritis Nodosa,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
251,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0031046,Pericarditis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
252,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0031049,"Pericarditis, Tuberculous",C01;C14,   Infections;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
253,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
254,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0031144,Chronic peritoneal effusion (disorder),C23;C06;C17,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
255,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0032226,Pleural Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
256,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0032749,Post-kala-azar dermal leishmaniasis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
257,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.01,1.0
258,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
259,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0034050,Pulmonary Alveolar Proteinosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
260,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
261,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0035204,Respiration Disorders,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
262,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0035242,Respiratory Tract Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
263,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
264,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
265,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
266,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
267,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0036857,Severe intellectual disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
268,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
269,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0039263,Takayasu Arteritis,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
270,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0041234,Chagas Disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
271,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
272,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
273,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0042798,Low Vision,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
274,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0043144,Wheezing,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
275,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0079772,T-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
276,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0085096,Peripheral Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
277,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
278,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0085628,Stupor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.01,1.0
279,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0085662,Macrocytosis,,,disease,Disease or Syndrome,0.01,1.0
280,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
281,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0155877,Allergic asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
282,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0206019,HIV Encephalopathy,C01;C20;C10;F03,   Infections;    Immune System Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
283,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0206647,Dermatofibrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
284,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0221023,Cyclic neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
285,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0233762,"Hallucinations, Auditory",C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
286,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
287,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0238694,Peripheral arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
288,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0238990,Acute lower respiratory tract infection,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
289,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0241910,Autoimmune Chronic Hepatitis,C06;C20,   Digestive System Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
290,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0262584,"Carcinoma, Small Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
291,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0264551,Pleurisy with effusion,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
292,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0264716,Chronic heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
293,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0266999,Vesicular Stomatitis,C01;C07;C22,   Infections;    Stomatognathic Diseases;    Animal Diseases,disease,Disease or Syndrome,0.01,1.0
294,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0268119,Combined molybdoflavoprotein enzyme deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
295,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0268233,GALACTOSIALIDOSIS,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
296,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0269102,Endometrioma,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
297,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0272024,Secondary acquired sideroblastic anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
298,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0276548,HIV encephalitis,C01;C20;C10;F03,   Infections;    Immune System Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
299,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
300,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0279068,Childhood Solid Neoplasm,,,phenotype,Neoplastic Process,0.01,1.0
301,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
302,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
303,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0280099,Adult Solid Neoplasm,,,group,Neoplastic Process,0.01,1.0
304,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
305,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0280141,Acute Undifferentiated Leukemia,,,disease,Neoplastic Process,0.01,1.0
306,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
307,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0282492,Sneddon Syndrome,C17;C10;C14,   Skin and Connective Tissue Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
308,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
309,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
310,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0345893,Juvenile polyposis syndrome,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0
311,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
312,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
313,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0392784,Dermatofibrosarcoma Protuberans,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
314,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0406322,Psoriasis of nail,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
315,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0410808,Prosthetic joint infection,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
316,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0476227,pricking of skin,,,phenotype,Sign or Symptom,0.01,1.0
317,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0497169,hiv-infection/aids,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
318,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
319,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0542476,Forgetful,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
320,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
321,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
322,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0677607,Hashimoto Disease,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
323,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0679362,"Tuberculosis, extrapulmonary",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
324,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
325,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0740447,Diabetic peripheral neuropathy,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
326,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0746102,Chronic lung disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
327,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0751213,Tactile Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
328,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.01,1.0
329,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0751690,Malignant Peripheral Nerve Sheath Tumor,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
330,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
331,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
332,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0856742,Post MI,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
333,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0949116,Congenital hypoplastic anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
334,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0949690,Spondylarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
335,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1096155,Macrophage Activation Syndrome,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
336,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
337,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1266184,Atypical Teratoid Rhabdoid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
338,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1274233,T-lymphocyte immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
339,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1320638,Bone marrow myeloid dysplasia,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
340,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
341,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1378511,Undifferentiated leukemia,,,disease,Neoplastic Process,0.01,1.0
342,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
343,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1519346,Skin Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
344,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1519678,Tumor Expansion,,,phenotype,Neoplastic Process,0.01,1.0
345,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
346,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1532237,Disorder of immune function,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.01,1.0
347,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1609538,Latent Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
348,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
349,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1840264,IMMUNE SUPPRESSION,,,phenotype,Disease or Syndrome,0.01,1.0
350,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1844376,"Granulomatous Disease, Chronic, X-Linked",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
351,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1960636,Dysglycemia,,,disease,Disease or Syndrome,0.01,1.0
352,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1962942,TRICHOMONAS VAGINALIS (finding),,,disease,Disease or Syndrome,0.01,1.0
353,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C1970827,Phosphoribosylpyrophosphate Synthetase Superactivity,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
354,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
355,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2349595,Fetal anemia,C16;C13;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
356,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2362324,Pediatric Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
357,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C2752147,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0
358,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3160718,"PARKINSON DISEASE, LATE-ONSET",,,disease,Disease or Syndrome,0.01,1.0
359,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3203653,IgG4-Related Sclerosing Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
360,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3250443,MYOTONIC DYSTROPHY 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
361,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
362,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3665444,Neutrophilia (disorder),C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
363,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3693482,Giant Cell Fibroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
364,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3694279,Middle East Respiratory Syndrome,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
365,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
366,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0
367,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3714757,Juvenile rheumatoid arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
368,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.01,1.0
369,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3887491,Exudative pleural effusion,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
370,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3887551,Memory dysfunction,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
371,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3887654,"POLYARTERITIS NODOSA, CHILDHOOD-ONSET",C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
372,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C3888523,Autoimmune uveitis,,,disease,Disease or Syndrome,0.01,1.0
373,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4021790,Abnormality of the skeletal system,,,disease,Anatomical Abnormality,0.01,1.0
374,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4048329,Immunosuppression,,,disease,Disease or Syndrome,0.01,1.0
375,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4054044,Secondary haemophagocytic lymphohistiocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
376,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4087124,Immunoglobulin G4-Related Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
377,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4721555,Autoimmune hepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
378,100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C4725027,Refractory Acute Leukemia,,,disease,Neoplastic Process,0.01,1.0
0,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
1,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.3,1.0
2,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1262760,"Hepatitis, Drug-Induced",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
3,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C3658290,Drug-Induced Acute Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
4,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
5,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C4279912,Chemically-Induced Liver Toxicity,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.3,1.0
6,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0
7,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0
8,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0
9,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0
10,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0
11,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,1.0
12,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,0.75
13,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.04,1.0
14,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667
15,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,0.667
16,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,0.667
17,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
18,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
19,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0
20,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0
21,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
22,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
23,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
24,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
25,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
26,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
27,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0266929,Chronic Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0
28,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
29,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
30,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
31,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
32,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.02,1.0
33,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
34,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C4703473,Atherosclerotic lesion,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
35,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
36,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
37,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
38,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0
39,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
40,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0007282,Carotid Stenosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
41,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0007682,CNS disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
42,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0007965,Chediak-Higashi Syndrome,C16;C11;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
43,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0008479,Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
44,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
45,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
46,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0017574,Gingivitis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
47,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
48,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
49,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
50,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
51,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
52,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
53,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
54,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
55,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0031094,Periodontal Pocket,C07,   Stomatognathic Diseases,disease,Anatomical Abnormality,0.01,1.0
56,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0039103,Synovitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
57,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
58,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0153633,Malignant neoplasm of brain,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
59,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0155094,Corneal pannus,C23;C11,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
60,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
61,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0220650,Metastatic malignant neoplasm to brain,C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
62,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0238790,bone destruction,,,disease,Disease or Syndrome,0.01,1.0
63,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0278510,Childhood Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
64,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0278876,Adult Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
65,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
66,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0333307,Superficial ulcer,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
67,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
68,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0521158,Recurrent tumor,,,phenotype,Neoplastic Process,0.01,1.0
69,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
70,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
71,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0750974,"Brain Tumor, Primary",C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
72,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
73,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
74,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
75,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
76,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1836653,Ascending aortic dissection,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
77,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
78,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
79,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
80,101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
0,102,ADAM10,O14672,0.489,0.846,1.0,,,C0406811,Reticulate acropigmentation of Kitamura,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.72,1.0
1,102,ADAM10,O14672,0.489,0.846,1.0,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.7,0.986
2,102,ADAM10,O14672,0.489,0.846,1.0,,,C3810041,ALZHEIMER DISEASE 18,,,disease,Disease or Syndrome,0.6,1.0
3,102,ADAM10,O14672,0.489,0.846,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0
4,102,ADAM10,O14672,0.489,0.846,1.0,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0
5,102,ADAM10,O14672,0.489,0.846,1.0,,,C0494463,"Alzheimer Disease, Late Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
6,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
7,102,ADAM10,O14672,0.489,0.846,1.0,,,C0276496,Familial Alzheimer Disease (FAD),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.31,0.5
8,102,ADAM10,O14672,0.489,0.846,1.0,,,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.31,0.5
9,102,ADAM10,O14672,0.489,0.846,1.0,,,C3714534,dowling-degos disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.31,1.0
10,102,ADAM10,O14672,0.489,0.846,1.0,,,C0546126,Acute Confusional Senile Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
11,102,ADAM10,O14672,0.489,0.846,1.0,,,C0750900,"Alzheimer's Disease, Focal Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
12,102,ADAM10,O14672,0.489,0.846,1.0,,,C0750901,"Alzheimer Disease, Early Onset",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
13,102,ADAM10,O14672,0.489,0.846,1.0,,,C1257931,"Mammary Neoplasms, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
14,102,ADAM10,O14672,0.489,0.846,1.0,,,C1321872,Stage IV Skin Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,
15,102,ADAM10,O14672,0.489,0.846,1.0,,,C4552092,Dowling-Degos disease 1,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.3,
16,102,ADAM10,O14672,0.489,0.846,1.0,,,C4704874,"Mammary Carcinoma, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
17,102,ADAM10,O14672,0.489,0.846,1.0,,,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.24,1.0
18,102,ADAM10,O14672,0.489,0.846,1.0,,,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.21,1.0
19,102,ADAM10,O14672,0.489,0.846,1.0,,,C0029531,Other cataract,C11,   Eye Diseases,disease,Disease or Syndrome,0.2,1.0
20,102,ADAM10,O14672,0.489,0.846,1.0,,,C0033141,"Cardiomyopathies, Primary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0
21,102,ADAM10,O14672,0.489,0.846,1.0,,,C0036529,"Myocardial Diseases, Secondary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0
22,102,ADAM10,O14672,0.489,0.846,1.0,,,C0162872,"Aortic Aneurysm, Thoracic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
23,102,ADAM10,O14672,0.489,0.846,1.0,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0
24,102,ADAM10,O14672,0.489,0.846,1.0,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
25,102,ADAM10,O14672,0.489,0.846,1.0,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,0.955
26,102,ADAM10,O14672,0.489,0.846,1.0,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.909
27,102,ADAM10,O14672,0.489,0.846,1.0,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
28,102,ADAM10,O14672,0.489,0.846,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
29,102,ADAM10,O14672,0.489,0.846,1.0,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
30,102,ADAM10,O14672,0.489,0.846,1.0,,,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.1,1.0
31,102,ADAM10,O14672,0.489,0.846,1.0,,,C0870082,Hyperkeratosis,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,
32,102,ADAM10,O14672,0.489,0.846,1.0,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0
33,102,ADAM10,O14672,0.489,0.846,1.0,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
34,102,ADAM10,O14672,0.489,0.846,1.0,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
35,102,ADAM10,O14672,0.489,0.846,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
36,102,ADAM10,O14672,0.489,0.846,1.0,,,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
37,102,ADAM10,O14672,0.489,0.846,1.0,,,C4553962,"Hyperkeratosis, CTCAE",,,phenotype,Finding,0.1,
38,102,ADAM10,O14672,0.489,0.846,1.0,,,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.08,1.0
39,102,ADAM10,O14672,0.489,0.846,1.0,,,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.05,1.0
40,102,ADAM10,O14672,0.489,0.846,1.0,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0
41,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
42,102,ADAM10,O14672,0.489,0.846,1.0,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,0.75
43,102,ADAM10,O14672,0.489,0.846,1.0,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.04,1.0
44,102,ADAM10,O14672,0.489,0.846,1.0,,,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,0.75
45,102,ADAM10,O14672,0.489,0.846,1.0,,,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.04,1.0
46,102,ADAM10,O14672,0.489,0.846,1.0,,,C0333463,Senile Plaques,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.04,1.0
47,102,ADAM10,O14672,0.489,0.846,1.0,,,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.04,1.0
48,102,ADAM10,O14672,0.489,0.846,1.0,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
49,102,ADAM10,O14672,0.489,0.846,1.0,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
50,102,ADAM10,O14672,0.489,0.846,1.0,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
51,102,ADAM10,O14672,0.489,0.846,1.0,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
52,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
53,102,ADAM10,O14672,0.489,0.846,1.0,,,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0
54,102,ADAM10,O14672,0.489,0.846,1.0,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
55,102,ADAM10,O14672,0.489,0.846,1.0,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
56,102,ADAM10,O14672,0.489,0.846,1.0,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.667
57,102,ADAM10,O14672,0.489,0.846,1.0,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
58,102,ADAM10,O14672,0.489,0.846,1.0,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
59,102,ADAM10,O14672,0.489,0.846,1.0,,,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.03,1.0
60,102,ADAM10,O14672,0.489,0.846,1.0,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
61,102,ADAM10,O14672,0.489,0.846,1.0,,,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
62,102,ADAM10,O14672,0.489,0.846,1.0,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.02,0.5
63,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
64,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
65,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,0.5
66,102,ADAM10,O14672,0.489,0.846,1.0,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
67,102,ADAM10,O14672,0.489,0.846,1.0,,,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
68,102,ADAM10,O14672,0.489,0.846,1.0,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
69,102,ADAM10,O14672,0.489,0.846,1.0,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0
70,102,ADAM10,O14672,0.489,0.846,1.0,,,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
71,102,ADAM10,O14672,0.489,0.846,1.0,,,C0024138,"Lupus Erythematosus, Discoid",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0
72,102,ADAM10,O14672,0.489,0.846,1.0,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
73,102,ADAM10,O14672,0.489,0.846,1.0,,,C0027430,Nasal Polyps,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.02,0.5
74,102,ADAM10,O14672,0.489,0.846,1.0,,,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
75,102,ADAM10,O14672,0.489,0.846,1.0,,,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
76,102,ADAM10,O14672,0.489,0.846,1.0,,,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
77,102,ADAM10,O14672,0.489,0.846,1.0,,,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
78,102,ADAM10,O14672,0.489,0.846,1.0,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
79,102,ADAM10,O14672,0.489,0.846,1.0,,,C0280321,Squamous cell carcinoma of the hypopharynx,,,disease,Neoplastic Process,0.02,1.0
80,102,ADAM10,O14672,0.489,0.846,1.0,,,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
81,102,ADAM10,O14672,0.489,0.846,1.0,,,C0349566,Squamous cell carcinoma of tongue,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.02,1.0
82,102,ADAM10,O14672,0.489,0.846,1.0,,,C0409974,Lupus Erythematosus,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.02,1.0
83,102,ADAM10,O14672,0.489,0.846,1.0,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
84,102,ADAM10,O14672,0.489,0.846,1.0,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
85,102,ADAM10,O14672,0.489,0.846,1.0,,,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
86,102,ADAM10,O14672,0.489,0.846,1.0,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
87,102,ADAM10,O14672,0.489,0.846,1.0,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
88,102,ADAM10,O14672,0.489,0.846,1.0,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
89,102,ADAM10,O14672,0.489,0.846,1.0,,,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0
90,102,ADAM10,O14672,0.489,0.846,1.0,,,C0002452,Amelogenesis Imperfecta,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
91,102,ADAM10,O14672,0.489,0.846,1.0,,,C0002792,anaphylaxis,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.01,1.0
92,102,ADAM10,O14672,0.489,0.846,1.0,,,C0002962,Angina Pectoris,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Sign or Symptom,0.01,1.0
93,102,ADAM10,O14672,0.489,0.846,1.0,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
94,102,ADAM10,O14672,0.489,0.846,1.0,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
95,102,ADAM10,O14672,0.489,0.846,1.0,,,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
96,102,ADAM10,O14672,0.489,0.846,1.0,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
97,102,ADAM10,O14672,0.489,0.846,1.0,,,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
98,102,ADAM10,O14672,0.489,0.846,1.0,,,C0006111,Brain Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
99,102,ADAM10,O14672,0.489,0.846,1.0,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
100,102,ADAM10,O14672,0.489,0.846,1.0,,,C0006840,Candidiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
101,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
102,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007129,Merkel cell carcinoma,C04;C01,   Neoplasms;    Infections,disease,Neoplastic Process,0.01,1.0
103,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
104,102,ADAM10,O14672,0.489,0.846,1.0,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
105,102,ADAM10,O14672,0.489,0.846,1.0,,,C0008073,Developmental Disabilities,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
106,102,ADAM10,O14672,0.489,0.846,1.0,,,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
107,102,ADAM10,O14672,0.489,0.846,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
108,102,ADAM10,O14672,0.489,0.846,1.0,,,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
109,102,ADAM10,O14672,0.489,0.846,1.0,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
110,102,ADAM10,O14672,0.489,0.846,1.0,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
111,102,ADAM10,O14672,0.489,0.846,1.0,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
112,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
113,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
114,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
115,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
116,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
117,102,ADAM10,O14672,0.489,0.846,1.0,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
118,102,ADAM10,O14672,0.489,0.846,1.0,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
119,102,ADAM10,O14672,0.489,0.846,1.0,,,C0014511,Epithelial cyst,C04,   Neoplasms,phenotype,Anatomical Abnormality,0.01,1.0
120,102,ADAM10,O14672,0.489,0.846,1.0,,,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
121,102,ADAM10,O14672,0.489,0.846,1.0,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
122,102,ADAM10,O14672,0.489,0.846,1.0,,,C0017658,Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
123,102,ADAM10,O14672,0.489,0.846,1.0,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
124,102,ADAM10,O14672,0.489,0.846,1.0,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
125,102,ADAM10,O14672,0.489,0.846,1.0,,,C0021933,Intussusception,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
126,102,ADAM10,O14672,0.489,0.846,1.0,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
127,102,ADAM10,O14672,0.489,0.846,1.0,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
128,102,ADAM10,O14672,0.489,0.846,1.0,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
129,102,ADAM10,O14672,0.489,0.846,1.0,,,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
130,102,ADAM10,O14672,0.489,0.846,1.0,,,C0024314,Lymphoproliferative Disorders,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
131,102,ADAM10,O14672,0.489,0.846,1.0,,,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
132,102,ADAM10,O14672,0.489,0.846,1.0,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
133,102,ADAM10,O14672,0.489,0.846,1.0,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
134,102,ADAM10,O14672,0.489,0.846,1.0,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
135,102,ADAM10,O14672,0.489,0.846,1.0,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
136,102,ADAM10,O14672,0.489,0.846,1.0,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
137,102,ADAM10,O14672,0.489,0.846,1.0,,,C0030805,Bullous pemphigoid,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
138,102,ADAM10,O14672,0.489,0.846,1.0,,,C0030809,Pemphigus Vulgaris,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
139,102,ADAM10,O14672,0.489,0.846,1.0,,,C0031036,Polyarteritis Nodosa,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
140,102,ADAM10,O14672,0.489,0.846,1.0,,,C0033575,Prostatic Diseases,C12,   Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
141,102,ADAM10,O14672,0.489,0.846,1.0,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0
142,102,ADAM10,O14672,0.489,0.846,1.0,,,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
143,102,ADAM10,O14672,0.489,0.846,1.0,,,C0036457,Scrapie,C01;C10;C22,   Infections;    Nervous System Diseases;    Animal Diseases,disease,Disease or Syndrome,0.01,1.0
144,102,ADAM10,O14672,0.489,0.846,1.0,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
145,102,ADAM10,O14672,0.489,0.846,1.0,,,C0037278,"Skin Diseases, Infectious",C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
146,102,ADAM10,O14672,0.489,0.846,1.0,,,C0038160,Staphylococcal Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
147,102,ADAM10,O14672,0.489,0.846,1.0,,,C0038356,Stomach Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
148,102,ADAM10,O14672,0.489,0.846,1.0,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
149,102,ADAM10,O14672,0.489,0.846,1.0,,,C0040021,Thromboangiitis Obliterans,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
150,102,ADAM10,O14672,0.489,0.846,1.0,,,C0040188,Tic disorder,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
151,102,ADAM10,O14672,0.489,0.846,1.0,,,C0041956,Ureteral obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0
152,102,ADAM10,O14672,0.489,0.846,1.0,,,C0042842,Vitamin A Deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
153,102,ADAM10,O14672,0.489,0.846,1.0,,,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
154,102,ADAM10,O14672,0.489,0.846,1.0,,,C0085220,Cerebral Amyloid Angiopathy,C18;C10;C14,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
155,102,ADAM10,O14672,0.489,0.846,1.0,,,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
156,102,ADAM10,O14672,0.489,0.846,1.0,,,C0085650,Purpura Fulminans,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
157,102,ADAM10,O14672,0.489,0.846,1.0,,,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
158,102,ADAM10,O14672,0.489,0.846,1.0,,,C0149654,Conduct Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
159,102,ADAM10,O14672,0.489,0.846,1.0,,,C0149678,Epstein-Barr Virus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
160,102,ADAM10,O14672,0.489,0.846,1.0,,,C0151650,Renal fibrosis,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
161,102,ADAM10,O14672,0.489,0.846,1.0,,,C0151718,Hypocholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
162,102,ADAM10,O14672,0.489,0.846,1.0,,,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
163,102,ADAM10,O14672,0.489,0.846,1.0,,,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
164,102,ADAM10,O14672,0.489,0.846,1.0,,,C0206019,HIV Encephalopathy,C01;C20;C10;F03,   Infections;    Immune System Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
165,102,ADAM10,O14672,0.489,0.846,1.0,,,C0206702,Klatskin Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
166,102,ADAM10,O14672,0.489,0.846,1.0,,,C0220597,Adult Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
167,102,ADAM10,O14672,0.489,0.846,1.0,,,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
168,102,ADAM10,O14672,0.489,0.846,1.0,,,C0220633,Uveal melanoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0
169,102,ADAM10,O14672,0.489,0.846,1.0,,,C0220644,Childhood Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
170,102,ADAM10,O14672,0.489,0.846,1.0,,,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
171,102,ADAM10,O14672,0.489,0.846,1.0,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
172,102,ADAM10,O14672,0.489,0.846,1.0,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
173,102,ADAM10,O14672,0.489,0.846,1.0,,,C0242584,Autoimmune thrombocytopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
174,102,ADAM10,O14672,0.489,0.846,1.0,,,C0264270,Hypertrophic rhinitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
175,102,ADAM10,O14672,0.489,0.846,1.0,,,C0264732,Cardiac dilatation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
176,102,ADAM10,O14672,0.489,0.846,1.0,,,C0272286,Thrombocytopenia due to platelet alloimmunization,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
177,102,ADAM10,O14672,0.489,0.846,1.0,,,C0276548,HIV encephalitis,C01;C20;C10;F03,   Infections;    Immune System Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
178,102,ADAM10,O14672,0.489,0.846,1.0,,,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
179,102,ADAM10,O14672,0.489,0.846,1.0,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
180,102,ADAM10,O14672,0.489,0.846,1.0,,,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
181,102,ADAM10,O14672,0.489,0.846,1.0,,,C0334634,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
182,102,ADAM10,O14672,0.489,0.846,1.0,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
183,102,ADAM10,O14672,0.489,0.846,1.0,,,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
184,102,ADAM10,O14672,0.489,0.846,1.0,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
185,102,ADAM10,O14672,0.489,0.846,1.0,,,C0376286,Avitaminosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
186,102,ADAM10,O14672,0.489,0.846,1.0,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
187,102,ADAM10,O14672,0.489,0.846,1.0,,,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
188,102,ADAM10,O14672,0.489,0.846,1.0,,,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
189,102,ADAM10,O14672,0.489,0.846,1.0,,,C0595989,Carcinoma of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
190,102,ADAM10,O14672,0.489,0.846,1.0,,,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
191,102,ADAM10,O14672,0.489,0.846,1.0,,,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
192,102,ADAM10,O14672,0.489,0.846,1.0,,,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
193,102,ADAM10,O14672,0.489,0.846,1.0,,,C0796149,Scott Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,0.0
194,102,ADAM10,O14672,0.489,0.846,1.0,,,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
195,102,ADAM10,O14672,0.489,0.846,1.0,,,C0850666,Infection caused by Helicobacter pylori,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
196,102,ADAM10,O14672,0.489,0.846,1.0,,,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
197,102,ADAM10,O14672,0.489,0.846,1.0,,,C0876973,Infectious Lung Disorder,C01;C08,   Infections;    Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
198,102,ADAM10,O14672,0.489,0.846,1.0,,,C0947751,Vascular inflammations,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
199,102,ADAM10,O14672,0.489,0.846,1.0,,,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
200,102,ADAM10,O14672,0.489,0.846,1.0,,,C0948588,Lymphangiosis carcinomatosa,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
201,102,ADAM10,O14672,0.489,0.846,1.0,,,C1275122,Familial multiple trichoepitheliomata,C16;C04;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.01,1.0
202,102,ADAM10,O14672,0.489,0.846,1.0,,,C1318485,Liver regeneration disorder,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.01,1.0
203,102,ADAM10,O14672,0.489,0.846,1.0,,,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
204,102,ADAM10,O14672,0.489,0.846,1.0,,,C1378703,Renal carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
205,102,ADAM10,O14672,0.489,0.846,1.0,,,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
206,102,ADAM10,O14672,0.489,0.846,1.0,,,C1510471,Vitamin Deficiency,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
207,102,ADAM10,O14672,0.489,0.846,1.0,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
208,102,ADAM10,O14672,0.489,0.846,1.0,,,C1519680,Tumor Immunity,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.01,1.0
209,102,ADAM10,O14672,0.489,0.846,1.0,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
210,102,ADAM10,O14672,0.489,0.846,1.0,,,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
211,102,ADAM10,O14672,0.489,0.846,1.0,,,C1719672,Severe Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
212,102,ADAM10,O14672,0.489,0.846,1.0,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
213,102,ADAM10,O14672,0.489,0.846,1.0,,,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
214,102,ADAM10,O14672,0.489,0.846,1.0,,,C1843013,"Alzheimer disease, familial, type 3",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
215,102,ADAM10,O14672,0.489,0.846,1.0,,,C1955760,Idiopathic normal pressure hydrocephalus (INPH),,,disease,Disease or Syndrome,0.01,1.0
216,102,ADAM10,O14672,0.489,0.846,1.0,,,C1960398,HER2-positive carcinoma of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
217,102,ADAM10,O14672,0.489,0.846,1.0,,,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
218,102,ADAM10,O14672,0.489,0.846,1.0,,,C2936349,"Plaque, Amyloid",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
219,102,ADAM10,O14672,0.489,0.846,1.0,,,C2936719,Mechanical Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
220,102,ADAM10,O14672,0.489,0.846,1.0,,,C3887654,"POLYARTERITIS NODOSA, CHILDHOOD-ONSET",C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
221,102,ADAM10,O14672,0.489,0.846,1.0,,,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
222,102,ADAM10,O14672,0.489,0.846,1.0,,,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
223,102,ADAM10,O14672,0.489,0.846,1.0,,,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0393591,AICARDI-GOUTIERES SYNDROME,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0
1,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0406775,Symmetrical dyschromatosis of extremities,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.8,1.0
2,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3539013,AICARDI-GOUTIERES SYNDROME 6,,,disease,Disease or Syndrome,0.6,1.0
3,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.54,1.0
4,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.44,1.0
5,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0
6,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3860213,Autoinflammatory disorder,,,disease,Disease or Syndrome,0.31,1.0
7,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0795996,"STRIATONIGRAL DEGENERATION, INFANTILE (disorder)",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0
8,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0796126,AICARDI-GOUTIERES SYNDROME 1,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
9,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1257931,"Mammary Neoplasms, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
10,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.3,1.0
11,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3489724,Aicardi-Goutieres Syndrome 2,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
12,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3489725,Pseudo-TORCH syndrome,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
13,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4704874,"Mammary Carcinoma, Human",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0
14,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0242488,Acute Lung Injury,C08,   Respiratory Tract Diseases,disease,Injury or Poisoning,0.2,1.0
15,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0008058,Chilblains,C26,   Wounds and Injuries,disease,Disease or Syndrome,0.11,1.0
16,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.11,1.0
17,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
18,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
19,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0004368,Autoimmune state,,,phenotype,Pathologic Function,0.1,
20,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0005745,Blepharoptosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
21,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
22,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
23,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
24,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,
25,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.1,
26,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,
27,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,
28,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0013423,Dystonia Musculorum Deformans,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
29,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
30,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
31,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
32,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.1,
33,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0019214,Hepatosplenomegaly,C23;C06;C15,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Hemic and Lymphatic Diseases",phenotype,Sign or Symptom,0.1,
34,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0019825,Hoarseness,C23;C08;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Sign or Symptom,0.1,
35,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0020302,Hydrophthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,
36,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,
37,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0
38,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0022107,Irritable Mood,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
39,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,
40,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023520,Leukodystrophy,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
41,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023787,Lipodystrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
42,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
43,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0026106,Mild Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,
44,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0
45,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0026837,Muscle Rigidity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
46,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0027066,Myoclonus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
47,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0027121,Myositis,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
48,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
49,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0028738,Nystagmus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
50,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0029124,Optic Atrophy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
51,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0030326,Panniculitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
52,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0033377,Ptosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
53,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0034735,Raynaud Phenomenon,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
54,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0034935,Babinski Reflex,,,phenotype,Finding,0.1,
55,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,
56,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
57,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0037771,"Paraparesis, Spastic",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
58,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
59,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0078982,Arhinencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
60,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0085583,Choreoathetosis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
61,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0151564,Cogwheel Rigidity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
62,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0151860,Acquired porencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
63,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0151889,Hyperreflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
64,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0151908,Dry skin,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.1,
65,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
66,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0
67,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0221170,Muscular stiffness,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.1,
68,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0221347,Acrocyanosis,C23;C17;C08;C14,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Respiratory Tract Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.1,
69,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0234132,Pyramidal sign,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
70,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0235946,Cerebral atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
71,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0239234,Low set ears,,,disease,Congenital Abnormality,0.1,
72,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0263401,Cutis marmorata,C16;C04;C17;C14;C26,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases;    Wounds and Injuries",disease,Disease or Syndrome,0.1,
73,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0265529,Plagiocephaly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
74,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0270685,Cerebral calcification,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,phenotype,Finding,0.1,
75,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0270790,Quadriparesis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
76,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0270922,Peripheral demyelinating neuropathy,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
77,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0311394,Difficulty walking,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
78,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0332573,Macule,,,phenotype,Finding,0.1,
79,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0344482,Hypoplasia of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
80,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0349588,Short stature,,,phenotype,Finding,0.1,
81,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0375206,Hemiplegia/hemiparesis,,,disease,Disease or Syndrome,0.1,
82,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0426970,Spastic Quadriplegia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
83,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0454644,Delayed speech and language development,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
84,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0521573,Coloboma of eyelid,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",phenotype,Disease or Syndrome,0.1,
85,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0542223,Loss of speech,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
86,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
87,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0575059,Spastic tetraparesis,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
88,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0745109,Macular hyperpigmentation,,,phenotype,Finding,0.1,
89,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0751837,Gait Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
90,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0850703,Frequent falls,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
91,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1096249,Calcification of the aorta,,,phenotype,Pathologic Function,0.1,
92,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0
93,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1280433,Lipoatrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,
94,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
95,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1387005,Penis agenesis,C12,   Male Urogenital Diseases,disease,Congenital Abnormality,0.1,
96,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1531647,Cerebral ventriculomegaly,C10,   Nervous System Diseases,phenotype,Finding,0.1,
97,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1698196,Muscle Weakness Upper Limb,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
98,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1704356,Enchondroma,C04,   Neoplasms,disease,Neoplastic Process,0.1,
99,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1833434,Multifocal cerebral white matter abnormalities,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
100,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1836296,Muscle Weakness Lower Limb,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
101,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1836830,Developmental regression,F03,   Mental Disorders,disease,Disease or Syndrome,0.1,
102,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1837251,Basal ganglia cysts,,,disease,Disease or Syndrome,0.1,
103,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1844662,Unexplained fevers,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
104,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1848701,Elevated hepatic transaminase,,,phenotype,Finding,0.1,
105,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1849097,Loss of ability to walk,,,phenotype,Finding,0.1,
106,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1852470,Extrapyramidal muscular rigidity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Finding,0.1,
107,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1853743,Muscular hypotonia of the trunk,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
108,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1856983,Increased CSF interferon alpha,,,phenotype,Finding,0.1,
109,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1859236,Prolonged neonatal jaundice,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",phenotype,Finding,0.1,
110,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1860834,Infantile muscular hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
111,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1866180,Horizontal pendular nystagmus,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
112,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1963094,"Dry Skin, CTCAE",,,phenotype,Finding,0.1,
113,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1963184,"Nystagmus, CTCAE 3.0",,,phenotype,Finding,0.1,
114,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2700617,Irritation - emotion,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,
115,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2750915,Basal ganglia gliosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
116,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2919142,"Short Stature, CTCAE",,,phenotype,Finding,0.1,
117,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2981140,Glaucoma of childhood,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,
118,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3161330,Profound intellectual disabilities,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,
119,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3278923,Dilated ventricles (finding),,,phenotype,Finding,0.1,
120,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3853779,Neonatal Alloimmune Thrombocytopenia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,
121,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3887640,Astrocytosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.1,
122,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4021570,Undetectable light- and dark-adapted electroretinogram,,,phenotype,Finding,0.1,
123,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4022417,Degeneration of the striatum,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
124,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4022769,Small basal ganglia,,,phenotype,Finding,0.1,
125,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4023169,Moyamoya phenomenon,,,disease,Disease or Syndrome,0.1,
126,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4024229,Chronic CSF lymphocytosis,,,phenotype,Finding,0.1,
127,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4024759,Macular hypopigmentation,,,phenotype,Finding,0.1,
128,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4024877,Hyperpigmented/hypopigmented macules,,,phenotype,Finding,0.1,
129,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4024895,Atrophy/Degeneration involving the caudate nucleus,,,phenotype,Anatomical Abnormality,0.1,
130,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4025579,Large beaked nose,,,disease,Anatomical Abnormality,0.1,
131,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4072900,Increased serum interferon-gamma level,,,phenotype,Finding,0.1,
132,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4082172,Porencephalic cyst,,,disease,Disease or Syndrome,0.1,
133,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4551584,Brain atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
134,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4552810,"Irritability, CTCAE",,,phenotype,Finding,0.1,
135,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4554036,"Nystagmus, CTCAE 5.0",,,phenotype,Finding,0.1,
136,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.09,1.0
137,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.08,1.0
138,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.07,1.0
139,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.05,0.8
140,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.05,1.0
141,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,1.0
142,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
143,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,0.75
144,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0393593,Dystonia Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.04,1.0
145,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0
146,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
147,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0
148,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
149,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
150,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
151,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.03,1.0
152,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
153,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.03,1.0
154,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.03,1.0
155,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.03,1.0
156,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
157,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.02,1.0
158,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
159,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0011226,Hepatitis D Infection,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0
160,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,0.5
161,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
162,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
163,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
164,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0025007,Measles,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
165,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0037277,"Skin Diseases, Genetic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",group,Disease or Syndrome,0.02,1.0
166,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.02,1.0
167,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
168,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0524909,"Hepatitis B, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0
169,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2062441,Influenza A,,,disease,Disease or Syndrome,0.02,1.0
170,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.02,1.0
171,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3714514,Infection,C01,   Infections,group,Pathologic Function,0.02,1.0
172,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0000737,Abdominal Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
173,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
174,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
175,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
176,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
177,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
178,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
179,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
180,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0010823,Cytomegalovirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
181,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
182,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
183,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
184,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
185,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
186,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
187,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
188,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
189,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0018916,Hemangioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
190,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
191,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0
192,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
193,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
194,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
195,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
196,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
197,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0024266,Lymphocytic Choriomeningitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
198,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.01,1.0
199,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
200,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
201,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0036117,Salmonella infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
202,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0037284,Skin lesion,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
203,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
204,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
205,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0085669,Acute leukemia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
206,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0
207,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0149614,Adnexal mass,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Anatomical Abnormality,0.01,1.0
208,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
209,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0151517,Complete atrioventricular block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
210,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
211,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
212,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0152021,Congenital heart disease,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
213,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0153014,Non-arthropod borne lymphocytic choriomeningitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
214,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0
215,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0206664,Teratocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
216,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0206708,Cervical Intraepithelial Neoplasia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
217,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
218,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
219,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
220,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0235031,Neurologic Symptoms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Sign or Symptom,0.01,1.0
221,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
222,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0266362,Ambiguous Genitalia,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,1.0
223,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0276289,Zika Virus Infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
224,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
225,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
226,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
227,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0339510,Vitelliform Macular Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
228,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
229,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0406811,Reticulate acropigmentation of Kitamura,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
230,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
231,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
232,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
233,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
234,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
235,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0751213,Tactile Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
236,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
237,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1290884,Inflammatory disorder,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.01,1.0
238,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1291077,Abdominal bloating,C06,   Digestive System Diseases,phenotype,Sign or Symptom,0.01,1.0
239,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
240,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1306587,Acute encephalopathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
241,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.01,1.0
242,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1739405,CML progression,,,disease,Neoplastic Process,0.01,1.0
243,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
244,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1840264,IMMUNE SUPPRESSION,,,phenotype,Disease or Syndrome,0.01,1.0
245,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
246,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C2930995,Dyschromatosis universalis hereditaria,C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
247,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0
248,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4024917,Congenital encephalopathy,C10,   Nervous System Diseases,disease,Congenital Abnormality,0.01,1.0
249,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
250,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4324298,Tumour inflammation,,,disease,Disease or Syndrome,0.01,1.0
251,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4521042,Complete Trisomy 21 Syndrome,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
252,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4552243,Dyschromatosis,,,disease,Congenital Abnormality,0.01,1.0
253,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
254,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
255,103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0
0,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.333
1,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
2,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0
3,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0
4,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
5,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1136382,Sclerocystic Ovaries,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0
6,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
7,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0
8,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0
9,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0202455,Platinum measurement,,,phenotype,Laboratory Procedure,0.1,1.0
10,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0
11,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
12,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0
13,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0
14,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
15,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
16,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
17,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
18,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
19,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
20,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
21,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
22,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
23,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
24,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
25,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
26,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
27,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
28,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
29,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
30,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
31,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
32,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
33,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
34,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
35,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0008060,child abuse behavior,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
36,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
37,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
38,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0011226,Hepatitis D Infection,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
39,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
40,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
41,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
42,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
43,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
44,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
45,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
46,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
47,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
48,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
49,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0035372,Rett Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
50,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
51,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
52,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
53,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
54,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0152021,Congenital heart disease,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0
55,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
56,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0206180,Ki-1+ Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
57,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
58,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
59,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
60,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0342418,Hypothalamic hamartomas,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Congenital Abnormality,0.01,1.0
61,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
62,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0393591,AICARDI-GOUTIERES SYNDROME,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
63,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,0.0
64,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
65,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0494165,Secondary malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
66,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
67,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
68,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
69,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1261473,Sarcoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
70,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
71,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1512409,Hepatocarcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
72,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
73,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1839839,MAJOR AFFECTIVE DISORDER 2,C16;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,1.0
74,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1852197,MAJOR AFFECTIVE DISORDER 1,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
75,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1862941,"Amyotrophic Lateral Sclerosis, Sporadic",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
76,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1970943,MAJOR AFFECTIVE DISORDER 4,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
77,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C1970945,MAJOR AFFECTIVE DISORDER 6,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
78,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C2062441,Influenza A,,,disease,Disease or Syndrome,0.01,1.0
79,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C2700438,MAJOR AFFECTIVE DISORDER 7,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
80,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C2700439,MAJOR AFFECTIVE DISORDER 8,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
81,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C2700440,MAJOR AFFECTIVE DISORDER 9,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
82,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
83,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C4551686,Malignant neoplasm of soft tissue,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
84,104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,
1,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
2,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0013170,Drug habituation,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.3,1.0
3,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0013222,Drug Use Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
4,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0029231,"Organic Mental Disorders, Substance-Induced",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
5,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0
6,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0038580,Substance Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
7,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0038586,Substance Use Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
8,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0236969,Substance-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
9,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0740858,Substance abuse problem,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
10,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C1510472,Drug Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
11,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C4316881,Prescription Drug Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Finding,0.3,1.0
12,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.11,0.5
13,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
14,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
15,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0154723,Migraine with Aura,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
16,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0869220,"Adverse effects, not elsewhere classified",,,disease,Injury or Poisoning,0.1,1.0
17,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
18,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0
19,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0
20,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
21,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
22,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
23,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
24,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
25,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
26,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
27,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
28,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
29,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
30,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
31,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.01,1.0
32,105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,106,ADCP1,,0.89,0.154,,,,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
1,106,ADCP1,,0.89,0.154,,,,C0268124,Adenosine deaminase deficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
2,106,ADCP1,,0.89,0.154,,,,C0392607,Severe combined immunodeficiency due to adenosine deaminase deficiency,C16;C18;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
0,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C1857809,"DEAFNESS, AUTOSOMAL RECESSIVE 44",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,1.0
1,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0038587,Substance Withdrawal Syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
2,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0086189,Drug Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
3,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0087169,Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
4,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0
5,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0751217,"Hyperkinesia, Generalized",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
6,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C1846647,"DEAFNESS, AUTOSOMAL RECESSIVE (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.3,1.0
7,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C3887506,Hyperkinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
8,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
9,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0
10,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
11,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C4021806,Prelingual sensorineural hearing impairment,,,disease,Disease or Syndrome,0.1,
12,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
13,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
14,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
15,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.02,1.0
16,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
17,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
18,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
19,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0007133,"Carcinoma, Papillary",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
20,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
21,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
22,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
23,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
24,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0020550,Hyperthyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
25,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0022104,Irritable Bowel Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
26,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
27,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0149978,Adenocarcinoma of rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
28,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0234245,Visceral Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
29,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
30,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0242292,McCune-Albright Syndrome,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
31,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
32,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
33,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0524662,Opiate Addiction,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
34,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
35,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
36,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C0751791,"Reflex Epilepsy, Audiogenic",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
37,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
38,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C3898222,mucosal melanoma,,,disease,Neoplastic Process,0.01,1.0
39,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
40,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C4545042,Chronic visceral pain,,,disease,Disease or Syndrome,0.01,1.0
41,107,ADCY1,Q08828,0.659,0.462,0.99747,,,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.62,1.0
1,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0
2,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0005587,"Depression, Bipolar",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
3,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0024713,Manic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
4,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0338831,Manic,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
5,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0
6,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0
7,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
8,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
9,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0
10,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0428474,Serum LDL cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
11,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0
12,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0
13,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
14,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C1837461,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3",,,disease,Finding,0.1,1.0
15,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
16,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
17,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
18,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C4290046,trachomatis,,,disease,Disease or Syndrome,0.02,1.0
19,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
20,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0006012,Borderline Personality Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
21,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
22,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
23,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
24,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
25,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0242231,Coronary Stenosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
26,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
27,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
28,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0730607,Severe chronic obstructive pulmonary disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
29,108,ADCY2,Q08462,0.695,0.308,0.99898,,,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.49,1.0
1,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0028756,"Obesity, Morbid",C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.31,1.0
2,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
3,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0011875,Diabetic Angiopathies,C19;C14,   Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
4,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0025945,"Microangiopathy, Diabetic",C19;C14,   Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
5,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
6,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,1.0
7,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.11,1.0
8,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0003126,Anosmia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
9,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
10,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0
11,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0
12,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0
13,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0
14,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,
15,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.1,
16,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0
17,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0
18,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0
19,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0
20,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0562350,Hip circumference,,,phenotype,Clinical Attribute,0.1,1.0
21,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0578022,Finding of body mass index,,,phenotype,Finding,0.1,1.0
22,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
23,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
24,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
25,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0
26,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C2364082,Sense of smell impaired,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.1,
27,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C4693522,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19,,,phenotype,Finding,0.1,
28,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
29,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
30,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
31,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
32,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
33,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
34,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
35,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
36,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
37,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
38,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
39,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0340164,Lofgrens syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
40,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0431375,Classical Lissencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
41,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
42,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
43,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
44,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
45,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C2362324,Pediatric Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
46,109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C2750737,"DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL",C23;C06;C18,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
0,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1847627,"Dyskinesia, Familial, with Facial Myokymia",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0
1,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,0.947
2,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.5,1.0
3,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.47,1.0
4,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.4,1.0
5,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.32,1.0
6,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
7,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0393584,Benign Hereditary Chorea,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.32,1.0
8,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
9,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
10,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
11,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
12,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0
13,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0016059,Fibrosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
14,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0024667,Animal Mammary Neoplasms,C04;C22,   Neoplasms;    Animal Diseases,phenotype,Neoplastic Process,0.3,1.0
15,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0
16,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
17,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0029459,"Osteoporosis, Senile",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
18,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0033141,"Cardiomyopathies, Primary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
19,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0036529,"Myocardial Diseases, Secondary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
20,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0205696,Anaplastic carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
21,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0205697,"Carcinoma, Spindle-Cell",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
22,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0205698,Undifferentiated carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
23,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0205699,Carcinomatosis,C04,   Neoplasms,phenotype,Neoplastic Process,0.3,1.0
24,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0242698,"Ventricular Dysfunction, Left",C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
25,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0751406,Post-Traumatic Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0
26,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
27,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1257925,"Mammary Carcinoma, Animal",C04;C22,   Neoplasms;    Animal Diseases,disease,Neoplastic Process,0.3,1.0
28,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
29,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.3,1.0
30,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1859098,"Chorea, Benign Familial",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
31,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
32,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0013384,Dyskinetic syndrome,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.18,1.0
33,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.17,1.0
34,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0270871,Facial Myokymia,C10;C07,   Nervous System Diseases;    Stomatognathic Diseases,phenotype,Disease or Syndrome,0.14,1.0
35,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0008489,Chorea,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.13,1.0
36,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0027066,Myoclonus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.12,1.0
37,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,
38,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
39,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,
40,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,
41,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
42,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0017741,Glucose tolerance test,,,phenotype,Laboratory Procedure,0.1,1.0
43,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,
44,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
45,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0
46,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,1.0
47,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0151889,Hyperreflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
48,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0152115,Lingual-Facial-Buccal Dyskinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
49,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
50,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
51,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0
52,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0
53,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0234379,Resting Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
54,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0311394,Difficulty walking,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
55,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0
56,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0
57,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0432072,Dysmorphic features,,,disease,Congenital Abnormality,0.1,1.0
58,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0575081,Gait abnormality,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Finding,0.1,
59,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0
60,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1261430,Fasting blood sugar result,,,phenotype,Laboratory or Test Result,0.1,1.0
61,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
62,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
63,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1837658,Gross motor development delay,F03,   Mental Disorders,disease,Disease or Syndrome,0.1,
64,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1838391,Limb hypertonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
65,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1842364,Central hypotonia,,,phenotype,Finding,0.1,
66,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1853743,Muscular hypotonia of the trunk,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
67,111,ADCY5,O95622,0.617,0.577,0.99928,,,C4021898,Upper limb hypertonia,,,phenotype,Anatomical Abnormality,0.1,
68,111,ADCY5,O95622,0.617,0.577,0.99928,,,C4551915,"Gait Disturbance, CTCAE",,,phenotype,Finding,0.1,
69,111,ADCY5,O95622,0.617,0.577,0.99928,,,C3887506,Hyperkinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.05,1.0
70,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0393593,Dystonia Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.04,1.0
71,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.04,1.0
72,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
73,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.03,1.0
74,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.03,1.0
75,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
76,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.02,1.0
77,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
78,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.02,1.0
79,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0007789,Cerebral Palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
80,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0012833,Dizziness,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
81,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
82,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0020615,Hypoglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
83,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
84,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0028850,Ocular Motility Disorders,C11;C10,   Eye Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
85,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
86,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0042571,Vertigo,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Sign or Symptom,0.01,1.0
87,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0158683,Polycystic liver disease,C23;C06;C04,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Neoplasms",disease,Disease or Syndrome,0.01,1.0
88,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0221163,Motor Disorders,F03,   Mental Disorders,group,Disease or Syndrome,0.01,1.0
89,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0234366,Ataxic,,,phenotype,Sign or Symptom,0.01,1.0
90,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0270742,Athetoid cerebral palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
91,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0271270,Oculovestibuloauditory syndrome,C11;C10;C14,   Eye Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
92,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0338488,Alternating hemiplegia of childhood,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
93,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0349204,Nonorganic psychosis,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
94,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
95,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0684219,Myokymia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
96,111,ADCY5,O95622,0.617,0.577,0.99928,,,C0871388,social stress,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
97,111,ADCY5,O95622,0.617,0.577,0.99928,,,C1834570,Myoclonic dystonia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
98,111,ADCY5,O95622,0.617,0.577,0.99928,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
99,111,ADCY5,O95622,0.617,0.577,0.99928,,,C3489733,Oculomotor apraxia,C23;C11;C10;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
100,111,ADCY5,O95622,0.617,0.577,0.99928,,,C4551854,HYPOPLASTIC LEFT HEART SYNDROME 1,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
101,111,ADCY5,O95622,0.617,0.577,0.99928,,,C4707562,Autoimmune encephalopathy with parasomnia and obstructive sleep apnea,C08;C10;C19;F03,   Respiratory Tract Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
102,111,ADCY5,O95622,0.617,0.577,0.99928,,,C4728082,Severe hypoglycaemia,,,disease,Disease or Syndrome,0.01,0.0
0,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C4225385,LETHAL CONGENITAL CONTRACTURE SYNDROME 8,,,disease,Disease or Syndrome,0.71,1.0
1,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0029866,Other ureteric obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Anatomical Abnormality,0.2,1.0
2,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0003886,Arthrogryposis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.11,1.0
3,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
4,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0234146,Absent reflex,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
5,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0267071,Oropharyngeal Dysphagia,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,
6,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0476273,Respiratory distress,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.1,
7,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0476403,Electromyogram abnormal,,,phenotype,Finding,0.1,
8,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C1836003,Facial diplegia,C01;C10;C07,   Infections;    Nervous System Diseases;    Stomatognathic Diseases,phenotype,Finding,0.1,
9,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C1857108,Limitation of joint mobility,,,phenotype,Finding,0.1,
10,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
11,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C1866934,Reduced tendon reflexes,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
12,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0
13,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
14,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
15,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0002063,Alkalosis,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
16,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
17,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0008354,Cholera,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
18,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
19,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
20,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0022679,Cystic kidney,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
21,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0028259,Nodule,,,phenotype,Acquired Abnormality,0.01,1.0
22,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
23,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
24,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0040137,Thyroid Nodule,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
25,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
26,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
27,112,ADCY6,O43306,0.729,0.5,0.0058268,,,C0162283,Nephrogenic Diabetes Insipidus,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
0,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.41,1.0
1,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,1.0
2,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0
3,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.32,1.0
4,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0
5,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
6,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
7,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
8,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0
9,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0026998,"Acute Myeloid Leukemia, M1",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
10,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
11,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
12,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C1879321,Acute Myeloid Leukemia (AML-M2),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0
13,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C3714758,Juvenile psoriatic arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
14,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C4552091,"Polyarthritis, Juvenile, Rheumatoid Factor Negative",C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
15,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C4704862,"Polyarthritis, Juvenile, Rheumatoid Factor Positive",C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0
16,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.11,1.0
17,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0
18,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,1.0
19,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
20,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0
21,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0
22,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0
23,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
24,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0
25,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0
26,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0920350,Autoimmune thyroiditis,C20;C19,   Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0
27,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C3150797,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6",,,disease,Finding,0.1,1.0
28,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C4014795,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1",,,disease,Disease or Syndrome,0.1,1.0
29,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C4310768,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2",,,disease,Disease or Syndrome,0.1,1.0
30,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
31,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0
32,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
33,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
34,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
35,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
36,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
37,113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.51,1.0
1,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0
2,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0
3,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
4,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,
5,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0011875,Diabetic Angiopathies,C19;C14,   Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
6,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0025945,"Microangiopathy, Diabetic",C19;C14,   Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
7,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0038587,Substance Withdrawal Syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
8,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0086189,Drug Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
9,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0087169,Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
10,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0751217,"Hyperkinesia, Generalized",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
11,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C3887506,Hyperkinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
12,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0
13,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0
14,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
15,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
16,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
17,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
18,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
19,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
20,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
21,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
22,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
23,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
24,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
25,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
26,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
27,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
28,114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
0,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0
1,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0
2,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0005910,Body Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0
3,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0
4,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
5,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0014547,"Epilepsies, Partial",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
6,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0
7,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
8,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0202230,Thyroid stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0
9,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0424678,Lean body mass,,,phenotype,Clinical Attribute,0.1,1.0
10,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0
11,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0455829,Waist Circumference,,,phenotype,Clinical Attribute,0.1,1.0
12,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0518026,body fat percentage (physical finding),,,phenotype,Finding,0.1,1.0
13,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0562350,Hip circumference,,,phenotype,Clinical Attribute,0.1,1.0
14,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0578022,Finding of body mass index,,,phenotype,Finding,0.1,1.0
15,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
16,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
17,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0
18,115,ADCY9,O60503,0.682,0.538,0.97943,,,C1304746,RDW - Red blood cell distribution width result,,,phenotype,Laboratory or Test Result,0.1,1.0
19,115,ADCY9,O60503,0.682,0.538,0.97943,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
20,115,ADCY9,O60503,0.682,0.538,0.97943,,,C4049938,Physical Activity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
21,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,1.0
22,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
23,115,ADCY9,O60503,0.682,0.538,0.97943,,,C2747816,Complicated malaria,C01,   Infections,disease,Disease or Syndrome,0.02,1.0
24,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
25,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0002312,alpha-Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
26,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
27,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
28,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
29,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
30,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
31,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0018889,Helminthiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
32,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
33,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0024534,"Malaria, Cerebral",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
34,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0035220,"Respiratory Distress Syndrome, Newborn",C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
35,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
36,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
37,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
38,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0476227,pricking of skin,,,phenotype,Sign or Symptom,0.01,1.0
39,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0476273,Respiratory distress,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0
40,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
41,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
42,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0852283,Respiratory Distress Syndrome,,,disease,Disease or Syndrome,0.01,1.0
43,115,ADCY9,O60503,0.682,0.538,0.97943,,,C0920296,Developmental reading disorder,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,1.0
44,115,ADCY9,O60503,0.682,0.538,0.97943,,,C1456873,alpha^+^ Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
45,115,ADCY9,O60503,0.682,0.538,0.97943,,,C1841972,Glucocorticoid Receptor Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
46,115,ADCY9,O60503,0.682,0.538,0.97943,,,C1859592,ATRICHIA WITH PAPULAR LESIONS,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
0,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.75
1,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.75
2,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0
3,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
4,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0020452,Hyperemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
5,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0022333,Jacksonian Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
6,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0026205,Miosis disorder,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
7,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0033141,"Cardiomyopathies, Primary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
8,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0036529,"Myocardial Diseases, Secondary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
9,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
10,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0042484,Venous Engorgement,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
11,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0149504,"Encephalopathy, Toxic",C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
12,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0149958,Complex partial seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
13,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0154659,Toxic Encephalitis,C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
14,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0178824,Reactive Hyperemia,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
15,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0234533,Generalized seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
16,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0234535,Clonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
17,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0235032,Neurotoxicity Syndromes,C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0
18,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0268849,Overactive Detrusor,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Disease or Syndrome,0.3,1.0
19,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
20,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0270844,Tonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
21,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0270846,Epileptic drop attack,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
22,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
23,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0333233,Active Hyperemia,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
24,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0392156,Akathisia,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.3,1.0
25,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0422850,"Seizures, Somatosensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
26,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0422852,"Seizures, Auditory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
27,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0422853,Olfactory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
28,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0422854,Gustatory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
29,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0422855,Vertiginous seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
30,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
31,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0751056,Non-epileptic convulsion,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
32,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0751110,Single Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
33,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0751123,Atonic Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
34,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0751494,Convulsive Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
35,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0751495,"Seizures, Focal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
36,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0751496,"Seizures, Sensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
37,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
38,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0878773,Overactive Bladder,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,1.0
39,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C3495874,Nonepileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
40,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C3887612,Psychomotor Agitation,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Finding,0.3,1.0
41,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4048158,Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
42,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4316903,Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
43,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4317109,Epileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
44,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4317123,Myoclonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
45,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4505436,Generalized Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
46,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0010692,Cystitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.21,1.0
47,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
48,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0
49,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.2,1.0
50,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0267941,"Pancreatitis, Acute Necrotizing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0
51,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0038644,Sudden infant death syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0
52,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0
53,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.09,0.889
54,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.09,1.0
55,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.09,1.0
56,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.09,1.0
57,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0
58,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.05,1.0
59,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.05,1.0
60,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.05,0.8
61,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,1.0
62,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,1.0
63,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.04,1.0
64,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.04,1.0
65,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0
66,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0
67,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0
68,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
69,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
70,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.03,1.0
71,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
72,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.03,1.0
73,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
74,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.03,1.0
75,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0
76,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
77,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
78,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
79,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
80,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0009088,Cluster Headache,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
81,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
82,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
83,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.02,1.0
84,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,0.5
85,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.02,1.0
86,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.02,1.0
87,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
88,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.02,1.0
89,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0035078,Kidney Failure,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
90,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.02,1.0
91,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0038443,"Stress, Psychological",F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,1.0
92,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
93,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
94,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
95,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
96,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0
97,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
98,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
99,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.02,1.0
100,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
101,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
102,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
103,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
104,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0
105,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
106,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
107,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0006012,Borderline Personality Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
108,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
109,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
110,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
111,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
112,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0007133,"Carcinoma, Papillary",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
113,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
114,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
115,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
116,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
117,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,0.0
118,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
119,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0013238,Dry Eye Syndromes,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
120,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
121,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
122,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0015674,Chronic Fatigue Syndrome,C01;C05;C10,   Infections;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
123,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
124,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
125,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
126,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
127,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
128,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0
129,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
130,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
131,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0020256,Congenital Hydrocephalus,C10,   Nervous System Diseases,disease,Congenital Abnormality,0.01,1.0
132,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
133,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
134,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
135,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
136,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0021670,insulinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
137,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0022408,Arthropathy,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0
138,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
139,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
140,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
141,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
142,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
143,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0026896,Myasthenia Gravis,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
144,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
145,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
146,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
147,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
148,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
149,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
150,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
151,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
152,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0042025,Urinary Stress Incontinence,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
153,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0042749,Viremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0
154,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0042842,Vitamin A Deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
155,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
156,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
157,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0085636,Photophobia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
158,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
159,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
160,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
161,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0151517,Complete atrioventricular block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
162,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0152459,Linear atrophy,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
163,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0205851,Germ cell tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
164,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
165,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0231341,Premature aging syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
166,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
167,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0234251,Inflammatory pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
168,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
169,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0235272,Retinal damage,C23;C11;C10;C26,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases;    Wounds and Injuries",phenotype,Disease or Syndrome,0.01,1.0
170,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
171,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0262493,Polyp of gallbladder,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Neoplastic Process,0.01,1.0
172,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0268406,Age-related amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
173,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0268784,Myeloma kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
174,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0275518,Acute infectious disease,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",group,Disease or Syndrome,0.01,1.0
175,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0278134,Absence of sensation,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
176,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
177,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
178,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
179,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0282488,Interstitial Cystitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
180,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0314719,Dryness of eye,C11,   Eye Diseases,phenotype,Sign or Symptom,0.01,1.0
181,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0333875,High-Grade Squamous Intraepithelial Lesions,C23;C04;C13,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Neoplastic Process,0.01,1.0
182,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0338480,Common Migraine,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
183,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0342623,Senile systemic amyloidosis,,,disease,Disease or Syndrome,0.01,1.0
184,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
185,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0349458,Cervical intraepithelial neoplasia grade 1,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
186,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0349782,Ischemic cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
187,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0376154,Skin callus,C17,   Skin and Connective Tissue Diseases,disease,Acquired Abnormality,0.01,1.0
188,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0391976,Pain Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
189,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0424139,Anxiety and fear,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
190,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0424295,Hyperactive behavior,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Mental or Behavioral Dysfunction,0.01,1.0
191,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0520679,"Sleep Apnea, Obstructive",C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
192,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0524909,"Hepatitis B, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
193,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0563625,Agnosia for Pain,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
194,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0595921,Intraocular pressure disorder,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
195,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
196,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0730285,Diabetic macular edema,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
197,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0851140,Carcinoma in situ of uterine cervix,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
198,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
199,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0858252,Breast adenocarcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
200,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0887833,"Carcinoma, Pancreatic Ductal",C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
201,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0947622,Cholecystolithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
202,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
203,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1257877,"Pheochromocytoma, Extra-Adrenal",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
204,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
205,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1302773,Low Grade Squamous Intraepithelial Neoplasia,C23;C04;C13,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications",disease,Neoplastic Process,0.01,1.0
206,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
207,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0
208,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
209,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1560249,Adverse Event Associated with Cardiac Arrhythmia,,,phenotype,Disease or Syndrome,0.01,1.0
210,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
211,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1839259,"Bulbo-Spinal Atrophy, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
212,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C1849718,"POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE",C16;C11;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
213,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.01,1.0
214,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C2936719,Mechanical Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
215,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C3160917,Bladder pain syndrome,,,disease,Disease or Syndrome,0.01,1.0
216,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
217,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0
218,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4048329,Immunosuppression,,,disease,Disease or Syndrome,0.01,1.0
219,116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C4053506,ROHHAD syndrome,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
0,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0
1,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0
2,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,0.0
3,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0
4,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0010692,Cystitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0
5,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0
6,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0
7,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0202251,Vitamin B6 measurement,,,phenotype,Laboratory Procedure,0.1,1.0
8,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.05,1.0
9,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
10,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0038644,Sudden infant death syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.04,0.75
11,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0
12,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
13,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
14,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.667
15,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
16,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
17,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.03,0.667
18,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
19,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
20,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,0.667
21,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,1.0
22,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.02,1.0
23,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
24,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.02,1.0
25,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
26,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
27,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.02,1.0
28,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
29,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
30,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
31,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
32,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
33,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
34,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
35,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
36,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
37,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
38,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
39,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
40,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
41,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
42,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
43,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
44,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0007112,Adenocarcinoma of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
45,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
46,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0007133,"Carcinoma, Papillary",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
47,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,0.0
48,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0009088,Cluster Headache,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
49,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
50,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
51,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
52,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
53,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
54,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
55,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
56,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
57,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
58,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0020256,Congenital Hydrocephalus,C10,   Nervous System Diseases,disease,Congenital Abnormality,0.01,1.0
59,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
60,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
61,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
62,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0025286,Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
63,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
64,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
65,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
66,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0028945,oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
67,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
68,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0
69,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0038443,"Stress, Psychological",F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
70,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
71,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0041912,Upper Respiratory Infections,C01;C08,   Infections;    Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
72,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
73,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0085281,Addictive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
74,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0085669,Acute leukemia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
75,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0153633,Malignant neoplasm of brain,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
76,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
77,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
78,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0234251,Inflammatory pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
79,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
80,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
81,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0270549,Generalized Anxiety Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
82,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0278764,Adult Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
83,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0278877,Adult Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
84,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0278879,Childhood Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
85,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0282488,Interstitial Cystitis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
86,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
87,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
88,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0349231,Phobic anxiety disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
89,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0393735,Headache Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
90,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0424139,Anxiety and fear,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
91,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0521991,Symptoms of stress,,,phenotype,Sign or Symptom,0.01,1.0
92,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0524528,Pervasive Development Disorder,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
93,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
94,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
95,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
96,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
97,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0751396,Well Differentiated Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
98,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0887833,"Carcinoma, Pancreatic Ductal",C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
99,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1257877,"Pheochromocytoma, Extra-Adrenal",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
100,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
101,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
102,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1292778,Chronic myeloproliferative disorder,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
103,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
104,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
105,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
106,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1519670,Tumor Angiogenesis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
107,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1522378,"Leukemia, Large Granular Lymphocytic",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
108,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
109,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.01,1.0
110,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1762616,"Meningioma, benign, no ICD-O subtype",C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
111,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1849718,"POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE",C16;C11;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0
112,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C1853926,NONAKA MYOPATHY,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
113,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C2936719,Mechanical Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
114,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
115,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C3203533,Psychological Trauma,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
116,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
117,117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
0,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,0.861
1,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,0.944
2,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
3,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
4,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0
5,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.13,1.0
6,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1840374,Elevated systolic blood pressure,C14,   Cardiovascular Diseases,phenotype,Finding,0.1,
7,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1840375,Elevated diastolic blood pressure,C14,   Cardiovascular Diseases,phenotype,Finding,0.1,
8,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1840376,Elevated mean arterial pressure,C14,   Cardiovascular Diseases,phenotype,Finding,0.1,
9,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.09,0.889
10,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.08,1.0
11,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.06,1.0
12,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0
13,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
14,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
15,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
16,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
17,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
18,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.03,1.0
19,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,0.667
20,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0
21,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,0.667
22,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
23,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.02,1.0
24,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
25,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,0.5
26,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0265706,Gastroschisis,C23;C16;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0
27,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
28,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.01,1.0
29,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
30,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
31,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,0.0
32,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
33,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
34,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
35,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
36,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
37,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020428,Hyperaldosteronism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
38,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020474,"Hyperlipidemia, Familial Combined",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
39,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020488,Hypernatremia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
40,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
41,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020625,Hyponatremia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
42,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
43,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
44,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
45,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0025281,Meniere Disease,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
46,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0025303,Meningococcal Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
47,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0026499,Monosomy,C23,"   Pathological Conditions, Signs and Symptoms",group,Congenital Abnormality,0.01,1.0
48,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
49,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0035078,Kidney Failure,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
50,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
51,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0206586,Endolymphatic Hydrops,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
52,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
53,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0272051,Xerocytosis,C23;C16;C13;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
54,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
55,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
56,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0745133,Isolated systolic hypertension,,,disease,Disease or Syndrome,0.01,0.0
57,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0751007,Intracranial Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
58,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0852036,Pregnancy associated hypertension,C13;C14,   Female Urogenital Diseases and Pregnancy Complications;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
59,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
60,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1332977,Childhood Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
61,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1384514,Conn Syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
62,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
63,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1565489,Renal Insufficiency,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
64,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
65,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
66,118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.24,1.0
1,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C2674218,"SPHEROCYTOSIS, TYPE 1 (disorder)",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.2,1.0
2,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
3,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
4,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.04,1.0
5,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0041671,Attention Deficit Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0
6,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
7,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0002878,"Anemia, Hemolytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
8,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
9,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
10,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
11,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
12,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0013902,"Elliptocytosis, Hereditary",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
13,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
14,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
15,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0024138,"Lupus Erythematosus, Discoid",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
16,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
17,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
18,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
19,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0042109,Urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
20,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
21,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0221232,Welts,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",phenotype,Sign or Symptom,0.01,1.0
22,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0272051,Xerocytosis,C23;C16;C13;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
23,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0409974,Lupus Erythematosus,C23;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
24,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
25,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
26,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C1850808,Miyoshi myopathy,,,disease,Disease or Syndrome,0.01,1.0
27,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C3711376,Isodicentric Chromosome 15 Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
28,119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C4551973,Miyoshi Muscular Dystrophy 1,C23;C16;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
0,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C4310767,"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3",,,disease,Disease or Syndrome,0.6,1.0
1,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0
2,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0005587,"Depression, Bipolar",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
3,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
4,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
5,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0024713,Manic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
6,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0149504,"Encephalopathy, Toxic",C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
7,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0154659,Toxic Encephalitis,C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0
8,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0235032,Neurotoxicity Syndromes,C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0
9,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0338831,Manic,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
10,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0917798,Cerebral Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Pathologic Function,0.3,1.0
11,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C2751938,"Cerebral Palsy, Spastic Quadriplegic, 1",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0
12,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0
13,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0007789,Cerebral Palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0
14,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,
15,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0015310,Exotropia,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
16,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0023882,Little's Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,
17,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
18,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0028738,Nystagmus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
19,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
20,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0234132,Pyramidal sign,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
21,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,
22,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0
23,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0426970,Spastic Quadriplegia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
24,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,
25,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1720037,Supranuclear gaze palsy,,,phenotype,Finding,0.1,
26,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1837461,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3",,,disease,Finding,0.1,1.0
27,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1848207,Poor speech,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
28,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1861403,Variable expressivity,,,phenotype,Finding,0.1,
29,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1963184,"Nystagmus, CTCAE 3.0",,,phenotype,Finding,0.1,
30,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C3278923,Dilated ventricles (finding),,,phenotype,Finding,0.1,
31,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C4021584,Frontotemporal cerebral atrophy,,,disease,Disease or Syndrome,0.1,
32,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C4554036,"Nystagmus, CTCAE 5.0",,,phenotype,Finding,0.1,
33,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.06,1.0
34,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C4520983,Congenital atresia of extrahepatic bile duct,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.06,1.0
35,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0
36,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0
37,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
38,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
39,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0008340,Choledochal Cyst,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Congenital Abnormality,0.01,1.0
40,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
41,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
42,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
43,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
44,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
45,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
46,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
47,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C0751691,Perineurioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
48,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
49,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1291077,Abdominal bloating,C06,   Digestive System Diseases,phenotype,Sign or Symptom,0.01,1.0
50,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1370657,Soft tissue perineurioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
51,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
52,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
53,120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0
0,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.38,1.0
1,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.33,1.0
2,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
3,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
4,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0038356,Stomach Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
5,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1708349,Hereditary Diffuse Gastric Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
6,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
7,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
8,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0339525,Autosomal dominant retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.06,1.0
9,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0
10,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.05,1.0
11,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,1.0
12,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.05,1.0
13,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0
14,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
15,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
16,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,1.0
17,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.04,1.0
18,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
19,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
20,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5
21,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
22,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
23,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.02,1.0
24,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0206684,Sebaceous Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
25,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.02,1.0
26,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.02,1.0
27,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
28,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
29,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1261473,Sarcoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
30,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1378703,Renal carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
31,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
32,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C2931852,Clear-cell metastatic renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0
33,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
34,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
35,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
36,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0006079,Bowen's Disease,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
37,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
38,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
39,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0007130,Mucinous Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
40,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
41,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0008497,Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
42,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
43,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
44,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
45,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
46,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
47,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
48,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
49,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
50,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
51,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023348,"Leprosy, Lepromatous",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
52,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023484,"Leukemia, Plasma Cell",C04;C20,   Neoplasms;    Immune System Diseases,disease,Neoplastic Process,0.01,1.0
53,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023794,Lipoidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
54,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023827,liposarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
55,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
56,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.01,1.0
57,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
58,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
59,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0027962,Melanocytic nevus,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
60,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0028756,"Obesity, Morbid",C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
61,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
62,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0040100,Thymoma,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
63,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
64,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0085078,Lysosomal Storage Diseases,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.01,1.0
65,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0151779,Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
66,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
67,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
68,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0205825,"Liposarcoma, Pleomorphic",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
69,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0205969,Thymic Carcinoma,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
70,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0221036,Acrodermatitis enteropathica,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,0.0
71,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0268238,Triglyceride storage disease with ichthyosis,C16;C18;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
72,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0278764,Adult Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
73,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0278879,Childhood Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
74,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0334371,Secretory breast carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
75,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0338106,Adenocarcinoma of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
76,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0346027,Eccrine epithelioma,,,disease,Neoplastic Process,0.01,1.0
77,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
78,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
79,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0855173,Placental Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
80,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C0872084,Sarcopenia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
81,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
82,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1332271,Perianal Squamous Intraepithelial Neoplasia,,,disease,Neoplastic Process,0.01,1.0
83,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1333001,Childhood Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
84,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
85,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
86,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1512127,HER2 gene amplification,,,disease,Disease or Syndrome,0.01,1.0
87,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1706827,Apocrine Carcinoma,,,disease,Neoplastic Process,0.01,1.0
88,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0
89,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1861453,Pseudohyperkalemia Cardiff,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
90,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C1879641,Primary Cutaneous Mucinous Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
91,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
92,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C3665593,Melanocytic nevus of skin,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
93,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C3805040,Phospholipidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
94,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C3811653,Experimental Organism Basal Cell Carcinoma,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
95,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C4042906,Mammary Analogue Secretory Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
96,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
97,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C4551686,Malignant neoplasm of soft tissue,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
98,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C4551687,Sarcoma of soft tissue,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
99,123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0
1,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
2,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
3,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8
4,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C4048195,Autosomal dominant hypocalcemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.04,1.0
5,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
6,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
7,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
8,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
9,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,0.5
10,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.02,0.5
11,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
12,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
13,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
14,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C1332347,Atypical Ductal Breast Hyperplasia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
15,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
16,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
17,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
18,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0006849,Oral candidiasis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
19,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
20,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
21,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
22,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
23,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
24,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0020598,Hypocalcemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
25,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0020626,Hypoparathyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
26,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.01,1.0
27,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
28,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
29,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0038580,Substance Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
30,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0085409,"Polyendocrinopathies, Autoimmune",C20;C19,   Immune System Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
31,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0085859,Polyglandular Type I Autoimmune Syndrome,C20;C19,   Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
32,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0086692,Benign Neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
33,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0153405,Malignant neoplasm of pharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,0.0
34,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
35,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0221253,Xanthoma tendinosum,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
36,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
37,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0342881,Familial hypercholesterolemia - homozygous,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
38,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
39,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
40,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
41,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0747548,Pharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,0.0
42,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.01,0.0
43,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0877008,Enzyme inhibition disorder,,,phenotype,Disease or Syndrome,0.01,1.0
44,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
45,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C3888506,LDLR mutation,,,disease,Congenital Abnormality,0.01,1.0
46,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
47,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
48,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
49,124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C4743983,Advanced Cutaneous Melanoma of the Extremity,,,disease,Neoplastic Process,0.01,1.0
0,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0
1,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,1.0
2,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.5,1.0
3,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0
4,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.958
5,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0031347,Pharyngeal Neoplasms,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,group,Neoplastic Process,0.4,1.0
6,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.4,1.0
7,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0
8,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,0.889
9,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.33,1.0
10,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.32,1.0
11,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.32,1.0
12,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0001969,Alcoholic Intoxication,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
13,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.31,1.0
14,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.31,1.0
15,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153405,Malignant neoplasm of pharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.31,0.5
16,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0349464,Wernicke-Korsakoff Syndrome,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.31,1.0
17,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0
18,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023055,Laryngeal neoplasm,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.3,1.0
19,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0026640,Mouth Neoplasms,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.3,1.0
20,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0393756,Hangover from alcohol,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
21,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
22,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0751010,"Cerebral Infarction, Left Hemisphere",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
23,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0751011,"Cerebral Infarction, Right Hemisphere",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
24,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0751012,Anterior Choroidal Artery Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
25,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0751014,Subcortical Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0
26,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0887799,Posterior Choroidal Artery Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
27,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.12,0.667
28,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0236664,Alcohol-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.12,1.0
29,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153382,Malignant neoplasm of oropharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.11,1.0
30,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C2349952,Oropharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.11,1.0
31,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0
32,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0
33,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.952
34,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0
35,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0016382,Flushing,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,1.0
36,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0018671,Head and Neck Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
37,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0
38,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153368,Malignant neoplasm of floor of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.1,1.0
39,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153369,Malignant neoplasm of anterior portion of floor of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.1,1.0
40,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153380,Malignant neoplasm of other specified parts of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.1,1.0
41,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153389,malignant neoplasm of lateral wall of oropharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0
42,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153390,Malignant neoplasm of posterior wall of oropharynx,C04;C08;C07;C09,   Neoplasms;    Respiratory Tract Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0
43,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153407,Malignant neoplasm of other sites within the lip and oral cavity,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.1,1.0
44,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0
45,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0236970,Alcohol-Induced Disorders,C25,   Chemically-Induced Disorders,group,Disease or Syndrome,0.1,1.0
46,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0337443,Sodium measurement,,,phenotype,Laboratory Procedure,0.1,1.0
47,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0496758,Malignant neoplasm of lateral floor of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.1,1.0
48,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0497552,Congenital neurologic anomalies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.1,
49,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
50,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0
51,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
52,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,0.947
53,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
54,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1838867,"PARKINSON DISEASE, MITOCHONDRIAL (disorder)",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
55,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0
56,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C3165521,Primary malignant neoplasm of lateral wall of oropharynx,,,disease,Neoplastic Process,0.1,1.0
57,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023891,"Liver Cirrhosis, Alcoholic",C23;C06;C25,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.09,0.778
58,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.09,0.667
59,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.09,0.667
60,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.08,0.875
61,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.08,1.0
62,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.08,0.5
63,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,0.857
64,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.07,1.0
65,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.07,1.0
66,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
67,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,0.857
68,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
69,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0
70,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.06,1.0
71,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.05,1.0
72,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0015923,Fetal Alcohol Syndrome,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.05,1.0
73,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.05,0.8
74,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.05,0.8
75,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.05,1.0
76,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0687132,heavy drinking,,,disease,Mental or Behavioral Dysfunction,0.05,0.8
77,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.04,1.0
78,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.04,1.0
79,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0002886,"Anemia, Macrocytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.03,1.0
80,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0
81,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,0.667
82,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
83,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
84,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
85,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0595989,Carcinoma of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.03,0.667
86,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.03,1.0
87,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4048195,Autosomal dominant hypocalcemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0
88,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0
89,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,1.0
90,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,0.5
91,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
92,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,0.5
93,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,0.5
94,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
95,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0
96,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
97,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0027497,Nausea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0
98,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0
99,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,0.5
100,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0085281,Addictive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
101,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0085662,Macrocytosis,,,disease,Disease or Syndrome,0.02,1.0
102,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
103,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,0.5
104,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0549393,Alcohol problem,,,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
105,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0683342,hazardous drinking,,,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
106,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
107,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
108,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
109,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C3146244,Alcohol Related Birth Defect,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.02,1.0
110,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
111,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
112,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
113,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
114,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0003431,Antisocial Personality Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
115,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
116,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
117,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
118,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
119,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
120,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
121,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,0.0
122,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
123,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
124,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.01,1.0
125,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
126,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
127,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0015302,External exotoses,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
128,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
129,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
130,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
131,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0018621,Hay fever,C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0
132,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
133,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0019337,Heroin Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
134,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0020598,Hypocalcemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
135,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
136,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0022638,Ketosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
137,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023051,Laryngeal Diseases,C08;C09,   Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.01,1.0
138,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023518,Leukocytosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.01,1.0
139,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
140,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
141,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0024312,Lymphopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
142,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
143,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
144,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,0.0
145,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
146,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
147,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0030299,Pancreatic Pseudocyst,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0
148,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
149,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
150,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.01,1.0
151,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
152,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0041834,Erythema,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",phenotype,Disease or Syndrome,0.01,1.0
153,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
154,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
155,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0085677,Alcoholic Neuropathy,C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.01,1.0
156,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0085681,Hyperphosphatemia (disorder),C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
157,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0085702,Monocytosis,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
158,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0086692,Benign Neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
159,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0087169,Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.01,1.0
160,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
161,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
162,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0152025,Polyneuropathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
163,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0153398,Hypopharyngeal Cancer,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
164,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0158266,Intervertebral Disc Degeneration,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
165,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
166,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0220810,Congenital defects,,,group,Congenital Abnormality,0.01,1.0
167,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
168,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0233523,Antisocial behavior,C10;F03;F01,   Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,0.0
169,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0235480,Paroxysmal atrial fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
170,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0235946,Cerebral atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
171,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0236663,Alcohol withdrawal syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
172,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.01,1.0
173,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0236788,Bipolar II disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
174,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
175,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0267952,Fibrosis of pancreas,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
176,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0270736,Essential Tremor,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,0.0
177,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
178,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0280321,Squamous cell carcinoma of the hypopharynx,,,disease,Neoplastic Process,0.01,1.0
179,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
180,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0339467,Proliferative retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
181,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0341439,Chronic liver disease,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
182,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0344720,Left atrial dilatation,,,disease,Congenital Abnormality,0.01,1.0
183,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
184,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0524909,"Hepatitis B, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
185,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0556374,Drunk driving,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
186,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0586354,Esophageal dysplasia,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0
187,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0679414,alcohol flush reaction,C23;C25;F03,"   Pathological Conditions, Signs and Symptoms;    Chemically-Induced Disorders;    Mental Disorders",phenotype,Disease or Syndrome,0.01,1.0
188,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
189,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
190,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
191,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0740394,Hyperuricemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
192,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0740703,ABUSE NEGLECT,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
193,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0746102,Chronic lung disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
194,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0747548,Pharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,0.0
195,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0851139,Malignant neoplasm of larnyx stage IV,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
196,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0853193,Bipolar I disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
197,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0877008,Enzyme inhibition disorder,,,phenotype,Disease or Syndrome,0.01,1.0
198,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1134719,Invasive Ductal Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
199,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1266025,Traditional Serrated Adenoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
200,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
201,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1282609,Granulocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
202,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1297883,Radial scar,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
203,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1302401,Adenoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
204,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
205,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1319317,Squamous cell carcinoma of pharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
206,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1332347,Atypical Ductal Breast Hyperplasia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
207,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1333177,Lymphoproliferative Disorder of the Skin,C17;C20;C15,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
208,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1333620,Flat Ductal Epithelial Atypia of the Breast,,,disease,Neoplastic Process,0.01,1.0
209,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1334015,High Grade Intraepithelial Neoplasia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
210,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1368404,Hypopharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
211,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1510472,Drug Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
212,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1867743,Premature coronary artery atherosclerosis,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
213,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1868653,"Pancreatitis, Calcific",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
214,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C1956089,Osteophyte,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
215,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C2609107,Hypo HDL cholesterolaemia,,,disease,Disease or Syndrome,0.01,0.0
216,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
217,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C2985290,Fetal Alcohol Spectrum Disorders,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",group,Disease or Syndrome; Congenital Abnormality,0.01,1.0
218,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C3699402,Alcohol abuse or dependence,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
219,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
220,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.01,1.0
221,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4551584,Brain atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
222,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4722419,Extrapulmonary Small Cell Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
223,125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C4732730,Blood spots,,,disease,Disease or Syndrome,0.01,1.0
0,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0
1,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,1.0
2,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0
3,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.34,1.0
4,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0001969,Alcoholic Intoxication,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
5,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0026640,Mouth Neoplasms,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.3,1.0
6,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C3160718,"PARKINSON DISEASE, LATE-ONSET",,,disease,Disease or Syndrome,0.3,
7,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0
8,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.6
9,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.882
10,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0009806,Constipation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,
11,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,
12,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,
13,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,
14,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
15,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0026837,Muscle Rigidity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
16,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0037317,Sleep disturbances,C10;F03;F01,   Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.1,
17,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
18,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0085606,Urgency of micturition,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Sign or Symptom,0.1,
19,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0233565,Bradykinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
20,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0234379,Resting Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,
21,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0236664,Alcohol-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0
22,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0236970,Alcohol-Induced Disorders,C25,   Chemically-Induced Disorders,group,Disease or Syndrome,0.1,1.0
23,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0240341,Micrographia,,,phenotype,Finding,0.1,
24,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0240735,Personality Change,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.1,
25,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0241700,Voice Fatigue,C23;C08;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Finding,0.1,
26,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,
27,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0424448,Mask-like facies,C10,   Nervous System Diseases,phenotype,Finding,0.1,
28,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,
29,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0497552,Congenital neurologic anomalies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.1,
30,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.6
31,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0700201,Dyssomnias,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,
32,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0851578,Sleep Disorders,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",group,Mental or Behavioral Dysfunction,0.1,
33,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,0.882
34,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0
35,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1838867,"PARKINSON DISEASE, MITOCHONDRIAL (disorder)",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,
36,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1843921,Postural instability,C10,   Nervous System Diseases,phenotype,Finding,0.1,
37,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1846865,Substantia nigra gliosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.1,
38,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1850496,Neuronal loss in central nervous system,,,phenotype,Finding,0.1,
39,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1853237,Isolated cases,,,phenotype,Finding,0.1,
40,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C3805715,Short stepped shuffling gait,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
41,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C4553976,"Urinary Urgency, CTCAE 5",,,phenotype,Finding,0.1,
42,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0023891,"Liver Cirrhosis, Alcoholic",C23;C06;C25,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.09,0.667
43,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.08,1.0
44,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.06,0.833
45,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.06,0.833
46,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.05,1.0
47,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.05,1.0
48,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
49,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0
50,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0
51,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.04,0.75
52,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
53,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,0.75
54,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
55,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,0.75
56,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.04,1.0
57,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
58,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
59,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0
60,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,0.75
61,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
62,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0
63,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1623038,Cirrhosis,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.04,1.0
64,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.04,0.75
65,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
66,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,0.667
67,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,0.667
68,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.03,0.667
69,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0
70,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
71,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
72,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
73,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,0.667
74,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
75,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,1.0
76,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0
77,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
78,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
79,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.02,1.0
80,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0016382,Flushing,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,0.5
81,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
82,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0153405,Malignant neoplasm of pharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,0.5
83,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.02,1.0
84,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0595989,Carcinoma of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,0.5
85,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0687132,heavy drinking,,,disease,Mental or Behavioral Dysfunction,0.02,1.0
86,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0747548,Pharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.02,0.5
87,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1302401,Adenoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
88,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
89,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
90,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
91,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
92,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
93,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
94,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0006870,Cannabis Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
95,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
96,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
97,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,0.0
98,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
99,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
100,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
101,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0019112,Hemorrhoids,C06;C14,   Digestive System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
102,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0023055,Laryngeal neoplasm,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
103,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
104,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0027497,Nausea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
105,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
106,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0
107,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0032584,polyps,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,0.0
108,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0086692,Benign Neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
109,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
110,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
111,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0153382,Malignant neoplasm of oropharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
112,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0206677,Adenomatous Polyps,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
113,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0220810,Congenital defects,,,group,Congenital Abnormality,0.01,1.0
114,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0262417,Acute on chronic pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
115,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
116,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0279606,Childhood Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
117,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0279607,Adult Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
118,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
119,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0343641,Human papilloma virus infection,C01,   Infections,disease,Disease or Syndrome,0.01,0.0
120,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
121,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
122,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.01,1.0
123,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0394006,Dysequilibrium syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
124,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0394996,Acute alcoholic intoxication,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
125,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0426576,Gastrointestinal symptom,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
126,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
127,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
128,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0683342,hazardous drinking,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
129,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0683357,Excessive drinking,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
130,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
131,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
132,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0746102,Chronic lung disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
133,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0810031,alcohol-related liver disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
134,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0877008,Enzyme inhibition disorder,,,phenotype,Disease or Syndrome,0.01,1.0
135,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0949059,Polyp of large intestine,C23;C06;C04,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0
136,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1266025,Traditional Serrated Adenoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
137,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1333177,Lymphoproliferative Disorder of the Skin,C17;C20;C15,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
138,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
139,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0
140,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C1837217,"Cleft lip, isolated",,,disease,Congenital Abnormality,0.01,1.0
141,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C2349952,Oropharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
142,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
143,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C4048195,Autosomal dominant hypocalcemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
144,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
145,126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C4722419,Extrapulmonary Small Cell Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0
1,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0
2,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0
3,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
4,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
5,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
6,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
7,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.11,1.0
8,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
9,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0
10,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0236664,Alcohol-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0
11,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0236970,Alcohol-Induced Disorders,C25,   Chemically-Induced Disorders,group,Disease or Syndrome,0.1,1.0
12,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0
13,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
14,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0009088,Cluster Headache,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0
15,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
16,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
17,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C4529962,Fatty Liver Disease,,,disease,Disease or Syndrome,0.03,1.0
18,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
19,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C1510472,Drug Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0
20,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
21,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
22,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
23,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
24,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
25,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0016382,Flushing,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
26,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
27,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0023891,"Liver Cirrhosis, Alcoholic",C23;C06;C25,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.01,1.0
28,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.01,0.0
29,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
30,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
31,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0038580,Substance Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
32,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
33,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0086692,Benign Neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
34,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0087169,Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.01,1.0
35,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
36,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0153405,Malignant neoplasm of pharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,0.0
37,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
38,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
39,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
40,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.01,1.0
41,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
42,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
43,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
44,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
45,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0747548,Pharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,0.0
46,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0751688,Malignant Squamous Cell Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
47,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0877008,Enzyme inhibition disorder,,,phenotype,Disease or Syndrome,0.01,1.0
48,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C1134719,Invasive Ductal Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
49,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C1297883,Radial scar,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0
50,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C1333620,Flat Ductal Epithelial Atypia of the Breast,,,disease,Neoplastic Process,0.01,1.0
51,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
52,127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
0,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0
1,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0
2,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0
3,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0037231,Sjogren-Larsson Syndrome,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.06,1.0
4,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0
5,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
6,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
7,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0
8,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
9,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
10,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
11,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
12,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
13,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
14,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
15,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
16,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
17,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
18,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
19,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0
20,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
21,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
22,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
23,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
24,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0013537,Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
25,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
26,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
27,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
28,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0016412,Folic Acid Deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
29,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
30,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0020551,Hyperthyroxinemia,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
31,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
32,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0023891,"Liver Cirrhosis, Alcoholic",C23;C06;C25,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.01,1.0
33,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
34,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.01,0.0
35,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
36,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
37,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
38,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
39,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
40,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0030312,Pancytopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
41,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
42,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
43,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0153382,Malignant neoplasm of oropharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
44,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0153405,Malignant neoplasm of pharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
45,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
46,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
47,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
48,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0262417,Acute on chronic pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
49,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0271623,Hypogonadotropic hypogonadism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
50,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0276447,Rhinovirus infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
51,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
52,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0342185,"Hyperthyroxinemia, Familial Dysalbuminemic",C16;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0
53,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
54,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0595989,Carcinoma of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
55,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
56,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0598608,Hyperhomocysteinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
57,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
58,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
59,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0747548,Pharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
60,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0751688,Malignant Squamous Cell Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
61,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0
62,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C1512409,Hepatocarcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
63,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C2349952,Oropharyngeal Carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0
64,128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C3469521,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
0,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
1,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
2,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
3,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
4,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
5,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
6,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0021053,Immune System Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
7,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
8,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
9,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0086692,Benign Neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
10,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
11,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
12,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
13,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0877008,Enzyme inhibition disorder,,,phenotype,Disease or Syndrome,0.01,1.0
14,130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0
1,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.3,1.0
2,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0
3,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0023055,Laryngeal neoplasm,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.3,1.0
4,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0026640,Mouth Neoplasms,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.3,1.0
5,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0031347,Pharyngeal Neoplasms,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,group,Neoplastic Process,0.3,1.0
6,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.3,1.0
7,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0153405,Malignant neoplasm of pharynx,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.3,1.0
8,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0
9,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.22,1.0
10,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0018671,Head and Neck Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
11,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0
12,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
13,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
14,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
15,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
16,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0751688,Malignant Squamous Cell Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
17,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
18,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
19,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0003076,Aniridia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0
20,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
21,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,0.0
22,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0
23,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
24,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
25,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
26,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
27,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
28,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0038356,Stomach Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
29,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0038580,Substance Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
30,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
31,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
32,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
33,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0
34,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0339527,Leber Congenital Amaurosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
35,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
36,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
37,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0854723,Retinal Dystrophies,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
38,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
39,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C3887461,Head and Neck Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
40,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
41,131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C4722419,Extrapulmonary Small Cell Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C3280381,HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0
1,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.31,1.0
2,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
3,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
4,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
5,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0
6,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0025363,"Mental Retardation, Psychosocial",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.3,1.0
7,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0242184,Hypoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
8,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0700292,Hypoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0
9,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0917816,Mental deficiency,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0
10,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0
11,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.21,1.0
12,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
13,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0015696,"Fatty Liver, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.2,1.0
14,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.2,1.0
15,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0020649,Hypotension,C14,   Cardiovascular Diseases,phenotype,Finding,0.2,1.0
16,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0751955,Brain Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
17,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.18,1.0
18,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4048705,Hypermethioninemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.12,1.0
19,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.11,1.0
20,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
21,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
22,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
23,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0020433,Hyperbilirubinemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,
24,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0020534,Orbital separation excessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",phenotype,Finding,0.1,
25,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0221354,Frontal bossing,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,
26,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0221355,Macrocephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,
27,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0232744,Decreased liver function,,,phenotype,Finding,0.1,
28,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0235946,Cerebral atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,
29,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0
30,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0454644,Delayed speech and language development,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,
31,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0541794,Skeletal muscle atrophy,,,phenotype,Pathologic Function,0.1,
32,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0576227,Narrow foot,C05,   Musculoskeletal Diseases,phenotype,Finding,0.1,
33,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.1,1.0
34,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
35,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0
36,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1837397,Severe global developmental delay,,,phenotype,Finding,0.1,
37,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1837461,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3",,,disease,Finding,0.1,1.0
38,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1848207,Poor speech,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
39,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1848701,Elevated hepatic transaminase,,,phenotype,Finding,0.1,
40,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1858120,Generalized hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,
41,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,
42,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C3805083,Portal fibrosis,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.1,
43,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4021765,Morphological abnormality of the central nervous system,,,group,Anatomical Abnormality,0.1,
44,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4021780,Abnormality of the liver,,,phenotype,Finding,0.1,
45,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4022737,Neurodevelopmental abnormality,,,phenotype,Pathologic Function,0.1,
46,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.08,1.0
47,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
48,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
49,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
50,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
51,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
52,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0268621,Hepatic methionine adenosyltransferase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0
53,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0393484,Rasmussen Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
54,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1096063,Drug Resistant Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
55,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C2930868,Rasmussen subacute encephalitis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
56,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
57,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
58,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
59,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
60,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0010403,Cryoglobulinemia,C20;C15;C14,   Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
61,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
62,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
63,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
64,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
65,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
66,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0024314,Lymphoproliferative Disorders,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
67,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0
68,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0
69,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
70,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0027947,Neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
71,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
72,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0036857,Severe intellectual disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0
73,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
74,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
75,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
76,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0
77,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0205646,"Adenoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
78,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0206685,Acinar Cell Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
79,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0238790,bone destruction,,,disease,Disease or Syndrome,0.01,1.0
80,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0242073,Pulmonary congestion,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
81,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0268119,Combined molybdoflavoprotein enzyme deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
82,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0268124,Adenosine deaminase deficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
83,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
84,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0
85,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
86,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0392607,Severe combined immunodeficiency due to adenosine deaminase deficiency,C16;C18;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
87,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0432072,Dysmorphic features,,,disease,Congenital Abnormality,0.01,1.0
88,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
89,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0748607,Recurrent seizure,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
90,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C0947751,Vascular inflammations,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
91,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0
92,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
93,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1504404,Hippocampal sclerosis,,,disease,Disease or Syndrome,0.01,1.0
94,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1853230,"Aphakia, congenital primary",C11,   Eye Diseases,disease,Congenital Abnormality,0.01,1.0
95,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1970827,Phosphoribosylpyrophosphate Synthetase Superactivity,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
96,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C1971021,Potassium depletion,,,disease,Disease or Syndrome,0.01,1.0
97,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C2349595,Fetal anemia,C16;C13;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
98,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4086152,Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
99,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
100,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4509226,Heart failure with preserved ejection fraction [HFpEF],,,disease,Disease or Syndrome,0.01,1.0
101,132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.6,1.0
1,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0017658,Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.51,1.0
2,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.51,1.0
3,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.5,1.0
4,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.4,1.0
5,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0
6,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C2936719,Mechanical Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.32,1.0
7,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.31,1.0
8,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
9,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
10,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,0.941
11,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,0.95
12,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
13,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0034189,Pyemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Pathologic Function,0.3,1.0
14,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0038358,Gastric ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0
15,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0234230,"Pain, Burning",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
16,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0234238,Ache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
17,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0234254,Radiating pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
18,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0458247,Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
19,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0458257,"Pain, Splitting",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
20,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0458259,"Pain, Crushing",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
21,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751211,"Hyperalgesia, Primary",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
22,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751212,"Hyperalgesia, Secondary",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
23,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751213,Tactile Allodynia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
24,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751214,"Hyperalgesia, Thermal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
25,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751407,"Pain, Migratory",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
26,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751408,"Suffering, Physical",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0
27,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1704377,Bright Disease,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0
28,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1719672,Severe Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.3,1.0
29,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.27,1.0
30,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.21,1.0
31,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.21,1.0
32,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0001122,Acidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.2,1.0
33,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
34,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
35,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0022354,"Jaundice, Obstructive",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.2,1.0
36,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0029866,Other ureteric obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Anatomical Abnormality,0.2,1.0
37,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0036982,"Shock, Hemorrhagic",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0
38,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0038187,Starvation,C18,   Nutritional and Metabolic Diseases,phenotype,Finding,0.2,1.0
39,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0156149,Gastrointestinal tract vascular insufficiency,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0
40,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0600327,Toxic Shock Syndrome,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.2,1.0
41,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0949658,"Cardiomyopathy, Hypertrophic, Familial",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
42,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C2004435,Vascular insufficiency of intestine,C06;C14,   Digestive System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
43,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
44,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
45,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0
46,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0
47,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
48,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0
49,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0
50,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0
51,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0
52,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0
53,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.09,1.0
54,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.09,1.0
55,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.09,1.0
56,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.08,1.0
57,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.07,1.0
58,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
59,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.07,1.0
60,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0278878,Adult Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
61,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0280474,Childhood Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
62,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.07,1.0
63,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0
64,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.07,1.0
65,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.06,1.0
66,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,1.0
67,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0
68,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.05,1.0
69,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.05,1.0
70,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.05,1.0
71,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.05,1.0
72,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0
73,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.04,1.0
74,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0
75,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0
76,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0
77,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0
78,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.04,1.0
79,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.04,1.0
80,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,0.75
81,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
82,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
83,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
84,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0008497,Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.03,1.0
85,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
86,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0
87,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.03,1.0
88,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
89,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
90,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.03,1.0
91,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
92,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
93,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0032969,Pregnancy in Diabetics,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Disease or Syndrome,0.03,1.0
94,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.03,1.0
95,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0035078,Kidney Failure,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
96,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.03,1.0
97,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0
98,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.03,1.0
99,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.03,1.0
100,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
101,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.03,1.0
102,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.03,1.0
103,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
104,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
105,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
106,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0
107,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0
108,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0700095,Central neuroblastoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.03,1.0
109,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
110,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0
111,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
112,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1519670,Tumor Angiogenesis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.03,1.0
113,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1565489,Renal Insufficiency,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0
114,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0
115,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4086165,Childhood Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0
116,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.03,1.0
117,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
118,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.02,1.0
119,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
120,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
121,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
122,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0
123,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
124,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
125,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
126,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
127,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0
128,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
129,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
130,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011269,"Dementia, Vascular",C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
131,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,1.0
132,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011875,Diabetic Angiopathies,C19;C14,   Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
133,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0013537,Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.02,1.0
134,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0014038,Encephalitis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
135,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0014173,Endometrial Hyperplasia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.02,1.0
136,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0015397,Disorder of eye,C11,   Eye Diseases,group,Disease or Syndrome,0.02,1.0
137,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
138,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
139,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.02,1.0
140,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020473,Hyperlipidemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
141,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
142,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
143,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023470,Myeloid Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
144,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0
145,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
146,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
147,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.02,1.0
148,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0031090,Periodontal Diseases,C07,   Stomatognathic Diseases,group,Disease or Syndrome,0.02,1.0
149,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
150,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0036983,Septic Shock,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Pathologic Function,0.02,1.0
151,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0042029,Urinary tract infection,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0
152,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.02,1.0
153,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0154830,Proliferative diabetic retinopathy,C23;C11;C19;C14,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0
154,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0178664,Glomerulosclerosis (disorder),C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
155,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206667,Adrenal Cortical Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
156,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206686,Adrenocortical carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0
157,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0234985,Mental deterioration,F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
158,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
159,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0264714,Acute heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
160,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.02,1.0
161,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0334579,Anaplastic astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
162,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
163,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.02,1.0
164,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.02,1.0
165,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
166,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0694549,Community acquired pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
167,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.02,1.0
168,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0743323,Acute dyspnea,,,phenotype,Sign or Symptom,0.02,1.0
169,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751295,Memory Loss,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.02,1.0
170,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
171,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1135191,"Heart Failure, Systolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
172,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1292769,Precursor B-cell lymphoblastic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0
173,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0
174,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
175,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.02,1.0
176,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,1.0
177,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C2316810,Chronic kidney disease stage 5,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
178,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.02,1.0
179,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4509226,Heart failure with preserved ejection fraction [HFpEF],,,disease,Disease or Syndrome,0.02,1.0
180,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0002965,"Angina, Unstable",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
181,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003123,Anorexia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
182,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
183,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
184,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
185,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003615,Appendicitis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
186,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0003838,Arterial Occlusive Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
187,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004045,Asphyxia Neonatorum,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0
188,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
189,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
190,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
191,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0005956,Bone Marrow Diseases,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,1.0
192,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
193,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0006840,Candidiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
194,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
195,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
196,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007789,Cerebral Palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
197,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
198,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0008495,Chorioamnionitis,C16;C13,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
199,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
200,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0009777,Conn Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
201,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0009782,Connective Tissue Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
202,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011127,Pressure Ulcer,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
203,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
204,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
205,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0
206,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0011880,Diabetic Ketoacidosis,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
207,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
208,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
209,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0014060,"Encephalitis, St. Louis",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
210,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0014130,Endocrine System Diseases,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
211,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0014170,Endometrial Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.01,1.0
212,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
213,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0
214,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0017185,Gastrointestinal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
215,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0017605,Angle Closure Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
216,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0017921,Glycogen storage disease type II,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
217,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0018081,Gonorrhea,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
218,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0018206,granulosa cell tumor,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
219,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0019212,Hepatorenal Syndrome,C06;C13;C12,   Digestive System Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
220,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0019243,"Angioedemas, Hereditary",C16;C17;C20;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
221,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0019270,Hernia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,1.0
222,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
223,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
224,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
225,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020488,Hypernatremia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.01,1.0
226,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020540,Malignant Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
227,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.01,1.0
228,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020545,"Hypertension, Renovascular",C13;C12;C14,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
229,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0020649,Hypotension,C14,   Cardiovascular Diseases,phenotype,Finding,0.01,1.0
230,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0
231,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0021670,insulinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
232,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
233,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0022118,Transient ischemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
234,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
235,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023186,Learning Disorders,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",group,Mental or Behavioral Dysfunction,0.01,1.0
236,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
237,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
238,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
239,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
240,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023646,Lichen Planus,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
241,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.01,0.0
242,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0
243,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
244,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0024266,Lymphocytic Choriomeningitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
245,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
246,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
247,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
248,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
249,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0026837,Muscle Rigidity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
250,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0
251,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0027947,Neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
252,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0028945,oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
253,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
254,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0029925,Ovarian Carcinoma,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
255,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
256,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0
257,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
258,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0033687,Proteinuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.01,1.0
259,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
260,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0034186,Pyelonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
261,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
262,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0035319,"Retinal Necrosis Syndrome, Acute",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
263,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0036429,Sclerosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
264,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0037284,Skin lesion,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0
265,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0037286,Skin Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
266,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0037928,Spinal Cord Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
267,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
268,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0039070,Syncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,0.0
269,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0040028,"Thrombocythemia, Essential",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0
270,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0041956,Ureteral obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0
271,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0042164,Uveitis,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
272,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
273,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0
274,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0085096,Peripheral Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
275,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0085669,Acute leukemia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
276,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0085693,Acute appendicitis NOS (disorder),C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
277,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0086942,Rous Sarcoma,C04;C01;C22,   Neoplasms;    Infections;    Animal Diseases,disease,Neoplastic Process; Experimental Model of Disease,0.01,1.0
278,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0149520,Acute Cholecystitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
279,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
280,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0149678,Epstein-Barr Virus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0
281,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
282,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0149746,Orthostasis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
283,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
284,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0150055,Chronic pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
285,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0151650,Renal fibrosis,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
286,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
287,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0152164,Cyclical vomiting syndrome (disorder),C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
288,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0152451,Chronic glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
289,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0153014,Non-arthropod borne lymphocytic choriomeningitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
290,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0
291,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0153690,Secondary malignant neoplasm of bone,C23;C04;C05,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Musculoskeletal Diseases",disease,Neoplastic Process,0.01,1.0
292,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0154743,Ulnar Neuropathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
293,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0154841,Central retinal vein occlusion,C11;C10;C14,   Eye Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
294,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0155094,Corneal pannus,C23;C11,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0
295,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0158369,Swelling of limb,,,phenotype,Sign or Symptom,0.01,1.0
296,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0162739,HELLP Syndrome,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
297,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0162836,Hidradenitis Suppurativa,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0
298,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
299,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
300,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206664,Teratocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
301,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206695,"Carcinoma, Neuroendocrine",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
302,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206708,Cervical Intraepithelial Neoplasia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
303,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206724,Sex Cord-Stromal Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
304,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0206728,Plexiform Neurofibroma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,0.0
305,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
306,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0221002,"Hyperparathyroidism, Primary",C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
307,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0233514,Abnormal behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0
308,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0234252,Mechanical pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
309,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0236788,Bipolar II disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
310,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0238577,Abdominal wall defect,,,group,Congenital Abnormality,0.01,1.0
311,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0242852,Proliferative vitreoretinopathy,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
312,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0242966,Systemic Inflammatory Response Syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
313,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0243038,"Carcinoma, Lewis Lung",C04,   Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.01,1.0
314,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0262655,Recurrent urinary tract infection,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
315,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0264716,Chronic heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
316,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0265110,Cerebral Vasospasm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
317,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0265116,Chronic cerebral ischemia,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
318,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0265191,Chronic acquired lymphedema,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
319,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0276289,Zika Virus Infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
320,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
321,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0278601,Inflammatory Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
322,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
323,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0280483,Adult Anaplastic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
324,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0280781,Adult Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
325,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0281361,Adenocarcinoma of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
326,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
327,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0333519,Caries (morphologic abnormality),C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0
328,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0334583,Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
329,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0338078,Non-Functioning Pituitary Gland Neoplasm,C04;C10;C19,   Neoplasms;    Nervous System Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
330,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0338106,Adenocarcinoma of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
331,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0340288,Stable angina,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
332,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0342257,Complications of Diabetes Mellitus,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0
333,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0343084,Capillary Leak Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
334,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0376154,Skin callus,C17,   Skin and Connective Tissue Diseases,disease,Acquired Abnormality,0.01,1.0
335,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0376618,Endotoxemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Disease or Syndrome,0.01,1.0
336,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0392788,Nasal Type Extranodal NK/T-Cell Lymphoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
337,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,0.0
338,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0431109,Choroid Plexus Carcinoma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
339,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
340,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0
341,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0524910,"Hepatitis C, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0
342,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0553718,Renal artery occlusion,,,disease,Disease or Syndrome,0.01,1.0
343,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0596240,Cancer Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
344,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0598935,Tumor Initiation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
345,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
346,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0694575,Macular fibrosis,,,disease,Disease or Syndrome,0.01,1.0
347,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0700200,Presyncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
348,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
349,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0730285,Diabetic macular edema,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
350,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0730328,Central Serous Chorioretinopathy,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
351,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0740577,Acute abdominal pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
352,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751072,Frontotemporal Lobar Degeneration,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
353,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751396,Well Differentiated Oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
354,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751606,Adult Acute Lymphocytic Leukemia,,,disease,Neoplastic Process,0.01,1.0
355,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751690,Malignant Peripheral Nerve Sheath Tumor,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
356,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751781,Dentatorubral-Pallidoluysian Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
357,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0751887,Medullary Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0
358,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0752304,Hypoxic-Ischemic Encephalopathy,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
359,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
360,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0852036,Pregnancy associated hypertension,C13;C14,   Female Urogenital Diseases and Pregnancy Complications;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0
361,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0853662,Oestrogen deficiency,,,disease,Disease or Syndrome,0.01,1.0
362,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0853879,Invasive carcinoma of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
363,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0860603,Anxiety symptoms,,,phenotype,Sign or Symptom,0.01,1.0
364,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0865800,asthma with copd,,,disease,Disease or Syndrome,0.01,1.0
365,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
366,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0948268,Hemodynamic instability,,,disease,Disease or Syndrome,0.01,1.0
367,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1112157,Intrauterine infection,,,disease,Disease or Syndrome,0.01,1.0
368,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1145670,Respiratory Failure,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
369,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1153706,Endometrial adenocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
370,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1261287,Stenosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
371,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
372,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
373,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1301034,Pancreatic intraepithelial neoplasia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
374,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1301700,Cardiovascular morbidity,,,phenotype,Disease or Syndrome,0.01,1.0
375,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1332206,Adult Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
376,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1332979,Childhood Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
377,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1332995,Childhood Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
378,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0
379,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1397307,Cardiac fibrosis,,,disease,Disease or Syndrome,0.01,1.0
380,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1401086,Peripheral Vascular Insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
381,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1443924,Severe diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
382,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1510885,Angiogenic Switch,,,disease,Neoplastic Process,0.01,1.0
383,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1527390,"Neoplasms, Intracranial",C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0
384,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.01,1.0
385,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1609524,ADHF,,,disease,Disease or Syndrome,0.01,1.0
386,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1658953,tumor vasculature,,,phenotype,Neoplastic Process,0.01,1.0
387,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1696708,Prehypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
388,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
389,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1836438,Familial neurocardiogenic syncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
390,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1837218,"Cleft palate, isolated",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0
391,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1845050,"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS",C23;C16;C18;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
392,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1853926,NONAKA MYOPATHY,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
393,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1855179,"CATARACT, ANTERIOR POLAR",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
394,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1960636,Dysglycemia,,,disease,Disease or Syndrome,0.01,1.0
395,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C1969372,Tubulointerstitial fibrosis,,,phenotype,Disease or Syndrome,0.01,1.0
396,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C2118460,Acute colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
397,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C2712360,Severe hypoxic ischemic encephalopathy,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
398,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C3161650,Primary immunoglobulin A nephropathy (disorder),C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
399,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C3714514,Infection,C01,   Infections,group,Pathologic Function,0.01,1.0
400,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C3811918,GRN-related frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
401,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0
402,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4551504,Oculocutaneous albinism type 1A,C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0
403,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4551548,Grade III Childhood Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
404,133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C4721918,Fibrothecoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
0,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0
1,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
2,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0007370,Catalepsy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.3,1.0
3,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
4,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0013182,Drug Allergy,C20;C25,   Immune System Diseases;    Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
5,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0013221,Drug toxicity,C25,   Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0
6,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0020649,Hypotension,C14,   Cardiovascular Diseases,phenotype,Finding,0.3,1.0
7,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
8,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0
9,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0027746,Nerve Degeneration,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0
10,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0033054,Prenatal Exposure Delayed Effects,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Injury or Poisoning,0.3,1.0
11,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0
12,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0038587,Substance Withdrawal Syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
13,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0041755,Adverse reaction to drug,C25,   Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
14,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0086189,Drug Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
15,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0087169,Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
16,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0233612,Waxy flexibility,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
17,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0238281,Middle Cerebral Artery Syndrome,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
18,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0242973,Ventricular Dysfunction,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
19,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0270192,Perinatal Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0
20,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0428977,Bradycardia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0
21,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0472381,Posterior Circulation Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
22,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0472383,"Subarachnoid Hemorrhage, Spontaneous",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0
23,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0740376,Middle Cerebral Artery Thrombosis,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0
24,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.3,1.0
25,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0740392,"Infarction, Middle Cerebral Artery",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0
26,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751019,Carotid Circulation Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
27,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751020,"Transient Ischemic Attack, Vertebrobasilar Circulation",C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
28,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751021,Crescendo Transient Ischemic Attacks,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
29,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751022,"Brain Stem Ischemia, Transient",C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
30,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751530,"Subarachnoid Hemorrhage, Aneurysmal",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0
31,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751845,Middle Cerebral Artery Embolus,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
32,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751846,Left Middle Cerebral Artery Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
33,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751847,"Embolic Infarction, Middle Cerebral Artery",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
34,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751848,"Thrombotic Infarction, Middle Cerebral Artery",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
35,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751849,Right Middle Cerebral Artery Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0
36,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0795688,"Subarachnoid Hemorrhage, Intracranial",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0
37,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0917805,Transient Cerebral Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
38,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C1527335,"Transient Ischemic Attack, Anterior Circulation",C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0
39,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0520679,"Sleep Apnea, Obstructive",C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.21,1.0
40,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
41,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
42,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0
43,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.2,1.0
44,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0
45,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0
46,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.2,1.0
47,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.2,1.0
48,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0042510,Ventricular Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0
49,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0242698,"Ventricular Dysfunction, Left",C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.2,1.0
50,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C1531647,Cerebral ventriculomegaly,C10,   Nervous System Diseases,phenotype,Finding,0.2,1.0
51,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C3278923,Dilated ventricles (finding),,,phenotype,Finding,0.2,1.0
52,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.13,1.0
53,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0035242,Respiratory Tract Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0
54,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0
55,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0
56,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0
57,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.04,1.0
58,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0
59,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.03,1.0
60,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
61,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
62,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0
63,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.02,1.0
64,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.02,1.0
65,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0563625,Agnosia for Pain,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.02,1.0
66,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
67,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0001883,Airway Obstruction,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
68,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
69,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,0.0
70,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,0.0
71,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0003504,Aortic Valve Insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
72,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
73,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
74,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
75,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
76,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
77,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
78,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
79,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,0.0
80,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
81,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0
82,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
83,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
84,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
85,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
86,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
87,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
88,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
89,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0
90,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
91,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
92,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
93,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0236642,Pick Disease of the Brain,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0
94,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
95,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0264716,Chronic heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
96,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
97,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
98,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0392156,Akathisia,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
99,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0393484,Rasmussen Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
100,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0442874,Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
101,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0521652,Caffeine withdrawal,,,disease,Mental or Behavioral Dysfunction,0.01,1.0
102,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
103,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
104,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0751781,Dentatorubral-Pallidoluysian Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
105,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0851578,Sleep Disorders,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",group,Mental or Behavioral Dysfunction,0.01,1.0
106,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0
107,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C1301797,Induced hypothermia (finding),C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
108,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C1839839,MAJOR AFFECTIVE DISORDER 2,C16;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,0.0
109,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C1852197,MAJOR AFFECTIVE DISORDER 1,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
110,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C1970943,MAJOR AFFECTIVE DISORDER 4,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
111,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C1970945,MAJOR AFFECTIVE DISORDER 6,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
112,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C2700438,MAJOR AFFECTIVE DISORDER 7,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
113,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C2700439,MAJOR AFFECTIVE DISORDER 8,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
114,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C2700440,MAJOR AFFECTIVE DISORDER 9,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0
115,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C2921125,Post traumatic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
116,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C2930868,Rasmussen subacute encephalitis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
117,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C2939419,Secondary Neoplasm,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",group,Neoplastic Process,0.01,1.0
118,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C4509226,Heart failure with preserved ejection fraction [HFpEF],,,disease,Disease or Syndrome,0.01,0.0
119,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C4551689,Sleep-Disordered Breathing,C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
120,134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C4722085,Malignant neoplasm of colon and/or rectum,,,disease,Neoplastic Process,0.01,1.0
0,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.5,1.0
1,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.39,0.909
2,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0030319,Panic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.875
3,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.75
4,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0
5,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.32,1.0
6,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0917801,Sleeplessness,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.32,1.0
7,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C4707658,Acute encephalopathy with biphasic seizures and late reduced diffusion,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.32,1.0
8,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.31,1.0
9,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0086769,Panic Attacks,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0
10,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0
11,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011573,Endogenous depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
12,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0013182,Drug Allergy,C20;C25,   Immune System Diseases;    Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
13,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0013221,Drug toxicity,C25,   Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0
14,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0020649,Hypotension,C14,   Cardiovascular Diseases,phenotype,Finding,0.3,1.0
15,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0021603,Sleep Initiation and Maintenance Disorders,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
16,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0022333,Jacksonian Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
17,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
18,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0025193,Melancholia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
19,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0
20,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0033139,Primary Insomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
21,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0033141,"Cardiomyopathies, Primary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
22,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0033937,"Psychoses, Drug",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
23,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0033941,"Psychoses, Substance-Induced",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
24,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0034189,Pyemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Pathologic Function,0.3,1.0
25,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0036529,"Myocardial Diseases, Secondary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
26,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.3,1.0
27,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0038587,Substance Withdrawal Syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
28,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
29,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0040827,Saturnine Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
30,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
31,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0041755,Adverse reaction to drug,C25,   Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0
32,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0086133,Depressive Syndrome,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
33,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0086189,Drug Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
34,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0087169,Withdrawal Symptoms,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
35,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0149840,Senile Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
36,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0149958,Complex partial seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
37,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234370,Persistent Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
38,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234371,Continuous Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
39,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234372,Intermittent Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
40,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234373,Fine Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
41,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234374,Coarse Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
42,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234375,Massive Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
43,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234376,Action Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
44,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234377,Passive Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
45,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234378,Static Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
46,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234379,Resting Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
47,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234381,Darkness Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
48,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234533,Generalized seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
49,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0234535,Clonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
50,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0235078,"Tremor, Perioral",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
51,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0235081,"Tremor, Limb",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
52,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0235082,"Tremor, Muscle",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
53,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0235083,Nerve Tremors,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
54,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0235843,"Tremor, Neonatal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
55,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0
56,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0236804,Amphetamine Addiction,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
57,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0236807,Amphetamine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
58,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0242973,Ventricular Dysfunction,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0
59,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.3,1.0
60,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0266487,Etat Marbre,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0
61,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0270541,Rebound Insomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
62,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
63,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0270844,Tonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
64,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0270846,Epileptic drop attack,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
65,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0282126,"Depression, Neurotic",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
66,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0349255,Nonorganic Insomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
67,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0376280,"Anxiety States, Neurotic",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
68,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0393759,Transient Insomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
69,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0422850,"Seizures, Somatosensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
70,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0422852,"Seizures, Auditory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.3,1.0
71,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0422853,Olfactory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
72,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0422854,Gustatory seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
73,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0422855,Vertiginous seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
74,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
75,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0541798,Early Awakening,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.3,1.0
76,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751056,Non-epileptic convulsion,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
77,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751110,Single Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0
78,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751123,Atonic Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
79,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751217,"Hyperkinesia, Generalized",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
80,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751249,Chronic Insomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
81,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751250,Psychophysiological Insomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
82,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751251,Secondary Insomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.3,1.0
83,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751252,Sleep Initiation Dysfunction,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0
84,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751494,Convulsive Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
85,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751495,"Seizures, Focal",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
86,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751496,"Seizures, Sensory",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
87,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751564,Pill Rolling Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
88,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0751565,"Tremor, Semirhythmic",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0
89,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0
90,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1262477,Weight decreased,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0
91,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1279420,Anxiety neurosis (finding),F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0
92,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1527384,Involuntary Quiver,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
93,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1719672,Severe Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.3,1.0
94,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C3495874,Nonepileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
95,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C3887506,Hyperkinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
96,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C4048158,Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
97,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C4316903,Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
98,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C4317109,Epileptic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
99,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C4317123,Myoclonic Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0
100,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C4505436,Generalized Absence Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0
101,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.21,1.0
102,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0
103,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.2,1.0
104,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0152171,Idiopathic pulmonary hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0
105,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0
106,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.1,1.0
107,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.07,0.857
108,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.04,1.0
109,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0
110,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.04,1.0
111,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0
112,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0013384,Dyskinetic syndrome,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0
113,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.03,1.0
114,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0001818,Agoraphobia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,0.5
115,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0
116,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0
117,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
118,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.02,1.0
119,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
120,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0
121,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
122,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0
123,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0039070,Syncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.02,1.0
124,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,0.5
125,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.02,1.0
126,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0235989,Renal interstitial fibrosis,C13;C17;C12,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0
127,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0686347,Tardive Dyskinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0
128,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
129,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
130,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0
131,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1969372,Tubulointerstitial fibrosis,,,phenotype,Disease or Syndrome,0.02,1.0
132,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C3714760,Drug-induced tardive dyskinesia,C23;C10;C25,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.02,1.0
133,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0
134,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
135,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
136,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
137,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
138,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0007682,CNS disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
139,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
140,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011269,"Dementia, Vascular",C10;F03;C14,   Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
141,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
142,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0014038,Encephalitis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
143,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
144,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
145,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0016059,Fibrosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
146,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
147,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,0.0
148,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
149,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
150,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0022104,Irritable Bowel Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
151,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0
152,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0023374,Lesch-Nyhan Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
153,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
154,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
155,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0024535,"Malaria, Falciparum",C01,   Infections,disease,Disease or Syndrome,0.01,1.0
156,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
157,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0026267,Mitral Valve Prolapse Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
158,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
159,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
160,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
161,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0
162,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,0.0
163,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
164,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0
165,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0039103,Synovitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
166,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
167,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0041956,Ureteral obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0
168,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0042420,Vasovagal syncope,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
169,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0085584,Encephalopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
170,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0149939,Obstructive nephropathy,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0
171,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
172,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
173,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0154723,Migraine with Aura,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
174,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0155877,Allergic asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
175,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0
176,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
177,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0264716,Chronic heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
178,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0270612,Leukoencephalopathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
179,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0
180,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0279068,Childhood Solid Neoplasm,,,phenotype,Neoplastic Process,0.01,1.0
181,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0280099,Adult Solid Neoplasm,,,group,Neoplastic Process,0.01,1.0
182,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0
183,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
184,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0349217,"Depressive episode, unspecified",F03;F01,   Mental Disorders;    Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0
185,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0349231,Phobic anxiety disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
186,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0376545,Hematologic Neoplasms,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0
187,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0376618,Endotoxemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Disease or Syndrome,0.01,1.0
188,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0392156,Akathisia,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
189,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0393484,Rasmussen Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0
190,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0426980,Motor symptoms,,,phenotype,Sign or Symptom,0.01,1.0
191,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0456909,Blindness,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0
192,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0524528,Pervasive Development Disorder,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0
193,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
194,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0574785,Lower Urinary Tract Symptoms,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0
195,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0683381,inflammatory joint disease,,,disease,Disease or Syndrome,0.01,1.0
196,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0
197,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
198,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
199,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0860602,Anxious personality,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
200,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0949664,Tauopathies,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0
201,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1112433,Thromboembolic stroke,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
202,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
203,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1333001,Childhood Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
204,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
205,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
206,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1533217,Methamphetamine dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0
207,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0
208,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C2747816,Complicated malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
209,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C2930868,Rasmussen subacute encephalitis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
210,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C3241937,Nonalcoholic Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
211,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C3543005,Surgical incision wound (morphologic abnormality),C26,   Wounds and Injuries,disease,Acquired Abnormality,0.01,1.0
212,135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
0,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0
1,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0034189,Pyemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Pathologic Function,0.3,1.0
2,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.3,1.0
3,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.3,1.0
4,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.3,1.0
5,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C1719672,Severe Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.3,1.0
6,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0
7,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.05,1.0
8,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.03,1.0
9,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0
10,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.03,1.0
11,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0
12,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.02,1.0
13,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0
14,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0
15,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.02,1.0
16,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0
17,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
18,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
19,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C2350344,Chronic Lung Injury,C08;C26,   Respiratory Tract Diseases;    Wounds and Injuries,disease,Disease or Syndrome,0.02,1.0
20,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0
21,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
22,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
23,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0
24,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
25,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
26,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
27,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
28,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
29,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
30,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0013537,Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0
31,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
32,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0
33,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0022104,Irritable Bowel Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
34,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0
35,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
36,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0
37,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
38,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0
39,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0030848,Peyronie Disease,C17;C12,   Skin and Connective Tissue Diseases;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0
40,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.01,1.0
41,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0
42,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
43,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0152171,Idiopathic pulmonary hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
44,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0
45,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
46,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0
47,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0264716,Chronic heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
48,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0278488,Carcinoma breast stage IV,,,disease,Neoplastic Process,0.01,1.0
49,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0279000,Liver and Intrahepatic Biliary Tract Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
50,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0279680,Transitional cell carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0
51,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
52,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
53,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
54,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
55,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0746102,Chronic lung disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
56,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
57,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
58,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0
59,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0
60,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
61,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0
62,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C2747816,Complicated malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0
63,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
64,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C4049343,Combined pulmonary fibrosis and emphysema,,,disease,Disease or Syndrome,0.01,1.0
65,136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C4722518,Triple-Negative Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0
0,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,
1,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0
2,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0
3,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0
4,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0
5,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.02,1.0
6,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.02,1.0
7,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0
8,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0
9,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
10,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
11,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
12,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0
13,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
14,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
15,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0
16,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0
17,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
18,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0021053,Immune System Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0
19,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0
20,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
21,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0
22,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
23,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
24,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0
25,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
26,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0392156,Akathisia,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.01,1.0
27,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0585442,Osteosarcoma of bone,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
28,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
29,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0686347,Tardive Dyskinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0
30,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C1306459,Primary malignant neoplasm,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0
31,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C1306460,Primary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0
32,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C1332986,Childhood Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0
33,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0
34,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C3714636,Pneumonitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0
35,140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C3714760,Drug-induced tardive dyskinesia,C23;C10;C25,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.01,1.0
